Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADIPOQ,Adiponectin,38013,-0.248191406451349,0.00596882304326799,-0.259890299616154,-0.236492513286544,0
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AGRP,Agouti-related protein,40516,0.272600103520372,0.00460059242168637,0.263582942373866,0.281617264666877,0
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCN1,CCN family member 1,40280,0.373736019984064,0.00679008841912383,0.360427446682581,0.387044593285547,0
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CES1,Liver carboxylesterase 1,40352,0.28545681011023,0.00688066255682631,0.27197071149885,0.298942908721609,0
NMR metabolomics,X23495.Concentration of Large VLDL Particles,F7,Coagulation factor VII,40376,0.113792638087745,0.00269925225944807,0.108502103659227,0.119083172516263,0
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FURIN,Furin,40411,0.129347222633118,0.0030333985352502,0.123401761504028,0.135292683762209,0
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GCG,Pro-glucagon,39980,0.45964208803569,0.0112702031392758,0.437552489882709,0.48173168618867,0
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GHR,Growth hormone receptor,37671,0.103664753753432,0.00260058203074054,0.0985676129731809,0.108761894533684,0
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HHEX,Hematopoietically-expressed homeobox protein HHEX,37942,0.294952623208161,0.00672458369397527,0.28177243916797,0.308132807248353,0
NMR metabolomics,X23495.Concentration of Large VLDL Particles,INHBC,Inhibin beta C chain,40332,0.152618291675004,0.00386722719355056,0.145038526375645,0.160198056974363,0
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LCAT,Phosphatidylcholine-sterol acyltransferase,37987,0.085286526669264,0.00198844454545386,0.0813891753601744,0.0891838779783535,0
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LDLR,Low-density lipoprotein receptor,40356,0.428019622852484,0.00364510973966817,0.420875207762734,0.435164037942233,0
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LPL,Lipoprotein lipase,40359,-0.185509152828094,0.00410470650187761,-0.193554377571774,-0.177463928084413,0
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MFGE8,Lactadherin,40332,0.216201601541676,0.00362924952630117,0.209088272470126,0.223314930613226,0
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NPY,Pro-neuropeptide Y,40489,0.353139507850557,0.00569389811674344,0.34197946754174,0.364299548159374,0
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PLA2G7,Platelet-activating factor acetylhydrolase,40332,0.131935056920517,0.00279935554158242,0.126448320059015,0.137421793782019,0
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RARRES2,Retinoic acid receptor responder protein 2,40424,0.178842120556778,0.00414721834850643,0.170713572593705,0.18697066851985,0
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SMOC1,SPARC-related modular calcium-binding protein 1,40489,0.130064278634656,0.002963978412761,0.124254880945645,0.135873676323668,0
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,40403,0.152870973079449,0.00381403665996645,0.145395461225914,0.160346484932983,0
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRAP1,Proline-rich acidic protein 1,37998,0.151177689028778,0.00382414845066674,0.143682358065471,0.158673019992085,1.1125369292536e-308
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCL27,C-C motif chemokine 27,40359,0.207713135963068,0.00540875159380218,0.197111982839216,0.21831428908692,1.70658076350353e-308
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PROC,Vitamin K-dependent protein C,40372,0.0874185080484655,0.00229678098376575,0.0829168173202846,0.0919201987766464,1.84599119600239e-303
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCL23,C-C motif chemokine 23,40422,0.141474590097488,0.00373200798115554,0.134159854454423,0.148789325740553,3.47458089552579e-301
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IGSF9,Protein turtle homolog A,37990,0.27336556138938,0.00721564638262759,0.25922289447943,0.28750822829933,1.30856911267176e-298
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PTH,Parathyroid hormone,37572,0.267123648711661,0.00714735714468611,0.253114828708077,0.281132468715246,1.33120842020499e-290
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NRP1,Neuropilin-1,40424,-0.0935774342712129,0.00257326869114244,-0.0986210409058521,-0.0885338276365737,2.92863921348723e-278
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DSG2,Desmoglein-2,40332,-0.0893437031874943,0.00246389285141363,-0.094172933176265,-0.0845144731987236,1.10731647423242e-276
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD4,T-cell surface glycoprotein CD4,40309,0.100860692322008,0.0027887177040543,0.0953948056220614,0.106326579021954,2.64933720142144e-275
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SLC39A5,Zinc transporter ZIP5,40341,0.176103752105565,0.00489362086231317,0.166512255215431,0.185695248995699,1.0600865983781e-272
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CPM,Carboxypeptidase M,40415,0.112232807193826,0.00313490679075462,0.106088389883947,0.118377224503705,4.50369184915454e-270
NMR metabolomics,X23495.Concentration of Large VLDL Particles,APCS,Serum amyloid P-component,37882,0.117052529209048,0.00327115353839823,0.110641068273787,0.123463990144308,6.18709192407847e-268
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SMAD1,Mothers against decapentaplegic homolog 1,39980,0.260583218861959,0.00735594631263948,0.246165564089186,0.275000873634732,2.08333650751548e-264
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GPR37,Prosaposin receptor GPR37,40042,0.217040000415881,0.00614676684116016,0.204992337407207,0.229087663424555,8.29531273040405e-263
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DNAJB1,DnaJ homolog subfamily B member 1,40305,0.283212165103047,0.00803305682858423,0.267467373719022,0.298956956487072,3.31962319804813e-262
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TMPRSS15,Enteropeptidase,40305,0.29241969451425,0.00843322281704223,0.275890577792847,0.308948811235653,5.25145333731349e-254
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TFPI,Tissue factor pathway inhibitor,40309,0.0987185211611494,0.00285403499416184,0.0931246125725921,0.104312429749707,8.24542960700867e-253
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TTR,Transthyretin,37871,0.0803999777465644,0.00233516377028525,0.0758230567568053,0.0849768987363235,5.14270774240036e-249
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,40330,0.323438388229021,0.00945576005397486,0.30490509852323,0.341971677934811,1.74961850396169e-247
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDKN1A,Cyclin-dependent kinase inhibitor 1,40305,0.32871689737971,0.00961256402542841,0.30987627188987,0.34755752286955,2.39257679796733e-247
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VPS37A,Vacuolar protein sorting-associated protein 37A,40305,0.247226392384192,0.00725522534844809,0.233006150701233,0.26144663406715,1.12383642936473e-245
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PLA2G10,Group 10 secretory phospholipase A2,40228,-0.183262970384812,0.00550622865734985,-0.194055178553218,-0.172470762216406,8.30262426992182e-235
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PLTP,Phospholipid transfer protein,40461,-0.104376255961879,0.00314732082671822,-0.110545004782247,-0.0982075071415118,2.62268245722312e-233
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD300LG,CMRF35-like molecule 9,40332,-0.115039814006811,0.00346893848080984,-0.121838933429199,-0.108240694584424,3.08467243755729e-233
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VMO1,Vitelline membrane outer layer protein 1 homolog,40305,0.205425321064282,0.00620440269200846,0.193264691787946,0.217585950340619,1.65611816408973e-232
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CXCL6,C-X-C motif chemokine 6,40516,0.236198327298275,0.00714925275969784,0.222185791889267,0.250210862707283,1.20597147269249e-231
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DEFB4A_DEFB4B,Beta-defensin 4A,40141,0.449074754737381,0.0136063443244595,0.42240631986144,0.475743189613321,5.0785870565933e-231
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ASGR1,Asialoglycoprotein receptor 1,40228,0.0889855099564158,0.00269885891191086,0.0836957464890705,0.0942752734237611,1.29009852653582e-230
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,40489,0.104875879430754,0.00319524174145156,0.0986132056175091,0.111138553243999,9.66989948774509e-229
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PAMR1,Inactive serine protease PAMR1,40332,0.0831687484016006,0.00257457778970523,0.0781225759337783,0.0882149208694228,8.6937767173004e-222
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CFI,Complement factor I,38013,0.0597083035518533,0.00184649304727096,0.0560891771792022,0.0633274299245044,4.8125771028696e-221
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CNTN3,Contactin-3,40332,0.102993740855181,0.00322504917670321,0.0966726444688429,0.109314837241519,5.85868697513512e-217
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SERPIND1,Heparin cofactor 2,37981,0.080486245138458,0.00251499085232756,0.075556863067896,0.08541562720902,1.07895799796013e-216
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CFH,Complement factor H,37301,0.0678489722954946,0.00212067577209971,0.0636924477821792,0.07200549680881,3.5255838084853e-216
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,40042,0.246802021252137,0.00775373343070319,0.231604703727959,0.261999338776316,1.82810886127827e-215
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CFP,Properdin,38013,0.0638675149044324,0.00201192350262775,0.0599241448392821,0.0678108849695828,2.19734473989192e-213
NMR metabolomics,X23495.Concentration of Large VLDL Particles,F9,Coagulation factor IX,40372,0.0523616323176539,0.00165682090699359,0.0491142633399464,0.0556090012953613,1.15251336800226e-212
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CRIP2,Cysteine-rich protein 2,40228,0.105227196775422,0.00333392079179104,0.0986927120235112,0.111761681527332,4.46154077042446e-212
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,40042,0.158118969086766,0.00502389886846939,0.148272127304566,0.167965810868966,7.48459441998677e-211
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GUSB,Beta-glucuronidase,40419,0.169506061415476,0.00539435050129928,0.158933134432929,0.180078988398023,2.37088421662522e-210
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SERPINA5,Plasma serine protease inhibitor,37835,0.095222399724822,0.00302914952743771,0.0892852666510441,0.1011595327986,2.46152371270577e-209
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SERPINF1,Pigment epithelium-derived factor,37790,0.0745108851168666,0.0023856223548325,0.0698350653013949,0.0791867049323383,9.53125914409086e-207
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,40471,0.149566083321507,0.00482015798861447,0.140118573663823,0.159013592979192,2.46352179109349e-205
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRCP,Lysosomal Pro-X carboxypeptidase,40443,0.0879360897289436,0.00284958195144063,0.0823509091041199,0.0935212703537672,3.62651241142564e-203
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AGR3,Anterior gradient protein 3,39963,0.168653486615746,0.00549900790630829,0.157875431119382,0.17943154211211,1.33267560529806e-200
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ERBB3,Receptor tyrosine-protein kinase erbB-3,40311,0.0532741202815995,0.00175283749869713,0.0498385587841531,0.0567096817790458,2.93795526572681e-197
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MXRA8,Matrix remodeling-associated protein 8,37671,-0.085736309169162,0.00281377775710668,-0.0912513135730911,-0.0802213047652329,3.89804878997867e-197
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GSTA1,Glutathione S-transferase A1,40333,0.231724984388181,0.00764305302166898,0.216744600465709,0.246705368310652,2.46746436577769e-196
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BCHE,Cholinesterase,37748,0.0784655413485654,0.00260998674462298,0.0733499673291043,0.0835811153680264,3.62145109497532e-192
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PSRC1,Proline/serine-rich coiled-coil protein 1,39980,0.161951519157644,0.00542184053814611,0.151324711702877,0.17257832661241,1.13494281217286e-190
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IGFBP1,Insulin-like growth factor-binding protein 1,40500,-0.323969792689269,0.0108564067000123,-0.345248349821293,-0.302691235557245,1.74570893960221e-190
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SERPINA4,Kallistatin,37781,0.0659505504343501,0.00221317787290344,0.0616127218034594,0.0702883790652409,5.88316773257953e-189
NMR metabolomics,X23495.Concentration of Large VLDL Particles,P4HB,Protein disulfide-isomerase,40266,0.106019314988311,0.00357855994692091,0.0990053374923465,0.113033292484276,8.90107661940476e-188
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GSTA3,Glutathione S-transferase A3,39980,0.20719760717323,0.00700502543745236,0.193467757315824,0.220927457030637,4.19684982221274e-187
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RBP5,Retinol-binding protein 5,40305,0.15125204408877,0.00511889860572899,0.141219002821541,0.161285085355999,7.83522241147134e-187
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NOS3,"Nitric oxide synthase, endothelial",39961,0.149615059634319,0.00506514804387412,0.139687369468326,0.159542749800312,1.31555657873409e-186
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PLAT,Tissue-type plasminogen activator,40490,0.133936017726786,0.00453926135446817,0.125039065472028,0.142832969981544,2.21267842581606e-186
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SNCA,Alpha-synuclein,37671,0.309307130465382,0.0105289130845235,0.288670460819716,0.329943800111048,8.15756517006099e-184
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL1RN,Interleukin-1 receptor antagonist protein,40313,0.149288676464468,0.00510469590404004,0.13928347249255,0.159293880436387,3.60686669830341e-183
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AMBP,Protein AMBP,40470,0.0541068340441327,0.00185555594783691,0.0504699443863724,0.0577437237018931,3.53158848662145e-182
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LAMP2,Lysosome-associated membrane glycoprotein 2,39887,0.0498984554116957,0.00171362492249828,0.0465397505635991,0.0532571602597923,1.62097803902615e-181
NMR metabolomics,X23495.Concentration of Large VLDL Particles,UPB1,Beta-ureidopropionase,37990,0.24641127107544,0.00844788205969213,0.229853422238444,0.262969119912437,1.88225314614189e-181
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,40228,0.199403359788083,0.00685593494768624,0.185965727290618,0.212840992285548,3.26967247326381e-181
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NOTCH3,Neurogenic locus notch homolog protein 3,40536,-0.0932281301926002,0.00320678274547501,-0.0995134243737312,-0.0869428360114692,3.78240700653781e-181
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CHMP6,Charged multivesicular body protein 6,37990,0.15015163100698,0.00515618645395931,0.14004550555722,0.16025775645674,6.97985287562226e-181
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IGSF8,Immunoglobulin superfamily member 8,40359,0.0803994217262218,0.00276817671077275,0.0749737953731072,0.0858250480793364,9.20005928736981e-181
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IGFBP2,Insulin-like growth factor-binding protein 2,40497,-0.170791755868752,0.00588863796966635,-0.182333486289298,-0.159250025448206,2.57719989024095e-180
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FLI1,Friend leukemia integration 1 transcription factor,39980,0.292046772671047,0.0100715233498944,0.272306586905254,0.31178695843684,4.32486840922644e-180
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ACY1,Aminoacylase-1,40359,0.157716310853321,0.00551394036405552,0.146908987739773,0.16852363396687,1.64552302343898e-175
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AFM,Afamin,38013,0.0494445285351099,0.0017267536938737,0.0460600912951175,0.0528289657751024,3.86453363726329e-175
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ERP44,Endoplasmic reticulum resident protein 44,40280,0.0673640299639396,0.00237527879350451,0.0627084835286708,0.0720195763992084,1.25073004316913e-172
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GLA,Alpha-galactosidase A,37642,0.0952824033624412,0.0033531460458492,0.0887102371125768,0.101854569612306,1.90839447371543e-172
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LATS1,Serine/threonine-protein kinase LATS1,37598,0.220921018508821,0.00781517939850927,0.205603266887743,0.236238770129899,1.02777377314365e-170
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SKAP1,Src kinase-associated phosphoprotein 1,40192,0.191953718456071,0.00680838460221639,0.178609284635727,0.205298152276415,1.17934753289313e-170
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,40160,0.120384422314226,0.00426980682755711,0.112015600932214,0.128753243696238,1.18219803919699e-170
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FGFR2,Fibroblast growth factor receptor 2,40411,0.0559292844899817,0.00198463218455873,0.0520394054082466,0.0598191635717168,1.45175644736914e-170
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PON3,Serum paraoxonase/lactonase 3,40422,-0.0715348372027509,0.00254312253670151,-0.0765193573746859,-0.066550317030816,5.89928123678851e-170
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EPHA1,Ephrin type-A receptor 1,40400,0.0891146579777309,0.00316875136569259,0.0829039053009734,0.0953254106544884,6.97790232854055e-170
NMR metabolomics,X23495.Concentration of Large VLDL Particles,F10,Coagulation factor X,37987,0.0677342743615431,0.00240511269900545,0.0630202534714924,0.0724482952515938,1.24358964314563e-169
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FGF21,Fibroblast growth factor 21,40453,0.304224395684256,0.0108753878186787,0.282908635559646,0.325540155808866,3.68183727856034e-168
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BPIFB1,BPI fold-containing family B member 1,40261,-0.159843996872547,0.00571842486642236,-0.171052109610735,-0.148635884134359,7.2316276248706e-168
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SHBG,Sex hormone-binding globulin,37987,-0.139735986429437,0.00500187332635837,-0.149539658149099,-0.129932314709774,4.99510488277646e-167
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDHR5,Cadherin-related family member 5,40359,0.100654233252247,0.00361436147695599,0.0935700847574136,0.107738381747081,1.09222209184957e-166
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KYNU,Kynureninase,40516,0.115284937548143,0.00414087476588144,0.107168823007015,0.12340105208927,1.22860050379559e-166
NMR metabolomics,X23495.Concentration of Large VLDL Particles,STAB2,Stabilin-2,37998,0.0722263149094274,0.00259351667841268,0.0671430222197386,0.0773096075991163,5.05248436565101e-166
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCL16,C-C motif chemokine 16,40536,0.136397929739338,0.00491343971319151,0.126767587901483,0.146028271577193,1.03223975131869e-165
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SMAD2,Mothers against decapentaplegic homolog 2,37900,0.174241542349948,0.00629978729366415,0.161893959254366,0.18658912544553,8.1367842175266e-164
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NUMB,Protein numb homolog,37598,0.213411667769125,0.00774233831905993,0.198236684663767,0.228586650874482,1.19997370271971e-162
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SNAPIN,SNARE-associated protein Snapin,37959,0.146092173322584,0.00532427052430698,0.135656603094942,0.156527743550225,2.39852565143439e-161
NMR metabolomics,X23495.Concentration of Large VLDL Particles,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,37901,0.354052230672017,0.0129526104226967,0.328665114243532,0.379439347100503,3.77435782205411e-160
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GRP,Gastrin-releasing peptide,37628,0.137808896240615,0.00505309631158053,0.127904827469918,0.147712965011313,2.30975925378713e-159
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,39980,0.17035921259054,0.00626217363549238,0.158085352264975,0.182633072916105,3.03297170437441e-159
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SYAP1,Synapse-associated protein 1,37671,0.142912921111146,0.00524775483183155,0.132627321640756,0.153198520581536,6.13094434663477e-159
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CXCL17,C-X-C motif chemokine 17,40516,0.104538235520839,0.00384919790679359,0.0969938076235238,0.112082663418155,7.6141547597534e-159
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL16,Pro-interleukin-16,40516,0.100832885118902,0.00375445228297125,0.0934741586442786,0.108191611593526,1.86094824242949e-155
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LAT2,Linker for activation of T-cells family member 2,40305,0.304923276870021,0.0113631867956275,0.282651430750591,0.327195122989451,3.6817615409801e-155
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCL22,C-C motif chemokine 22,40204,0.128382986206881,0.00478554810981852,0.119003311911636,0.137762660502125,4.64092754489912e-155
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FAM20A,Pseudokinase FAM20A,37990,0.0706314151605585,0.0026282526375527,0.0654800399909553,0.0757827903301618,4.98948325005461e-155
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ENO3,Beta-enolase,37628,0.141734120014507,0.00527463197387666,0.131395841345708,0.152072398683305,6.89853255447668e-155
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NCS1,Neuronal calcium sensor 1,40489,0.0712581859520293,0.00265895434678922,0.0660466354323225,0.0764697364717362,8.27984770171989e-155
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FTCD,Formimidoyltransferase-cyclodeaminase,37920,0.206876251825647,0.00773722844497129,0.191711284073503,0.222041219577791,1.67891977793354e-153
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ANGPTL2,Angiopoietin-related protein 2,40377,0.0984544870527855,0.00370968826963014,0.0911834980443104,0.105725476061261,6.6436947814525e-152
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NOMO1,Nodal modulator 1,40332,0.0584223831010279,0.00220440111935542,0.0541017569070913,0.0627430092949645,1.74805350752929e-151
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DPY30,Protein dpy-30 homolog,40414,0.146215803788868,0.00553363660873841,0.13536987603574,0.157061731541995,1.26716507821534e-150
NMR metabolomics,X23495.Concentration of Large VLDL Particles,F11R,Junctional adhesion molecule A,40332,0.139050990290758,0.00526281457774457,0.128735873718379,0.149366106863138,1.37269215186561e-150
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DTYMK,Thymidylate kinase,37990,0.170071677817481,0.00643997774030746,0.157449321446478,0.182694034188483,6.59482158693917e-150
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TIMP4,Metalloproteinase inhibitor 4,40332,-0.0997320317370373,0.0037869898176141,-0.107154531779561,-0.0923095316945136,1.20922068905314e-149
NMR metabolomics,X23495.Concentration of Large VLDL Particles,C9,Complement component C9,37987,-0.11944049351472,0.00452966240457074,-0.128318631827679,-0.110562355201761,1.81548464660406e-149
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NAA80,N-alpha-acetyltransferase 80,37572,0.291153153553332,0.0110457349447075,0.269503513061706,0.312802794044959,3.01267378804137e-149
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL18R1,Interleukin-18 receptor 1,40516,0.079593204510776,0.00303128971134534,0.0736518766765391,0.0855345323450128,8.02743609016507e-149
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,37990,0.177189618418165,0.00675589756129274,0.163948059198031,0.190431177638299,6.22038765633528e-148
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SNAP29,Synaptosomal-associated protein 29,40411,0.222091529208614,0.00848840398228748,0.20545425740333,0.238728801013897,8.75203725688313e-148
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KDR,Vascular endothelial growth factor receptor 2,40411,0.0614907434082455,0.00235271487522989,0.0568794222527949,0.0661020645636961,1.76930311770645e-147
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MEGF9,Multiple epidermal growth factor-like domains protein 9,40490,0.0510340388736824,0.00195318815856082,0.0472057900829032,0.0548622876644616,2.06393375631642e-147
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLUL1,Clusterin-like protein 1,40338,-0.110571802134376,0.00423697505166845,-0.118876273235646,-0.102267331033105,4.8824387790689e-147
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EEF1D,Elongation factor 1-delta,37990,0.222754189016251,0.00852362411888375,0.206047885743238,0.239460492289263,6.43967722165885e-147
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CREG1,Protein CREG1,40145,0.0869016682759099,0.00335845984900526,0.0803190869718596,0.0934842495799602,1.33326843029541e-144
NMR metabolomics,X23495.Concentration of Large VLDL Particles,COL4A1,Collagen alpha-1(IV) chain,40359,-0.0954461976114426,0.00369095271214671,-0.10268046492725,-0.088211930295635,1.8094217480182e-144
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PROS1,Vitamin K-dependent protein S,38013,0.0604327601836645,0.0023374367074011,0.0558513842371583,0.0650141361301706,6.49202105124565e-144
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ABL1,Tyrosine-protein kinase ABL1,40305,0.163124072836615,0.00632565254703672,0.150725793844423,0.175522351828807,1.09962406501949e-143
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MTSS1,Protein MTSS 1,37901,0.266047817351145,0.0103074987207731,0.24584511985843,0.28625051484386,2.00799299829846e-143
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,37562,0.163421999102998,0.00633744556662966,0.151000605792404,0.175843392413592,4.46674523998607e-143
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RTN4R,Reticulon-4 receptor,40489,0.0812110770227092,0.00315683264863015,0.0750236850313941,0.0873984690140243,4.75900286944466e-143
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,40305,0.0993713947095034,0.00386560646419398,0.0917948060396832,0.106947983379324,8.19675430607276e-143
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MLN,Promotilin,40341,0.212132174646704,0.00826715212488089,0.195928556481937,0.22833579281147,2.57203911609758e-142
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDHR2,Cadherin-related family member 2,40305,0.182706100581287,0.00715836581604344,0.168675703581842,0.196736497580732,7.45851681027935e-141
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CXCL13,C-X-C motif chemokine 13,40471,0.150769365963812,0.00591197170289889,0.139181901426131,0.162356830501494,1.17093507879968e-140
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AP1G2,AP-1 complex subunit gamma-like 2,37900,0.189618534973259,0.00742513101295696,0.175065278187864,0.204171791758655,1.64649179495572e-140
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SERPINF2,Alpha-2-antiplasmin,37755,0.0322838768570967,0.00126430768570127,0.0298058337931222,0.0347619199210711,1.90123145642712e-140
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KLKB1,Plasma kallikrein,37721,0.0598482025388697,0.00234699625406422,0.0552480898809038,0.0644483151968355,4.5369643047395e-140
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IPCEF1,Interactor protein for cytohesin exchange factors 1,40203,0.210571590525106,0.00828632276096929,0.194330397913606,0.226812783136606,1.19325002291279e-139
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,40411,0.0814437913988297,0.00321984517746026,0.0751328948510076,0.0877546879466519,1.94110020245589e-138
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ATRN,"Attractin, Isoform 2",38013,0.038574621971284,0.0015248563615028,0.0355859035027385,0.0415633404398295,5.29940926087526e-138
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SOST,Sclerostin,40330,0.0908598101442083,0.00360238181945721,0.0837991417780722,0.0979204785103445,1.15837984719868e-137
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MYH9,Myosin-9,37998,0.264338062856662,0.0104687958938791,0.243819222904659,0.284856902808665,1.66870137006673e-137
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CANT1,Soluble calcium-activated nucleotidase 1,40312,0.047736412708678,0.00189574795152789,0.0440207467236834,0.0514520786936727,3.18318820308253e-137
NMR metabolomics,X23495.Concentration of Large VLDL Particles,YES1,Tyrosine-protein kinase Yes,40305,0.266073363487975,0.0105757201885345,0.245344951918448,0.286801775057503,5.42612032147507e-137
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FCN2,Ficolin-2,40291,0.0961574086595432,0.00382544772838319,0.0886595311119121,0.103655286207174,9.43907114527589e-137
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FYB1,FYN-binding protein 1,40311,0.214236791888141,0.00852659054615624,0.197524674417674,0.230948909358607,1.20853086441271e-136
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SIT1,Signaling threshold-regulating transmembrane adapter 1,40044,0.130034639876146,0.00519587558086276,0.119850723737655,0.140218556014637,1.46891180489972e-135
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SCLY,Selenocysteine lyase,40434,0.111175914961093,0.00444887572477923,0.102456118540525,0.11989571138166,3.08485141842286e-135
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SELPLG,P-selectin glycoprotein ligand 1,40341,0.0644070502765885,0.00257989115489118,0.0593504636130018,0.0694636369401752,5.77561528006781e-135
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PCSK9,Proprotein convertase subtilisin/kexin type 9,40536,0.0910293490732659,0.00364943876345279,0.0838764490968985,0.0981822490496334,9.05933225429628e-135
NMR metabolomics,X23495.Concentration of Large VLDL Particles,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",37628,0.133177553759217,0.00533387119397289,0.12272316621903,0.143631941299404,1.76234209381252e-134
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,40305,0.0713958643423107,0.00286866669632576,0.0657732776175122,0.0770184510671091,3.70896657715841e-134
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IGFBP3,Insulin-like growth factor-binding protein 3,40403,0.0630357297317173,0.00253786956044082,0.0580615053932533,0.0680099540701813,1.19043810854782e-133
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DNAJC6,Putative tyrosine-protein phosphatase auxilin,37628,0.195152847509972,0.00787196405458274,0.179723797962989,0.210581897056954,1.20189541867727e-132
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRSS8,Prostasin,40293,0.0930023096041973,0.00376882951340886,0.0856154037579159,0.100389215450479,5.83022502135894e-132
NMR metabolomics,X23495.Concentration of Large VLDL Particles,YTHDF3,YTH domain-containing family protein 3,40044,0.194836114210323,0.00790814885743295,0.179336142449754,0.210336085970891,1.6230934506163e-131
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HEG1,Protein HEG homolog 1,37671,0.0606207519297388,0.0024659475272726,0.0557874947762845,0.0654540090831931,1.59488956462847e-130
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,39980,0.141027192996843,0.00575369177231348,0.129749957123109,0.152304428870578,3.3394600466731e-130
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SORT1,Sortilin,40330,0.0829116412412962,0.00338856572966872,0.0762700524111455,0.0895532300714469,8.10210385091254e-130
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CKB,Creatine kinase B-type,37998,-0.138266095894296,0.00565556648351443,-0.149351006201984,-0.127181185586608,3.28439464616411e-129
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GPD1,Glycerol-3-phosphate dehydrogenase,37900,0.115151766568816,0.004774339123645,0.105794061886471,0.12450947125116,7.32340287395928e-126
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CTBS,Di-N-acetylchitobiase,37819,0.0609344149945986,0.0025310586930265,0.0559735399562667,0.0658952900329305,2.11172526857987e-125
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TJAP1,Tight junction-associated protein 1,40411,0.18513075571893,0.0077082715765046,0.170022543428981,0.200238968008879,3.04232938208398e-125
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SARG,Specifically androgen-regulated gene protein,37931,0.243446718167733,0.0101437152138862,0.223565036348516,0.26332839998695,1.1333088823222e-124
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NPPC,C-type natriuretic peptide,40341,0.0962363961447426,0.00402745419822235,0.0883425859162268,0.104130206373258,5.25455957708375e-124
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SORD,Sorbitol dehydrogenase,40417,0.149147798156701,0.00624915590341499,0.136899452586007,0.161396143727394,9.85123267855924e-124
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TXLNA,Alpha-taxilin,40228,0.198799694811098,0.00832931263310472,0.182474242050213,0.215125147571983,1.0296920468165e-123
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EHBP1,EH domain-binding protein 1,37990,0.166561173425268,0.00697207763333263,0.152895901263936,0.1802264455866,1.38910982123369e-123
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DKK1,Dickkopf-related protein 1,40471,0.132677313829571,0.00557571544768011,0.121748911552118,0.143605716107024,5.01560207972116e-123
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ATP6V1G1,V-type proton ATPase subunit G 1,37628,0.160906582233701,0.00675780460431296,0.147661285209248,0.174151879258154,9.98340688134765e-123
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",40341,0.211409763326354,0.00889728336607502,0.193971087928847,0.228848438723861,1.15101642184578e-122
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DNAJA2,DnaJ homolog subfamily A member 2,40471,0.182085177151324,0.00767016001472285,0.167051663522467,0.197118690780181,1.82429212029328e-122
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AGRN,Agrin,40422,0.0734489002788491,0.0031016415784766,0.0673696827850349,0.0795281177726632,7.12921865166908e-122
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SEMA3F,Semaphorin-3F,40359,0.0568258658759574,0.00241717900243163,0.0520881950311914,0.0615635367207234,3.64768407340344e-120
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NUCB2,Nucleobindin-2,40447,0.0816333094674329,0.00347260205834608,0.0748270094330746,0.0884396095017912,3.66709909722731e-120
NMR metabolomics,X23495.Concentration of Large VLDL Particles,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",40305,0.213413436152113,0.00907996319164068,0.195616708296497,0.231210164007729,4.18882205615598e-120
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,37922,0.184268103545745,0.00783731983118601,0.16890695667662,0.19962925041487,7.9093195874397e-120
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KHK,Ketohexokinase,37628,0.141310735462292,0.00602412032091313,0.129503459633302,0.153118011291282,3.02885493501543e-119
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,37942,0.0881362646311113,0.00375868420612749,0.0807692435871014,0.0955032856751211,3.2524258113177e-119
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,37901,0.0656045925907957,0.00279870282758416,0.0601191350487308,0.0710900501328607,3.92682925150944e-119
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EFCAB14,EF-hand calcium-binding domain-containing protein 14,37901,0.0590163539885175,0.00252079008446486,0.0540756054229664,0.0639571025540687,7.58966617765916e-119
NMR metabolomics,X23495.Concentration of Large VLDL Particles,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,40228,0.118490158486859,0.00507697129865735,0.108539294741491,0.128441022232228,1.80732939103183e-118
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADH1B,All-trans-retinol dehydrogenase,37671,0.161555611921028,0.00691162348005883,0.148008829900113,0.175102393941944,1.93001657934301e-118
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NHLRC3,NHL repeat-containing protein 3,37370,0.0698500360607826,0.00298771706501781,0.0639941106133477,0.0757059615082175,1.97289566831272e-118
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,37671,0.105991557022894,0.00454221199736528,0.0970888215080577,0.11489429253773,4.70874475953198e-118
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BECN1,Beclin-1,37628,0.132876094622147,0.00570173510297624,0.121700693820314,0.14405149542398,9.45322376371719e-118
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CES3,Carboxylesterase 3,40305,0.148995023538169,0.00641450877893526,0.136422586331456,0.161567460744882,2.15857086950059e-117
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DAAM1,Disheveled-associated activator of morphogenesis 1,37671,0.180284510171754,0.00777107054170539,0.165053211910011,0.195515808433496,9.75331998311331e-117
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HJV,Hemojuvelin,37959,0.0998532811080669,0.00431317245091034,0.0913994631042827,0.108307099111851,2.58722515195521e-116
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TARBP2,RISC-loading complex subunit TARBP2,39961,0.170451180088657,0.00737863072354642,0.155989063870506,0.184913296306808,4.12458474626975e-116
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MAPK9,Mitogen-activated protein kinase 9,40341,0.0926521144833936,0.00401503415987334,0.0847826475300418,0.100521581436745,6.40252624407543e-116
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CTSD,Cathepsin D,39243,0.0862162653744381,0.00373392721269834,0.0788977680375494,0.0935347627113269,6.48249524781222e-116
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD63,CD63 antigen,40203,0.112409268288742,0.00487860376443237,0.102847204910455,0.12197133166703,1.45381858000251e-115
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MVK,Mevalonate kinase,40044,0.165146085537809,0.00716926439256307,0.151094327328385,0.179197843747233,1.73614221854679e-115
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CES2,Cocaine esterase,40305,0.115156196072562,0.00500566641610784,0.10534508989699,0.124967302248133,3.16624075550616e-115
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BTD,Biotinidase,38013,0.0444705735451742,0.00193330232263236,0.0406813009928148,0.0482598460975337,6.88128084026338e-115
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CRHBP,Corticotropin-releasing factor-binding protein,40357,0.0602573693575167,0.00262524443027556,0.0551118902741766,0.0654028484408568,9.97390507066093e-115
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,40305,0.0974940058815425,0.00425096788136128,0.0891621088340744,0.105825902929011,1.52640198019479e-114
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DCTN1,Dynactin subunit 1,40489,0.140981410862156,0.00615309245579728,0.128921349648793,0.153041472075519,2.38634131248444e-114
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CEP20,Centrosomal protein 20,39980,0.157876952103971,0.00688867510991512,0.144375148888537,0.171378755319405,2.38877095887436e-114
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FGFBP1,Fibroblast growth factor-binding protein 1,40411,0.0678877993867268,0.00296353839146384,0.0620792641394577,0.073696334633996,2.6972142261795e-114
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD2AP,CD2-associated protein,40359,0.136859868584513,0.00598010863150655,0.12513885566676,0.148580881502265,4.44003726197642e-114
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCL17,C-C motif chemokine 17,40333,0.193659461873631,0.00847113140331115,0.177056044323141,0.210262879424121,7.73955137987169e-114
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLEC1B,C-type lectin domain family 1 member B,40471,0.205747176487823,0.00901412098206916,0.188079499362967,0.223414853612678,1.66333523820423e-113
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HBEGF,Proheparin-binding EGF-like growth factor,40434,0.15439151891929,0.00677740975092822,0.141107795807471,0.16767524203111,4.51172661758922e-113
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,37663,0.0971119159603477,0.00425808827831292,0.0887660629348544,0.105457768985841,5.92058922945308e-113
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AP3S2,AP-3 complex subunit sigma-2,37942,0.0993942623512475,0.00436387444551161,0.0908410684380448,0.10794745626445,1.03169415514991e-112
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HGF,Hepatocyte growth factor,40516,0.0728128829515399,0.00320552639102103,0.0665300512251387,0.0790957146779411,1.87762277732251e-112
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GGT1,Glutathione hydrolase 1 proenzyme,40303,0.102938962528394,0.0045363964322388,0.0940476255212061,0.111830299535582,3.28843118407228e-112
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,37714,0.237025291113747,0.0104503214572426,0.216542661057551,0.257507921169942,9.07396697862146e-112
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,37671,0.0451007500779747,0.00198958719399414,0.0412011591777462,0.0490003409782032,1.21796441346292e-111
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AXIN1,Axin-1,40341,0.198916986278328,0.00879289714918288,0.18168290786593,0.216151064690727,1.49599730761162e-111
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,40403,-0.0792518143199181,0.00351468477719185,-0.0861405964832141,-0.072363032156622,7.41397526990742e-111
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LGALS9,Galectin-9,40350,0.0678298410877809,0.00301082645541127,0.0619286212351748,0.0737310609403869,1.16667946522648e-110
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RNF41,E3 ubiquitin-protein ligase NRDP1,39980,0.140934182203257,0.0062702360537908,0.128644519537827,0.153223844868687,3.98035710488092e-110
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CTSO,Cathepsin O,40516,0.0632650899186517,0.0028167394104484,0.0577442806741728,0.0687858991631305,4.97825059746006e-110
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FN1,Fibronectin,38013,0.055214440236872,0.00245516089082207,0.0504023248908608,0.0600265555828833,5.38095244410688e-110
NMR metabolomics,X23495.Concentration of Large VLDL Particles,COL18A1,Collagen alpha-1(XVIII) chain,40391,0.0486742197890323,0.00216958916228443,0.0444218250309548,0.0529266145471098,8.97022506815594e-110
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FABP4,"Fatty acid-binding protein, adipocyte",40536,0.103012043377669,0.00459486879003706,0.0940061005491961,0.112017986206141,1.22362688472787e-109
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GCC1,GRIP and coiled-coil domain-containing protein 1,37942,0.225351931787876,0.0100506647219555,0.205652628932843,0.245051234642908,2.38415899474347e-109
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PAXX,Protein PAXX,37671,0.0951429233624408,0.00424582869337174,0.0868210991234322,0.103464747601449,3.46448187717776e-109
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DAB2,Disabled homolog 2,40489,0.230721243579467,0.0103228470227351,0.210488463414906,0.250954023744028,5.47555390097412e-109
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BANK1,B-cell scaffold protein with ankyrin repeats,40341,0.221720259312721,0.00992135460264083,0.202274404291545,0.241166114333897,6.02063069102353e-109
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ZBTB16,Zinc finger and BTB domain-containing protein 16,39980,0.146251971073567,0.00655415448642622,0.133405828280171,0.159098113866962,1.35570589471116e-108
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",37860,0.22642683776007,0.0101439330001625,0.206544729079752,0.246308946440389,2.13546480972767e-108
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FGFBP3,Fibroblast growth factor-binding protein 3,37942,0.0769001426183252,0.00344872615015579,0.0701406393640199,0.0836596458726306,3.43346311294466e-108
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PTPRB,Receptor-type tyrosine-protein phosphatase beta,37990,0.060604595107316,0.00271968243316827,0.0552740175383062,0.0659351726763258,4.61286933526198e-108
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FETUB,Fetuin-B,40372,0.0703661151716078,0.00316332167033951,0.0641660046977424,0.0765662256454733,5.6150236279179e-108
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BTN3A2,Butyrophilin subfamily 3 member A2,40341,0.0785783815114257,0.00353423683030793,0.0716512773240221,0.0855054856988292,7.1574529129807e-108
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FABP5,Fatty acid-binding protein 5,40432,0.144003817007571,0.00647758925900941,0.131307742059912,0.156699891955229,7.38060171831367e-108
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",40277,0.216746732351112,0.00975673228282835,0.197623537076768,0.235869927625455,1.08065889942589e-107
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LDLRAP1,Low density lipoprotein receptor adapter protein 1,37959,0.199320957342622,0.00897499406178872,0.181729968981516,0.216911945703728,2.34861492488551e-107
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CPB2,Carboxypeptidase B2,37981,0.046422671219641,0.00209357165908241,0.0423192707678395,0.0505260716714426,4.8961969465637e-107
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ARF6,ADP-ribosylation factor 6,37901,0.217450925518411,0.00984477610232772,0.198155164357849,0.236746686678974,3.16003121864355e-106
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LECT2,Leukocyte cell-derived chemotaxin-2,37990,0.134847871173751,0.0061149200910283,0.122862627795335,0.146833114552166,6.5823558833272e-106
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SELP,P-selectin,40403,0.11884233852751,0.00539844199330809,0.108261392220626,0.129423284834393,7.8868072684046e-106
NMR metabolomics,X23495.Concentration of Large VLDL Particles,S100A4,Protein S100-A4,40411,0.119062477880209,0.00540861905673697,0.108461584529004,0.129663371231413,7.9952716802891e-106
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NFKBIE,NF-kappa-B inhibitor epsilon,39980,0.102184553868547,0.00464744449210334,0.0930755626640246,0.11129354507307,1.54522881109549e-105
NMR metabolomics,X23495.Concentration of Large VLDL Particles,THOP1,Thimet oligopeptidase,40288,0.0616113765326668,0.0028048557543876,0.0561138592540671,0.0671088938112665,2.26937300518424e-105
NMR metabolomics,X23495.Concentration of Large VLDL Particles,STC1,Stanniocalcin-1,40471,0.0849971481421531,0.00388102463999222,0.0773903398477684,0.0926039564365379,8.77365401849303e-105
NMR metabolomics,X23495.Concentration of Large VLDL Particles,OTUD7B,OTU domain-containing protein 7B,37959,0.129895846851608,0.00592443828852631,0.118283947806097,0.14150774589712,9.87171587902651e-105
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KAZN,Kazrin,37901,0.213293271069467,0.00972821145815256,0.194225976611488,0.232360565527446,1.00901806793509e-104
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ERBB2,Receptor tyrosine-protein kinase erbB-2,40411,0.0497323556814802,0.00227247094412667,0.0452783126309919,0.0541863987319685,1.2496072172189e-104
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NFE2,Transcription factor NF-E2 45 kDa subunit,37628,0.153483033042204,0.00701428248734578,0.139735039367006,0.167231026717402,2.77397947699111e-104
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ATG16L1,Autophagy-related protein 16-1,37901,0.173534737142002,0.00793276006428833,0.157986527415997,0.189082946868007,2.88166859895372e-104
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MTSS2,Protein MTSS 2,37900,0.20129330934846,0.00921869624451358,0.183224664709213,0.219361953987706,6.77044554574571e-104
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CXCL5,C-X-C motif chemokine 5,40309,0.233931139746497,0.0107509721571302,0.212859234318522,0.255003045174472,1.84007672926533e-103
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ARHGEF12,Rho guanine nucleotide exchange factor 12,40341,0.211148330333945,0.0097103369011121,0.192116070007765,0.230180590660124,2.47724805244265e-103
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CEP85,Centrosomal protein of 85 kDa,39980,0.128372465815298,0.0059037089458026,0.116801196281525,0.139943735349071,2.69898151518138e-103
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PLXNA4,Plexin-A4,40341,0.168072419441744,0.00773283857692143,0.152916055830978,0.18322878305251,3.04821540129155e-103
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EZR,Ezrin,40471,0.0481557642123035,0.00221889862643477,0.0438067229044913,0.0525048055201156,5.87539733294592e-103
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PLIN1,Perilipin-1,39961,0.0719688545818412,0.00332365297388449,0.0654544947530276,0.0784832144106548,1.84327054690013e-102
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ERBIN,Erbin,40305,0.207310983372556,0.00959508026836702,0.188504626046557,0.226117340698556,4.65962659267788e-102
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNIP1,TNFAIP3-interacting protein 1,37942,0.179755235872002,0.00831188224080812,0.163463946680018,0.196046525063986,5.43539115255339e-102
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PTS,6-pyruvoyl tetrahydrobiopterin synthase,39886,0.111024643663252,0.00514343209619655,0.100943516754707,0.121105770571797,7.80307474452606e-102
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PPP1R9B,Neurabin-2,40516,0.189696298657242,0.00879634793413038,0.172455456706347,0.206937140608138,1.04773012903901e-101
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NPL,N-acetylneuraminate lyase,37990,0.0872566072235172,0.00404446224545857,0.0793294612224184,0.095183753224616,1.59002763915629e-101
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD6,T-cell differentiation antigen CD6,40502,0.107217261323804,0.00498088117377085,0.0974547342232135,0.116979788424395,2.41129044232997e-101
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KRT18,"Keratin, type I cytoskeletal 18",40305,0.155312380756102,0.00721535926663088,0.141170276593505,0.169454484918698,2.53742993425518e-101
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IDUA,Alpha-L-iduronidase,40489,0.0912480677084375,0.00424046253172209,0.0829367611462622,0.0995593742706128,2.81966452689937e-101
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TGFB1,Transforming growth factor beta-1 proprotein,40502,0.0764279703918955,0.00355222971848242,0.06946560014367,0.0833903406401211,2.99048134334139e-101
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PYY,Peptide YY,37562,0.191545601394917,0.00891680694667808,0.174068659779428,0.209022543010406,1.2496638641148e-100
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IRAK1,Interleukin-1 receptor-associated kinase 1,40044,0.1386407128687,0.00646930274447092,0.125960879489537,0.151320546247863,1.94062893899623e-100
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LBR,Delta(14)-sterol reductase LBR,40471,0.131766826797046,0.0061505754037392,0.119711699005717,0.143821954588375,2.06083295653716e-100
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PDLIM7,PDZ and LIM domain protein 7,40422,0.250874307138591,0.0117146816249215,0.227913531153745,0.273835083123437,2.46528437729157e-100
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BCR,Breakpoint cluster region protein,40341,0.182421350890727,0.00853180617158936,0.165699010794412,0.199143690987042,5.09481126804854e-100
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AAMDC,Mth938 domain-containing protein,37628,0.107599915273917,0.00503457069835894,0.0977321567051333,0.1174676738427,1.18138707453732e-99
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL13RA1,Interleukin-13 receptor subunit alpha-1,40109,0.0414650223610175,0.00194587066729126,0.0376511158531267,0.0452789288689084,2.38997208413557e-99
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MCAM,Cell surface glycoprotein MUC18,40403,-0.0678627566182066,0.00318970674921558,-0.0741145818466692,-0.0616109313897441,4.53428578020973e-99
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,40516,0.199326511474965,0.00937425558844537,0.180952970521612,0.217700052428318,5.7324755969901e-99
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RBPMS2,RNA-binding protein with multiple splicing 2,37628,0.205347371175545,0.00964552984356278,0.186442132682162,0.224252609668928,6.54229031550938e-99
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PHACTR2,Phosphatase and actin regulator 2,37959,0.227688220315766,0.0106983537254398,0.206719447013904,0.248656993617628,6.87301932923677e-99
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EIF4B,Eukaryotic translation initiation factor 4B,40228,0.117943139930939,0.00555679374888942,0.107051824183116,0.128834455678762,1.33560063709529e-98
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNFSF10,Tumor necrosis factor ligand superfamily member 10,40516,0.0515088479827805,0.00243003049123065,0.0467459882199684,0.0562717077455926,2.26511818860597e-98
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VEGFC,Vascular endothelial growth factor C,40411,0.110928577508454,0.00523738445442139,0.100663303977788,0.12119385103912,3.25888786313409e-98
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LSP1,Lymphocyte-specific protein 1,40341,0.0793009743934046,0.00374683715427571,0.0719571735710242,0.086644775215785,4.53594713685988e-98
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NFKB1,Nuclear factor NF-kappa-B p105 subunit,37562,0.147457846759878,0.00696157947324062,0.133813150992327,0.16110254252743,6.11521144011914e-98
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,37959,0.166743141108301,0.00789227384405582,0.151274284373952,0.182211997842651,1.67130713938323e-97
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SCAMP3,Secretory carrier-associated membrane protein 3,40305,0.168297551022599,0.00799700869879143,0.152623413972968,0.183971688072231,5.36232068351011e-97
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PPY,Pancreatic prohormone,40337,0.199138249178648,0.00946455586602923,0.180587719681231,0.217688778676065,5.86255641791892e-97
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SNAP23,Synaptosomal-associated protein 23,40359,0.1714076757433,0.00815076884867081,0.155432168799905,0.187383182686695,7.2845844633024e-97
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GH1,Somatotropin,40330,-0.345210921013586,0.0164175937866163,-0.377389404835354,-0.313032437191819,7.74818525405964e-97
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SERPINH1,Serpin H1,37714,0.254433133084613,0.0120871429480196,0.230742332906495,0.278123933262732,8.70412332467143e-97
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IKBKG,NF-kappa-B essential modulator,40341,0.181103005105748,0.00862212298987591,0.164203644045591,0.198002366165905,1.22449902087268e-96
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BACH1,Transcription regulator protein BACH1,40341,0.142847147209059,0.00680874085305357,0.129502015137074,0.156192279281044,2.02163325564983e-96
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ELN,Elastin,37990,0.0693011160610998,0.00329962726506497,0.0628338466215725,0.0757683855006271,2.12041823361543e-96
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CRELD2,Protein disulfide isomerase CRELD2,40396,0.101837789745434,0.0048570767748806,0.0923179192666679,0.1113576602242,2.61487362146752e-96
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RAB11FIP3,Rab11 family-interacting protein 3,37990,0.210761997786933,0.0100475467994315,0.191068806060047,0.230455189513819,3.6196244753119e-96
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PDGFC,Platelet-derived growth factor C,39980,0.0583691356671093,0.00278747797643933,0.0529056788332882,0.0638325925009304,4.92229203959959e-96
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TPD52L2,Tumor protein D54,37671,0.212363397557471,0.01013447321477,0.192499830056522,0.23222696505842,6.14036065307769e-96
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MME,Neprilysin,40305,0.159315654537577,0.00762695854138001,0.144366815796472,0.174264493278682,1.31743993554867e-95
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LEP,Leptin,40359,0.124958721366261,0.00599113859955312,0.113216089711137,0.136701353021385,2.46406915746437e-95
NMR metabolomics,X23495.Concentration of Large VLDL Particles,YOD1,Ubiquitin thioesterase OTU1,37562,0.124517661351424,0.00597228853064099,0.112811975831368,0.136223346871481,5.34781784944685e-95
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CXCL10,C-X-C motif chemokine 10,40422,0.131785842404408,0.00633426898115181,0.11937067520135,0.144201009607465,7.01640924886865e-95
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MAMDC4,Apical endosomal glycoprotein,37900,0.106686324651225,0.00512875473910827,0.0966339653625728,0.116738683939877,1.28421736949284e-94
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MINK1,Misshapen-like kinase 1,37942,0.180631267678391,0.00869747018436146,0.163584226117042,0.197678309239739,2.49161317459043e-94
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PLSCR3,Phospholipid scramblase 3,37919,0.116736014795744,0.00562207391317865,0.105716749925914,0.127755279665574,2.73738765953195e-94
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SLA2,Src-like-adapter 2,37959,0.200491773878217,0.00968446612034815,0.181510220282335,0.2194733274741,9.34662503991358e-94
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DOK2,Docking protein 2,40359,0.233939215955666,0.0113191300717515,0.211753721015033,0.256124710896299,1.14960145333211e-93
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NCK2,Cytoplasmic protein NCK2,40422,0.201920037578921,0.00980284205211183,0.182706467156781,0.22113360800106,4.60965964336614e-93
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SRPK2,SRSF protein kinase 2,40341,0.159783081759995,0.00775791168479955,0.144577574857788,0.174988588662202,4.86283631968012e-93
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PBLD,Phenazine biosynthesis-like domain-containing protein,39961,0.0971604922571329,0.00471705758970115,0.0879150593813186,0.106405925132947,5.04223445943335e-93
NMR metabolomics,X23495.Concentration of Large VLDL Particles,OGFR,Opioid growth factor receptor,40305,0.0638265133679728,0.00309965414932086,0.0577511912353039,0.0699018355006417,5.37286227163589e-93
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PDCD5,Programmed cell death protein 5,40471,0.11273564971739,0.00547641604724459,0.102001874264791,0.12346942516999,5.87163256463116e-93
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BID,BH3-interacting domain death agonist,40341,0.129339198975035,0.00628413165300058,0.117022300935153,0.141656097014916,6.47874273683866e-93
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SDCCAG8,Serologically defined colon cancer antigen 8,37900,0.220897342974872,0.0107301283137177,0.199866291479985,0.241928394469758,9.66663147603954e-93
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PGF,Placenta growth factor,40516,0.0506513627587991,0.00246538612529539,0.0458192059532202,0.0554835195643781,1.31861672685355e-92
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SUGP1,SURP and G-patch domain-containing protein 1,37901,0.0764989105921846,0.00372112560482149,0.0692055044067345,0.0837923167776347,1.71336587245516e-92
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCL5,C-C motif chemokine 5,40403,0.192962278181705,0.00939880841149467,0.174540613695175,0.211383942668234,1.79751514309998e-92
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,40411,0.18351801387118,0.00894648090738617,0.165982911292703,0.201053116449657,2.55598413844516e-92
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DCXR,L-xylulose reductase,40411,0.100517830434188,0.00490638028798755,0.090901325069732,0.110134335798643,4.27628648380678e-92
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",40305,0.0840469004310104,0.00411420712643805,0.0759830544631918,0.0921107463988289,1.40688985964888e-91
NMR metabolomics,X23495.Concentration of Large VLDL Particles,STAT5B,Signal transducer and activator of transcription 5B,40305,0.263892786196328,0.0129189155130855,0.23857171179068,0.289213860601975,1.45262449636332e-91
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TOP2B,DNA topoisomerase 2-beta,37598,0.151909370488726,0.00742975090915984,0.137347058706773,0.16647168227068,1.71291684439535e-91
NMR metabolomics,X23495.Concentration of Large VLDL Particles,USO1,General vesicular transport factor p115,40305,0.173473491722098,0.00850305786950251,0.156807498297873,0.190139485146322,2.41748603073021e-91
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HCLS1,Hematopoietic lineage cell-specific protein,40516,0.107101903308274,0.00525065963995492,0.0968106104139627,0.117393196202586,2.50375801586256e-91
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",40536,0.0546508049760259,0.00268587070319072,0.0493864983977721,0.0599151115542797,6.79044874694422e-91
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EGLN1,Egl nine homolog 1,40341,0.101258005284022,0.00498162596687896,0.0914940183889395,0.111021992179105,1.06860396954791e-90
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PON2,Serum paraoxonase/arylesterase 2,40042,0.0656234886283454,0.0032285526158041,0.0592955255013693,0.0719514517553214,1.13052030838893e-90
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MASP1,Mannan-binding lectin serine protease 1,40192,0.0453976393124385,0.00223481104669236,0.0410174096609215,0.0497778689639555,1.40196072557065e-90
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NFX1,Transcriptional repressor NF-X1,37562,0.12964138411505,0.00638283974839641,0.117131018208193,0.142151750021907,2.51108709230534e-90
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TANK,TRAF family member-associated NF-kappa-B activator,40044,0.132710438241559,0.00654356211687591,0.119885056492482,0.145535819990636,2.75327433541292e-90
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",39980,0.1567808594324,0.00773418892238673,0.141621849144522,0.171939869720278,3.38776733648279e-90
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CMIP,C-Maf-inducing protein,37900,0.156594362370118,0.0077172390027699,0.141468573924689,0.171720150815547,3.40612517793425e-90
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IGF2R,Cation-independent mannose-6-phosphate receptor,40332,0.0436666138728379,0.00215473531035965,0.039443332664533,0.0478898950811429,3.57890662282138e-90
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,40228,0.180085390252977,0.00889132935251294,0.162658384722052,0.197512395783902,4.55934672374682e-90
NMR metabolomics,X23495.Concentration of Large VLDL Particles,STK11,Serine/threonine-protein kinase STK11,40042,0.138628555598393,0.00684954262025246,0.125203452062698,0.152053659134087,6.31984381861981e-90
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HEXIM1,Protein HEXIM1,40341,0.155038008314961,0.00766827915884192,0.140008181163631,0.170067835466291,9.11274351094743e-90
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCL7,C-C motif chemokine 7,40341,0.115133716705428,0.00571205053903033,0.103938097648929,0.126329335761928,3.0853453167015e-89
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LAT,Linker for activation of T-cells family member 1,40516,0.142951713987084,0.00709324436419625,0.129048955033259,0.156854472940908,3.18853151598928e-89
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ZFYVE19,Abscission/NoCut checkpoint regulator,37901,0.172318200612411,0.00854445349326738,0.155571071765607,0.189065329459215,3.92680901641101e-89
NMR metabolomics,X23495.Concentration of Large VLDL Particles,USP8,Ubiquitin carboxyl-terminal hydrolase 8,40042,0.182467287815209,0.00906150669454434,0.164706734693902,0.200227840936516,4.77747994242487e-89
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ACE2,Angiotensin-converting enzyme 2,40042,0.0924644103169826,0.0045925534593197,0.083463005536716,0.101465815097249,5.06566171941615e-89
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FUOM,Fucose mutarotase,37671,0.118206036425532,0.00586583371825402,0.106709002337754,0.12970307051331,5.61890722133325e-89
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,40044,0.082860971910789,0.00412141709070977,0.0747829944129979,0.0909389494085802,8.88170055076674e-89
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCN2,CCN family member 2,40358,0.108575731204525,0.00540766693085164,0.0979767040200561,0.119174758388994,1.43159229934744e-88
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,37901,0.205587802032311,0.0102308016147401,0.185535430867421,0.225640173197202,1.61784990177001e-88
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FOXO1,Forkhead box protein O1,40341,0.159117952383274,0.00794279669077229,0.14355007086936,0.174685833897187,3.47719361447475e-88
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PLEKHO1,Pleckstrin homology domain-containing family O member 1,37942,0.129949415606307,0.00648277897774534,0.117243168809926,0.142655662402688,4.23065100234307e-88
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,37990,0.145078797942688,0.00724244630145383,0.130883603191839,0.159273992693538,5.45842864513653e-88
NMR metabolomics,X23495.Concentration of Large VLDL Particles,THPO,Thrombopoietin,40042,0.0717412635063882,0.00358718151043544,0.0647103877459347,0.0787721392668416,7.04075915127397e-88
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GLB1,Beta-galactosidase,40228,0.0765796514393088,0.00383481103958559,0.069063421801721,0.0840958810768965,1.22238515038438e-87
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SH2D1A,SH2 domain-containing protein 1A,40341,0.102737875109679,0.00514793242073593,0.0926479275650367,0.112827822654322,1.53294584619217e-87
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ORM1,Alpha-1-acid glycoprotein 1,37950,0.0372617936961156,0.00186640839592296,0.0336036332401066,0.0409199541521246,2.04117909527152e-87
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLIP2,CAP-Gly domain-containing linker protein 2,40341,0.208607285442402,0.0104939066705601,0.188039228368104,0.229175342516699,7.03564539350929e-87
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PSIP1,PC4 and SFRS1-interacting protein,40341,0.115694515834694,0.00582389030759096,0.104279690831816,0.127109340837572,9.12785491920745e-87
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VEGFA,Vascular endothelial growth factor A,40456,0.109415363281826,0.00551837690939719,0.0985993445394072,0.120231382024244,1.87854814417661e-86
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DNMBP,Dynamin-binding protein,40228,0.11460574362611,0.00579072614867371,0.10325592037471,0.125955566877511,3.91912997423423e-86
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDC42BPB,Serine/threonine-protein kinase MRCK beta,37901,0.191027046171517,0.00964755647642625,0.172117835477721,0.209936256865312,4.92574159125654e-86
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TCTN3,Tectonic-3,37990,0.0543339889313403,0.00274482709996268,0.0489541278154135,0.0597138500472672,5.37975945834468e-86
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,37990,0.120154316461457,0.0060702196371246,0.108256685972693,0.132051946950221,5.48300588597247e-86
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CEP43,Centrosomal protein 43,39934,0.128007754697761,0.0064834152087552,0.115300260888601,0.140715248506922,1.02430391952191e-85
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",37959,0.142682259854825,0.0072339508533297,0.128503716182299,0.156860803527351,2.12717432158201e-85
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SERPINE1,Plasminogen activator inhibitor 1,40536,0.124860661776815,0.00634380675914094,0.112426800528899,0.137294523024732,3.0742832285592e-85
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GIGYF2,GRB10-interacting GYF protein 2,37959,0.140440692412676,0.00712884432828787,0.126468157529231,0.15441322729612,3.34916704424359e-85
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ITGA5,Integrin alpha-5,40332,0.046055673532052,0.00234124875542095,0.0414668259714269,0.050644521092677,3.90300786117579e-85
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AHSG,Alpha-2-HS-glycoprotein,37987,0.050080219608707,0.00254536200313047,0.0450913100825713,0.0550691291348427,5.40752615451678e-85
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AP3B1,AP-3 complex subunit beta-1,37901,0.141113761244813,0.00718100341803934,0.127038994545455,0.15518852794417,8.73089265216287e-85
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCL13,C-C motif chemokine 13,40483,0.128513827662879,0.00654984992020775,0.115676121819272,0.141351533506487,1.00952076405748e-84
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GP1BA,Platelet glycoprotein Ib alpha chain,40283,0.0593807428560592,0.00302828463516464,0.0534453049711365,0.0653161807409819,1.31214190203412e-84
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SNCG,Gamma-synuclein,40228,0.123361931846318,0.00629345642155492,0.11102675726007,0.135697106432565,1.51525042957817e-84
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RABEP1,Rab GTPase-binding effector protein 1,37671,0.145702374722789,0.00742712926228854,0.131145201368703,0.160259548076874,1.73261112627396e-84
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SMAD5,Mothers against decapentaplegic homolog 5,40305,0.0380210157409591,0.00194090399283734,0.0342168439149979,0.0418251875669202,1.89679103206794e-84
NMR metabolomics,X23495.Concentration of Large VLDL Particles,USP25,Ubiquitin carboxyl-terminal hydrolase 25,37900,0.133349097122484,0.0068024627132732,0.120016270204469,0.1466819240405,2.18400766824157e-84
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MTDH,Protein LYRIC,37598,0.168815673155749,0.00861093754288053,0.151938235571704,0.185693110739795,2.24583400612286e-84
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GFRA1,GDNF family receptor alpha-1,40453,0.0512352418463886,0.00261792133967513,0.0461041160206253,0.0563663676721518,2.64174255979278e-84
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VPS53,Vacuolar protein sorting-associated protein 53 homolog,40305,0.139795099761036,0.00714943782701127,0.125782201620094,0.153807997901978,3.78310998828386e-84
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HYOU1,Hypoxia up-regulated protein 1,40536,0.0397740809615895,0.0020345620270431,0.0357863393885851,0.043761822534594,3.96139801913604e-84
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FKBPL,FK506-binding protein-like,37901,0.108445872014147,0.00554583949689509,0.0975760266002328,0.119315717428062,5.52146140536001e-84
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD5,T-cell surface glycoprotein CD5,40470,0.0613390309805731,0.00314282322016918,0.0551790974690415,0.0674989644921047,7.37794535324331e-84
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PCBP2,Poly(rC)-binding protein 2,37959,0.131821126887228,0.00675325871703274,0.118584739801843,0.145057513972612,1.05984827053233e-83
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CRELD1,Protein disulfide isomerase CRELD1,37671,0.0691113135458789,0.00354134678639973,0.0621702738445354,0.0760523532472223,1.21233167152752e-83
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDC27,Cell division cycle protein 27 homolog,39980,0.111381202480096,0.00572334020728799,0.100163455673812,0.122598949286381,2.31487976517954e-83
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DNAJB6,DnaJ homolog subfamily B member 6,37557,0.154958790744799,0.00795381289714919,0.139369317466386,0.170548264023211,2.33200355734167e-83
NMR metabolomics,X23495.Concentration of Large VLDL Particles,C1S,Complement C1s subcomponent,38013,0.0379899459106658,0.00195242486929702,0.0341631931668437,0.041816698654488,3.39571366127494e-83
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ARHGEF1,Rho guanine nucleotide exchange factor 1,37942,0.166574511937092,0.00856417900343661,0.149788721090357,0.183360302783828,3.98194614805083e-83
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GFER,FAD-linked sulfhydryl oxidase ALR,39980,0.116888387140706,0.0060325963172121,0.10506449835897,0.128712275922441,1.15898533994457e-82
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PSME1,Proteasome activator complex subunit 1,40216,0.068654181849036,0.00354510308107993,0.0617057798101193,0.0756025838879526,1.36097597810636e-82
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CST3,Cystatin-C,40372,0.0510588542141338,0.00263795223191805,0.0458884678395744,0.0562292405886932,1.62374668445608e-82
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AKT1S1,Proline-rich AKT1 substrate 1,39961,0.122893691883483,0.00635239331941419,0.110443000977431,0.135344382789535,2.05552474630848e-82
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,40192,0.203112914475354,0.0105018099636433,0.182529366946614,0.223696462004095,2.20012870952727e-82
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PAK4,Serine/threonine-protein kinase PAK 4,39961,0.111221662209072,0.00575108156231871,0.0999495423469272,0.122493782071217,2.33738514055944e-82
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LZTFL1,Leucine zipper transcription factor-like protein 1,37671,0.129636237321569,0.00670491135074405,0.116494611074111,0.142777863569027,3.7352607395769e-82
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GAS6,Growth arrest-specific protein 6,40429,-0.0466706793853071,0.00241687852304766,-0.0514077612904805,-0.0419335974801336,3.79150797007434e-82
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HDGFL2,Hepatoma-derived growth factor-related protein 2,37942,0.113285027296896,0.00586714857072628,0.101785416098272,0.124784638495519,5.80935777964527e-82
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,40422,0.187820233376151,0.00974944609865455,0.168711319022788,0.206929147729514,8.98505195705853e-82
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDH2,Cadherin-2,40359,0.0638217681117948,0.00331315363581821,0.0573279869855911,0.0703155492379985,9.33098022945912e-82
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EREG,Proepiregulin,40192,0.145435666200849,0.00755027555211045,0.130637126118712,0.160234206282985,9.69620987766535e-82
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DLK1,Protein delta homolog 1,40536,0.095744953560629,0.00498411479771501,0.0859760885571075,0.10551381856415,2.48233139170942e-81
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VNN1,Pantetheinase,37987,0.130893576360676,0.00681322715654603,0.117539651133846,0.144247501587506,3.54579249742906e-81
NMR metabolomics,X23495.Concentration of Large VLDL Particles,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,40305,0.079757906966413,0.00415607285108942,0.0716120041782777,0.0879038097545483,3.68029059184811e-81
NMR metabolomics,X23495.Concentration of Large VLDL Particles,METAP2,Methionine aminopeptidase 2,40453,0.106087806446992,0.0055356673501732,0.095237898440652,0.116937714453331,5.91606620717342e-81
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PLXNB3,Plexin-B3,40310,0.0840348533977893,0.00438587469432889,0.0754385389969047,0.092631167798674,6.50553570720665e-81
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CIRBP,Cold-inducible RNA-binding protein,37901,0.171990820548497,0.00896793733113849,0.154413663379465,0.189567977717528,6.71704500581533e-81
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DAG1,Dystroglycan,40422,0.0852245295242795,0.00444947456850586,0.076503559370008,0.093945499678551,7.24392529533875e-81
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SIAE,Sialate O-acetylesterase,40374,0.0843331541026979,0.00440416737991557,0.0757009860380634,0.0929653221673324,8.05916262891671e-81
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CMC1,COX assembly mitochondrial protein homolog,37990,0.161822641017599,0.00847270857979919,0.145216132201193,0.178429149834005,2.89985205157833e-80
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NIT2,Omega-amidase NIT2,37936,0.135820666935147,0.00711168157112832,0.121881771055735,0.149759562814558,2.98454173332424e-80
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ARSB,Arylsulfatase B,40305,0.0984654016998484,0.00516249707838447,0.0883469074262148,0.108583895973482,3.33088734262051e-80
NMR metabolomics,X23495.Concentration of Large VLDL Particles,QDPR,Dihydropteridine reductase,40290,0.0784719050956342,0.00411788188530831,0.0704008566004299,0.0865429535908385,4.57132543663909e-80
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SEC31A,Protein transport protein Sec31A,37628,0.137395512862061,0.0072024159695482,0.123278777561746,0.151512248162375,4.74928249686821e-80
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD36,Platelet glycoprotein 4,37598,0.0797058133506173,0.00417972092849934,0.0715135603307586,0.087898066370476,5.40587906603111e-80
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GPKOW,G-patch domain and KOW motifs-containing protein,39961,0.04786066790588,0.00251536344387026,0.0429305555558942,0.0527907802558657,8.2044224270599e-80
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RGCC,Regulator of cell cycle RGCC,37959,0.134246576718153,0.00705052137139827,0.120427554830212,0.148065598606094,8.68595942327261e-80
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VAMP8,Vesicle-associated membrane protein 8,37598,0.158997447191845,0.00835394181257962,0.142623721239189,0.175371173144501,1.07592371881746e-79
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GOLM2,Protein GOLM2,40471,0.0400823564091245,0.00211140888826879,0.0359439949881177,0.0442207178301313,1.73277477317659e-79
NMR metabolomics,X23495.Concentration of Large VLDL Particles,A1BG,Alpha-1B-glycoprotein,38013,0.0313457873189333,0.00164966236596351,0.0281124490816448,0.0345791255562218,1.78652911088199e-79
NMR metabolomics,X23495.Concentration of Large VLDL Particles,WASHC3,WASH complex subunit 3,37942,0.134142699138985,0.00705994404650209,0.120305208807841,0.147980189470129,1.83572420660119e-79
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SELE,E-selectin,40536,0.0890855405321001,0.00470042558863091,0.0798727063783835,0.0982983746858167,3.06285891078688e-79
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MYDGF,Myeloid-derived growth factor,37990,0.179258377022322,0.00945165002293659,0.160733142977366,0.197783611067277,3.46463393616081e-79
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SYTL4,Synaptotagmin-like protein 4,37990,0.130741539824513,0.0068937624180604,0.117229765485115,0.144253314163911,3.50564176801573e-79
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CNST,Consortin,40359,0.19166594192244,0.0101364619713061,0.17179847645868,0.2115334073862,7.09690769438752e-79
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RNASE4,Ribonuclease 4,37575,0.0487246408530251,0.00257530169983384,0.0436770495213508,0.0537722321846994,8.70403344321208e-79
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RAPGEF2,Rap guanine nucleotide exchange factor 2,37714,0.0938426368501383,0.00496553266806257,0.0841101928207356,0.103575080879541,1.25511623299309e-78
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SIGLEC7,Sialic acid-binding Ig-like lectin 7,40359,0.0494676507678058,0.00262115252244288,0.0443301918238177,0.0546051097117938,1.38487395272425e-78
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LGALS1,Galectin-1,40359,0.059707279592038,0.0031642392188381,0.0535053707231153,0.0659091884609607,1.46627681305483e-78
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PDGFB,Platelet-derived growth factor subunit B,40422,0.151924751268639,0.00805833913825826,0.136130406557653,0.167719095979625,1.96670595050713e-78
NMR metabolomics,X23495.Concentration of Large VLDL Particles,OXT,Oxytocin-neurophysin 1,40471,0.234444348014825,0.0124438652822544,0.210054372061606,0.258834323968044,2.48427225106004e-78
NMR metabolomics,X23495.Concentration of Large VLDL Particles,STAMBP,STAM-binding protein,40192,0.114602951963564,0.00608639112084154,0.102673625366715,0.126532278560414,3.13645644515912e-78
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AHNAK,Neuroblast differentiation-associated protein AHNAK,37628,0.0555006096810514,0.00294652795906571,0.0497254148812826,0.0612758044808202,4.05796774394167e-78
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SKAP2,Src kinase-associated phosphoprotein 2,40422,0.18470819373191,0.00981877498175365,0.165463394767673,0.203952992696147,4.22387172997659e-78
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CA5A,"Carbonic anhydrase 5A, mitochondrial",40042,0.16238278562264,0.00863354601965217,0.145461035424121,0.179304535821158,4.71042106048165e-78
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,37901,0.158355480445978,0.00841724052981057,0.14185768900755,0.174853271884407,5.87803477036854e-78
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NT5E,5'-nucleotidase,40411,0.102258626535862,0.00544432643845529,0.0915877467164899,0.112929506355235,7.23770192672708e-78
NMR metabolomics,X23495.Concentration of Large VLDL Particles,WASF1,Wiskott-Aldrich syndrome protein family member 1,40042,0.162693668107403,0.00866784353316464,0.1457046947824,0.179682641432405,9.58464740582e-78
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GIT1,ARF GTPase-activating protein GIT1,37598,0.172811928131567,0.00921083816194866,0.154758685334148,0.190865170928987,1.5909477801003e-77
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SNX15,Sorting nexin-15,37671,0.0958004987221193,0.00510664487039902,0.0857914747761372,0.105809522668101,1.62466498986448e-77
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",37628,0.123615423433947,0.00659922743558579,0.110680937660199,0.136549909207695,2.74140623310523e-77
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AZI2,5-azacytidine-induced protein 2,37959,0.0971644016352576,0.00518925438216775,0.0869934630462088,0.107335340224306,2.98277042200811e-77
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NTproBNP,N-terminal prohormone of brain natriuretic peptide,40359,-0.172655447218364,0.00923139122423416,-0.190748974017863,-0.154561920418865,3.14360638218788e-77
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ANGPTL7,Angiopoietin-related protein 7,40489,0.0651086988336385,0.00348384979693953,0.058280353231637,0.07193704443564,4.02933342336928e-77
NMR metabolomics,X23495.Concentration of Large VLDL Particles,COMMD1,COMM domain-containing protein 1,37628,0.108376730235829,0.00579833186875004,0.0970119997730786,0.119741460698579,5.77734567719394e-77
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ISM1,Isthmin-1,40341,0.0684965674943988,0.00366926648678852,0.0613048051802933,0.0756883298085043,6.03275733204951e-77
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,37959,0.115547169628282,0.00618471969006509,0.103425119035754,0.127669220220809,6.36647189563813e-77
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SMNDC1,Survival of motor neuron-related-splicing factor 30,37901,0.101346755102042,0.00544098065718882,0.0906824330139524,0.112011077190133,1.7885460576698e-76
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ARHGAP45,Rho GTPase-activating protein 45,37671,0.144349258636178,0.00775167965423803,0.129155966513872,0.159542550758485,2.03024743214578e-76
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TGFBI,Transforming growth factor-beta-induced protein ig-h3,40273,0.047276144632448,0.00254293330097877,0.0422919953625296,0.0522602939023664,2.4607668467483e-76
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HAO1,Hydroxyacid oxidase 1,40489,0.228116793658919,0.0122714480724242,0.204064755436968,0.252168831880871,2.48749432981312e-76
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SSNA1,Sjoegren syndrome nuclear autoantigen 1,37901,0.0892340951020039,0.0047984534002722,0.0798291264374703,0.0986390637665374,3.09470743424552e-76
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MITD1,MIT domain-containing protein 1,40228,0.168929360221848,0.00909482198827295,0.151103509124833,0.186755211318863,3.36982961636879e-76
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,40379,0.0519323341776581,0.00279881425343103,0.0464466582409333,0.057418010114383,4.69141352690266e-76
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PHLDB1,Pleckstrin homology-like domain family B member 1,37901,0.0929552156099998,0.00500485586597919,0.0831456981126806,0.102764733107319,4.73661703558619e-76
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MUC13,Mucin-13,39961,0.0876581687534864,0.00472535689814345,0.0783964692331252,0.0969198682738475,5.35030360196835e-76
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TBCC,Tubulin-specific chaperone C,40228,0.14180134973433,0.00764794382379642,0.126811379839689,0.156791319628971,6.16094714933049e-76
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD99L2,CD99 antigen-like protein 2,40332,0.0414732507304009,0.00223907221976507,0.0370846691796614,0.0458618322811405,8.53746886439817e-76
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BAG4,BAG family molecular chaperone regulator 4,37598,0.0850368699829482,0.00458602270481809,0.0760482654815047,0.0940254744843917,8.63639443727635e-76
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,37714,0.185295585942693,0.0100119524595437,0.165672159121987,0.204919012763398,1.60226320404092e-75
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TAX1BP1,Tax1-binding protein 1,37942,0.111734608221266,0.00604265768871897,0.0998909991513771,0.123578217291156,2.08133860270042e-75
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CTSZ,Cathepsin Z,40345,0.0539985600486842,0.00292371690444215,0.0482680749159775,0.0597290451813908,2.24676341385166e-75
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,40341,0.173949488756526,0.00945603517408683,0.155415659815315,0.192483317697736,8.50806694529133e-75
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NSFL1C,NSFL1 cofactor p47,40471,0.115403612148371,0.00627730493378406,0.103100094478155,0.127707129818588,1.02945724066687e-74
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ASAH2,Neutral ceramidase,40228,0.090894668611586,0.00494724557902483,0.0811980672766973,0.100591269946475,1.3008626878799e-74
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NT5C1A,Cytosolic 5'-nucleotidase 1A,37942,0.0550445174983427,0.00300201952154702,0.0491605592361106,0.0609284757605749,3.40499303561312e-74
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LYN,Tyrosine-protein kinase Lyn,40305,0.144393386041006,0.00789394998493822,0.128921244070528,0.159865528011485,5.55773440811702e-74
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AMN,Protein amnionless,40044,0.0820419363928144,0.0044849568155976,0.0732514210342431,0.0908324517513857,5.61479659684748e-74
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TRIM5,Tripartite motif-containing protein 5,40341,0.146502978945593,0.00801124837815532,0.130800932124408,0.162205025766777,6.0013394452319e-74
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,37671,0.101035984528409,0.00552269802136077,0.0902114964065418,0.111860472650276,7.42050637415063e-74
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SCPEP1,Retinoid-inducible serine carboxypeptidase,37563,0.0850501541787287,0.00465013746819181,0.0759358847410727,0.0941644236163846,8.2336696944286e-74
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LEFTY2,Left-right determination factor 2,40453,0.0893105654764401,0.00489005428977629,0.0797260590684786,0.0988950718844017,9.0327254908914e-74
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NUDT5,ADP-sugar pyrophosphatase,40332,0.0896280148264101,0.00491458762187908,0.0799954230875271,0.0992606065652931,1.47365596008622e-73
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD40,Tumor necrosis factor receptor superfamily member 5,40350,0.0847867446901717,0.00465001521996918,0.0756727148590321,0.0939007745213113,1.56570047459879e-73
NMR metabolomics,X23495.Concentration of Large VLDL Particles,STAT2,Signal transducer and activator of transcription 2,37598,0.132140635381523,0.00724436316420754,0.117941683579677,0.14633958718337,1.97706256144095e-73
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SH2B3,SH2B adapter protein 3,39980,0.167540496062504,0.00919545234485541,0.149517409466587,0.18556358265842,2.084234779498e-73
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DTNB,Dystrobrevin beta,37878,0.0717595970391472,0.00393644090104401,0.0640441728731009,0.0794750212051935,2.30171818346777e-73
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,37959,0.184903263555447,0.0101538999453893,0.165001619662484,0.20480490744841,3.21961336513149e-73
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,40333,0.104292044852937,0.00575781820528465,0.0930067211705786,0.115577368535294,1.34964338449002e-72
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TALDO1,Transaldolase,37966,0.0762370892978,0.00420874191490667,0.0679879551445829,0.0844862234510171,1.77598432032215e-72
NMR metabolomics,X23495.Concentration of Large VLDL Particles,C3,Complement C3,37360,0.0802697508594007,0.00443379054038103,0.0715795214002539,0.0889599803185475,2.317879473261e-72
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GORASP2,Golgi reassembly-stacking protein 2,37901,0.0799136452810283,0.00441653341273554,0.0712572397920666,0.0885700507699899,2.54579266800491e-72
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FAM13A,Protein FAM13A,37901,0.11484777277885,0.00634832127676399,0.102405063076392,0.127290482481307,2.69215935345627e-72
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SRP14,Signal recognition particle 14 kDa protein,40305,0.100906772518562,0.00558380685125103,0.0899625110901098,0.111851033947014,2.84600163364445e-72
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GZMA,Granzyme A,40516,0.0598849686709207,0.00331449927782035,0.0533885500863928,0.0663813872554486,2.97671324362681e-72
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",37959,0.13506776344398,0.0074698741340349,0.120426810141271,0.149708716746688,3.15241490147976e-72
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ACP5,Tartrate-resistant acid phosphatase type 5,40419,0.0541095939156233,0.00299956726646543,0.0482304420733511,0.0599887457578956,4.98005466434652e-72
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FLT4,Vascular endothelial growth factor receptor 3,40411,0.0564794050324042,0.00313191406209295,0.050340853470702,0.0626179565941063,5.50660702879496e-72
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CRKL,Crk-like protein,40374,0.180718978718972,0.0100254288928149,0.161069138089055,0.200368819348889,6.30770375309189e-72
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BRAP,BRCA1-associated protein,37778,0.185898359374447,0.0103182359312434,0.16567461694921,0.206122101799684,1.02389263688624e-71
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BIRC2,Baculoviral IAP repeat-containing protein 2,39980,0.107337603206173,0.00597046232508643,0.0956354970490036,0.119039709363342,1.53508542517671e-71
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TACC3,Transforming acidic coiled-coil-containing protein 3,40305,0.19604147023542,0.0109099480611896,0.174657972035488,0.217424968435352,1.74144852203163e-71
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NAGK,N-acetyl-D-glucosamine kinase,37608,0.0959648987618427,0.00533726742647716,0.0855038546059474,0.106425942917738,1.99099601096861e-71
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DDHD2,Phospholipase DDHD2,37959,0.112175124857355,0.00623988445626752,0.0999449513230711,0.12440529839164,1.99746261795843e-71
NMR metabolomics,X23495.Concentration of Large VLDL Particles,COCH,Cochlin,37990,0.0790362495334671,0.00439658041433477,0.0704189519213709,0.0876535471455632,2.00153034962092e-71
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PXN,Paxillin,39961,0.0875336295341974,0.00487309256882211,0.0779823680993061,0.0970848909690888,2.02105126849969e-71
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CXCL3,C-X-C motif chemokine 3,40350,0.157312966598704,0.00876354664455508,0.140136415175376,0.174489518022032,2.39149389649824e-71
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL1RL2,Interleukin-1 receptor-like 2,40044,0.0684277287333484,0.00381598290551171,0.0609484022385455,0.0759070552281514,3.44729963547648e-71
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TRIM21,E3 ubiquitin-protein ligase TRIM21,40341,0.135113693118386,0.007542851274619,0.120329704620133,0.149897681616639,4.67917657386124e-71
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TDRKH,Tudor and KH domain-containing protein,39961,0.143416605193113,0.00800982760483278,0.127717343087641,0.159115867298585,5.5740424417076e-71
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IST1,IST1 homolog,37812,0.168982460546529,0.00944030547256834,0.150479461820295,0.187485459272763,7.891200308021e-71
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MPHOSPH8,M-phase phosphoprotein 8,40042,0.125617254809577,0.00703926866967313,0.111820288217018,0.139414221402136,1.58248150087982e-70
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DGKA,Diacylglycerol kinase alpha,37598,0.0914787705319176,0.00512546552391641,0.0814328581050414,0.101524682958794,2.02899799807841e-70
NMR metabolomics,X23495.Concentration of Large VLDL Particles,OGA,Protein O-GlcNAcase,37901,0.118003142423672,0.00661972096553341,0.105028489331227,0.130977795516118,2.85156526830412e-70
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IFNLR1,Interferon lambda receptor 1,40341,0.0627286347386764,0.00352397761670398,0.0558216386099366,0.0696356308674162,3.36157656123312e-70
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,37391,0.0589235082120496,0.00330681515017286,0.0524421505177108,0.0654048659063884,3.47453418591296e-70
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PACS2,Phosphofurin acidic cluster sorting protein 2,37562,0.104214535097833,0.00585217911793344,0.0927442640266838,0.115684806168983,4.10612362517984e-70
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TBC1D23,TBC1 domain family member 23,40305,0.149845168697108,0.00843710180260125,0.133308449164009,0.166381888230206,6.82014256442351e-70
NMR metabolomics,X23495.Concentration of Large VLDL Particles,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,40414,0.0974489507875814,0.00548722795751913,0.0866939839908439,0.108203917584319,6.87192968343253e-70
NMR metabolomics,X23495.Concentration of Large VLDL Particles,APOD,Apolipoprotein D,37345,-0.0747298057795827,0.00420560740614624,-0.0829727962956293,-0.066486815263536,8.31848739560111e-70
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HS1BP3,HCLS1-binding protein 3,37628,0.14978243353586,0.00843350453897833,0.133252764639463,0.166312102432258,9.29210326967758e-70
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MARS1,"Methionine--tRNA ligase, cytoplasmic",37642,0.143193334249439,0.00806540456901812,0.127385141294164,0.159001527204715,1.03634843352637e-69
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EVI5,Ecotropic viral integration site 5 protein homolog,37598,0.150459005249263,0.00847779992613945,0.13384251739403,0.167075493104497,1.16967399516468e-69
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PARP1,Poly [ADP-ribose] polymerase 1,40341,0.0903292133236772,0.00509811353001173,0.0803369108048543,0.1003215158425,1.41688649945395e-69
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",37628,0.0434068708320306,0.00244823840400739,0.0386083235601761,0.0482054181038851,1.58083866780165e-69
NMR metabolomics,X23495.Concentration of Large VLDL Particles,OPHN1,Oligophrenin-1,37942,0.178457097023744,0.0100798922818473,0.158700508151323,0.198213685896165,2.36207140334666e-69
NMR metabolomics,X23495.Concentration of Large VLDL Particles,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",37901,0.246066916320785,0.0139021569411397,0.218818688716151,0.273315143925418,2.56143438263273e-69
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IGSF3,Immunoglobulin superfamily member 3,40305,0.0574506720843419,0.00325158981604748,0.0510775560448889,0.063823788123795,3.37565026092616e-69
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",40280,0.125792252198593,0.0071285739962447,0.111820247165954,0.139764257231233,4.98333736752805e-69
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MSRA,Mitochondrial peptide methionine sulfoxide reductase,40411,0.120934935892966,0.00685396827303197,0.107501158077823,0.134368713708108,5.06866013220862e-69
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SAMD9L,Sterile alpha motif domain-containing protein 9-like,40341,0.119438079075585,0.00678804199549517,0.106133516764414,0.132742641386755,1.19621344223921e-68
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RAB27B,Ras-related protein Rab-27B,37990,0.136148154241243,0.00773581184996203,0.120985963015317,0.151310345467169,1.43370827486424e-68
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TIMP3,Metalloproteinase inhibitor 3,40422,0.218459868749088,0.0124248528510523,0.194107157161026,0.242812580337151,1.4836518627729e-68
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LGALS8,Galectin-8,40471,0.100080372133833,0.00569249672495879,0.0889230785529134,0.111237665714752,1.51291736471199e-68
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HMOX2,Heme oxygenase 2,39961,0.075565743025466,0.00429828187174388,0.067141110556848,0.083990375494084,1.6053921125983e-68
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,39980,0.0736816914515297,0.00419352044538252,0.0654623913785799,0.0819009915244794,1.90769895205947e-68
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,40228,0.129099531602826,0.00734916391894518,0.114695170321693,0.143503892883959,1.98981399463762e-68
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GOLGA3,Golgin subfamily A member 3,37959,0.12984507386896,0.00739227899485675,0.115356207039041,0.14433394069888,2.62147996254264e-68
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TREM2,Triggering receptor expressed on myeloid cells 2,40357,0.0831656072911311,0.00473998380889401,0.0738752390256988,0.0924559755565634,2.82668853278988e-68
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CASC3,Protein CASC3,37572,0.0678798997362648,0.00386638098979467,0.0603017929962673,0.0754580064762624,3.1932418473607e-68
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCL3,C-C motif chemokine 3,40341,0.101643227423309,0.0057970303729556,0.0902810478923157,0.113005406954302,3.47489451352966e-68
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ELOA,Elongin-A,40305,0.0841150414783891,0.00480364271914614,0.0746999017488626,0.0935301812079155,5.18307750398814e-68
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ASPSCR1,Tether containing UBX domain for GLUT4,37959,0.112945378486456,0.00644480118721249,0.100313568159519,0.125577188813392,5.2109751908267e-68
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DBNL,Drebrin-like protein,40422,0.152126957162162,0.00869308841959494,0.135088503859756,0.169165410464568,6.18967107773572e-68
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RTBDN,Retbindin,40305,0.0482076712548207,0.00275672973086985,0.0428044809823158,0.0536108615273256,7.75699738196555e-68
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TIA1,Nucleolysin TIA-1 isoform p40,39836,0.198536318441563,0.0113575185973868,0.176275581990685,0.220797054892442,9.09073085086509e-68
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCL11,Eotaxin,40516,0.0619293604867292,0.00354598743774269,0.0549792251087536,0.0688794958647049,1.1235470466003e-67
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TXNDC5,Thioredoxin domain-containing protein 5,40471,0.110181835786207,0.00631710371061828,0.0978003125133949,0.122563359059019,1.66914183264789e-67
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PDLIM5,PDZ and LIM domain protein 5,37959,0.194709383430503,0.0111673898189025,0.172821299385454,0.216597467475552,2.41841868360477e-67
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SPART,Spartin,37671,0.126952586651996,0.00728353231140758,0.112676863321637,0.141228309982355,2.75287555364738e-67
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GASK1A,Golgi-associated kinase 1A,37562,0.0713039539662604,0.00409400277608917,0.0632797085251257,0.0793281994073952,3.51051719662651e-67
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TWF2,Twinfilin-2,37998,0.136121362591896,0.00781967771612977,0.120794794268281,0.15144793091551,3.88381843364716e-67
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SUSD1,Sushi domain-containing protein 1,40042,0.0804768739200491,0.00464177188692122,0.0713790010216835,0.0895747468184147,1.03428824985765e-66
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MENT,Protein MENT,37671,-0.0355136957928163,0.00204747424570534,-0.0395267453143988,-0.0315006462712339,1.17237625612002e-66
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PPP1R2,Protein phosphatase inhibitor 2,40359,0.12937007617417,0.00746660732093522,0.114735525825137,0.144004626523203,1.21396457843691e-66
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SDC4,Syndecan-4,40359,0.0737813874784794,0.00426184936583637,0.0654281627214401,0.0821346122355187,1.55265371002129e-66
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,40359,0.136814030261365,0.00790725795749783,0.121315804664669,0.152312255858061,1.83251300501724e-66
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,39980,0.127595711779365,0.00738560847271877,0.113119919172836,0.142071504385894,2.9540439453832e-66
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SHMT1,"Serine hydroxymethyltransferase, cytosolic",40396,0.141888525105371,0.00822161949197676,0.125774150901096,0.158002899309645,3.88608190033895e-66
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,37900,0.134390730009904,0.00778224360614293,0.119137532541864,0.149643927477944,4.15963690024178e-66
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDNF,Cerebral dopamine neurotrophic factor,40305,0.0526487504308213,0.00305201399413652,0.0466668030023137,0.0586306978593289,4.44776663599307e-66
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GMPR2,GMP reductase 2,37671,0.110490839134128,0.00640190685681895,0.0979431016947628,0.123038576573493,5.05375393652159e-66
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ESM1,Endothelial cell-specific molecule 1,40357,-0.0549462053126695,0.00319273503781405,-0.0612039659867851,-0.048688444638554,8.83935423633412e-66
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RWDD1,RWD domain-containing protein 1,40471,0.104376235427059,0.00607259641867802,0.09247394644645,0.116278524407668,1.26420540497791e-65
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ST13,Hsc70-interacting protein,37671,0.0924494369409404,0.00538017452024051,0.081904294881269,0.102994579000612,1.81635337309262e-65
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,37900,0.077362366155325,0.00450272699405471,0.0685370212469777,0.0861877110636722,1.83174753424145e-65
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NIT1,Deaminated glutathione amidase,37628,0.0803619496584584,0.00468234172249295,0.0711845598823722,0.0895393394345446,2.58313120173244e-65
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TRAF2,TNF receptor-associated factor 2,40341,0.114987898887302,0.00670831800567257,0.101839595596183,0.12813620217842,2.82864222900858e-65
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CHMP1A,Charged multivesicular body protein 1a,40228,0.128343308854603,0.00749083690401915,0.113661268522725,0.14302534918648,3.25324304326244e-65
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GTPBP2,GTP-binding protein 2,37572,0.129232454280483,0.00753830352997892,0.114457379361724,0.144007529199241,3.60112642703033e-65
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CNPY4,Protein canopy homolog 4,40305,0.120625508356304,0.0070434557399681,0.106820335105967,0.134430681606642,3.6666682558262e-65
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SIRT2,NAD-dependent protein deacetylase sirtuin-2,40305,0.144312508108943,0.00842861337672304,0.127792425890566,0.16083259032732,3.9332830410188e-65
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VWA1,von Willebrand factor A domain-containing protein 1,40453,0.0677412585268873,0.00395665823031773,0.0599862083954645,0.07549630865831,3.94533013403437e-65
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ICA1,Islet cell autoantigen 1,40044,0.127814252367443,0.00747328354189372,0.113166616625331,0.142461888109555,5.53189471905327e-65
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",40332,0.0738147886312471,0.00431668126538755,0.0653540933510875,0.0822754839114067,5.67157756758424e-65
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RILPL2,RILP-like protein 2,37990,0.156868606186604,0.00918188732440888,0.138872107030762,0.174865105342445,9.216926058448e-65
NMR metabolomics,X23495.Concentration of Large VLDL Particles,STIP1,Stress-induced-phosphoprotein 1,40307,0.105350435240758,0.00617389310469975,0.0932496047555461,0.117451265725969,1.04232128980991e-64
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MAX,Protein max,39961,0.167923070596629,0.0098474658194793,0.148622037590449,0.187224103602808,1.30084391891722e-64
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BPIFB2,BPI fold-containing family B member 2,37951,0.109374334647905,0.00641206501126357,0.0968066872258281,0.121941982069981,1.45558952614196e-64
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SEMA4D,Semaphorin-4D,40471,0.0477730857672254,0.00281403494008097,0.0422575772846667,0.0532885942497841,4.43597133948798e-64
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SH3GLB2,Endophilin-B2,37942,0.107257374938537,0.00632267289520856,0.094864936063928,0.119649813813146,6.96894429704306e-64
NMR metabolomics,X23495.Concentration of Large VLDL Particles,OCLN,Occludin,37959,0.0698280752737504,0.00411797304107241,0.0617568481132485,0.0778993024342523,7.8195964296641e-64
NMR metabolomics,X23495.Concentration of Large VLDL Particles,UBXN1,UBX domain-containing protein 1,37671,0.110669941735429,0.00652634648054745,0.0978783026335565,0.123461580837302,8.01106363937284e-64
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MOCS2,Molybdopterin synthase catalytic subunit,37671,0.107371097158371,0.00635262485789394,0.0949199524368991,0.119822241879843,2.01806477094785e-63
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ALDH1A1,Retinal dehydrogenase 1,40332,0.0840947730716337,0.00498205706447039,0.0743299412252718,0.0938596049179957,2.27059780726892e-63
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GMPR,GMP reductase 1,40516,0.0812082424833158,0.00481146519612445,0.0717777706989118,0.0906387142677197,2.29315361666944e-63
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MAVS,Mitochondrial antiviral-signaling protein,39980,0.147174047299011,0.00874803226415803,0.130027904061261,0.164320190536761,5.9066555262531e-63
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DOK1,Docking protein 1,37942,0.216667683283594,0.0128711164370087,0.191440295067057,0.241895071500131,6.06500066138063e-63
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CSNK2A1,Casein kinase II subunit alpha,37959,-0.0719925765577514,0.00427857560553016,-0.0803785847445906,-0.0636065683709123,6.83545569795389e-63
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NUB1,NEDD8 ultimate buster 1,40341,0.132300647425509,0.0078697890675359,0.116875860853138,0.147725433997879,7.05687938104158e-63
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,40305,0.0438602595048688,0.00261003159038437,0.0387445975877154,0.0489759214220221,7.90936867967564e-63
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KYAT1,Kynurenine--oxoglutarate transaminase 1,40340,0.0897122620337515,0.00533900819423339,0.079247805973054,0.100176718094449,8.06276016362337e-63
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD22,B-cell receptor CD22,40516,0.0648674927415097,0.00386435377501754,0.0572933593424753,0.072441626140544,1.05506716411757e-62
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL18,Interleukin-18,40292,0.0748827740780099,0.00446702135005908,0.0661274122318941,0.0836381359241257,1.5610971665346e-62
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PLG,Plasminogen,37705,0.0355148169709123,0.00211688766752632,0.0313657171425607,0.0396639167992639,1.58854997922273e-62
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TP53,Cellular tumor antigen p53,39980,0.0680972565910515,0.00406426828091326,0.0601312907604616,0.0760632224216415,1.83699513643275e-62
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KRT5,"Keratin, type II cytoskeletal 5",39961,0.0771121884072309,0.00460938051472065,0.0680778025983784,0.0861465742160834,2.81193327732084e-62
NMR metabolomics,X23495.Concentration of Large VLDL Particles,F13B,Coagulation factor XIII B chain,37934,0.0407863060969002,0.00243818438120443,0.0360074647097395,0.0455651474840608,3.45874831549421e-62
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ESYT2,Extended synaptotagmin-2,37942,0.128721604159781,0.00770340382761351,0.113622932657659,0.143820275661904,4.67956682974954e-62
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FUS,RNA-binding protein FUS,39960,0.0619448919208505,0.0037198473343816,0.0546539911454626,0.0692357926962384,9.96223351354413e-62
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,39980,0.134327730246131,0.00807792988283059,0.118494987675783,0.150160472816479,1.46397845711135e-61
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CRADD,Death domain-containing protein CRADD,40192,0.1201377375466,0.00722542707468504,0.105975900480218,0.134299574612983,1.48591440771331e-61
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SPRY2,Protein sprouty homolog 2,40044,0.144313661107861,0.00868469567073139,0.127291657593227,0.161335664622495,1.77254811475889e-61
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LRP11,Low-density lipoprotein receptor-related protein 11,40359,0.0553012770049061,0.00332961547332567,0.0487752306771878,0.0618273233326244,1.976535336731e-61
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRSS2,Trypsin-2,40403,0.0785577891593796,0.00473118931789577,0.0692846580963039,0.0878309202224553,2.12680614890236e-61
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RBM17,Splicing factor 45,37959,0.119768959846012,0.00720828584719446,0.10564071958551,0.133897200106513,2.18831234529088e-61
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PENK,Proenkephalin-A,37671,0.0484380817068301,0.00291519545623987,0.0427242986125999,0.0541518648010602,2.2454221304988e-61
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GPC5,Glypican-5,40228,0.0877299628457156,0.00528470607785559,0.0773719389331187,0.0980879867583126,2.28213638583969e-61
NMR metabolomics,X23495.Concentration of Large VLDL Particles,APPL2,DCC-interacting protein 13-beta,37671,0.174947293364398,0.010545434370991,0.154278241997256,0.19561634473154,3.42473028141169e-61
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,37959,0.0741357897912389,0.00447387224198697,0.0653670001969445,0.0829045793855334,4.533067838609e-61
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ANXA11,Annexin A11,40312,0.105118647699606,0.00635014537980017,0.0926723627551972,0.117564932644014,4.89038890646611e-61
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RRM2,Ribonucleoside-diphosphate reductase subunit M2,39980,0.0825010721379733,0.00498458178044976,0.0727312918482918,0.0922708524276549,5.22141027531777e-61
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNFSF14,Tumor necrosis factor ligand superfamily member 14,40228,0.0896327385575483,0.00542974325655897,0.0789904417746928,0.100275035340404,1.04206815135288e-60
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GHRL,Appetite-regulating hormone,40359,0.122499317625065,0.0074360453678345,0.107924668704109,0.137073966546021,1.79523153770515e-60
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KIFBP,KIF-binding protein,40305,0.127771928885712,0.00776517792841955,0.112552180146009,0.142991677625414,2.46366835524882e-60
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RABGAP1L,Rab GTPase-activating protein 1-like,40044,0.0933058091771349,0.00567605374897899,0.0821807438291361,0.104430874525134,3.25409422948792e-60
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD69,Early activation antigen CD69,40288,0.136172838975012,0.00828904132773439,0.119926317972653,0.152419359977371,3.78676475094325e-60
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MAP2,Microtubule-associated protein 2,37942,0.0710771332078211,0.00433199462025296,0.0625864237521253,0.0795678426635169,6.4266032352788e-60
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GYS1,"Glycogen [starch] synthase, muscle",40042,0.143933775802592,0.00877941351975685,0.126726125303869,0.161141426301316,6.64135107663615e-60
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNFSF12,Tumor necrosis factor ligand superfamily member 12,40516,0.0449741480689172,0.00274470956725912,0.0395945173170893,0.050353778820745,7.39270017814589e-60
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HSPA1A,Heat shock 70 kDa protein 1A,40400,0.11012793842864,0.00672393271429321,0.0969490303086252,0.123306846548655,8.3803717520786e-60
NMR metabolomics,X23495.Concentration of Large VLDL Particles,YJU2,Splicing factor YJU2,37900,0.0495597977726887,0.00302538114403315,0.0436300507303838,0.0554895448149937,9.83876483017402e-60
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CPB1,Carboxypeptidase B,40536,0.0868877404613237,0.00531377312286398,0.0764727451405103,0.0973027357821371,1.28586399071582e-59
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CETN3,Centrin-3,37901,0.118599660012239,0.00725168853260117,0.104386350488341,0.132812969536138,1.50941144621883e-59
NMR metabolomics,X23495.Concentration of Large VLDL Particles,OTUD6B,Deubiquitinase OTUD6B,37901,0.0909518522283755,0.00556162780150283,0.0800510617374299,0.101852642719321,1.54146850104872e-59
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLEC4A,C-type lectin domain family 4 member A,40341,-0.0530424235917871,0.0032461232445918,-0.059404825151187,-0.0466800220323871,1.56099010380624e-59
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ATOX1,Copper transport protein ATOX1,40411,0.110500096883757,0.00676593790287588,0.0972388585941207,0.123761335173394,1.7792212722017e-59
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ATP5IF1,"ATPase inhibitor, mitochondrial",40422,0.169982813211728,0.0104232961261009,0.149553152804571,0.190412473618886,2.61094253452121e-59
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DLG4,Disks large homolog 4,37942,0.108017278453979,0.00662397060086705,0.0950342960762799,0.121000260831679,3.23832896911109e-59
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MEP1A,Meprin A subunit alpha,37901,0.105441409496743,0.00646713951039561,0.0927658160563681,0.118117002937119,3.40311349427908e-59
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SERPINC1,Antithrombin-III,37981,0.022674452057253,0.00139133640652815,0.0199474327004578,0.0254014714140481,3.7965775146049e-59
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD74,HLA class II histocompatibility antigen gamma chain,40471,0.053435793928652,0.0032814058424616,0.0470042384774273,0.0598673493798768,3.80115797592324e-59
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",37608,0.123876298851307,0.00760277922886101,0.10897485156274,0.138777746139875,4.15284102326475e-59
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FARSA,Phenylalanine--tRNA ligase alpha subunit,37572,0.104965294218914,0.00644217408359697,0.0923386330150639,0.117591955422764,4.17428795278956e-59
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,39853,0.136031122533131,0.00835692980187434,0.119651540121457,0.152410704944805,4.42638270417171e-59
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HARS1,"Histidine--tRNA ligase, cytoplasmic",40332,0.118949069250771,0.00730966095196468,0.10462213378492,0.133276004716621,4.62103446230796e-59
NMR metabolomics,X23495.Concentration of Large VLDL Particles,XIAP,E3 ubiquitin-protein ligase XIAP,37598,0.0885915256726427,0.00544020643069735,0.0779287210684759,0.0992543302768095,4.79935126716252e-59
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IRAK4,Interleukin-1 receptor-associated kinase 4,40341,0.160259644228663,0.0098611088183775,0.140931870944643,0.179587417512683,6.48783581020834e-59
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PKD2,Polycystin-2,37562,0.0916491441850685,0.00563461394830068,0.0806053008463992,0.102692987523738,6.5511850687295e-59
NMR metabolomics,X23495.Concentration of Large VLDL Particles,STX4,Syntaxin-4,40305,0.0915129474298006,0.00563294680679955,0.0804723716884735,0.102553523171128,7.123066520238e-59
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FMNL1,Formin-like protein 1,39961,0.0918485818331841,0.00565518412406047,0.0807644209500256,0.102932742716343,7.84611371149242e-59
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DFFA,DNA fragmentation factor subunit alpha,40516,0.103989914879233,0.00640457399415654,0.0914369498506863,0.11654287990778,8.13861953452878e-59
NMR metabolomics,X23495.Concentration of Large VLDL Particles,YWHAQ,14-3-3 protein theta,37671,0.113261216339266,0.00697410519044316,0.099591970165997,0.126930462512534,9.68707937669537e-59
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NUDC,Nuclear migration protein nudC,40516,0.0967724050083011,0.0059652831131606,0.0850804501065064,0.108464359910096,1.02218771021677e-58
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRKG1,cGMP-dependent protein kinase 1,37671,0.192034394242116,0.0118341777302844,0.168839405890759,0.215229382593474,1.19517760017954e-58
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TBL1X,F-box-like/WD repeat-containing protein TBL1X,39980,0.129412905766763,0.00798147030982831,0.1137692239595,0.145056587574027,1.21360878550714e-58
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,37671,0.128559441535948,0.00794149740083951,0.112994106630303,0.144124776441594,2.21896880117204e-58
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GPRC5C,G-protein coupled receptor family C group 5 member C,37900,0.0881330322764354,0.0054470241160348,0.0774568650090072,0.0988091995438636,2.47751312159491e-58
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PF4,Platelet factor 4,37934,0.148556852538893,0.0091926721838141,0.130539215058617,0.166574490019168,3.37846966220466e-58
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DRG2,Developmentally-regulated GTP-binding protein 2,40305,0.0854427668122624,0.00529360067927202,0.0750673094808892,0.0958182241436355,3.83334763191388e-58
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IGBP1,Immunoglobulin-binding protein 1,37959,0.0934732419498942,0.00578784719112376,0.0821290614552917,0.104817422444497,3.97976107134495e-58
NMR metabolomics,X23495.Concentration of Large VLDL Particles,F2,Prothrombin,38013,0.0224475064813898,0.00139109066484322,0.0197209687782971,0.0251740441844825,4.89210974457535e-58
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LPP,Lipoma-preferred partner,37562,0.102420179652401,0.00634875295162702,0.0899766238672116,0.114863735437589,5.4631867946547e-58
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TRIM40,E3 ubiquitin ligase TRIM40,37572,0.109475765118467,0.0067975834147583,0.0961525016255403,0.122799028611393,8.40724488569692e-58
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLEC4G,C-type lectin domain family 4 member G,40341,0.0499850377503512,0.00310698218945473,0.0438953526590199,0.0560747228416825,8.8606739919738e-58
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,37628,0.117944703685924,0.00732796776706305,0.10358188686248,0.132307520509368,9.79176032963295e-58
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KLK10,Kallikrein-10,40354,0.0595851211737476,0.00370893077564518,0.0523156168534831,0.0668546254940122,1.26877088011441e-57
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PALM2,Paralemmin-2,37942,0.0561234497857858,0.00349403546953759,0.0492751402654921,0.0629717593060795,1.59131040272907e-57
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,39980,0.149726740444713,0.00932811784368658,0.131443629471088,0.168009851418339,1.62892229942898e-57
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",37942,0.14669704027137,0.00913562046300642,0.128791224163878,0.164602856378863,1.72081768402994e-57
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",40341,0.145580758970582,0.00908962015096342,0.127765103474694,0.16339641446647,2.76712101131144e-57
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CACYBP,Calcyclin-binding protein,37642,0.155116858416132,0.00969065979682065,0.136123165214364,0.174110551617901,3.94789524754654e-57
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GLOD4,Glyoxalase domain-containing protein 4,40328,0.0548585849104651,0.00343022579171834,0.0481353423586971,0.061581827462233,4.01255475501491e-57
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,37671,0.0956248834680414,0.00597658994846962,0.0839107671690409,0.107338999767042,4.39203946217912e-57
NMR metabolomics,X23495.Concentration of Large VLDL Particles,STX8,Syntaxin-8,40341,0.0735912590862652,0.00460941700819817,0.0645568017501968,0.0826257164223336,6.16818215670075e-57
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MED18,Mediator of RNA polymerase II transcription subunit 18,39980,0.115365066236828,0.00722583268722835,0.101202434169861,0.129527698303796,6.29189873652869e-57
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RFC4,Replication factor C subunit 4,37900,0.0310040135217619,0.00194217903157726,0.0271973426198704,0.0348106844236533,7.62904828921464e-57
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RRAS,Ras-related protein R-Ras,37572,0.196601962291487,0.0123272341117367,0.172440583432483,0.220763341150491,9.93704237105969e-57
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GP1BB,Platelet glycoprotein Ib beta chain,37562,0.102012488183481,0.0063996783261671,0.0894691186641936,0.114555857702769,1.13368570837919e-56
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNFSF11,Tumor necrosis factor ligand superfamily member 11,40341,0.0912159312468914,0.00573549795091052,0.0799743552631067,0.102457507230676,1.62864053500014e-56
NMR metabolomics,X23495.Concentration of Large VLDL Particles,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",40305,0.0484785462292453,0.00304897590011755,0.0425025534650149,0.0544545389934757,1.73294488318255e-56
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GPI,Glucose-6-phosphate isomerase,37987,0.0704111654021147,0.00442598504197353,0.0617362347198465,0.0790860960843828,1.79392543776681e-56
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GRAP2,GRB2-related adapter protein 2,40359,0.190194945882907,0.0119641297755729,0.166745251522784,0.213644640243029,1.80607769066848e-56
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,40044,0.0819989719804734,0.00516138513417916,0.0718826571174822,0.0921152868434645,2.15883702640412e-56
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TMED8,Protein TMED8,37901,0.154102100017246,0.00970416735427351,0.13508193200287,0.173122268031622,2.82838006851561e-56
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PPBP,Platelet basic protein,37934,0.125881156422736,0.00793118223507987,0.110336039241979,0.141426273603492,3.21223346633848e-56
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SCARB2,Lysosome membrane protein 2,40011,0.0462351474129553,0.00291602163112169,0.0405197450159568,0.0519505498099538,3.54263488569604e-56
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FGF19,Fibroblast growth factor 19,40422,0.114606188105184,0.00723118060685895,0.10043307411574,0.128779302094627,3.8325660252365e-56
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IMPACT,Protein IMPACT,37942,0.0852629582771431,0.00537875668400208,0.074720595176499,0.0958053213777872,4.38000018869311e-56
NMR metabolomics,X23495.Concentration of Large VLDL Particles,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,37990,0.0925779350155281,0.00584106559267239,0.0811294464538902,0.104026423577166,4.52195264094064e-56
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,39976,0.116425164934009,0.00735278908600961,0.10201369832543,0.130836631542588,4.9641558870452e-56
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TRIAP1,TP53-regulated inhibitor of apoptosis 1,40489,0.0942012265553316,0.00595507776419208,0.0825292741375152,0.105873178973148,6.12845481545554e-56
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDCP1,CUB domain-containing protein 1,40228,0.072465688112712,0.00458562708684713,0.0634778590224916,0.0814535172029324,7.97721634341794e-56
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AP2B1,AP-2 complex subunit beta,37572,0.073117279753782,0.00462565466586949,0.0640509966086778,0.0821835628988862,9.11169051662514e-56
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",37714,0.0736849032809002,0.00466535787897273,0.0645408018381136,0.0828290047236867,1.09918171287184e-55
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SPARC,SPARC,40411,0.105298793406758,0.00668162432572753,0.092202809728332,0.118394777085184,1.55074563225075e-55
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PEBP1,Phosphatidylethanolamine-binding protein 1,40332,0.0870164909065944,0.00552356766565276,0.076190298281915,0.0978426835312738,1.70504549806257e-55
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",37671,0.154601287926285,0.0098211164458957,0.13535189969233,0.173850676160241,2.48790101491892e-55
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TBCB,Tubulin-folding cofactor B,40228,0.150048321858124,0.00954794505005631,0.131334349560013,0.168762294156234,3.11921643068843e-55
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TRIM58,E3 ubiquitin-protein ligase TRIM58,37900,0.128748170577541,0.00819751005679039,0.112681050866232,0.14481529028885,4.26048996635688e-55
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SCGB3A2,Secretoglobin family 3A member 2,40396,-0.12552745319726,0.00800520344550997,-0.141217651950459,-0.10983725444406,5.27641112801751e-55
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NEXN,Nexilin,37987,0.101289135909559,0.00645801145666146,0.0886314334545026,0.113946838364616,5.90056233004263e-55
NMR metabolomics,X23495.Concentration of Large VLDL Particles,C2,Complement C2,40372,0.0353741758484952,0.00226270299052583,0.0309392779870646,0.0398090737099258,1.09625797144395e-54
NMR metabolomics,X23495.Concentration of Large VLDL Particles,STK24,Serine/threonine-protein kinase 24,39961,0.0911291739148518,0.00583199935533231,0.0796984551784005,0.102559892651303,1.26885983891244e-54
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ATXN3,Ataxin-3,37942,0.0921523797738255,0.00589490011966987,0.0805983755392726,0.103706384008378,1.31580635482278e-54
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TMSB10,Thymosin beta-10,40332,0.111929673191744,0.00716924705596883,0.097877948962045,0.125981397421443,1.52274569606266e-54
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ELAC1,Zinc phosphodiesterase ELAC protein 1,37959,0.126239886007114,0.00808139027830263,0.110400361061641,0.142079410952587,1.56879137576542e-54
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD207,C-type lectin domain family 4 member K,40029,0.0566032709883386,0.00362881108015677,0.0494908012712313,0.0637157407054458,1.92936808657203e-54
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DYNLT1,Dynein light chain Tctex-type 1,37572,0.119617418839072,0.0076635030011147,0.104596952956887,0.134637884721257,1.95884135644002e-54
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MPRIP,Myosin phosphatase Rho-interacting protein,37863,0.0640517819335161,0.00410447240566107,0.0560070160184204,0.0720965478486118,2.01327384732638e-54
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD72,B-cell differentiation antigen CD72,37671,0.0625024011197497,0.00400889961016609,0.0546449578838242,0.0703598443556753,2.5543620027717e-54
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DNM3,Dynamin-3,37959,0.0808024001645717,0.00518708308018721,0.0706357173274048,0.0909690830017387,3.06085759131268e-54
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CPA1,Carboxypeptidase A1,40536,0.0840044705072479,0.00540088990760875,0.0734187262883347,0.094590214726161,3.71680875209115e-54
NMR metabolomics,X23495.Concentration of Large VLDL Particles,JAM3,Junctional adhesion molecule C,37671,0.0745463919999822,0.00479083771329878,0.0651563500819166,0.0839364339180478,4.09375268622227e-54
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD244,Natural killer cell receptor 2B4,40516,0.0390904635114957,0.00251425842414942,0.0341625170001629,0.0440184100228286,4.10013547364708e-54
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD226,CD226 antigen,37598,0.0617051982636173,0.00396589620184738,0.0539320417079965,0.0694783548192382,4.19807295209862e-54
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TP53I3,Quinone oxidoreductase PIG3,37419,0.0789331567993734,0.00507667783563951,0.0689828682415199,0.0888834453572268,5.02677672132117e-54
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IQGAP2,Ras GTPase-activating-like protein IQGAP2,40305,0.0797528005080317,0.00514362187466512,0.069671301633688,0.0898342993823753,7.94872885850451e-54
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ATXN2L,Ataxin-2-like protein,37959,0.0707894417108975,0.00456544343689031,0.0618411725745925,0.0797377108472025,9.24880577162323e-54
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DNAJB14,DnaJ homolog subfamily B member 14,37901,0.0941970928842925,0.00607804084039172,0.0822841328371247,0.10611005293146,1.04286722429626e-53
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ERP29,Endoplasmic reticulum resident protein 29,37671,0.173626567227999,0.0112076461455352,0.15165958078275,0.195593553673248,1.16670755708688e-53
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MMP10,Stromelysin-2,40341,-0.0875245201225359,0.00565933796426097,-0.0986168225324874,-0.0764322177125844,1.4567185189862e-53
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EGF,Pro-epidermal growth factor,40324,0.149754916848244,0.00969770755513571,0.130747410040178,0.16876242365631,2.07900176274557e-53
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PDGFA,Platelet-derived growth factor subunit A,40536,0.104755083603452,0.00678455659691546,0.0914573526734972,0.118052814533406,2.12107723349805e-53
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,37959,0.117019326867973,0.00757514186506692,0.102172048812442,0.131866604923504,2.23165664301352e-53
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,40228,0.0656467193628101,0.00425328137224436,0.0573102878732112,0.073983150852409,2.35935814540731e-53
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MPI,Mannose-6-phosphate isomerase,40305,0.125035392560425,0.00810176577771781,0.109155931636098,0.140914853484752,2.39505856130349e-53
NMR metabolomics,X23495.Concentration of Large VLDL Particles,UROD,Uroporphyrinogen decarboxylase,37671,0.102802699365852,0.00665768253122086,0.0897536416046589,0.115851757127045,2.52387368163676e-53
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SERPINE2,Glia-derived nexin,37990,0.0937463223801808,0.0060729699984992,0.0818433011831224,0.105649343577239,2.63885922096962e-53
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SLMAP,Sarcolemmal membrane-associated protein,37901,0.121528666756744,0.0078726015159551,0.106098367785472,0.136958965728016,2.64639423749347e-53
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VPS28,Vacuolar protein sorting-associated protein 28 homolog,37714,0.0970354447734996,0.00628959697294325,0.0847078347065308,0.109363054840468,3.07915034126533e-53
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LACTB2,Endoribonuclease LACTB2,40359,0.0958854110979278,0.00623109451861219,0.0836724658414479,0.108098356354408,4.73446580981777e-53
NMR metabolomics,X23495.Concentration of Large VLDL Particles,F2R,Proteinase-activated receptor 1,40396,0.0832911881366694,0.00542459381339253,0.0726589842624201,0.0939233920109188,7.90666660723123e-53
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",37901,0.149846009841493,0.00975620562949739,0.130723846807678,0.168968172875308,8.63958454765095e-53
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PCDH9,Protocadherin-9,37901,0.049134678980886,0.00319969649025416,0.0428632738599879,0.0554060841017842,9.04178973026405e-53
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FAM172A,Cotranscriptional regulator FAM172A,37628,0.0897220973744889,0.00584497969892821,0.0782659371645896,0.101178257584388,1.00764230752623e-52
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VASP,Vasodilator-stimulated phosphoprotein,37987,0.104672512944466,0.00682372798152125,0.0912980061006844,0.118047019788248,1.15436900441286e-52
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SMOC2,SPARC-related modular calcium-binding protein 2,40422,0.0554328786768099,0.00361755388160989,0.0483424730688545,0.0625232842847653,1.26516284705645e-52
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MIF,Macrophage migration inhibitory factor,40307,0.0997085752876403,0.00650983511934176,0.0869492984537305,0.11246785212155,1.40909709130804e-52
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PLPBP,Pyridoxal phosphate homeostasis protein,40359,0.0980973523998167,0.00641006680713294,0.0855336214578361,0.110661083341797,1.71017347498555e-52
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADD1,Alpha-adducin,37671,0.101664338381425,0.00664297905509435,0.0886440994334405,0.11468457732941,2.02135220168574e-52
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,40471,-0.0653666304468986,0.00427553168549861,-0.0737466725504758,-0.0569865883433213,2.13669866319143e-52
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TRIM24,Transcription intermediary factor 1-alpha,37687,0.0929638354090233,0.00608506182322866,0.0810371142354952,0.104890556582552,3.01783958323899e-52
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ARHGEF10,Rho guanine nucleotide exchange factor 10,37959,0.133954162956754,0.00878210260451641,0.116741241851902,0.151167084061607,4.26449015457746e-52
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SUOX,"Sulfite oxidase, mitochondrial",37959,0.0889083457530634,0.00583788611686265,0.0774660889640126,0.100350602542114,6.07730281694769e-52
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VAV3,Guanine nucleotide exchange factor VAV3,37541,0.143743514764778,0.00943742152819221,0.125246168569522,0.162240860960035,6.11415133843966e-52
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ANGPTL3,Angiopoietin-related protein 3,40355,0.0520932095692836,0.0034260709198827,0.0453781105663135,0.0588083085722537,7.59114362837425e-52
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL17RB,Interleukin-17 receptor B,40126,-0.0767157510905316,0.00504953035637779,-0.0866128305890321,-0.0668186715920312,9.24438066086856e-52
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SULT2A1,Bile salt sulfotransferase,40341,0.0763861479769172,0.00502900139608286,0.0665293052405948,0.0862429907132396,9.63698217877876e-52
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PDIA4,Protein disulfide-isomerase A4,37998,0.0869414380215349,0.00572114685656106,0.0757279901826752,0.0981548858603946,9.95459097408164e-52
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BIN2,Bridging integrator 2,40332,0.130163852991198,0.00857242043760674,0.113361908933489,0.146965797048907,1.04102199550817e-51
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CASP7,Caspase-7,37942,0.120353575109569,0.00792195633526294,0.104826540692454,0.135880609526685,1.06287946855636e-51
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ANKRD54,Ankyrin repeat domain-containing protein 54,39980,0.0829539202251306,0.00546620546117073,0.0722401575212359,0.0936676829290252,1.20065937774993e-51
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KCTD5,BTB/POZ domain-containing protein KCTD5,37716,0.0606454349261446,0.0039989858115787,0.0528074227354504,0.0684834471168389,1.62442904564169e-51
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LRRC59,Leucine-rich repeat-containing protein 59,37990,0.067408455584944,0.00444637926051181,0.0586935522343408,0.0761233589355471,1.71368966919832e-51
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CIAPIN1,Anamorsin,40411,0.0911361687289409,0.00602672319558841,0.0793237912655876,0.102948546192294,2.62872858923387e-51
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FOXJ3,Forkhead box protein J3,37598,0.0625784238278867,0.00413622451958325,0.0544714237695035,0.0706854238862699,2.80086287298515e-51
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MMP7,Matrilysin,40015,0.0688838650312922,0.00456077389514168,0.0599447481968145,0.0778229818657699,3.53709327756812e-51
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PARK7,Parkinson disease protein 7,40332,0.0763797818255587,0.00505820163075238,0.066465706629284,0.0862938570218333,3.65854783945687e-51
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ANG,Angiogenin,40309,0.0491113055294348,0.00325457652351417,0.0427323355433471,0.0554902755155226,4.2701013168513e-51
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,39939,0.082400451477869,0.00546043780776856,0.0716979933746426,0.0931029095810954,4.319369461635e-51
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD274,Programmed cell death 1 ligand 1,40228,0.0495616480153312,0.00328459635515428,0.0431238391592288,0.0559994568714336,4.33995960001086e-51
NMR metabolomics,X23495.Concentration of Large VLDL Particles,THTPA,Thiamine-triphosphatase,37884,0.126417392995524,0.00838110903378439,0.109990419289306,0.142844366701741,5.42756926908024e-51
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IGFBP4,Insulin-like growth factor-binding protein 4,40063,0.0604115112450304,0.00401319090226617,0.0525456570765887,0.0682773654134721,7.47633699185561e-51
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PPCDC,Phosphopantothenoylcysteine decarboxylase,40471,0.0670965894540941,0.0044587566603734,0.0583574263997622,0.0758357525084259,7.88520110563626e-51
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SERPINB1,Leukocyte elastase inhibitor,40287,0.126444118346272,0.00840388418488224,0.109972505343903,0.142915731348641,8.24288612978786e-51
NMR metabolomics,X23495.Concentration of Large VLDL Particles,REEP4,Receptor expression-enhancing protein 4,37959,0.0884870684667887,0.00588132846010858,0.0769596646849759,0.100014472248601,9.53039521905264e-51
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CTSS,Cathepsin S,37057,0.0351129990769643,0.00233329730618783,0.0305397363568361,0.0396862617970924,9.71159819763794e-51
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HTRA2,"Serine protease HTRA2, mitochondrial",40411,0.0871622941872855,0.00579885583099126,0.0757965367585426,0.0985280516160283,1.0237272991381e-50
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RILP,Rab-interacting lysosomal protein,40434,0.0855250363195098,0.00569237092168484,0.0743679893130075,0.0966820833260121,1.12551206909006e-50
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ECHS1,"Enoyl-CoA hydratase, mitochondrial",37628,0.138704735290917,0.00923608589862722,0.120602006929608,0.156807463652226,1.47245616141638e-50
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CPPED1,Serine/threonine-protein phosphatase CPPED1,40471,0.0935038160288763,0.00623165224958402,0.0812897776196917,0.105717854438061,1.50908518840371e-50
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RBKS,Ribokinase,39991,0.0704557000316985,0.00469615654934052,0.0612512331949911,0.0796601668684059,1.5883044698544e-50
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EIF4E,Eukaryotic translation initiation factor 4E,37598,0.129584293248794,0.00863516709968801,0.112659365733406,0.146509220764183,1.7401165654533e-50
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FHIT,Bis(5'-adenosyl)-triphosphatase,39961,0.106684291934406,0.00711976288728635,0.0927295566753245,0.120639027193487,2.09648974764072e-50
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SERPINB6,Serpin B6,40433,0.0845652733199356,0.00564551690113467,0.0735000601937116,0.0956304864461595,2.20681501039463e-50
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CALB2,Calretinin,39961,0.0445583556535333,0.00297731691799714,0.0387228144942589,0.0503938968128077,2.75018178068812e-50
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CETN2,Centrin-2,39961,0.0949353889651926,0.00634774680525361,0.0824938052268955,0.10737697270349,3.19787542313833e-50
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CASP10,Caspase-10,39961,0.101348706425633,0.00678077043753344,0.088058396368067,0.114639016483198,3.66845467875139e-50
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL10RB,Interleukin-10 receptor subunit beta,40422,0.0401985991722781,0.0026902699515662,0.0349256700672084,0.0454715282773479,3.81903638645029e-50
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RNF5,E3 ubiquitin-protein ligase RNF5,37628,0.103883228413938,0.00694904286879431,0.0902631043911008,0.117503352436774,4.05211540866005e-50
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MGLL,Monoglyceride lipase,40396,0.121603573691068,0.00814732493738248,0.105634816813798,0.137572330568337,4.89073341718146e-50
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CTF1,Cardiotrophin-1,40042,0.11920897644657,0.00798903391528605,0.103550469972609,0.134867482920531,5.28069656951083e-50
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AMOT,Angiomotin,37671,0.0589847569161274,0.00395141418408381,0.0512399851153232,0.0667295287169317,5.57103819851533e-50
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VSNL1,Visinin-like protein 1,37942,0.0529242481235323,0.00354633137236706,0.0459734386336928,0.0598750576133717,5.78725992707729e-50
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PPIB,Peptidyl-prolyl cis-trans isomerase B,40338,0.132522042491006,0.00888800479653431,0.115101553089799,0.149942531892213,6.15512866332213e-50
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CASP2,Caspase-2,40341,0.0951178285416544,0.00638357619844579,0.0826060191927007,0.107629637890608,7.11391399052738e-50
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL12A_IL12B,Interleukin-12,40305,0.11023524565222,0.00740436140062579,0.0957226973069935,0.124747793997447,8.57193074642203e-50
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BAG6,Large proline-rich protein BAG6,40042,0.0504863097615522,0.00339375081950747,0.0438345581553176,0.0571380613677868,1.03062775401882e-49
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RASSF2,Ras association domain-containing protein 2,39980,0.0772933197884897,0.00519799344979976,0.0671052526268821,0.0874813869500972,1.13635729213234e-49
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MESD,LRP chaperone MESD,40332,0.17001936854982,0.0114356134906045,0.147605566108235,0.192433170991404,1.15544845132133e-49
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CRYZL1,Quinone oxidoreductase-like protein 1,37628,0.131302939500725,0.00882658418162451,0.114002834504741,0.148603044496709,1.19530190016424e-49
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GGH,Gamma-glutamyl hydrolase,40077,0.0480559806982573,0.00323682191926058,0.0417118097365066,0.054400151660008,1.59067796326398e-49
NMR metabolomics,X23495.Concentration of Large VLDL Particles,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",37628,0.0648918281700479,0.00437137698439822,0.0563239292806274,0.0734597270594684,1.88804645401785e-49
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,40228,0.0770381977027086,0.00519348512191857,0.0668589668637482,0.087217428541669,1.91248013824203e-49
NMR metabolomics,X23495.Concentration of Large VLDL Particles,C1RL,Complement C1r subcomponent-like protein,37993,0.0272512020110583,0.0018362769362678,0.0236520992159734,0.0308503048061432,1.96074900517411e-49
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DNAJB2,DnaJ homolog subfamily B member 2,37671,0.0766003060342044,0.0051613375289008,0.0664840844775588,0.0867165275908499,1.98270588074081e-49
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DBI,Acyl-CoA-binding protein,40270,0.110542757271293,0.00745632646740591,0.0959283573951771,0.125157157147408,2.15482707308775e-49
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SCARF1,Scavenger receptor class F member 1,40536,0.0592250476391204,0.00400027049919732,0.0513845174606937,0.0670655778175472,2.85867654521753e-49
NMR metabolomics,X23495.Concentration of Large VLDL Particles,JPT2,Jupiter microtubule associated homolog 2,37901,0.122723515219428,0.00829819860756589,0.106459045948599,0.138987984490258,4.18030140520131e-49
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TBC1D5,TBC1 domain family member 5,40341,0.109394621295017,0.00740211117917396,0.0948864833838359,0.123902759206198,4.24901012488234e-49
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,37900,0.0540194351416732,0.00365443172154204,0.0468567489674508,0.0611821213158956,4.64976097211027e-49
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HSPB1,Heat shock protein beta-1,40116,0.0945881699561033,0.00640274572808554,0.0820387883290556,0.107137551583151,4.67363964532857e-49
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ATP6AP2,Renin receptor,39980,0.0581012971644576,0.00394267539642664,0.0503736533874614,0.0658289409414538,8.0265752238599e-49
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,40341,0.139995992529032,0.0095023085673921,0.121371467736943,0.15862051732112,8.3255901206865e-49
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EHD3,EH domain-containing protein 3,37628,0.163446939250863,0.0110875095452935,0.141715420542087,0.185178457959638,8.53062370170241e-49
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MSR1,Macrophage scavenger receptor types I and II,40471,0.0622032824894369,0.00422721923076316,0.0539179327971411,0.0704886321817327,1.07465132416114e-48
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PSAP,Prosaposin,37901,0.0396668374730921,0.00269400194378486,0.0343865936632738,0.0449470812829105,1.07965497860666e-48
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,39980,0.080564200659459,0.00547550360796056,0.0698322135878564,0.0912961877310617,1.1217944461243e-48
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MAPKAPK2,MAP kinase-activated protein kinase 2,37714,0.102096163237239,0.00693665278345914,0.0885003237816589,0.115692002692819,1.1885824835998e-48
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL1R2,Interleukin-1 receptor type 2,40330,0.0270853362353367,0.00184462240680701,0.0234698763179949,0.0307007961526784,1.71237333486489e-48
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CALCA,Calcitonin,40192,0.0762750538892891,0.00520266399184764,0.0660778324652678,0.0864722753133105,2.39498118174172e-48
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",37990,0.10317628715485,0.00703409871279962,0.0893894536777625,0.116963120631937,2.42633111369434e-48
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MICALL2,MICAL-like protein 2,37572,0.0949880068210312,0.00648039304742849,0.0822864364480714,0.107689577193991,2.89227915353836e-48
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,40397,0.152194754973702,0.0104005043419389,0.131809766463502,0.172579743483903,3.53029083215697e-48
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MYO9B,Unconventional myosin-IXb,40044,0.0917113599870884,0.0062684645945967,0.0794251693816789,0.103997550592498,3.73678936803938e-48
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HPSE,Heparanase,37848,0.128747213096656,0.00879817993228942,0.111502780429368,0.145991645763943,4.04281052834977e-48
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ARHGAP25,Rho GTPase-activating protein 25,39980,0.0820649770481573,0.00561280518177948,0.0710638788918695,0.093066075204445,4.30547417818769e-48
NMR metabolomics,X23495.Concentration of Large VLDL Particles,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,37990,0.124334187995353,0.00850028701279687,0.107673625450271,0.140994750540435,4.39170471004879e-48
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NARS1,"Asparagine--tRNA ligase, cytoplasmic",37959,0.0658699107417251,0.00450974968207538,0.0570308013648573,0.0747090201185928,5.95608507953736e-48
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RAB33A,Ras-related protein Rab-33A,37562,0.0923028448435106,0.00631937853937335,0.0799168629063388,0.104688826780682,6.09014066038397e-48
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TMEM106A,Transmembrane protein 106A,37900,0.0968557326335081,0.00663516873161512,0.0838508019195424,0.109860663347474,6.78641238978798e-48
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LAP3,Cytosol aminopeptidase,40044,0.0677033118592487,0.00464456820419992,0.0585999581790168,0.0768066655394805,8.13085020999252e-48
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DDT,D-dopachrome decarboxylase,37998,0.0565161574230735,0.0038753152931115,0.0489205394485749,0.064111775397572,8.22017847451461e-48
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TREML2,Trem-like transcript 2 protein,40332,0.0461648065098164,0.00317069557213391,0.039950243188434,0.0523793698311989,1.0265815532235e-47
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MDH1,"Malate dehydrogenase, cytoplasmic",37928,0.0561114537151515,0.00385476936821079,0.0485561057534583,0.0636668016768446,1.22274015159104e-47
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CXCL11,C-X-C motif chemokine 11,40471,0.10921403299135,0.00751504118285568,0.0944845522729532,0.123943513709747,1.50858850033858e-47
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PPP3R1,Calcineurin subunit B type 1,40228,0.0567673542075427,0.00390674273420932,0.0491101384484924,0.0644245699665929,1.57191641554609e-47
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NACC1,Nucleus accumbens-associated protein 1,37900,0.0756751957726202,0.00520498303176875,0.0654734290303535,0.085876962514887,1.5728882227334e-47
NMR metabolomics,X23495.Concentration of Large VLDL Particles,APP,Amyloid-beta precursor protein,40309,0.091910418010789,0.00633382730021584,0.079496116502366,0.104324719519212,2.07608081654368e-47
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,40396,0.10498772423733,0.00723818802478892,0.0908008757087442,0.119174572765917,2.26583260553573e-47
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TXNDC9,Thioredoxin domain-containing protein 9,37942,0.0730083729085488,0.00503184052734603,0.0631459654749506,0.082870780342147,2.40427315470926e-47
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CSTB,Cystatin-B,40097,0.0573836357440969,0.00395923368896883,0.049623537713718,0.0651437337744758,2.6920336424761e-47
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GGCT,Gamma-glutamylcyclotransferase,37978,0.0663872422367628,0.00457900700401243,0.0574123885088985,0.0753620959646272,2.81344356179005e-47
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PDAP1,28 kDa heat- and acid-stable phosphoprotein,37990,0.134362086462857,0.00927067112385251,0.116191571060106,0.152532601865608,3.01747859933525e-47
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FIS1,Mitochondrial fission 1 protein,40354,0.10566894544805,0.00729581810524914,0.0913691419617612,0.119968748934338,3.07863786009227e-47
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SMAD3,Mothers against decapentaplegic homolog 3,37900,0.0695770906898118,0.00480237399350378,0.0601644376625444,0.0789897437170792,3.26769478881247e-47
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NTRK3,NT-3 growth factor receptor,40471,-0.0298597848335695,0.00206408257817714,-0.0339053866867967,-0.0258141829803423,3.91688603392604e-47
NMR metabolomics,X23495.Concentration of Large VLDL Particles,UMOD,Uromodulin,40502,-0.0741149076990408,0.00512463455789297,-0.0841591914325111,-0.0640706239655706,4.13653355645614e-47
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MCEMP1,Mast cell-expressed membrane protein 1,37598,0.1266617855716,0.00875456242666464,0.109502843215337,0.143820727927863,4.43117755621103e-47
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CTRB1,Chymotrypsinogen B,40332,0.0727646608554985,0.00503471698430101,0.0628966155662685,0.0826327061447285,4.801638201246e-47
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,37671,0.0836290261994429,0.00578778379709058,0.0722849699571453,0.0949730824417404,5.7764955007388e-47
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ANGPT1,Angiopoietin-1,40263,0.115726450574543,0.00801437965149839,0.100018266457606,0.13143463469148,5.77945347627886e-47
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ABRAXAS2,BRISC complex subunit Abraxas 2,37562,0.0918300003417341,0.00635712022084796,0.0793700447088721,0.104289955974596,6.15882521943392e-47
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CERT,Ceramide transfer protein,39961,0.0839288465033688,0.00581573852520264,0.0725299989939716,0.095327694012766,6.61627382685213e-47
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCL8,C-C motif chemokine 8,40470,0.0823397237160254,0.00570766205653954,0.0711527060852079,0.0935267413468429,6.96778451450607e-47
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GP5,Platelet glycoprotein V,37671,0.0490135975555127,0.00340155427778102,0.0423465511710619,0.0556806439399635,1.02317224626077e-46
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,40228,0.129203085534324,0.00897275098950296,0.111616493594898,0.146789677473749,1.03078846680068e-46
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,37671,0.0392676778070353,0.00272578598869675,0.0339251372691897,0.0446102183448809,1.07053902988666e-46
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CEP170,Centrosomal protein of 170 kDa,37628,0.105403606548889,0.00732037195547418,0.0910556775161595,0.119751535581618,1.19157006133736e-46
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,40305,0.128386783381695,0.00892542318912077,0.110892953931018,0.145880612832372,1.27460041210136e-46
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCL18,C-C motif chemokine 18,40172,0.095538355266777,0.00664217224974889,0.0825196976572691,0.108557012876285,1.296386467578e-46
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TADA3,Transcriptional adapter 3,37900,0.0530422788228953,0.00368661658524485,0.0458165103158154,0.0602680473299752,1.36866812594986e-46
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",37942,0.0527168919310882,0.00366454847376002,0.0455343769225185,0.0598994069396578,1.40773377519246e-46
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD83,CD83 antigen,40341,0.0456987318962479,0.00317881139371354,0.0394682615645694,0.0519292022279265,1.43359393031849e-46
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VPS4B,Vacuolar protein sorting-associated protein 4B,37900,0.128548016059785,0.00893816097967396,0.111029220539624,0.146066811579946,1.48778590103527e-46
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,37990,0.054541625296703,0.00379430286191247,0.0471047916873546,0.0619784589060515,1.64251988506185e-46
NMR metabolomics,X23495.Concentration of Large VLDL Particles,F12,Coagulation factor XII,38013,0.0568041161111064,0.00395612167365567,0.0490501176307413,0.0645581145914715,2.06157280202853e-46
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CTSL,Cathepsin L1,40359,0.0328567334851291,0.00229073030444639,0.0283669020884141,0.037346564881844,2.28234241881594e-46
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CXCL16,C-X-C motif chemokine 16,40517,0.0321855694617502,0.00224547575239268,0.0277844369870605,0.0365867019364398,2.60772168496319e-46
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FAS,Tumor necrosis factor receptor superfamily member 6,40490,0.0433941247801687,0.00302875697226309,0.037457761114533,0.0493304884458043,2.84904751961444e-46
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PTGDS,Prostaglandin-H2 D-isomerase,40234,0.0400267789340245,0.00279361531475617,0.0345512929171024,0.0455022649509466,2.85576622849113e-46
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,39961,0.152111150871751,0.0106166821716202,0.131302453815375,0.172919847928127,2.90529502015969e-46
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,37900,0.146535841920217,0.0102255326263325,0.126493797972605,0.166577885867828,3.0944037396282e-46
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NPC2,NPC intracellular cholesterol transporter 2,37815,0.0420603738474181,0.00293676380571677,0.0363043167882132,0.0478164309066229,3.50164970442319e-46
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCL4,C-C motif chemokine 4,40376,0.0915217042037342,0.00639456682490757,0.0789883532269154,0.104055055180553,3.53989451124462e-46
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LGALS3BP,Galectin-3-binding protein,38013,0.0401710831286472,0.00280558232920359,0.0346721417634081,0.0456700244938862,3.65081372333517e-46
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TSC22D1,TSC22 domain family protein 1,37959,0.0912560642103043,0.00637427270715332,0.0787624897042838,0.103749638716325,3.76512377497203e-46
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DTD1,D-aminoacyl-tRNA deacylase 1,37671,0.118402913616534,0.00827190184956642,0.102189985991384,0.134615841241684,3.96350317636249e-46
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ASRGL1,Isoaspartyl peptidase/L-asparaginase,37628,0.138825818131387,0.00970126318476016,0.119811342289257,0.157840293973517,4.19287764964324e-46
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GMFG,Glia maturation factor gamma,37990,0.0971109965345508,0.00679161586984298,0.0837994294296586,0.110422563639443,4.8259522226307e-46
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCT5,T-complex protein 1 subunit epsilon,39980,0.0614330206475352,0.00429948044932365,0.0530060389668608,0.0698600023282095,5.05474133160795e-46
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BCL2L1,Bcl-2-like protein 1,37942,0.135035338080418,0.00944912692524437,0.116515049306939,0.153555626853897,5.4102197760786e-46
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NRGN,Neurogranin,37987,0.12253306530644,0.0085773005909263,0.105721556148224,0.139344574464656,5.79493045379459e-46
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CASP3,Caspase-3,40536,0.118711112902045,0.00831898212355174,0.102405907939883,0.135016317864206,6.42613550268956e-46
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,37959,0.133885212479973,0.00937885363458186,0.115502659356193,0.152267765603754,6.73435580105429e-46
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SUGT1,Protein SGT1 homolog,39980,0.10973307119054,0.0076982395299809,0.0946445217117772,0.124821620669302,8.19874827545915e-46
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DXO,Decapping and exoribonuclease protein,37942,0.0618858905814486,0.00433977688235465,0.0533799278920335,0.0703918532708637,8.33930702140517e-46
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EFNA4,Ephrin-A4,40203,0.0397005676025323,0.00278618598984509,0.0342396430624359,0.0451614921426286,8.74643350958813e-46
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SORCS2,VPS10 domain-containing receptor SorCS2,39980,0.0484632302012016,0.00340289490027696,0.0417935561966588,0.0551329042057445,9.78875856785766e-46
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL7,Interleukin-7,40341,0.0866814305380821,0.00608914838158559,0.0747466997101743,0.0986161613659898,1.05518088475172e-45
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KLK13,Kallikrein-13,40032,0.0582787850120037,0.00410353576018438,0.0502358549220423,0.0663217151019651,1.70950871825119e-45
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PMVK,Phosphomevalonate kinase,39951,0.148555696443958,0.0104725906276458,0.128029418813773,0.169081974074144,2.17611797479163e-45
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DCTD,Deoxycytidylate deaminase,37671,0.126884786434842,0.00895000275432978,0.109342781036355,0.144426791833328,2.7271175406552e-45
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KLRB1,Killer cell lectin-like receptor subfamily B member 1,40516,0.0499904314924937,0.00352893542179068,0.043073718065784,0.0569071449192034,2.79155797169092e-45
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NPDC1,Neural proliferation differentiation and control protein 1,40359,0.0414669006875322,0.00293022757309474,0.0357236546442666,0.0472101467307979,3.44064334066749e-45
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SMTN,Smoothelin,37905,0.129048365687738,0.00912193162517749,0.11116937970239,0.146927351673086,4.10045938450063e-45
NMR metabolomics,X23495.Concentration of Large VLDL Particles,COMT,Catechol O-methyltransferase,39877,0.113688569867949,0.00804388989636895,0.0979225456710659,0.129454594064832,4.5100082061306e-45
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,37901,0.0869214120351726,0.00615655945845758,0.0748545554965957,0.0989882685737494,6.11488142959612e-45
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,40516,0.0508883171434037,0.00360680868900083,0.043818972112962,0.0579576621738453,6.20393169420214e-45
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CRYBB1,Beta-crystallin B1,37990,0.0866645646951959,0.00613902654683312,0.074632072663403,0.0986970567269888,6.21594331460621e-45
NMR metabolomics,X23495.Concentration of Large VLDL Particles,STXBP1,Syntaxin-binding protein 1,37959,0.103387010763255,0.00732775385252474,0.0890246132123068,0.117749408314204,6.96534051986671e-45
NMR metabolomics,X23495.Concentration of Large VLDL Particles,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",40182,0.0546589169363369,0.00387674461143491,0.0470604974979245,0.0622573363747493,7.20724596725252e-45
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,40379,0.0355221642336538,0.00252049238927346,0.0305819991506778,0.0404623293166298,7.76034637515943e-45
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SERPINB9,Serpin B9,40228,0.0446890077796344,0.0031747079893288,0.0384665801205499,0.0509114354387188,9.868595830088e-45
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ATG4A,Cysteine protease ATG4A,39980,0.0791621703063614,0.00563145925158228,0.0681245101732601,0.0901998304394626,1.30736271647183e-44
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TBCA,Tubulin-specific chaperone A,37671,0.115921756053338,0.00825758980657424,0.0997368800324527,0.132106632074224,1.89682997925021e-44
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,37594,0.0514027056642779,0.00366478955955719,0.0442197181275458,0.05858569320101,2.25390822902273e-44
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CFB,Complement factor B,37770,0.0435521367465581,0.00310865076003187,0.0374591812568957,0.0496450922362206,2.792202307565e-44
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VASH1,Tubulinyl-Tyr carboxypeptidase 1,40341,0.107004616021101,0.00765623009124771,0.0919984050422555,0.122010826999947,3.97777241941487e-44
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EDAR,Tumor necrosis factor receptor superfamily member EDAR,40341,0.121189780636329,0.00868578660546616,0.104165638889615,0.138213922383042,5.50953752349685e-44
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GP6,Platelet glycoprotein VI,40311,0.115973150879516,0.00832200703573302,0.0996620170894795,0.132284284669553,6.97326738743869e-44
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KLRD1,Natural killer cells antigen CD94,40516,0.0599879875927289,0.00431297694610537,0.0515345527783624,0.0684414224070954,1.00527358668967e-43
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SLAMF6,SLAM family member 6,39980,0.0499787214265117,0.00359720701316393,0.0429281956807104,0.057029247172313,1.26078667304602e-43
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,37598,0.105028919786707,0.00755646703663217,0.0902182443949076,0.119839595178506,1.30285818057643e-43
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GIP,Gastric inhibitory polypeptide,37628,0.0680755239325851,0.00489901003527375,0.0584734642634485,0.0776775836017216,1.36382395164376e-43
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CRIM1,Cysteine-rich motor neuron 1 protein,40422,-0.0270093249400722,0.00194920881813953,-0.0308297742236257,-0.0231888756565188,2.07062674649257e-43
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DIABLO,"Diablo homolog, mitochondrial",40314,0.143146180920031,0.0103464411944004,0.122867156179007,0.163425205661056,2.78430262814805e-43
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NUDT16,U8 snoRNA-decapping enzyme,37880,0.114710622141369,0.00829360041394945,0.0984551653300285,0.13096607895271,3.267225554537e-43
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SETMAR,Histone-lysine N-methyltransferase SETMAR,40182,0.0389772274267656,0.00282266802463864,0.0334447980984739,0.0445096567550574,4.03399221936017e-43
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,37900,0.0459896725281665,0.00332982103699431,0.0394632232956576,0.0525161217606753,4.27893813727876e-43
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ANXA3,Annexin A3,40442,0.0913018729120443,0.00661920746114135,0.0783282262882073,0.104275519535881,4.92053222031707e-43
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,37575,0.0467193701928945,0.00338554370571926,0.0400837045296848,0.0533550358561043,5.11192879564852e-43
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LARP1,La-related protein 1,37900,0.0829359649187163,0.00601713230422373,0.0711423856024378,0.0947295442349948,6.28822014080863e-43
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MFAP5,Microfibrillar-associated protein 5,40536,0.0533744177408505,0.00387820754445981,0.0457731309537093,0.0609757045279917,7.47865668897315e-43
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,40471,0.0743467417444683,0.0054200384012479,0.0637234664780224,0.0849700170109141,1.3975405403733e-42
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LONP1,"Lon protease homolog, mitochondrial",37628,0.112620136008333,0.00821746131961387,0.0965139118218896,0.128726360194776,1.85277089342622e-42
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TIMP1,Metalloproteinase inhibitor 1,40167,0.0364198829978116,0.00266088149596587,0.0312045552657185,0.0416352107299047,2.12092049972476e-42
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CEBPB,CCAAT/enhancer-binding protein beta,40042,0.0489373999490721,0.00357843631507759,0.04192366477152,0.0559511351266242,2.49116518795277e-42
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,39980,0.084718433429209,0.00620717201973317,0.072552376270532,0.096884490587886,3.60966535160327e-42
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TPP1,Tripeptidyl-peptidase 1,40255,0.0576808252147706,0.00422753213438235,0.0493948622313812,0.06596678819816,3.79397127081318e-42
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MANF,Mesencephalic astrocyte-derived neurotrophic factor,40422,0.153162805972918,0.011230299616124,0.131151418725315,0.175174193220521,4.07734850751367e-42
NMR metabolomics,X23495.Concentration of Large VLDL Particles,POSTN,Periostin,37998,-0.049007099049993,0.00359210512824121,-0.0560476251013457,-0.0419665729986402,4.21604908240889e-42
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RELT,Tumor necrosis factor receptor superfamily member 19L,40332,0.0352604921117082,0.00258805442601051,0.0301879054367276,0.0403330787866888,4.94585008844804e-42
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AIF1,Allograft inflammatory factor 1,39980,0.0679965350312971,0.00499305604507821,0.0582101451829438,0.0777829248796504,5.43786982652878e-42
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LGALS3,Galectin-3,40374,0.0380812715752754,0.00279789282039436,0.0325974016473024,0.0435651415032483,5.93895142178883e-42
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDC37,Hsp90 co-chaperone Cdc37,40411,0.107500057738927,0.00791514433021692,0.0919863748517013,0.123013740626152,8.79263668364673e-42
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LEPR,Leptin receptor,40359,-0.0393148246131145,0.00290040789150196,-0.0449996240804583,-0.0336300251457706,1.26145218490459e-41
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PSMG3,Proteasome assembly chaperone 3,40341,0.0656825706217498,0.00484760337288207,0.056181268010901,0.0751838732325987,1.35809387678318e-41
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,37225,0.138514314538817,0.0102223086287542,0.118478589626459,0.158550039451175,1.52984421017556e-41
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,40341,0.0783179198757146,0.00578478550753321,0.0669797402809496,0.0896560994704797,1.57251217259355e-41
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SIGLEC8,Sialic acid-binding Ig-like lectin 8,37628,0.058066443723474,0.00429030401534573,0.0496574478533964,0.0664754395935517,1.85534284228236e-41
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCL2,C-C motif chemokine 2,40203,0.0676649851320597,0.00500693522009981,0.057851392100664,0.0774785781634553,2.19165238359952e-41
NMR metabolomics,X23495.Concentration of Large VLDL Particles,F11,Coagulation factor XI,37810,0.0387891422756415,0.00286917948923628,0.0331655504767384,0.0444127340745447,2.25240917858625e-41
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IMMT,MICOS complex subunit MIC60,37900,0.0569378970946035,0.00421461090195892,0.048677259726764,0.0651985344624429,2.5511602679917e-41
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HNMT,Histamine N-methyltransferase,40147,0.0592830880748696,0.00439084072084668,0.0506770402620101,0.0678891358877291,2.60457554435418e-41
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDC26,Anaphase-promoting complex subunit CDC26,37879,0.0902079054393829,0.00667849451718636,0.0771180561856976,0.103297754693068,2.63789780948957e-41
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PLA2G15,Phospholipase A2 group XV,40411,0.0328608144084887,0.00243440032763005,0.0280893897663338,0.0376322390506436,2.68837559130381e-41
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PTX3,Pentraxin-related protein PTX3,40341,-0.062722581660131,0.00464983733860051,-0.071836262843788,-0.053608900476474,3.05358160624773e-41
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL12B,Interleukin-12 subunit beta,40516,0.0691931760695175,0.00513385273925478,0.0591308247005781,0.0792555274384568,3.53642519657693e-41
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CHM,Rab proteins geranylgeranyltransferase component A 1,37572,0.0781656112423811,0.00579932381313161,0.0667989365686431,0.089532285916119,3.93540264953424e-41
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,37598,0.062475606670737,0.00463532873457988,0.0533903623509604,0.0715608509905135,3.94431138169668e-41
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BLNK,B-cell linker protein,37598,0.0490027346799328,0.00363797276766446,0.0418723080553105,0.0561331613045552,4.40978266265398e-41
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",37990,0.0944927654289943,0.00701751651502024,0.0807384330595547,0.108247097798434,4.60075915931703e-41
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AKT2,RAC-beta serine/threonine-protein kinase,37959,0.160043037833746,0.0119039312166197,0.136711332649172,0.183374743018321,6.0750079529953e-41
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RP2,Protein XRP2,40305,0.052476820520748,0.00390687249617466,0.0448193504282457,0.0601342906132504,6.57896103365576e-41
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PTP4A3,Protein tyrosine phosphatase type IVA 3,37598,0.0676786525963387,0.00503911340880857,0.0578019903150739,0.0775553148776035,7.43172276805715e-41
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ITGB1BP2,Integrin beta-1-binding protein 2,40042,0.14035963809908,0.0104590560336014,0.119859888273221,0.160859387924939,7.7896087848633e-41
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,39980,0.0861944938824107,0.00642391309013973,0.0736036242257368,0.0987853635390845,8.03380364864922e-41
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,37628,0.0669254977961321,0.00500426527356141,0.0571171378599518,0.0767338577323125,1.58288565367594e-40
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BDNF,Brain-derived neurotrophic factor,37998,0.104855367577293,0.00784186350485352,0.0894853151077797,0.120225420046806,1.60870483854365e-40
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MIA,Melanoma-derived growth regulatory protein,40411,0.0467736116473572,0.00350047722433327,0.039912676287664,0.0536345470070504,1.6627630056293e-40
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BMPER,BMP-binding endothelial regulator protein,37671,0.0284951299269873,0.00213184177656819,0.0243167200449136,0.032673539809061,1.73933752172911e-40
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",37990,0.112114142687476,0.00839454937345408,0.0956608259155063,0.128567459459446,1.98028253128327e-40
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GNPDA2,Glucosamine-6-phosphate isomerase 2,37671,0.0461036738120424,0.00345552277405872,0.0393308491748874,0.0528764984491975,2.40355569183564e-40
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ITPA,Inosine triphosphate pyrophosphatase,37562,0.0859225963411284,0.00644671095080141,0.0732870428775576,0.0985581498046992,2.9030064714367e-40
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NBN,Nibrin,40044,0.064121946941742,0.00482106815060535,0.0546726533665555,0.0735712405169285,3.81164887401441e-40
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DNAJC9,DnaJ homolog subfamily C member 9,37901,0.0970217059678576,0.00729615961307332,0.0827212331262339,0.111322178809481,4.27818413037862e-40
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FADD,FAS-associated death domain protein,40359,0.0959536713028429,0.00722007994263394,0.0818023146152804,0.110105027990405,4.33769262687117e-40
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,37628,0.0596673411576155,0.00448937921419567,0.050868157897792,0.068466524417439,4.73993793941913e-40
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FAM3C,Protein FAM3C,40330,0.0372628652588981,0.00280692128301428,0.0317612995441901,0.0427644309736061,5.25706327209278e-40
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HAVCR1,Hepatitis A virus cellular receptor 1,40470,0.0767955070755913,0.00578725845673762,0.0654524805003855,0.088138533650797,5.63602188780594e-40
NMR metabolomics,X23495.Concentration of Large VLDL Particles,WDR46,WD repeat-containing protein 46,37900,0.044810954994395,0.00337555006008734,0.0381948768766239,0.0514270331121662,5.75507742266464e-40
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HSPB6,Heat shock protein beta-6,40489,0.0457478039409479,0.00345306124402278,0.0389798039026632,0.0525158039792325,7.4577306612888e-40
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LTBP2,Latent-transforming growth factor beta-binding protein 2,40536,-0.0396022809010475,0.00298964305425834,-0.0454619812873938,-0.0337425805147011,7.64479604206993e-40
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FOXO3,Forkhead box protein O3,39980,0.12155123151378,0.00917918528563852,0.103560028353929,0.139542434673632,8.24490296820377e-40
NMR metabolomics,X23495.Concentration of Large VLDL Particles,XCL1,Lymphotactin,40489,0.0706511613006499,0.00533648111348546,0.0601916583182184,0.0811106642830814,8.41855246743675e-40
NMR metabolomics,X23495.Concentration of Large VLDL Particles,C19orf12,Protein C19orf12,39961,0.0778648519888227,0.00588112957046535,0.0663378380307106,0.0893918659469348,8.50038178557355e-40
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ARSA,Arylsulfatase A,40332,0.0557384203960419,0.00421919914383219,0.0474687900741308,0.064008050717953,1.23244728303434e-39
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CYB5R2,NADH-cytochrome b5 reductase 2,37746,0.0696815636418294,0.0052798123483932,0.0593331314389788,0.0800299958446801,1.60208833629421e-39
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,40359,0.079878126197404,0.00605589832843971,0.0680085654736621,0.0917476869211458,1.61242522748372e-39
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GGACT,Gamma-glutamylaminecyclotransferase,37990,0.0884000360042698,0.00671746516625917,0.0752338042784018,0.101566267730138,2.60750964571744e-39
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FCN1,Ficolin-1,37967,0.0703097383439311,0.00535011010625728,0.0598235225356668,0.0807959541521953,3.30131130091214e-39
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SCRG1,Scrapie-responsive protein 1,37990,0.034180373622998,0.00260385419282242,0.0290768194050661,0.03928392784093,4.00566295143326e-39
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PNLIPRP1,Inactive pancreatic lipase-related protein 1,37942,0.094985251140785,0.00723649516322838,0.0808017206208574,0.109168781660713,4.06475560240306e-39
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PLA2G4A,Cytosolic phospholipase A2,40422,0.108037982488828,0.00823554130190931,0.0918963215370857,0.12417964344057,4.10978533945531e-39
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PNMA1,Paraneoplastic antigen Ma1,37628,0.0695457593729837,0.00530430745446801,0.0591493167622264,0.079942201983741,4.9856230956467e-39
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GIPC3,PDZ domain-containing protein GIPC3,37901,0.121551383745923,0.00927552111396097,0.103371362362559,0.139731405129286,5.37533249483615e-39
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IFT20,Intraflagellar transport protein 20 homolog,37572,0.0535899641139338,0.00409133446597324,0.0455709485606263,0.0616089796672414,5.90137833909199e-39
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AKT3,RAC-gamma serine/threonine-protein kinase,39897,0.0709410829736581,0.00542362908981441,0.0603107699576219,0.0815713959896943,6.8947194982076e-39
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VWC2,Brorin,40167,0.0481378322816045,0.00368252244882594,0.0409200882819056,0.0553555762813033,7.59212840702507e-39
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ABHD14B,Protein ABHD14B,40171,0.0723873521016505,0.00554068679337614,0.0615276059866332,0.0832470982166677,8.34526435671341e-39
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ACYP1,Acylphosphatase-1,37622,0.0819904395897075,0.00627556237518232,0.0696903373343502,0.0942905418450649,9.08410920925269e-39
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ERMAP,Erythroid membrane-associated protein,37598,0.0555660178963256,0.00426199801837152,0.0472125017803174,0.0639195340123338,1.2983636055468e-38
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ARL13B,ADP-ribosylation factor-like protein 13B,37562,0.0860109620375789,0.00660277621987159,0.0730695206466306,0.0989524034285272,1.50052132080182e-38
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MZT1,Mitotic-spindle organizing protein 1,39980,0.0649019428375373,0.00499345675662796,0.0551147675945465,0.0746891180805282,2.00819936625287e-38
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SPINT2,Kunitz-type protease inhibitor 2,40422,0.0515833184209821,0.00396961433864605,0.0438028743172359,0.0593637625247284,2.05751078959215e-38
NMR metabolomics,X23495.Concentration of Large VLDL Particles,APOA2,Apolipoprotein A-II,37987,-0.0586395692601006,0.0045122592966743,-0.0674835974815822,-0.049795541038619,2.19834020135926e-38
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADGRF5,Adhesion G protein-coupled receptor F5,37990,0.036797251460586,0.00283418130236498,0.0312422561079506,0.0423522468132213,2.57394162307092e-38
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TTF2,Transcription termination factor 2,37572,0.0599019859304503,0.00461595193521741,0.0508547201374242,0.0689492517234764,2.83527584560098e-38
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MTIF3,"Translation initiation factor IF-3, mitochondrial",37901,0.107407522759357,0.00827906187198425,0.0911805614902677,0.123634484028446,2.93777373747368e-38
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CEMIP2,Cell surface hyaluronidase,37598,0.0415485960080477,0.00320751254568673,0.0352618714185017,0.0478353205975937,3.84019299949345e-38
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SEPTIN9,Septin-9,40305,0.0344790467920465,0.00266399267635338,0.0292576211463939,0.0397004724376991,4.03485291718111e-38
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL32,Interleukin-32,40341,-0.0523009805622993,0.00404222430797424,-0.0602237402059288,-0.0443782209186698,4.24160533345394e-38
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DBN1,Drebrin,37598,0.0634827078053113,0.00491195862860072,0.0538552688932539,0.0731101467173687,5.60423009168014e-38
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SNRPB2,U2 small nuclear ribonucleoprotein B'',37942,0.0484221427969463,0.00374937917633068,0.0410733596113382,0.0557709259825545,6.23867307801022e-38
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FXYD5,FXYD domain-containing ion transport regulator 5,40044,0.0808401408716418,0.00627045282170444,0.0685500533411011,0.0931302284021825,7.76912850088526e-38
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FGL1,Fibrinogen-like protein 1,37987,-0.0768096898795727,0.00595646729399533,-0.0884843657758036,-0.0651350139833419,8.00096562499793e-38
NMR metabolomics,X23495.Concentration of Large VLDL Particles,C1R,Complement C1r subcomponent,38013,0.0242689177398147,0.00188925667184847,0.0205659746629917,0.0279718608166377,1.50412084777481e-37
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,37671,0.0504189595148285,0.00392766868637184,0.0427207288895397,0.0581171901401173,1.70655175255396e-37
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,37598,0.0690403376235953,0.00538011404454362,0.0584953140962898,0.0795853611509008,1.80930106761401e-37
NMR metabolomics,X23495.Concentration of Large VLDL Particles,APOA1,Apolipoprotein A-I,38013,-0.03354911247823,0.0026174384692587,-0.0386792918779771,-0.028418933078483,2.15552234702528e-37
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SCG2,Secretogranin-2,40392,0.039115362716111,0.00305465910242262,0.0331282308753627,0.0451024945568594,2.34435368758433e-37
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,37337,0.0600353465032472,0.0046884336142024,0.0508460166194105,0.0692246763870839,2.59526630687534e-37
NMR metabolomics,X23495.Concentration of Large VLDL Particles,INPP1,Inositol polyphosphate 1-phosphatase,40305,0.065098525490058,0.00509203318227233,0.0551181404528042,0.0750789105273117,3.0612429174891e-37
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BOLA2_BOLA2B,BolA-like protein 2,37628,0.0679175415459292,0.00531859693651258,0.0574930915503646,0.0783419915414938,4.01119466794492e-37
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PCYT2,Ethanolamine-phosphate cytidylyltransferase,37901,0.093224101550513,0.00730330971823205,0.0789096145027781,0.107538588598248,4.24056404154e-37
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SLC27A4,Long-chain fatty acid transport protein 4,39961,0.0803088942152476,0.00629641157597664,0.0679679275263334,0.0926498609041619,4.5062539509693e-37
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MGMT,Methylated-DNA--protein-cysteine methyltransferase,40341,0.147848312110715,0.0115963206779361,0.12511952358196,0.17057710063947,4.76027791740364e-37
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RNASEH2A,Ribonuclease H2 subunit A,37959,0.0598886262511764,0.00469534760103617,0.0506857449531455,0.0690915075492073,4.78874878917954e-37
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NFAT5,Nuclear factor of activated T-cells 5,37598,0.105998725262485,0.00831695270426957,0.0896974979621163,0.122299952562853,5.50806718862647e-37
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BGLAP,Osteocalcin,37998,0.110330298352789,0.00866031348993792,0.0933560839125111,0.127304512793068,5.79262455974321e-37
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CPXM1,Probable carboxypeptidase X1,40411,0.0828285873949998,0.00650711585890017,0.0700746403115555,0.0955825344784441,6.17592302615676e-37
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RAB10,Ras-related protein Rab-10,37990,0.0648094865263127,0.00509069831210427,0.0548317178345884,0.0747872552180371,6.47689381358985e-37
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GRPEL1,"GrpE protein homolog 1, mitochondrial",40305,0.0721353254223974,0.00567558072439154,0.0610111872025899,0.0832594636422048,7.89359071244565e-37
NMR metabolomics,X23495.Concentration of Large VLDL Particles,XPNPEP2,Xaa-Pro aminopeptidase 2,40411,0.105716460494669,0.00832473305537404,0.0893999837061359,0.122032937283202,9.01220433221766e-37
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,40305,0.0463204640000276,0.00364965743875426,0.0391671354200692,0.0534737925799859,9.91712461873535e-37
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MDK,Midkine,40352,0.0609185932644954,0.00480012001780666,0.0515103580295943,0.0703268284993965,9.98977266446863e-37
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRDX5,"Peroxiredoxin-5, mitochondrial",40516,0.0829801658731567,0.00656336495484624,0.0701159705616581,0.0958443611846553,1.82597642265252e-36
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EGFL7,Epidermal growth factor-like protein 7,39980,0.0482850221395973,0.00382363043689867,0.0407907064832759,0.0557793377959187,2.23222747858814e-36
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD164,Sialomucin core protein 24,40332,0.0317127000718021,0.00251409363984662,0.0267850765377027,0.0366403236059015,2.6407342378051e-36
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD8A,T-cell surface glycoprotein CD8 alpha chain,40471,0.0577098629578082,0.00457972840232993,0.0487335952892415,0.0666861306263748,3.09125662021718e-36
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD84,SLAM family member 5,40341,0.0367073392106528,0.00291569072199364,0.0309925853955453,0.0424220930257604,3.58570708372074e-36
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ITGAL,Integrin alpha-L,37598,0.0521374550329424,0.00414225843401438,0.0440186285022742,0.0602562815636106,4.03540567895062e-36
NMR metabolomics,X23495.Concentration of Large VLDL Particles,APLP1,Amyloid-like protein 1,40359,-0.0619152568892368,0.00492465971085472,-0.0715675899225121,-0.0522629238559616,4.44041838527039e-36
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ESAM,Endothelial cell-selective adhesion molecule,40536,0.0371640628976773,0.0029633056627641,0.0313559837986596,0.0429721419966949,6.52247461224157e-36
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AK2,"Adenylate kinase 2, mitochondrial",37942,0.125591928063007,0.0100111197201309,0.10597013341155,0.145213722714463,6.69520417931216e-36
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SDHB,Succinate dehydrogenase,37901,0.0846111386698166,0.0067519195440229,0.0713773763635317,0.0978449009761015,7.96596132991048e-36
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AGXT,Serine--pyruvate aminotransferase,40359,0.0909840442895407,0.00727205246248509,0.0767308214630699,0.105237267116012,9.5202135937092e-36
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADGRD1,Adhesion G-protein coupled receptor D1,37671,0.043380216233205,0.00346622493465851,0.0365864153612743,0.0501740171051356,9.83700711439227e-36
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FAM3B,Protein FAM3B,40305,0.0427493800073167,0.00341769616744677,0.036050695519121,0.0494480644955123,9.9234097331205e-36
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SCRN1,Secernin-1,40341,0.0665764223494363,0.00532403441465287,0.0561413148967167,0.0770115298021559,1.03390775863064e-35
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TSNAX,Translin-associated protein X,37562,0.0468681300718361,0.00374914756501662,0.0395198008444035,0.0542164592992687,1.17692713191073e-35
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",37959,0.107666576979954,0.00861917154056565,0.0907730007604452,0.124560153199463,1.306296121526e-35
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FRMD4B,FERM domain-containing protein 4B,37562,0.0835768695830143,0.00669082935916209,0.0704628440390566,0.096690895126972,1.3285711542665e-35
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CXCL1,Growth-regulated alpha protein,40329,0.114922363610161,0.00920550055408719,0.0968795825241497,0.132965144696172,1.33967949814164e-35
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,39961,0.075630808929503,0.00606071832310492,0.0637518010162173,0.0875098168427886,1.44300149251402e-35
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ICAM1,Intercellular adhesion molecule 1,40291,0.0336303288443193,0.00270048931565174,0.0283373697856419,0.0389232879029968,1.9631227368208e-35
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SOD1,Superoxide dismutase [Cu-Zn],39978,0.0578149699837106,0.00464353875127973,0.0487136340312023,0.0669163059362188,2.04795967053093e-35
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,37628,-0.0428745013002817,0.00344982459154779,-0.0496361574997153,-0.036112845100848,2.9020871433594e-35
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ZNRD2,Protein ZNRD2,37901,0.0802176934426332,0.00645679360254156,0.0675623779816517,0.0928730089036146,3.03102757343447e-35
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ACRBP,Acrosin-binding protein,37900,0.0446325574407346,0.00359428706909938,0.0375877547852998,0.0516773600961694,3.2695817951103e-35
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NECAP2,Adaptin ear-binding coat-associated protein 2,37562,0.0796890482269065,0.00641903129049148,0.0671077468975432,0.0922703495562698,3.43776394001269e-35
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DUSP13,Dual specificity protein phosphatase 13 isoform A,37900,0.0484423776833533,0.0039027522744852,0.0407929832253623,0.0560917721413443,3.48975191275182e-35
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PCDH7,Protocadherin-7,37901,0.041088629770472,0.00331057027028643,0.0345999120407106,0.0475773475002334,3.5337844080803e-35
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ITGA6,Integrin alpha-6,40341,0.0623907085454056,0.00503214575740325,0.0525277028608952,0.0722537142299159,3.87442078776862e-35
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",40042,0.103090138546727,0.00832008710189809,0.0867827678270067,0.119397509266447,4.3031089611748e-35
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ING1,Inhibitor of growth protein 1,39925,0.0523755349089673,0.00422905144740649,0.0440865940720506,0.060664475745884,4.63640212295115e-35
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CA13,Carbonic anhydrase 13,40173,0.12136959895543,0.00980595364607571,0.102149929809121,0.140589268101738,5.05975648390329e-35
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NECTIN2,Nectin-2,40330,0.0336428461339869,0.002736206496144,0.0282798814015447,0.0390058108664292,1.37688160361345e-34
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SNAP25,Synaptosomal-associated protein 25,37541,0.0545606169129233,0.00444706994666907,0.0458443598174519,0.0632768740083946,2.05614148180673e-34
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PQBP1,Polyglutamine-binding protein 1,39980,0.0641106802580466,0.00522858505388934,0.0538626535524235,0.0743587069636697,2.10094559313195e-34
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SNX9,Sorting nexin-9,40359,0.079597144066923,0.00650075554455304,0.066855663199599,0.0923386249342469,2.57248067706347e-34
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FNDC1,Fibronectin type III domain-containing protein 1,37942,0.0533262843849866,0.00435515123538497,0.044790187963632,0.0618623808063411,2.73632524043258e-34
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,40379,0.0383356557825141,0.00313504347726319,0.0321909705670782,0.0444803409979499,3.13263735783857e-34
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BRSK2,Serine/threonine-protein kinase BRSK2,37959,0.0456298052099358,0.00373025403491554,0.0383185073015014,0.0529411031183703,3.16768406079314e-34
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,37865,0.0363071870636165,0.00296859290073928,0.0304887449781675,0.0421256291490655,3.2521128654924e-34
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SFTPA2,Pulmonary surfactant-associated protein A2,39980,0.0576267403501126,0.00471355689084257,0.0483881688440612,0.0668653118561641,3.25351921999036e-34
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TST,Thiosulfate sulfurtransferase,39923,0.0878095379300273,0.00718269745159215,0.0737314509249067,0.101887624935148,3.28159994840877e-34
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SPON2,Spondin-2,40267,-0.0399522827032491,0.003269801419457,-0.0463610934853848,-0.0335434719211134,3.52788101515078e-34
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TGFA,Protransforming growth factor alpha,40341,0.0554436490593148,0.00453805081330268,0.0465490694652415,0.064338228653388,3.56798708960388e-34
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RAB2B,Ras-related protein Rab-2B,37900,0.071231993887204,0.00582888732065847,0.0598073747387134,0.0826566130356946,3.6656235721338e-34
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PARD3,Partitioning defective 3 homolog,37714,0.0861203430208575,0.00705252615260765,0.0722973917617465,0.0999432942799685,4.12525129812606e-34
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SRC,Proto-oncogene tyrosine-protein kinase Src,40385,0.138318558467756,0.0113339859197347,0.116103946065076,0.160533170870436,4.20794961768531e-34
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD40LG,CD40 ligand,40516,0.088271387974659,0.00724712306031013,0.0740670267764511,0.102475749172867,5.5961518503585e-34
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CORO1A,Coronin-1A,39990,0.1037163816198,0.00852535202529081,0.08700669165023,0.12042607158937,6.75550970643956e-34
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,37598,0.0518705860616124,0.00426298991915898,0.0435151258200608,0.060226046303164,7.02937541542901e-34
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNF,Tumor necrosis factor,40014,0.0458617955451776,0.00377209613068332,0.0384684871290383,0.0532551039613169,7.39204115789655e-34
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LAMP3,Lysosome-associated membrane glycoprotein 3,40502,0.0585610370121568,0.00481834725428253,0.0491170763937631,0.0680049976305506,7.71542659685751e-34
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCL26,C-C motif chemokine 26,40341,0.102102873532007,0.00841429926332909,0.085610846975882,0.118594900088132,9.78256258234214e-34
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ARAF,Serine/threonine-protein kinase A-Raf,37714,0.0774268739678387,0.00638366277160288,0.064914894935497,0.0899388530001803,1.11904017288051e-33
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TPK1,Thiamin pyrophosphokinase 1,37990,0.0311913214173332,0.00257270270207849,0.0261488241212594,0.036233818713407,1.17828092436868e-33
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BLMH,Bleomycin hydrolase,40536,0.0370351093365543,0.0030588259926503,0.0310398103909597,0.0430304082821489,1.34749637288973e-33
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AKR1B1,Aldo-keto reductase family 1 member B1,39980,0.0880634477568402,0.00727713620159206,0.0738002608017197,0.102326634711961,1.47032608573512e-33
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FGF2,Fibroblast growth factor 2,40341,0.075854471255019,0.00626982523064289,0.063565613802959,0.0881433287070791,1.51350836634835e-33
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,37901,0.0522368384522178,0.00432301919107949,0.043763720837702,0.0607099560667335,1.92572212763502e-33
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GLO1,Lactoylglutathione lyase,40042,0.0677873213697592,0.00561206050579246,0.056787682778406,0.0787869599611124,1.92650058565417e-33
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BAP18,Chromatin complexes subunit BAP18,37942,0.0743111508354812,0.00615146891391103,0.0622542717642155,0.0863680299067468,1.99860589294844e-33
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DMD,Dystrophin,37628,0.0595885880581791,0.00493912995031679,0.0499078933555582,0.0692692827608,2.43468205429103e-33
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,39980,0.0703762572644239,0.00583753766412994,0.0589346834427292,0.0818178310861185,2.54604124048173e-33
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BPIFA2,BPI fold-containing family A member 2,37150,-0.127102047950917,0.0105454603369927,-0.147771150211423,-0.106432945690412,2.84847668589348e-33
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PKN3,Serine/threonine-protein kinase N3,37714,0.0883329274131107,0.00733238869866783,0.0739614455637217,0.1027044092625,3.0011965849023e-33
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FGR,Tyrosine-protein kinase Fgr,39961,0.0630573958346941,0.00523793757687114,0.0527910381840267,0.0733237534853616,3.1326495819116e-33
NMR metabolomics,X23495.Concentration of Large VLDL Particles,APOF,Apolipoprotein F,37987,-0.0275981074490932,0.00229199320470934,-0.0320904141303236,-0.0231058007678629,3.19397810207642e-33
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HPCAL1,Hippocalcin-like protein 1,40516,0.0834830339513465,0.00694456225457221,0.069871691932385,0.097094375970308,3.80799998676614e-33
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ASAH1,Acid ceramidase,37882,0.0526155619137939,0.00438254358342339,0.0440257764902841,0.0612053473373037,4.89418859811561e-33
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PAGR1,PAXIP1-associated glutamate-rich protein 1,37628,0.05083496407445,0.00423456931735366,0.0425352082124369,0.0591347199364632,4.98765844798605e-33
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NID1,Nidogen-1,40355,0.0449396017304212,0.00374525806049391,0.0375988959318531,0.0522803075289892,4.99016711460214e-33
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCN4,CCN family member 4,40489,0.0464900980041821,0.00387808215182973,0.0388890569865958,0.0540911390217684,5.68753103820784e-33
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BTC,Probetacellulin,39980,0.0856017767315684,0.00714247862272992,0.0716025186310177,0.099601034832119,5.95975325330475e-33
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADAMTSL2,ADAMTS-like protein 2,37998,0.0351748706027011,0.00293525672342411,0.0294217674247899,0.0409279737806124,6.35526790359539e-33
NMR metabolomics,X23495.Concentration of Large VLDL Particles,OPLAH,5-oxoprolinase,37628,0.0774093605819729,0.00646531736408637,0.0647373385483636,0.0900813826155822,7.28580028420043e-33
NMR metabolomics,X23495.Concentration of Large VLDL Particles,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",40305,0.078634181514376,0.00659252410832919,0.0657128342620508,0.0915555287667012,1.16991932913096e-32
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NT5C3A,Cytosolic 5'-nucleotidase 3A,40312,0.100269343724341,0.00841207996437428,0.0837816669941675,0.116757020454515,1.28805015870027e-32
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SFRP1,Secreted frizzled-related protein 1,40178,0.0492157681434496,0.00413148126639566,0.0411180648613141,0.0573134714255851,1.40879254471532e-32
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MCFD2,Multiple coagulation factor deficiency protein 2,40291,0.0485946635454006,0.0040861566814008,0.040585796449855,0.0566035306409462,1.77970829488766e-32
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NCAM2,Neural cell adhesion molecule 2,40332,-0.0304278310922061,0.00256078299771937,-0.0354469657677361,-0.0254086964166762,2.00878284346371e-32
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RGS10,Regulator of G-protein signaling 10,37959,0.0675582365735472,0.00569018080671955,0.0564054821923768,0.0787109909547175,2.37437455134927e-32
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,40341,0.13401350051476,0.0112969634199299,0.111871452211697,0.156155548817822,2.52897395737901e-32
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KLF4,Krueppel-like factor 4,37541,0.0440998542377961,0.00371806574373729,0.0368124453800711,0.0513872630955212,2.76236109744346e-32
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BAG3,BAG family molecular chaperone regulator 3,40203,0.0445199573456984,0.00375991140731268,0.0371505309873655,0.0518893837040313,3.29346075151171e-32
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DNAJC21,DnaJ homolog subfamily C member 21,37942,0.0423054663075616,0.00357271407473254,0.0353029467210858,0.0493079858940373,3.44702805192256e-32
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GET3,ATPase GET3,37990,0.0631179484163858,0.00533394249023596,0.0526634211355234,0.0735724756972483,3.78354892528217e-32
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EPPK1,Epiplakin,37628,0.0826282039858563,0.00698654875264049,0.068934568430681,0.0963218395410317,4.12610251180229e-32
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SH3BP1,SH3 domain-binding protein 1,37901,0.0524801707435502,0.0044378821173838,0.043781921793478,0.0611784196936225,4.15622040913222e-32
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,37598,0.0485890588902103,0.0041097362286595,0.0405339758820377,0.0566441418983829,4.32080639462403e-32
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TACSTD2,Tumor-associated calcium signal transducer 2,38484,-0.0350538605276472,0.00296703800443952,-0.0408692550163487,-0.0292384660389457,4.66441064424739e-32
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PSG1,Pregnancy-specific beta-1-glycoprotein 1,40228,-0.130826892368201,0.0110774370504379,-0.15253866898706,-0.109115115749343,4.71729787148506e-32
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PDZD2,PDZ domain-containing protein 2,37562,0.0689839657757292,0.00583896814276859,0.0575395882159028,0.0804283433355556,4.78080544908103e-32
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FEN1,Flap endonuclease 1,39980,0.0693431538643713,0.00587566317916864,0.0578268540332007,0.0808594536955418,5.23730395925575e-32
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PTGES2,Prostaglandin E synthase 2,37484,0.0613356769919024,0.00519499783086409,0.0511534812434087,0.071517872740396,5.24777596218823e-32
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GBP1,Guanylate-binding protein 1,37931,0.072172539150943,0.00611494971672691,0.0601872377061583,0.0841578405957277,5.43574564632013e-32
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,40228,0.0357656647564192,0.00303317727671616,0.0298206372940555,0.0417106922187829,5.88178088164764e-32
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CPA2,Carboxypeptidase A2,40398,0.0715908753786773,0.00607482452807123,0.0596842193036577,0.0834975314536969,6.33896246414854e-32
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,38013,0.0301514140373297,0.00256255856730664,0.0251287992454086,0.0351740288292507,8.32806691829657e-32
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PPM1F,Protein phosphatase 1F,37990,0.0583845539787841,0.00496752592919718,0.0486482031575576,0.0681209048000106,9.69256113541932e-32
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,40384,-0.0340462209468657,0.00289806088630199,-0.0397264202840177,-0.0283660216097138,9.78316635231653e-32
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MAN2B2,Epididymis-specific alpha-mannosidase,37990,0.0664641982664843,0.00566157433631294,0.0553675125673109,0.0775608839656576,1.13820113743113e-31
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD46,Membrane cofactor protein,40250,0.0318305170271547,0.00271541265979231,0.0265083082139618,0.0371527258403476,1.32646505866616e-31
NMR metabolomics,X23495.Concentration of Large VLDL Particles,S100P,Protein S100-P,40042,0.0593582505267238,0.00508245965679084,0.0493966295994138,0.0693198714540339,2.20409835628319e-31
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PECAM1,Platelet endothelial cell adhesion molecule,40332,0.033133456539148,0.00283780300991689,0.0275713626397109,0.0386955504385851,2.27803380050454e-31
NMR metabolomics,X23495.Concentration of Large VLDL Particles,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",40341,0.091080476576426,0.00780188625577006,0.0757887795151167,0.106372173637735,2.32003553562328e-31
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD302,CD302 antigen,40305,0.033251671098921,0.00285019556346782,0.0276652877945241,0.0388380544033179,2.53980873389118e-31
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DYNLT3,Dynein light chain Tctex-type 3,37900,0.0482075699283424,0.00413490694209893,0.0401031523218285,0.0563119875348563,2.92940565623391e-31
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MRI1,Methylthioribose-1-phosphate isomerase,37572,0.076298973933104,0.00654426103858904,0.0634722222974695,0.0891257255687385,2.94679073434533e-31
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,37942,0.0954321731958733,0.00819119393409126,0.0793774330850545,0.111486913306692,3.21519137498827e-31
NMR metabolomics,X23495.Concentration of Large VLDL Particles,COLEC12,Collectin-12,40357,0.0281823815303364,0.00242117901568385,0.0234368706595961,0.0329278924010767,3.45450457391158e-31
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ZHX2,Zinc fingers and homeoboxes protein 2,37942,0.0333475119934088,0.00286407233665587,0.0277339302135633,0.0389610937732543,3.49527688527898e-31
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LGMN,Legumain,40422,0.0391191448845495,0.00336294163262861,0.0325277792845974,0.0457105104845015,3.76569103990938e-31
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GNAS,Neuroendocrine secretory protein 55,37959,0.0996850151405837,0.00857310431439493,0.0828817306843697,0.116488299596798,4.19413859901167e-31
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ASGR2,Asialoglycoprotein receptor 2,37987,0.028504377166252,0.00245549498592685,0.0236916069938354,0.0333171473386687,5.23802006193038e-31
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MARCO,Macrophage receptor MARCO,40359,0.0291962266786121,0.00251681415589858,0.0242632709330509,0.0341291824241733,5.46174210598897e-31
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DARS1,"Aspartate--tRNA ligase, cytoplasmic",40192,0.0814749104000606,0.00702718554558997,0.0677016267307043,0.095248194069417,5.88792199528416e-31
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RAD23B,UV excision repair protein RAD23 homolog B,39980,0.0523693412022834,0.00451735325861714,0.0435153288153938,0.061223353589173,6.00209170318969e-31
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DCTN6,Dynactin subunit 6,39961,0.0774694292202635,0.00670798197114682,0.0643217845568158,0.0906170738837113,9.99316774691121e-31
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCDC134,Coiled-coil domain-containing protein 134,37900,0.0538545100603942,0.00466786886310159,0.0447054870887151,0.0630035330320733,1.19305270379872e-30
NMR metabolomics,X23495.Concentration of Large VLDL Particles,STX7,Syntaxin-7,37598,0.0550993291389663,0.00478591533837531,0.0457189350757507,0.064479723202182,1.59260953243389e-30
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,37562,0.0306153515852487,0.00266218499148066,0.0253974690019466,0.0358332341685508,1.84471465068288e-30
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DCTN2,Dynactin subunit 2,40305,0.102309387037501,0.00890775736854788,0.0848501825951467,0.119768591479854,2.06013795537095e-30
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCL24,C-C motif chemokine 24,40396,0.0901789257633701,0.0078535217450252,0.0747860231431207,0.105571828383619,2.12445360600977e-30
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SCARA5,Scavenger receptor class A member 5,40471,0.0318910077263811,0.00277834581613857,0.0264454499267495,0.0373365655260127,2.22631950944143e-30
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ABCA2,ATP-binding cassette sub-family A member 2,37562,0.0403761072032668,0.0035203626102969,0.0334761964870848,0.0472760179194487,2.62459017635742e-30
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,40228,0.0406850276635242,0.00355510684112622,0.0337170182549168,0.0476530370721316,3.31156673873845e-30
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FXN,"Frataxin, mitochondrial",40489,0.0801728431278279,0.00700913718210027,0.0664349342509114,0.0939107520047445,3.52195746780601e-30
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FGF23,Fibroblast growth factor 23,40469,0.0667840884727295,0.00584486828690521,0.0553281466303953,0.0782400303150638,4.05129358245607e-30
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",40192,0.103180171471927,0.00903416376240747,0.0854732104976085,0.120887132446246,4.30933872226898e-30
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LETM1,Mitochondrial proton/calcium exchanger protein,37959,0.0563370200335118,0.0049419108905194,0.0466508746880937,0.0660231653789298,5.74162947546681e-30
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FCRL1,Fc receptor-like protein 1,40359,0.0485703828180566,0.00426654133313521,0.0402079618051116,0.0569328038310016,6.55757873766669e-30
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,37901,0.125728723542468,0.0110571305340969,0.104056747695638,0.147400699389298,7.99491561801349e-30
NMR metabolomics,X23495.Concentration of Large VLDL Particles,UNC79,Protein unc-79 homolog,37482,0.061057915174771,0.00537643115762698,0.0505201101058222,0.0715957202437199,9.49026239354678e-30
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LTBP3,Latent-transforming growth factor beta-binding protein 3,39980,0.0582390947012428,0.00514036434041874,0.0481639805940221,0.0683142088084635,1.22176608678961e-29
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DKK4,Dickkopf-related protein 4,40203,0.0489658024461964,0.00432370618876469,0.0404913383162176,0.0574402665761752,1.28513533289271e-29
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,40377,0.0242261060884885,0.00214020587548993,0.0200313025725283,0.0284209096044488,1.36282619418203e-29
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,37562,0.043866026677399,0.00387995949950718,0.0362613060583649,0.0514707472964331,1.68214152031891e-29
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ARFIP1,Arfaptin-1,37959,0.0737821042443447,0.00652686533915772,0.0609894481795956,0.0865747603090938,1.69377618023708e-29
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",40044,0.0771443409239625,0.00682775031433116,0.0637619503078734,0.0905267315400515,1.73506071296287e-29
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SWAP70,Switch-associated protein 70,37901,0.0377352157713915,0.00334148226455829,0.0311859105328572,0.0442845210099257,1.92899191074477e-29
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MMP1,Interstitial collagenase,39757,0.0992542768657357,0.00881224067568725,0.0819822851413887,0.116526268590083,2.59943727477168e-29
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NGRN,Neugrin,37942,0.0235646000095507,0.00209325822660787,0.0194618138853993,0.0276673861337021,2.87647082416263e-29
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GLRX,Glutaredoxin-1,40260,0.0603636366775446,0.00536661167875056,0.0498450777871935,0.0708821955678957,3.05957125045943e-29
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NADK,NAD kinase,40359,0.0570293759913692,0.00507251399540657,0.0470872485603723,0.0669715034223661,3.23774650369251e-29
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SERPINB8,Serpin B8,40516,0.0580771930388902,0.00516829927782274,0.0479473264543576,0.0682070596234227,3.44061138169142e-29
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",37671,0.0949607854073076,0.00845221781673562,0.0783944384865058,0.111527132328109,3.72011727970936e-29
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DMP1,Dentin matrix acidic phosphoprotein 1,37628,-0.0678449045952101,0.00604063533065571,-0.0796845498432953,-0.0560052593471249,3.87698295289394e-29
NMR metabolomics,X23495.Concentration of Large VLDL Particles,WAS,Wiskott-Aldrich syndrome protein,40044,0.0724993591773187,0.00647047155015758,0.0598172349390099,0.0851814834156276,4.99442688325934e-29
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IMPA1,Inositol monophosphatase 1,40228,0.0645643084654618,0.00577774513447332,0.0532399280018941,0.0758886889290295,6.96537967552504e-29
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BOLA1,BolA-like protein 1,37541,0.0583004743030234,0.00521564175517209,0.0480778164628861,0.0685231321431607,7.0604433904748e-29
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,37671,0.0716080958032227,0.00640685285905058,0.0590506641994836,0.0841655274069619,7.13529532053547e-29
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCS,Copper chaperone for superoxide dismutase,40228,0.0510290025384713,0.00457931584362586,0.0420535434849647,0.060004461591978,9.87578698214087e-29
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SPINK6,Serine protease inhibitor Kazal-type 6,40489,0.0569082895319612,0.0051209123991447,0.0468713012296375,0.0669452778342848,1.38045169227362e-28
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,37959,0.0617460586901259,0.00555427570380458,0.0508596783106689,0.0726324390695829,1.3819741835973e-28
NMR metabolomics,X23495.Concentration of Large VLDL Particles,COX6B1,Cytochrome c oxidase subunit 6B1,37990,0.0341818653720756,0.00307561033125795,0.02815366912281,0.0402100616213412,1.427910342755e-28
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,40044,0.0440543560659812,0.00397265112842855,0.0362679598542612,0.0518407522777012,1.80443447566713e-28
NMR metabolomics,X23495.Concentration of Large VLDL Particles,POMC,Pro-opiomelanocortin,37628,0.0719138448789683,0.00648287610367614,0.0592074077157631,0.0846202820421736,1.81547197459742e-28
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DTX3,Probable E3 ubiquitin-protein ligase DTX3,40305,0.0251500035622393,0.00226849698985873,0.0207037494621162,0.0295962576623625,1.85332168475597e-28
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADM,Pro-adrenomedullin,40489,0.0282939723276686,0.00255354457255466,0.0232890249654614,0.0332989196898757,1.98335173621578e-28
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PALM,Paralemmin-1,37824,0.0308454628140112,0.00278482776162384,0.0253872004012284,0.0363037252267939,2.17345101023492e-28
NMR metabolomics,X23495.Concentration of Large VLDL Particles,STX16,Syntaxin-16,39980,0.0619969020349361,0.00560522897785094,0.0510106532383483,0.0729831508315239,2.48665678556315e-28
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ITGA2,Integrin alpha-2,37671,0.0355562818202414,0.00321853755090008,0.0292479482204773,0.0418646154200056,3.00129455207788e-28
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,40400,0.0544865559916502,0.00494087238847735,0.0448024461102346,0.0641706658730658,3.551119242743e-28
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RNASET2,Ribonuclease T2,40465,0.0275778397676418,0.00250365961214146,0.0226706669278446,0.0324850126074391,4.08143346651324e-28
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DPT,Dermatopontin,40536,0.0276490030046066,0.00251033889121178,0.0227287387778315,0.0325692672313817,4.12061991837926e-28
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NID2,Nidogen-2,40332,0.076984910958178,0.00699841484255538,0.0632680178667695,0.0907018040495866,4.80671759171502e-28
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ANXA4,Annexin A4,40279,0.0747271572788487,0.00679794978365834,0.0614031757028783,0.088051138854819,5.23764765885674e-28
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",37628,0.0953905264516422,0.008680648417892,0.0783764555525739,0.112404597350711,5.71724456308383e-28
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CA4,Carbonic anhydrase 4,40536,-0.0243051455096895,0.00221469040907978,-0.0286459387114859,-0.0199643523078932,6.36613003615334e-28
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NFASC,Neurofascin,40516,0.0283168353952612,0.00258087829954786,0.0232583139281474,0.033375356862375,6.56164073371888e-28
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SF3B4,Splicing factor 3B subunit 4,40305,0.0760470680156787,0.00695216157290843,0.0624208313327781,0.0896733046985792,9.46657563496819e-28
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GRK5,G protein-coupled receptor kinase 5,40042,0.0544651696678079,0.00499216950629768,0.0446805174354644,0.0642498219001513,1.29765880529025e-27
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ENTR1,Endosome-associated-trafficking regulator 1,37628,0.0591193056185564,0.00541702941133544,0.048501927972339,0.0697366832647739,1.30271703339871e-27
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KIF22,Kinesin-like protein KIF22,37562,0.126929864899765,0.0116341973036753,0.104126838184562,0.149732891614969,1.35576706054241e-27
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,40341,0.0387067857320842,0.0035492213282686,0.0317503119286777,0.0456632595354906,1.35578384866602e-27
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SPINK2,Serine protease inhibitor Kazal-type 2,37671,0.0394607626666451,0.00361699030319625,0.0323714616723804,0.0465500636609097,1.35617202781888e-27
NMR metabolomics,X23495.Concentration of Large VLDL Particles,APOL1,Apolipoprotein L1,37987,0.0674032963796465,0.0061836117333092,0.0552834173823604,0.0795231753769325,1.49505612723281e-27
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FUT8,"Alpha-(1,6)-fucosyltransferase",40228,0.0605554230796287,0.00555961263495459,0.0496585823151177,0.0714522638441397,1.57664928832467e-27
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AMOTL2,Angiomotin-like protein 2,37855,0.0497808333226974,0.00457466554904028,0.0408144888465784,0.0587471777988163,1.83250131003492e-27
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HMOX1,Heme oxygenase 1,40184,-0.0482679413492516,0.0044472209401396,-0.0569844943919252,-0.039551388306578,2.39895896447786e-27
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MMP12,Macrophage metalloelastase,40346,0.0532650339440877,0.0049108743437607,0.0436397202303168,0.0628903476578587,2.58714286247311e-27
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FST,Follistatin,40396,0.0534113215560956,0.0049256393909247,0.0437570683498832,0.063065574762308,2.66555076090595e-27
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,40228,0.035632352322669,0.00329757181517027,0.0291691115649353,0.0420955930804027,4.02832210581279e-27
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IDO1,"Indoleamine 2,3-dioxygenase 1",37628,0.0665889097144781,0.00616351232189568,0.0545084255635626,0.0786693938653936,4.29231288074646e-27
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ENO2,Gamma-enolase,40471,0.0671669697724453,0.00623666424454183,0.0549431078531433,0.0793908316917472,5.91919612375202e-27
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TCL1A,T-cell leukemia/lymphoma protein 1A,40215,0.0962333705092141,0.00893920623667041,0.0787125262853401,0.113754214733088,6.2267042743614e-27
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SERPING1,Plasma protease C1 inhibitor,37981,0.0190418722419505,0.00176837837990749,0.0155758506173318,0.0225078938665692,6.2682922732975e-27
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TSPYL1,Testis-specific Y-encoded-like protein 1,37598,0.0415861267792937,0.00386439013881811,0.0340119221072102,0.0491603314513772,6.78004888084894e-27
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LTA,Lymphotoxin-alpha,40341,0.0410363410727667,0.00381759119041041,0.0335538623395623,0.0485188198059711,7.38824341586513e-27
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PTPRM,Receptor-type tyrosine-protein phosphatase mu,40324,0.0248224120252322,0.00230990482328897,0.0202949985715858,0.0293498254788786,7.64884095629357e-27
NMR metabolomics,X23495.Concentration of Large VLDL Particles,COL6A3,Collagen alpha-3(VI) chain,40536,0.034898792769873,0.00325259458984937,0.0285237073737682,0.0412738781659778,9.11325108655758e-27
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EFCAB2,Dynein regulatory complex protein 8,37714,0.0354645628515944,0.00330673856860673,0.0289833552571252,0.0419457704460635,1.00047543750934e-26
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TREH,Trehalase,37998,0.0757723413099898,0.00707604417963138,0.0619032947179123,0.0896413879020673,1.18960056391459e-26
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,40450,0.030816625541287,0.00288046998540351,0.0251709043698961,0.0364623467126779,1.27305708951821e-26
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BGN,Biglycan,39956,-0.123103806037054,0.0115367657017363,-0.145715866812458,-0.100491745261651,1.7272513550697e-26
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DDX58,Antiviral innate immune response receptor RIG-I,39980,0.0578230806090474,0.0054289439804088,0.0471823504074461,0.0684638108106486,2.13025006992804e-26
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ATP6V1F,V-type proton ATPase subunit F,39925,0.0666984829047918,0.0062709881767651,0.0544073460783322,0.0789896197312514,2.49736882045031e-26
NMR metabolomics,X23495.Concentration of Large VLDL Particles,STX6,Syntaxin-6,39980,0.0694961098401589,0.0065351795469867,0.056687157928065,0.0823050617522528,2.54614836587266e-26
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCL25,C-C motif chemokine 25,40516,0.0492464614737409,0.00463312130041397,0.0401655437249295,0.0583273792225523,2.6650324023169e-26
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DSCAM,Down syndrome cell adhesion molecule,37959,0.0355588792740535,0.00334928700655836,0.0289942767411991,0.0421234818069079,3.15673058107874e-26
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RNASE6,Ribonuclease K6,37917,0.0297171126029972,0.00280514369068332,0.0242190309692579,0.0352151942367364,4.03455685995188e-26
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HLA_E,,40341,0.0289335230134877,0.00273293202514662,0.0235769762442003,0.0342900697827751,4.18342954539467e-26
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DNM1,Dynamin-1,37901,0.114181941532463,0.010783394015907,0.0930464892612858,0.135317393803641,4.26023145798485e-26
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,37959,0.0687549046229073,0.00649631663482976,0.056022124018641,0.0814876852271737,4.48775859769658e-26
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",37998,0.0623043753859521,0.00590230171559943,0.0507358640233772,0.0738728867485269,6.01307412940765e-26
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCL20,C-C motif chemokine 20,40516,0.088717791079027,0.00840988261292835,0.0722344211576874,0.105201161000367,6.22599510165511e-26
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TREML1,Trem-like transcript 1 protein,37987,0.0528240844210817,0.00501351437335597,0.042997596249304,0.0626505725928594,7.39666320741029e-26
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RPE,Ribulose-phosphate 3-epimerase,37714,0.0699255512417724,0.00665060183183834,0.0568903716513693,0.0829607308321756,9.38587998471135e-26
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NPPB,Natriuretic peptides B,40042,-0.128079868093819,0.0121859421398837,-0.151964314687992,-0.104195421499647,9.42712925080967e-26
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SERPINA9,Serpin A9,40228,0.0718255289513984,0.00683785330927517,0.0584233364652191,0.0852277214375778,1.00560447390094e-25
NMR metabolomics,X23495.Concentration of Large VLDL Particles,C4BPB,C4b-binding protein beta chain,40411,0.0410955453269614,0.00391262979766265,0.0334267909235426,0.0487642997303802,1.01184295594374e-25
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ACOT13,Acyl-coenzyme A thioesterase 13,37901,0.113133862049159,0.0107694302165417,0.0920257788247369,0.13424194527358,1.02926937384726e-25
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CASP8,Caspase-8,40434,0.0615888406968501,0.00586991425473319,0.050083808757573,0.0730938726361271,1.13583552797313e-25
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRSS27,Serine protease 27,40314,0.0402426567298118,0.00383627608112782,0.0327235556108012,0.0477617578488223,1.16480481059262e-25
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CBLN4,Cerebellin-4,40489,0.0313109215800282,0.00298818334159315,0.0254540822305056,0.0371677609295508,1.31556142568612e-25
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TPR,Nucleoprotein TPR,37562,0.0468370891243065,0.00446916712492286,0.0380775215594577,0.0555966566891553,1.34669839280855e-25
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADA,Adenosine deaminase,40516,0.0337791933347159,0.00322457700433156,0.027459022406226,0.0400993642632057,1.35301320181328e-25
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ERI1,3'-5' exoribonuclease 1,37714,0.0335033372923027,0.00319869601900705,0.0272338930950489,0.0397727814895565,1.4301455177658e-25
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ANXA2,Annexin A2,37441,0.0711112817642639,0.00680091869036759,0.0577814811311434,0.0844410823973844,1.73384323473848e-25
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TLR3,Toll-like receptor 3,40516,0.0602386943345164,0.00577500454333763,0.0489196854295746,0.0715577032394581,2.15899923303567e-25
NMR metabolomics,X23495.Concentration of Large VLDL Particles,THBD,Thrombomodulin,40359,0.0274464097976415,0.00263128591560576,0.0222890894030542,0.0326037301922287,2.16607197345593e-25
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MAGED1,Melanoma-associated antigen D1,39980,0.0480621824626781,0.00461366599526219,0.0390193971119642,0.057104967813392,2.50411622902833e-25
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LAMP1,Lysosome-associated membrane glycoprotein 1,37621,0.0284168818735061,0.00272733467254084,0.023071305915326,0.0337624578316861,2.53959435744403e-25
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,37901,0.0785279490384041,0.0075450247927215,0.0637397004446699,0.0933161976321382,2.84592190349694e-25
NMR metabolomics,X23495.Concentration of Large VLDL Particles,C7,Complement component C7,37678,-0.0311419583806077,0.00299603233309685,-0.0370141817534776,-0.0252697350077379,3.2879081233308e-25
NMR metabolomics,X23495.Concentration of Large VLDL Particles,STK4,Serine/threonine-protein kinase 4,40359,0.084558710747036,0.00814774373683799,0.0685891330228335,0.100528288471238,3.7496226872806e-25
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TPMT,Thiopurine S-methyltransferase,39980,0.0728782463804053,0.00702341602441552,0.0591123509725509,0.0866441417882597,3.83399508312343e-25
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TXN,Thioredoxin,37819,0.0439634541282856,0.00423671063078062,0.0356595012919556,0.0522674069646156,3.93924965246419e-25
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CPXM2,Inactive carboxypeptidase-like protein X2,37990,0.024793625168669,0.00239082863172508,0.0201076010504879,0.0294796492868502,4.20200537734038e-25
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AFP,Alpha-fetoprotein,40182,0.0683069040603386,0.00659840602203362,0.0553740282571527,0.0812397798635244,4.92997121313475e-25
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SFRP4,Secreted frizzled-related protein 4,37671,0.0411455826385047,0.00397964125787877,0.0333454857730623,0.048945679503947,5.84199318456678e-25
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCDC80,Coiled-coil domain-containing protein 80,40359,0.0344256623229692,0.00333178025015605,0.0278953730326633,0.040955951613275,6.02331553396149e-25
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GSR,"Glutathione reductase, mitochondrial",37944,0.0217379726360508,0.00210538708362128,0.0176114139521531,0.0258645313199485,6.7289260661977e-25
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ENAH,Protein enabled homolog,40044,0.0461629258755434,0.00448992712271599,0.0373626687150201,0.0549631830360667,1.02466056230474e-24
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ERBB4,Receptor tyrosine-protein kinase erbB-4,40411,-0.023734193979001,0.00231014024820584,-0.0282620688654845,-0.0192063190925176,1.10266025132662e-24
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCL14,C-C motif chemokine 14,40309,0.0379239877651264,0.00369776009702237,0.0306763779749626,0.0451715975552903,1.32837092022305e-24
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,40228,0.0286225469133902,0.00279520747854909,0.023143940255434,0.0341011535713465,1.56828792685342e-24
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DENR,Density-regulated protein,37598,0.0561087641942144,0.00548119876110315,0.0453656146224522,0.0668519137659765,1.67996695182084e-24
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PNLIP,Pancreatic triacylglycerol lipase,37987,0.0586740589809369,0.00573679866743468,0.047429933592765,0.0699181843691089,1.82969111619489e-24
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CTSE,Cathepsin E,37671,0.0500477067213104,0.00490486366288715,0.0404341739420516,0.0596612395005693,2.34977223355586e-24
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,40228,0.0676037455681838,0.00663662873729509,0.0545959532430854,0.0806115378932822,2.70999094800285e-24
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL6R,Interleukin-6 receptor subunit alpha,40273,0.0325058475519139,0.00319284914657498,0.0262478632246269,0.0387638318792008,2.86900332923497e-24
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EPCAM,Epithelial cell adhesion molecule,40358,-0.0963323184137941,0.00946728114782579,-0.114888189463533,-0.0777764473640556,3.03312165065855e-24
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BMP6,Bone morphogenetic protein 6,40024,0.0407910162017203,0.00401654441561178,0.0329185891471212,0.0486634432563194,3.71523075524898e-24
NMR metabolomics,X23495.Concentration of Large VLDL Particles,STXBP3,Syntaxin-binding protein 3,39980,0.0425625478450073,0.00419481467944074,0.0343407110733034,0.0507843846167111,4.08541315686586e-24
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IGFBP6,Insulin-like growth factor-binding protein 6,40291,0.0279048412886459,0.00275185609817003,0.0225112033362327,0.0332984792410592,4.33212371429576e-24
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PTN,Pleiotrophin,40042,0.0482666328431358,0.004765453872623,0.0389263432527947,0.0576069224334769,4.90364468688209e-24
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HIP1R,Huntingtin-interacting protein 1-related protein,37910,0.0395312752592212,0.00390517259130189,0.0318771369802695,0.0471854135381729,5.33480598883826e-24
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NAA10,N-alpha-acetyltransferase 10,37562,0.0494519092256382,0.00488762065071331,0.0398721727502401,0.0590316457010362,5.64220347888328e-24
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PSME2,Proteasome activator complex subunit 2,40152,0.0355579561030287,0.00351686972346653,0.0286648914450343,0.0424510207610231,5.86534103055299e-24
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FRZB,Secreted frizzled-related protein 3,40176,0.0255624840698064,0.00252931797928493,0.0206050208304079,0.0305199473092049,6.11958840453733e-24
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TCOF1,Treacle protein,37990,0.0290527673397535,0.0028752648978303,0.0234172481400061,0.0346882865395009,6.42212696063106e-24
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCL19,C-C motif chemokine 19,40471,0.125002440139982,0.0124313047324241,0.100637082864431,0.149367797415533,1.02205265726918e-23
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FCER2,Low affinity immunoglobulin epsilon Fc receptor,40332,0.0463351425115878,0.004614267874171,0.0372911774782126,0.055379107544963,1.17563673962708e-23
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GRSF1,G-rich sequence factor 1,37402,0.075477403895711,0.00751381862421043,0.0607503193922586,0.0902044883991635,1.1780148236089e-23
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AK1,Adenylate kinase isoenzyme 1,40359,0.0608670770122392,0.00606227866762988,0.0489850108236847,0.0727491432007938,1.19217441828369e-23
NMR metabolomics,X23495.Concentration of Large VLDL Particles,APRT,Adenine phosphoribosyltransferase,40216,0.0461557022789513,0.00460032391159511,0.0371390674122248,0.0551723371456777,1.28312051847311e-23
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PMM2,Phosphomannomutase 2,37562,0.0577607280724158,0.00575747718652415,0.0464760727868284,0.0690453833580031,1.33728991895529e-23
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SPAG1,Sperm-associated antigen 1,37959,0.0548815369298348,0.00547762378280872,0.0441453943155297,0.0656176795441399,1.51633785923357e-23
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RNF149,E3 ubiquitin-protein ligase RNF149,37628,0.0288662259080898,0.00288298697075213,0.0232155714454156,0.034516880370764,1.62808708036479e-23
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PIGR,Polymeric immunoglobulin receptor,40154,0.0333786331141682,0.00333940440181897,0.026833400486603,0.0399238657417334,1.87632915191552e-23
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CARHSP1,Calcium-regulated heat-stable protein 1,39961,0.0498795247595018,0.00500148879511205,0.0400766067210822,0.0596824427979214,2.35424155153903e-23
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,37564,0.0270596143108505,0.00271838083865461,0.0217315878670875,0.0323876407546136,2.92018848512183e-23
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LIPF,Gastric triacylglycerol lipase,37628,0.0564783835183455,0.00568520799050074,0.045335375856964,0.0676213911797269,3.56276075022264e-23
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HDGF,Hepatoma-derived growth factor,40471,0.0898216581446833,0.00906123159456073,0.0720616442193442,0.107581672070022,4.27078723111887e-23
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CAPG,Macrophage-capping protein,40185,0.0545260328180243,0.00550423519639287,0.0437377318330942,0.0653143338029543,4.570791747735e-23
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRL,Prolactin,40471,-0.0719705615974197,0.00728272865154909,-0.086244709754456,-0.0576964134403835,5.77568089229999e-23
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IGF1R,Insulin-like growth factor 1 receptor,40305,0.0205701643817747,0.00208366072069831,0.016486189369206,0.0246541393943434,6.40266476411821e-23
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SGSH,N-sulphoglucosamine sulphohydrolase,37790,0.0526275325550592,0.00533333342513543,0.0421741990417938,0.0630808660683247,6.88587814425341e-23
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CPQ,Carboxypeptidase Q,37986,0.0342983144749118,0.00347651931776768,0.0274843366120871,0.0411122923377364,7.00228341861125e-23
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ANGPTL4,Angiopoietin-related protein 4,40396,-0.0426816231573367,0.00432840184425523,-0.051165290772077,-0.0341979555425965,7.15478719587988e-23
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LAMB1,Laminin subunit beta-1,37628,0.0276463070946855,0.00280792132421485,0.0221427812992244,0.0331498328901466,8.56330775951402e-23
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRDX6,Peroxiredoxin-6,40489,-0.0558334624716737,0.00567542398422514,-0.0669572934807549,-0.0447096314625924,8.98016417555381e-23
NMR metabolomics,X23495.Concentration of Large VLDL Particles,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,40403,0.0385689973139703,0.00392206904678661,0.0308817419822685,0.046256252645672,9.3421721139642e-23
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PZP,Pregnancy zone protein,38013,0.0609753885583453,0.00620227293961962,0.0488189335966909,0.0731318435199998,9.84865024178345e-23
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SV2A,Synaptic vesicle glycoprotein 2A,37572,0.0577525527196689,0.0058755491971826,0.046236476293191,0.0692686291461468,1.00870759236272e-22
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CIT,Citron Rho-interacting kinase,37572,0.0420891076192986,0.00428918360944412,0.0336823077447881,0.050495907493809,1.18616279905165e-22
NMR metabolomics,X23495.Concentration of Large VLDL Particles,C7orf50,Uncharacterized protein C7orf50,37942,0.0204148190770041,0.00208855752935719,0.016321246319464,0.0245083918345441,1.71866987857867e-22
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,37900,0.0508329287503488,0.00520865594065046,0.0406239631066739,0.0610418943940237,1.99738405510414e-22
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RANBP1,Ran-specific GTPase-activating protein,37628,0.0492357031369603,0.00505488058872397,0.0393281371830614,0.0591432690908593,2.41578806572229e-22
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CXCL8,Interleukin-8,40209,0.0626517227062448,0.00643650735996889,0.0500361682807057,0.0752672771317838,2.50058938203913e-22
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,37572,0.0497149765077734,0.00511983305387729,0.0396801037221739,0.0597498492933729,3.23820916455567e-22
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PTGR1,Prostaglandin reductase 1,37990,0.0733339179727295,0.00755630004866359,0.0585235698773489,0.0881442660681102,3.3907743500338e-22
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",37990,0.0497850629436596,0.00515008976084322,0.0396908870124069,0.0598792388749123,4.91382915501609e-22
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TGFBR2,TGF-beta receptor type-2,40411,0.0288729056201924,0.00299574916782048,0.0230012372512642,0.0347445739891205,6.34263641961456e-22
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BRK1,Protein BRICK1,39961,0.0403077225508042,0.00419570950939808,0.032084131912384,0.0485313131892245,8.59847227721475e-22
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RPL14,60S ribosomal protein L14,37628,0.0377712556841594,0.00393522775862711,0.0300582092772503,0.0454843020910686,9.57914135285185e-22
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SMS,Spermine synthase,37541,0.0584234811650358,0.00608990977044489,0.0464872580149638,0.0703597043151077,1.00383671384656e-21
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CSPG4,Chondroitin sulfate proteoglycan 4,37998,-0.0301149821679621,0.00314059167810586,-0.0362705418570496,-0.0239594224788746,1.04287990892435e-21
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LAMA4,Laminin subunit alpha-4,40422,0.0297472898441908,0.00311198979330164,0.0236477898493196,0.035846789839062,1.35912079834619e-21
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,40042,0.0520003432937288,0.00544596576151696,0.0413262504011556,0.062674436186302,1.50832466130342e-21
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,37714,0.0792351853056145,0.00830622464445185,0.0629549850024889,0.0955153856087401,1.68620769396851e-21
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LGALS7_LGALS7B,Galectin-7,40270,0.0363465185482638,0.00381408737060897,0.0288709073018702,0.0438221297946574,1.80389531168783e-21
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FABP6,Gastrotropin,40017,0.0504910597568813,0.00530525259165839,0.0400927646772309,0.0608893548365318,2.03482424209869e-21
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDA,Cytidine deaminase,37970,0.0415213446056516,0.00436238475996656,0.0329710704761171,0.050071618735186,2.05949622764079e-21
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDH5,Cadherin-5,40536,-0.0273951726173344,0.00288253012952214,-0.0330449316711978,-0.021745413563471,2.30119360501215e-21
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MMP3,Stromelysin-1,40332,-0.0436027762948533,0.00459035528614024,-0.0525998726556881,-0.0346056799340184,2.4196539781068e-21
NMR metabolomics,X23495.Concentration of Large VLDL Particles,XRCC4,DNA repair protein XRCC4,39961,0.0335540008109364,0.00353701485754449,0.0266214516901492,0.0404865499317236,2.7280780634204e-21
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GRN,Progranulin,40262,0.0218391455280141,0.00230470788420455,0.0173219180749731,0.026356372981055,3.01180620364438e-21
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ELOB,Elongin-B,37562,0.0362432278853823,0.00382447268255512,0.0287472614275743,0.0437391943431903,3.07030508972865e-21
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SORBS1,Sorbin and SH3 domain-containing protein 1,37959,0.0357897980720496,0.00377795346906635,0.0283850092726796,0.0431945868714197,3.15468476453898e-21
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SCRIB,Protein scribble homolog,37628,0.0838449581075528,0.00885502598960792,0.0664891071679213,0.101200809047184,3.31142964288976e-21
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PVR,Poliovirus receptor,40471,0.0329683213715116,0.00348843546610333,0.0261309878579491,0.0398056548850741,3.81903389598041e-21
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NCF2,Neutrophil cytosol factor 2,40324,0.0745393535164094,0.0078881708681176,0.0590785386148989,0.0900001684179199,3.86868810196311e-21
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,37942,0.0429540441392952,0.00455431512171919,0.0340275865007256,0.0518805017778649,4.69325147210642e-21
NMR metabolomics,X23495.Concentration of Large VLDL Particles,WARS,"Tryptophan--tRNA ligase, cytoplasmic",40332,0.033910733969791,0.00359794256194035,0.0268587665483879,0.0409627013911941,4.87963538237373e-21
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EDF1,Endothelial differentiation-related factor 1,37959,0.0624220448277599,0.00662383143874764,0.0494393352078146,0.0754047544477053,5.04475291883708e-21
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ASS1,Argininosuccinate synthase,37562,0.0719316731691362,0.00764942345295034,0.0569388032013536,0.0869245431369189,6.14039900592323e-21
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SLIT2,Slit homolog 2 protein,39961,0.0467933359692556,0.00498101983214388,0.0370305370982536,0.0565561348402577,6.54406660088902e-21
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PTPRC,Receptor-type tyrosine-protein phosphatase C,37998,0.0200202438723793,0.00213066677658734,0.0158441369902681,0.0241963507544904,6.54713251302159e-21
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PPME1,Protein phosphatase methylesterase 1,40305,0.0544643189475441,0.00581535038135784,0.0430662322000827,0.0658624056950054,8.55604883693821e-21
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD200R1,Cell surface glycoprotein CD200 receptor 1,40291,0.0306546201167994,0.00327675426112308,0.0242321817649981,0.0370770584686006,9.44008194885588e-21
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLTA,Clathrin light chain A,40042,0.0420918832155081,0.00450082690565331,0.0332702624804276,0.0509135039505886,9.74256169740275e-21
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KIT,Mast/stem cell growth factor receptor Kit,40372,-0.0262930689080986,0.0028130701572602,-0.0318066864163286,-0.0207794513998686,1.02121729229226e-20
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AKR7L,Aflatoxin B1 aldehyde reductase member 4,37598,0.0623436934244752,0.0066779264985332,0.0492549574873501,0.0754324293616003,1.16131704502569e-20
NMR metabolomics,X23495.Concentration of Large VLDL Particles,STAM,Signal transducing adapter molecule 1,37900,0.0333623411719097,0.00357436705822131,0.026356581737796,0.0403681006060235,1.17953267724345e-20
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DKK3,Dickkopf-related protein 3,40536,-0.0260596076708562,0.00279504290163828,-0.0315378917580673,-0.0205813235836452,1.26868783101575e-20
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ACP6,Lysophosphatidic acid phosphatase type 6,40453,0.0585682138275752,0.00628228611423884,0.0462549330436671,0.0708814946114833,1.2784814343108e-20
NMR metabolomics,X23495.Concentration of Large VLDL Particles,C5,Complement C5,38013,0.0135608296637521,0.00145554680539957,0.0107079579251689,0.0164137014023352,1.38311036898177e-20
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ECI2,Enoyl-CoA delta isomerase 2,37562,0.0556636771644438,0.00597963313106286,0.0439435962275606,0.067383758101327,1.4947409930305e-20
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MTUS1,Microtubule-associated tumor suppressor 1,37714,0.048979083828885,0.00527582493624436,0.038638466953846,0.0593197007039239,1.88821610588315e-20
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PDCD1,Programmed cell death protein 1,40455,0.0385073289378997,0.004155746522664,0.0303620657534783,0.0466525921223212,2.1724592565421e-20
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CA6,Carbonic anhydrase 6,40295,-0.0561229534780934,0.00605726193860447,-0.0679951868777582,-0.0442507200784286,2.18812109651715e-20
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TF,Serotransferrin,38013,0.0192330811050247,0.00207571284603949,0.0151646839267873,0.0233014782832621,2.22431544424706e-20
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD248,Endosialin,37998,-0.0353278174337026,0.00381441344347621,-0.0428040677829159,-0.0278515670844892,2.31136986287742e-20
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCL15,C-C motif chemokine 15,40536,0.0390815858993364,0.00422182275317118,0.0308068133031209,0.0473563584955519,2.36116156070274e-20
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HEPH,Hephaestin,37990,0.0220801717348767,0.00238539037224333,0.0174048066052798,0.0267555368644736,2.42720061676843e-20
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL7R,Interleukin-7 receptor subunit alpha,40332,-0.0463245259025263,0.00500707783412268,-0.0561383984574067,-0.0365106533476458,2.48272110473665e-20
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ULBP2,UL16-binding protein 2,40228,0.0327278968390993,0.00354083855773098,0.0257878532659466,0.0396679404122521,2.69733972943568e-20
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,40489,0.0273370600331408,0.00296176903702122,0.0215319927205793,0.0331421273457024,3.03794377407711e-20
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CR1,Complement receptor type 1,37959,0.0318211388604368,0.00344861764336382,0.0250618482794437,0.0385804294414299,3.18456589330125e-20
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,37628,0.0363864639698333,0.00395171409918564,0.0286411043354295,0.0441318236042372,3.8263160689499e-20
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",37990,0.0267358102080851,0.00290640229707974,0.0210392617058088,0.0324323587103614,4.13671122548747e-20
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NEK7,Serine/threonine-protein kinase Nek7,37714,0.0664161657857659,0.00722423302807215,0.0522566690507445,0.0805756625207873,4.3610702536895e-20
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SUSD2,Sushi domain-containing protein 2,40332,-0.0250065004265688,0.00272086689682535,-0.0303393995443465,-0.0196736013087911,4.37924970707976e-20
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,37562,0.0586836108207849,0.00639669941914082,0.0461460799592689,0.0712211416823009,5.22844335996372e-20
NMR metabolomics,X23495.Concentration of Large VLDL Particles,WFDC2,WAP four-disulfide core domain protein 2,39535,0.0331231340369967,0.00361657785895845,0.0260346414334382,0.0402116266405553,5.91637478922259e-20
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AARSD1,Alanyl-tRNA editing protein Aarsd1,40305,0.0482171350036644,0.00528533816992598,0.0378578721906095,0.0585763978167193,8.18318870890952e-20
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FAP,Prolyl endopeptidase FAP,40536,0.0234115071527865,0.00256702565582302,0.0183801368673733,0.0284428774381996,8.37666604230433e-20
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD1C,T-cell surface glycoprotein CD1c,40411,0.0206426158487831,0.00227257786904693,0.0161883632254512,0.0250968684721151,1.17391058944964e-19
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD300A,CMRF35-like molecule 8,37671,0.0255915541717915,0.00281761498671156,0.0200690287978368,0.0311140795457461,1.20770085256172e-19
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KLB,Beta-klotho,39961,-0.0634248166884078,0.00698717450899106,-0.0771196787260302,-0.0497299546507853,1.24431242538057e-19
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ALCAM,CD166 antigen,40536,0.0166370754947991,0.00184108641540909,0.0130285461205973,0.0202456048690009,1.79736835916489e-19
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLSTN3,Calsyntenin-3,37942,0.0262618235913911,0.0029105904179271,0.0205570663722539,0.0319665808105282,2.07725508500969e-19
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GAST,Gastrin,37942,0.111769239395329,0.0123910933992394,0.0874826963328196,0.136055782457838,2.12923984315479e-19
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CBLIF,Cobalamin binding intrinsic factor,40330,0.0624536291063854,0.00692772131148848,0.0488752953358679,0.0760319628769028,2.18860458260706e-19
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GDF2,Growth/differentiation factor 2,40359,0.0305080384602104,0.00339001917332789,0.0238636008804877,0.0371524760399331,2.52214863718833e-19
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PER3,Period circadian protein homolog 3,37598,0.101202348434782,0.0112485938051372,0.0791551045767131,0.123249592292851,2.63686308370881e-19
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BTN2A1,Butyrophilin subfamily 2 member A1,40422,0.0220582117784086,0.00245324153035259,0.0172498583789175,0.0268665651778997,2.70849411152805e-19
NMR metabolomics,X23495.Concentration of Large VLDL Particles,WFDC1,WAP four-disulfide core domain protein 1,37653,0.046695504538859,0.00519377420588538,0.0365157070953237,0.0568753019823944,2.7880250549077e-19
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",37628,0.0429725867987434,0.00478051025743811,0.0336027866941647,0.0523423869033221,2.82799293452523e-19
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD300E,CMRF35-like molecule 2,40436,0.0340727668315001,0.00379356315379975,0.0266373830500525,0.0415081506129476,2.95735567336027e-19
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NAP1L4,Nucleosome assembly protein 1-like 4,37879,0.0355275670291898,0.00396599872527747,0.0277542095276459,0.0433009245307336,3.73535202890057e-19
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CRYGD,Gamma-crystallin D,37942,0.0817510545714563,0.00913430491131311,0.0638478169452826,0.09965429219763,4.01746569868784e-19
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FCRL2,Fc receptor-like protein 2,40442,0.0413371303940768,0.00462139114265193,0.032279203754479,0.0503950570336746,4.12967174895367e-19
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MNDA,Myeloid cell nuclear differentiation antigen,40333,0.0823027201824204,0.00920309605205748,0.0642646519203878,0.100340788444453,4.20007868548196e-19
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,37959,0.0568144918758213,0.00635398351028154,0.0443606841956695,0.0692682995559731,4.32996052280516e-19
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ZBTB17,Zinc finger and BTB domain-containing protein 17,40042,0.0345622408650563,0.00387105672881462,0.0269749696765797,0.042149512053533,4.79743469721855e-19
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FBP1,"Fructose-1,6-bisphosphatase 1",40359,0.061317913875454,0.00687133815848485,0.0478500910848237,0.0747857366660843,4.9919707193297e-19
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,40332,0.0244529743951472,0.00274796576422202,0.019066961497272,0.0298389872930223,6.25722961637077e-19
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,40536,0.0193242748679115,0.00217276678175474,0.0150656519756722,0.0235828977601508,6.51910388006012e-19
NMR metabolomics,X23495.Concentration of Large VLDL Particles,REG4,Regenerating islet-derived protein 4,40379,0.0410674809333309,0.0046177719112706,0.0320166479872405,0.0501183138794213,6.55487713234398e-19
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SRPX,Sushi repeat-containing protein SRPX,37990,-0.0276108086310038,0.00311298502003766,-0.0337122592702776,-0.02150935799173,8.25273250355972e-19
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CSNK1D,Casein kinase I isoform delta,37598,0.0538405013821167,0.00607182119517029,0.0419397318395829,0.0657412709246505,8.45213164990175e-19
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LRRC25,Leucine-rich repeat-containing protein 25,40305,0.0326702999042067,0.00368689431564411,0.0254439870455442,0.0398966127628691,8.74290388233597e-19
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CXADR,Coxsackievirus and adenovirus receptor,40341,0.0446365113130362,0.0050383430500893,0.0347613589348612,0.0545116636912112,8.88526178981439e-19
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD28,T-cell-specific surface glycoprotein CD28,39980,0.0302901135270238,0.00341936464770776,0.0235881588175166,0.036992068236531,8.98224164695124e-19
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AHCY,Adenosylhomocysteinase,40359,0.0568869997544414,0.00643242364144262,0.0442794494172139,0.069494550091669,1.02079685094808e-18
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD80,T-lymphocyte activation antigen CD80,37990,0.0286575402912993,0.00324044936699182,0.0223062595319954,0.0350088210506033,1.03932200370598e-18
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CHCHD6,MICOS complex subunit MIC25,37900,0.0244204597127935,0.00276182919440463,0.0190072744917604,0.0298336449338266,1.0546732777552e-18
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLEC4D,C-type lectin domain family 4 member D,40341,0.0513538484024536,0.00581048081873706,0.0399653059977289,0.0627423908071782,1.0735897176162e-18
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SNX5,Sorting nexin-5,37628,0.0252142788312715,0.00285482924201443,0.0196188135169232,0.0308097441456197,1.15536306787461e-18
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",37901,0.0856826286309658,0.00970360322214002,0.0666635663155714,0.10470169094636,1.17505086805522e-18
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MATN2,Matrilin-2,40379,0.0248521489597482,0.00281683165696458,0.0193311589120976,0.0303731390073988,1.23106474253821e-18
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HRG,Histidine-rich glycoprotein,37934,0.0264541995859083,0.00299995232019939,0.0205742930383175,0.0323341061334991,1.30424236995861e-18
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PDIA3,Protein disulfide-isomerase A3,37671,0.0214422986803957,0.00243372871016189,0.0166721904084784,0.0262124069523131,1.40006882502994e-18
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RARRES1,Retinoic acid receptor responder protein 1,39980,0.029342336174333,0.00333243571337641,0.0228107621761153,0.0358739101725508,1.44366923613495e-18
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SERPINA7,Thyroxine-binding globulin,38013,0.0156613011254721,0.0017807212558501,0.012171087464006,0.0191515147869383,1.60228590122974e-18
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LRG1,Leucine-rich alpha-2-glycoprotein,38013,-0.0214099816744745,0.0024345617447105,-0.0261817226941071,-0.0166382406548419,1.61277692709675e-18
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL12RB1,Interleukin-12 receptor subunit beta-1,40044,0.0317343123477474,0.00361498808290959,0.0246489357052446,0.0388196889902502,1.8254712878645e-18
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IFNAR1,Interferon alpha/beta receptor 1,37901,0.0220263290725416,0.00251540206700643,0.017096141021209,0.0269565171238742,2.25042039379817e-18
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MPO,Myeloperoxidase,40332,0.038877378016903,0.0044429204503243,0.0301692539342674,0.0475855020995387,2.33621944318605e-18
NMR metabolomics,X23495.Concentration of Large VLDL Particles,APOBR,Apolipoprotein B receptor,37628,-0.0353286054457474,0.0040386132192205,-0.0432442873554196,-0.0274129235360752,2.43914527670659e-18
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MSTN,Growth/differentiation factor 8,40042,0.0422745939879523,0.00485827790347301,0.0327523692971451,0.0517968186787594,3.59634973918447e-18
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ARHGAP1,Rho GTPase-activating protein 1,39980,0.0379002560804948,0.00435781812050387,0.0293589325643072,0.0464415795966824,3.74209778608479e-18
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CTSB,Cathepsin B,40353,-0.0444424348119721,0.00512652905111932,-0.054490431752166,-0.0343944378717783,4.76944936564233e-18
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CA14,Carbonic anhydrase 14,40489,-0.0283871183807245,0.00327874822951266,-0.0348134649105693,-0.0219607718508797,5.25536885005873e-18
NMR metabolomics,X23495.Concentration of Large VLDL Particles,COL2A1,Collagen alpha-1(II) chain,37628,0.0678287821366539,0.00783537251892972,0.0524714519995517,0.0831861122737562,5.41338458003998e-18
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RGMB,RGM domain family member B,40471,0.0213134168840972,0.0024659647265159,0.016480126020126,0.0261467077480683,5.98427746910198e-18
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CWC15,Spliceosome-associated protein CWC15 homolog,37835,0.0483110979667398,0.00558902350691032,0.0373566118931956,0.0592655840402841,6.04282413108854e-18
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EFNA1,Ephrin-A1,40303,0.0223865395501234,0.00259462270840341,0.0173010790416527,0.0274720000585941,6.82459074627714e-18
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HPGDS,Hematopoietic prostaglandin D synthase,39980,0.0307827785370759,0.00357160766859116,0.0237824275066372,0.0377831295675145,7.41349919652506e-18
NMR metabolomics,X23495.Concentration of Large VLDL Particles,B4GAT1,"Beta-1,4-glucuronyltransferase 1",40332,0.0197127088748273,0.00229256636560437,0.0152192787982428,0.0242061389514119,8.81770939050626e-18
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BAX,Apoptosis regulator BAX,39934,0.072719905443782,0.00848318079380395,0.0560928710879262,0.0893469397996377,1.1096350387633e-17
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BST2,Bone marrow stromal antigen 2,40471,0.0435793963968762,0.00508577771372005,0.0336112720779849,0.0535475207157675,1.13902916257759e-17
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,39925,0.038780602268879,0.00453220952426834,0.029897471601313,0.0476637329364449,1.26952901821782e-17
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",37959,0.0386671089661427,0.00451853847580029,0.0298107735535742,0.0475234443787113,1.27743795564682e-17
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CASP9,Caspase-9,37598,0.0508353553236714,0.00595284788270081,0.0391677734735778,0.062502937173765,1.49286153247131e-17
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLEC3B,Tetranectin,37681,0.0171177006901567,0.0020070221323405,0.0131839373107693,0.021051464069544,1.63662849442699e-17
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BRDT,Bromodomain testis-specific protein,37562,0.0302126764189932,0.00354940521703319,0.0232558421936082,0.0371695106443783,1.89343511830445e-17
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PAM,Peptidyl-glycine alpha-amidating monooxygenase,40432,0.0225540641707585,0.00265417930417258,0.0173518727345803,0.0277562556069368,2.10481695797943e-17
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL18BP,Interleukin-18-binding protein,40403,0.0245913244880429,0.00289517836345733,0.0189167748956665,0.0302658740804193,2.17253864358018e-17
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SMARCA2,Probable global transcription activator SNF2L2,39961,0.0590773424827199,0.0069555610942079,0.0454444427380725,0.0727102422273674,2.18421456808476e-17
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,37714,0.0298389046260034,0.00352180976794676,0.0229361574808278,0.0367416517711791,2.65061881054431e-17
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD276,CD276 antigen,40357,-0.0288903083297759,0.00341713776101938,-0.0355878983413739,-0.0221927183181779,3.04238914043267e-17
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DAPK2,Death-associated protein kinase 2,37598,0.0422024971018574,0.00499159104485398,0.0324189786539436,0.0519860155497712,3.0903461024653e-17
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD300C,CMRF35-like molecule 6,40471,0.0272975699630135,0.00323961646762602,0.0209479216864665,0.0336472182395605,3.87146310238267e-17
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CRYM,Ketimine reductase mu-crystallin,37541,0.0618630471331135,0.0073487938506073,0.0474594111859231,0.0762666830803038,4.2206295971714e-17
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TDP1,Tyrosyl-DNA phosphodiesterase 1,37900,0.0526766595041629,0.00625955389646573,0.04040793386709,0.0649453851412357,4.30796438237393e-17
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLGN,Calmegin,37572,0.035621386264414,0.00423453666701145,0.0273216943970715,0.0439210781317564,4.44052800541768e-17
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CA2,Carbonic anhydrase 2,40291,0.0564737497147558,0.00671547415883968,0.04331142036343,0.0696360790660815,4.46483582299235e-17
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,40359,0.0388635501646034,0.00463404309421553,0.0297808256999409,0.0479462746292658,5.42237999622257e-17
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SLITRK2,SLIT and NTRK-like protein 2,40489,0.0301505154599724,0.00359999365633681,0.0230945278935523,0.0372065030263926,5.96621788081579e-17
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FLT3LG,Fms-related tyrosine kinase 3 ligand,40516,0.0261491471379136,0.00312808541919179,0.0200180997162977,0.0322801945595295,6.81049597406358e-17
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CSDE1,Cold shock domain-containing protein E1,37562,0.0931823610298982,0.0111595478596664,0.0713096472249521,0.115055074834844,7.5058876647188e-17
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CELA3A,Chymotrypsin-like elastase family member 3A,40522,0.0437710094284752,0.00524691848392309,0.0334870491999859,0.0540549696569644,7.87582778154435e-17
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SPRR3,Small proline-rich protein 3,37942,0.0565669786004528,0.00678124167619946,0.0432757449151019,0.0698582122858038,8.02957288296591e-17
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CBS,Cystathionine beta-synthase,37628,0.0403290273847748,0.00483643260243433,0.0308496194840035,0.0498084352855461,8.2593827122342e-17
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,39980,0.0379116606036481,0.00454941443252724,0.0289948083158947,0.0468285128914014,8.51318789213618e-17
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MET,Hepatocyte growth factor receptor,40375,-0.0158996828642757,0.00190832702746753,-0.0196400038381121,-0.0121593618904393,8.60914578220568e-17
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SLITRK6,SLIT and NTRK-like protein 6,40042,-0.0269475219695362,0.00324552376829551,-0.0333087485553954,-0.020586295383677,1.09787524645719e-16
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD59,CD59 glycoprotein,39665,0.0177975049267067,0.00214394976165759,0.0135953633938578,0.0219996464595556,1.11588947148589e-16
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PLXNB2,Plexin-B2,40472,0.0183308260224099,0.0022135981630194,0.0139921736228919,0.0226694784219279,1.31687865509599e-16
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",40310,0.049571871890301,0.00598880873764881,0.0378338067645093,0.0613099370160927,1.3580568120964e-16
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TAFA5,Chemokine-like protein TAFA-5,40305,0.0282006205871117,0.0034073228123526,0.0215222678749006,0.0348789732993228,1.36883828457038e-16
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PSMD9,26S proteasome non-ATPase regulatory subunit 9,40305,0.0430885873185382,0.0052156445180741,0.032865924063113,0.0533112505739634,1.55231045489239e-16
NMR metabolomics,X23495.Concentration of Large VLDL Particles,COL15A1,Collagen alpha-1(XV) chain,37998,0.0203895798408238,0.00246953243682634,0.0155492962646442,0.0252298634170034,1.63863899614817e-16
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,40228,0.032034280871261,0.00388666914257161,0.0244164093518206,0.0396521523907013,1.82416756130124e-16
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MEP1B,Meprin A subunit beta,40359,0.0923364736190829,0.0112386300246083,0.0703087587708506,0.114364188467315,2.2647242676601e-16
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SNX2,Sorting nexin-2,37900,0.0609958002284427,0.00743120050367948,0.0464306472412309,0.0755609532156545,2.45104635788699e-16
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CGREF1,Cell growth regulator with EF hand domain protein 1,40359,0.0327259968545215,0.00399206572271678,0.0249015480379967,0.0405504456710464,2.63421414932749e-16
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IFNGR2,Interferon gamma receptor 2,40228,0.0401835002741619,0.00490391753263022,0.0305718219102067,0.0497951786381171,2.71547860484336e-16
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KLK7,Kallikrein-7,37352,0.0302595480672844,0.00369655832445994,0.023014293751343,0.0375048023832259,2.95591794245144e-16
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TOR1AIP1,Torsin-1A-interacting protein 1,37628,0.0392241611320039,0.00479747998030342,0.0298211003706092,0.0486272218933986,3.20116565796416e-16
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",39925,0.036562923699494,0.00447531703416282,0.0277913023125349,0.0453345450864531,3.32303916731768e-16
NMR metabolomics,X23495.Concentration of Large VLDL Particles,REPS1,RalBP1-associated Eps domain-containing protein 1,37598,0.0305083303353048,0.00373438599044957,0.0231889337940236,0.037827726876586,3.37600430637809e-16
NMR metabolomics,X23495.Concentration of Large VLDL Particles,WASF3,Wiskott-Aldrich syndrome protein family member 3,39961,0.0650023221118179,0.00795938487995188,0.0494019277471122,0.0806027164765236,3.4101046132463e-16
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",40044,0.0449531107245993,0.00550990995191085,0.034153687218854,0.0557525342303446,3.64602694418795e-16
NMR metabolomics,X23495.Concentration of Large VLDL Particles,COPB2,Coatomer subunit beta',37562,0.0335290180796032,0.00412090845228348,0.0254520375131276,0.0416059986460788,4.4398527022843e-16
NMR metabolomics,X23495.Concentration of Large VLDL Particles,C2orf69,UPF0565 protein C2orf69,37572,0.0467337430063445,0.00574622485291954,0.0354711422946222,0.0579963437180668,4.56415175785147e-16
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,37598,0.0275707162595429,0.00339009513322746,0.020926129798417,0.0342153027206687,4.57165978303459e-16
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PDGFRA,Platelet-derived growth factor receptor alpha,40359,-0.0219670277575388,0.00270422474780339,-0.0272673082632334,-0.0166667472518442,4.87015882120109e-16
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLEC5A,C-type lectin domain family 5 member A,40314,-0.0217543189889724,0.00268288967684833,-0.0270127827555951,-0.0164958552223496,5.49461184910391e-16
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD163,Scavenger receptor cysteine-rich type 1 protein M130,40403,0.0327609085939186,0.00404401316819822,0.0248346427842501,0.0406871744035871,5.83815904171285e-16
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PTPRR,Receptor-type tyrosine-protein phosphatase R,37942,0.0275390738526659,0.00339921087876628,0.020876620530284,0.0342015271750478,5.88718659600381e-16
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CHL1,Neural cell adhesion molecule L1-like protein,40379,-0.0243526817194507,0.00300826813168581,-0.0302488872575549,-0.0184564761813465,6.12456037307683e-16
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CNTN1,Contactin-1,40536,-0.0211871541203341,0.00262259515894776,-0.0263274406318717,-0.0160468676087965,7.00710383707092e-16
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SERPINI2,Serpin I2,37901,0.0430613399385518,0.00532997194733876,0.0326145949217678,0.0535080849553357,7.07797507493675e-16
NMR metabolomics,X23495.Concentration of Large VLDL Particles,OMD,Osteomodulin,40422,-0.03395482843018,0.00420976543268417,-0.042205968678241,-0.025703688182119,7.79297910260293e-16
NMR metabolomics,X23495.Concentration of Large VLDL Particles,S100A12,Protein S100-A12,40139,0.0585940971744125,0.00726696791311731,0.0443508400647026,0.0728373542841225,7.97327267741031e-16
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,40502,0.0290528010933146,0.00360454325065997,0.021987896322021,0.0361177058646081,8.15937739512061e-16
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SPTLC1,Serine palmitoyltransferase 1,37942,0.0274472526457306,0.00342150005107707,0.0207411125456195,0.0341533927458417,1.12579935366265e-15
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AMFR,E3 ubiquitin-protein ligase AMFR,39961,0.0491241373964829,0.00612813125794183,0.0371130001309169,0.0611352746620489,1.16820973339279e-15
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PPL,Periplakin,37598,0.0251935383998153,0.00314703984667623,0.0190253403003299,0.0313617364993007,1.28956322150892e-15
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LMNB2,Lamin-B2,37942,0.0208119584833146,0.00260584889221341,0.0157044946545763,0.0259194223120529,1.4985003972983e-15
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ACVRL1,Serine/threonine-protein kinase receptor R3,40203,0.0183616508821544,0.00230041959977625,0.013852828466593,0.0228704732977159,1.54005458690336e-15
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MOG,Myelin-oligodendrocyte glycoprotein,40489,0.024609753706571,0.00308367928965742,0.0185657422988424,0.0306537651142995,1.55351185862081e-15
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BSG,Basigin,40502,0.0152203299923654,0.00191784140165872,0.0114613608451144,0.0189792991396165,2.2219303907489e-15
NMR metabolomics,X23495.Concentration of Large VLDL Particles,APOC1,Apolipoprotein C-I,37981,0.0273679933529527,0.00344852139157726,0.0206088914254613,0.0341270952804442,2.24877036000064e-15
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRSS22,Brain-specific serine protease 4,37598,0.026756770901916,0.00337235853999657,0.0201469481635228,0.0333665936403093,2.29034045097963e-15
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",40341,0.0339028706276458,0.00428930117733395,0.0254958403200712,0.0423099009352203,2.87587322628229e-15
NMR metabolomics,X23495.Concentration of Large VLDL Particles,INSL5,Insulin-like peptide INSL5,37901,0.0706064556207817,0.00894817190273746,0.0530680386914163,0.0881448725501471,3.23875075883613e-15
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GDNF,Glial cell line-derived neurotrophic factor,39961,0.0287179313897103,0.00364010087151807,0.0215833336815349,0.0358525290978857,3.23998412708186e-15
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,40341,-0.0289735353657524,0.00367939653849248,-0.0361851525811977,-0.0217619181503072,3.63989576570323e-15
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,40442,0.0208216779644008,0.00264839215843899,0.0156308293338604,0.0260125265949412,4.02003495556811e-15
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SFTPD,Pulmonary surfactant-associated protein D,40359,0.0494839810064352,0.0063077800156697,0.0371207321757226,0.0618472298371478,4.60640795169737e-15
NMR metabolomics,X23495.Concentration of Large VLDL Particles,INSR,Insulin receptor,37598,0.0125864594304899,0.00161126415806127,0.00942838168068986,0.01574453718029,6.07635190505326e-15
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CFHR2,Complement factor H-related protein 2,37911,0.0425401932355153,0.0054467429591143,0.0318645770356512,0.0532158094353793,6.13042395708086e-15
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VSIG2,V-set and immunoglobulin domain-containing protein 2,37900,0.0426743391401595,0.00547137649284946,0.0319504412141746,0.0533982370661445,6.66821859560987e-15
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VCAM1,Vascular cell adhesion protein 1,40372,-0.0199816802026176,0.00256727445356513,-0.0250135381316053,-0.01494982227363,7.50217717522826e-15
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GIMAP8,GTPase IMAP family member 8,37482,0.0384227064133588,0.00493591940848882,0.0287483043727207,0.0480971084539969,7.53703607614964e-15
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRG2,Bone marrow proteoglycan,37998,-0.0386090137267269,0.00497509792458802,-0.0483602056589194,-0.0288578217945344,9.06667518302474e-15
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RNASE3,Eosinophil cationic protein,40288,0.0800070612122403,0.010316576318539,0.0597865716279039,0.100227550796577,9.3553806050803e-15
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ZBP1,Z-DNA-binding protein 1,37598,0.0297923783614879,0.00384096574097958,0.0222640855091679,0.0373206712138079,9.37330828105108e-15
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LY75,Lymphocyte antigen 75,40341,0.0286107141697944,0.00369661375672689,0.0213653512066097,0.0358560771329791,1.05614694373414e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ROBO1,Roundabout homolog 1,40379,0.017664971327398,0.00228710565312139,0.0131822442472801,0.0221476984075159,1.19675984626053e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DHPS,Deoxyhypusine synthase,37900,0.0302515162036164,0.00392489336250323,0.02255872521311,0.0379443071941227,1.37170439550725e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KLRF1,Killer cell lectin-like receptor subfamily F member 1,37598,0.0316353807936633,0.00411076866717837,0.0235782742059936,0.0396924873813329,1.50694510675521e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,39980,0.0319494936866396,0.00416273142554103,0.0237905400925792,0.0401084472807001,1.75053725956343e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MYOM3,Myomesin-3,37671,-0.0658702321991028,0.00859354673201205,-0.0827135837938465,-0.0490268806043592,1.91158526920081e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,40332,0.026225759722239,0.00342439936598563,0.0195139369649072,0.0329375824795709,1.98924729656936e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FGA,Fibrinogen alpha chain,37698,0.0224386901995777,0.00293222464813315,0.0166915298892368,0.0281858505099187,2.1079804985165e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD93,Complement component C1q receptor,39725,-0.0229442360471749,0.00299930711674085,-0.0288228779959869,-0.0170655940983628,2.13196648717477e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HEPACAM2,HEPACAM family member 2,37942,-0.0296856368245187,0.00388051333875635,-0.0372914429684811,-0.0220798306805562,2.1469469311695e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CST5,Cystatin-D,40070,0.0400415623219244,0.0052457542767847,0.0297598839394264,0.0503232407044224,2.42317953527751e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DGKZ,Diacylglycerol kinase zeta,40044,0.0253937023067056,0.00333255590807937,0.01886189272687,0.0319255118865412,2.68456972307148e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IGFBPL1,Insulin-like growth factor-binding protein-like 1,40359,0.0244693232555666,0.00321525425330046,0.0181674249190977,0.0307712215920355,2.88557427627017e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CNDP1,Beta-Ala-His dipeptidase,40403,0.0329923641235881,0.00433993382562914,0.024486093825355,0.0414986344218212,3.07668890706195e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KLRK1,NKG2-D type II integral membrane protein,37942,0.033409449549877,0.00439488319411245,0.0247954784894166,0.0420234206103374,3.1105644976358e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ITGA11,Integrin alpha-11,40341,-0.0245795432491202,0.00323609335165921,-0.0309222862183723,-0.0182368002798682,3.2378807170302e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IGHMBP2,DNA-binding protein SMUBP-2,37562,0.0401812440775717,0.00530481360751989,0.0297838094068327,0.0505786787483107,3.84667619875754e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PVALB,Parvalbumin alpha,40417,0.0812050386255008,0.0107391366061575,0.0601563308774322,0.10225374637357,4.19752486190883e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,C1QA,Complement C1q subcomponent subunit A,40442,-0.0163190080073171,0.00215987894078324,-0.0205523707312523,-0.012085645283382,4.39721118089333e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",37598,0.0321151488936891,0.00426512340027191,0.0237555070291562,0.040474790758222,5.41642289113145e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CX3CL1,Fractalkine,40228,-0.0244014115050011,0.00325006127871846,-0.0307715316112893,-0.0180312913987129,6.32495365728143e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CKAP4,Cytoskeleton-associated protein 4,40457,0.0186165705453627,0.00248442044299249,0.0137471064770974,0.023486034613628,7.06544940355952e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VGF,Neurosecretory protein VGF,37959,0.0217797827554664,0.00290614196124761,0.0160837445114211,0.0274758209995117,7.07424030472413e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DEFB103A_DEFB103B,Beta-defensin 103,37539,0.0294472813557561,0.00393050236950337,0.0217434967115295,0.0371510659999827,7.21864107516926e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL6,Interleukin-6,40305,0.0516066399510025,0.00693235489666824,0.0380192243535328,0.0651940555484723,1.02449429843656e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CFHR5,Complement factor H-related protein 5,37785,0.0296115200833781,0.00398267583030927,0.021805475455972,0.0374175647107843,1.10876162692634e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DDC,Aromatic-L-amino-acid decarboxylase,40330,-0.0342858002652614,0.00461771867834271,-0.0433365288748131,-0.0252350716557097,1.18645854336505e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GCLM,Glutamate--cysteine ligase regulatory subunit,37562,0.0323471305825066,0.00435773495706793,0.0238059700666534,0.0408882910983597,1.21624961321695e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NRP2,Neuropilin-2,40332,-0.0204498032919857,0.00276300277904928,-0.0258652887389223,-0.0150343178450492,1.41611286372551e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MANSC1,MANSC domain-containing protein 1,40411,-0.0192707930791733,0.00260573482568068,-0.0243780333375074,-0.0141635528208392,1.47836223477336e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PI3,Elafin,40074,0.0376370937638812,0.00508927561811033,0.0276621135523849,0.0476120739753774,1.48165609003156e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VEGFD,Vascular endothelial growth factor D,40483,-0.0233937658452833,0.0031639088847395,-0.0295950272593727,-0.0171925044311939,1.49573749825231e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FSTL3,Follistatin-related protein 3,40293,0.0219135519070734,0.00296786412800392,0.0160965382161857,0.0277305655979611,1.61710304108654e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NFIC,Nuclear factor 1 C-type,37959,0.030674977724693,0.00416025389710419,0.0225208800863688,0.0388290753630172,1.76083620286697e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLSTN2,Calsyntenin-2,40516,-0.0272946565671995,0.00370978023857965,-0.0345658258348157,-0.0200234872995834,1.96457735707186e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",40305,0.0241723549038028,0.00329200195688105,0.0177200310683159,0.0306246787392896,2.1940753402315e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DPP7,Dipeptidyl peptidase 2,40251,0.0404361171934997,0.00550755339340368,0.0296413125424285,0.0512309218445709,2.20777539815386e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SCGB3A1,Secretoglobin family 3A member 1,37671,-0.0175027085166597,0.00238578845572934,-0.0221788538898892,-0.0128265631434302,2.32487554816145e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CRH,Corticoliberin,39947,0.0605399274376904,0.00826438185808897,0.044341738995836,0.0767381158795448,2.49910222185415e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CXCL9,C-X-C motif chemokine 9,40422,0.0470433733968684,0.00643457861404972,0.0344315993133309,0.0596551474804058,2.77667924709849e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",40305,-0.0290944857887674,0.00398312309513352,-0.0369014070552291,-0.0212875645223057,2.91663071760564e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCN5,CCN family member 5,40332,0.0272555699100024,0.00373142546207464,0.0199419760043361,0.0345691638156687,2.9187506893469e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LBP,Lipopolysaccharide-binding protein,40403,-0.0403830594047561,0.00553154668593869,-0.051224890909196,-0.0295412279003163,3.00218245708245e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,UBAC1,Ubiquitin-associated domain-containing protein 1,40305,0.0246320460237532,0.00337884430266988,0.0180095111905202,0.0312545808569862,3.24385598681941e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD300LF,CMRF35-like molecule 1,40489,0.0420640337696128,0.00577259850551285,0.0307497406988076,0.0533783268404179,3.32064778196859e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADAMTSL4,ADAMTS-like protein 4,37628,0.0163215482540135,0.0022399740456016,0.0119311991246344,0.0207118973833926,3.36235026563375e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",39980,0.035406327099343,0.00486558576416596,0.0258697790015777,0.0449428751971083,3.57948664461089e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SEL1L,Protein sel-1 homolog 1,37628,0.0224940880585636,0.00309518425085709,0.0164275269268838,0.0285606491902435,3.86969053350763e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ICAM4,Intercellular adhesion molecule 4,40341,-0.036404829213648,0.00501493302712004,-0.0462340979468032,-0.0265755604804927,4.07149874575568e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCL21,C-C motif chemokine 21,40422,0.0292723578529378,0.00403873711063333,0.0213564331160965,0.0371882825897791,4.42651861543789e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,37572,0.0376860446452134,0.00520019636494988,0.0274936597699117,0.0478784295205152,4.49784831238627e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HSPA2,Heat shock-related 70 kDa protein 2,37900,0.0229447332412746,0.00316821452205151,0.0167350327780537,0.0291544337044956,4.65582778252944e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CFC1,Cryptic protein,39980,0.0316401816554061,0.00439035715806857,0.0230350816255917,0.0402452816852205,5.99423811502751e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CSF1,Macrophage colony-stimulating factor 1,40422,0.0185229765278862,0.00257181701865201,0.0134822151713283,0.0235637378844442,6.18498947149005e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RSPO3,R-spondin-3,40489,0.0194906282021856,0.00271694402521806,0.0141654179127582,0.024815838491613,7.61707204063953e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MCTS1,Malignant T-cell-amplified sequence 1,37901,0.0177989072363487,0.00248132095415253,0.0129355181662097,0.0226622963064876,7.7120429996528e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,COL24A1,Collagen alpha-1(XXIV) chain,37901,0.0375975573589048,0.00524215040562868,0.0273229425638726,0.047872172153937,7.76810071937044e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SCARF2,Scavenger receptor class F member 2,40471,-0.0202655686126911,0.00282617478378528,-0.0258048711889102,-0.0147262660364719,7.7891855337439e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,S100A11,Protein S100-A11,40207,0.0305841556617165,0.00427084817539121,0.0222132932379497,0.0389550180854832,8.35432871284803e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD101,Immunoglobulin superfamily member 2,37901,0.0290070379156575,0.004053551223212,0.0210620775181619,0.036951998313153,8.7395512876307e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",39980,0.0544708359928263,0.00762885409807222,0.0395182819606047,0.0694233900250478,9.73926013390053e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SHISA5,Protein shisa-5,37998,0.0169109329266557,0.00237124476441743,0.0122632931883976,0.0215585726649139,1.04188854483526e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RBP2,Retinol-binding protein 2,40305,-0.051411001335945,0.00723206663476425,-0.0655858519400829,-0.0372361507318071,1.22086913931097e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PECR,Peroxisomal trans-2-enoyl-CoA reductase,37628,0.0193476932907062,0.00272429756919662,0.0140080700550809,0.0246873165263316,1.29365829701977e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,37598,0.0410253028652295,0.00578698522360127,0.029682811826971,0.052367793903488,1.41740774274822e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",37628,0.0462005929656791,0.00653787201639128,0.0333863638135522,0.059014822117806,1.66749165895363e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ROBO2,Roundabout homolog 2,40471,0.0156375289490523,0.00221379113693335,0.011298498320663,0.0199765595774417,1.6881127266187e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],40305,0.0383160808016129,0.00542563615957462,0.0276818339288466,0.0489503276743791,1.70886343365652e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AGER,Advanced glycosylation end product-specific receptor,40311,0.0271880695005988,0.00385100691626775,0.019640095944714,0.0347360430564836,1.734208685659e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NPTX2,Neuronal pentraxin-2,37998,-0.0219668016573982,0.00311500535584269,-0.0280722121548498,-0.0158613911599465,1.85007521264549e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LRRC37A2,Leucine-rich repeat-containing protein 37A2,37901,0.0282787390674871,0.00401318824941655,0.0204128900986306,0.0361445880363435,1.92473673675512e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",37628,0.0523364695098628,0.00742760447268347,0.0377783647434032,0.0668945742763224,1.92995470687e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,C2CD2L,Phospholipid transfer protein C2CD2L,39925,0.0293380660952862,0.00416552997011354,0.0211736273538637,0.0375025048367087,1.95988531303678e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,40042,0.0327007988376821,0.00464479511148928,0.0235970004191631,0.0418045972562011,1.99817331506603e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FSHB,Follitropin subunit beta,37628,0.0467279145675974,0.00666208771056123,0.0336702226548974,0.0597856064802974,2.42895318212905e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SIGLEC6,Sialic acid-binding Ig-like lectin 6,40489,0.0225391302570754,0.00321416993909004,0.0162393571764589,0.0288389033376919,2.43568201961322e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AGR2,Anterior gradient protein 2 homolog,39839,0.0675249184976938,0.00963827878796494,0.0486338920732825,0.0864159449221051,2.55561976049464e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,37998,-0.0172999818272913,0.00246948108994685,-0.0221401647635871,-0.0124597988909955,2.57702019447899e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AMIGO2,Amphoterin-induced protein 2,40305,0.0150031543231268,0.00214245449159563,0.0108039435195994,0.0192023651266542,2.60996029897523e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FABP3,"Fatty acid-binding protein, heart",37990,0.0316998120270973,0.00453060201473044,0.0228198320782257,0.040579791975969,2.74144513397176e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,YAP1,Transcriptional coactivator YAP1,37942,0.017737653189532,0.00253931628110697,0.0127605932785624,0.0227147131005017,2.97764879327441e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LACRT,Extracellular glycoprotein lacritin,37863,0.035462516376949,0.00507783007341699,0.0255099694330517,0.0454150633208463,3.00850645353842e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GC,Vitamin D-binding protein,38013,0.0172978283150157,0.00247723168151762,0.0124424542192411,0.0221532024107902,3.02985543384928e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RHOC,Rho-related GTP-binding protein RhoC,40152,0.0770012838865992,0.0110359839713693,0.0553707553027154,0.0986318124704829,3.12952610096233e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,S100A13,Protein S100-A13,37598,0.0231243841025213,0.00332580821376171,0.0166058000035483,0.0296429682014942,3.74459605003629e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,40359,0.0384885114493077,0.00554134011888093,0.0276274848163011,0.0493495380823143,3.91163118528264e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FCRL3,Fc receptor-like protein 3,40044,0.0360172419824466,0.00520722720046236,0.0258110766695404,0.0462234072953528,4.79989698201051e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VAMP5,Vesicle-associated membrane protein 5,40042,0.0367636508538176,0.0053274415326721,0.0263218654497803,0.0472054362578549,5.36997311543854e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LAMTOR5,Ragulator complex protein LAMTOR5,37900,0.0269485317171813,0.0039093700587362,0.0192861664020584,0.0346108970323043,5.69361892324774e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LYZL2,Lysozyme-like protein 2,37482,0.0235978700066415,0.0034232926189249,0.0168882164735487,0.0303075235397343,5.70128460674138e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GOT1,"Aspartate aminotransferase, cytoplasmic",37998,0.0264030646477875,0.00383661051836058,0.0188833080318008,0.0339228212637743,6.16680729151328e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GM2A,Ganglioside GM2 activator,37714,0.0252458103920951,0.00366867238814148,0.0180552125113378,0.0324364082728524,6.19046156603517e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,COL28A1,Collagen alpha-1(XXVIII) chain,37572,0.0475724297538354,0.00692278267546809,0.0340037757099179,0.0611410837977528,6.62295000467793e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,B2M,Beta-2-microglobulin,38013,0.0207795168009209,0.00302420354234694,0.0148520778579209,0.0267069557439209,6.65027599626585e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,37714,0.0485341875936469,0.00707388570005281,0.0346693716215434,0.0623990035657504,7.13970820570209e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL17D,Interleukin-17D,40044,0.0223364594675442,0.00325933838806628,0.0159481562269343,0.0287247627081541,7.4992410227343e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",37900,0.024143172247759,0.00352354872765911,0.0172370167415471,0.0310493277539708,7.60222468699352e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LCP1,Plastin-2,37998,0.0307547329560268,0.00449026706995637,0.0219538094989123,0.0395556564131413,7.74683049454905e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SPOCK1,Testican-1,40228,0.0163720797184527,0.00239262395631983,0.0116825367640658,0.0210616226728395,8.05575521907554e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CTSC,Dipeptidyl peptidase 1,40349,0.0276649129404441,0.0040466613684439,0.019733456658294,0.0355963692225941,8.41168043661932e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LPCAT2,Lysophosphatidylcholine acyltransferase 2,40305,0.0241526781696567,0.00353468932493473,0.0172246870927846,0.0310806692465288,8.61603203189724e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MSLN,Mesothelin,40271,0.0351483440636977,0.00515043021819625,0.0250535008360331,0.0452431872913624,9.1530687557043e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,40305,-0.0128893321057801,0.00189018664146136,-0.0165940979230443,-0.00918456628851582,9.49354858505728e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FABP2,"Fatty acid-binding protein, intestinal",40359,-0.0500703119071236,0.00734438924373528,-0.0644653148248448,-0.0356753089894025,9.59754603699488e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SART1,U4/U6.U5 tri-snRNP-associated protein 1,37562,0.0232623247845992,0.00341186192490623,0.016575075411783,0.0299495741574154,9.63106371611545e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LGALS4,Galectin-4,40357,0.0341528749402894,0.00501761584765196,0.0243183478788915,0.0439874020016872,1.03507809445478e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SCT,Secretin,37572,0.0297971176780884,0.00438358257809777,0.0212052958250168,0.03838893953116,1.11102650729421e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",40379,-0.0221273561014441,0.00326128642248893,-0.0285194774895224,-0.0157352347133658,1.20297523912542e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ENSA,Alpha-endosulfine,37900,0.0341259883410016,0.00503471341223568,0.0242579500530197,0.0439940266289836,1.26808033635275e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BCAM,Basal cell adhesion molecule,40332,-0.015222385694947,0.00225364867154562,-0.0196395370911765,-0.0108052342987176,1.48252151682095e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KLK6,Kallikrein-6,40387,0.019510276238799,0.00289419302872446,0.0138376579024991,0.025182894575099,1.62497886077844e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CAT,Catalase,37786,0.0349719856553292,0.00519121875706014,0.0247971968914914,0.0451467744191671,1.68604938547165e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GPR15L,Protein GPR15L,37901,0.0386324351926502,0.00574843023714844,0.0273655119278393,0.0498993584574612,1.88373136873245e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SIGLEC9,Sialic acid-binding Ig-like lectin 9,40470,0.0187519431471273,0.00279776762247803,0.0132683186070704,0.0242355676871843,2.11769435873715e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GSTT2B,Glutathione S-transferase theta-2B,37942,0.152544764035825,0.022763119425196,0.107929049962441,0.197160478109209,2.1462921976686e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MST1,Hepatocyte growth factor-like protein,37787,0.0392671924734722,0.00587039446686562,0.0277612193184156,0.0507731656285288,2.33628460671186e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADGRG2,Adhesion G-protein coupled receptor G2,40359,-0.0170359651763923,0.0025535278597024,-0.022040879781409,-0.0120310505713756,2.61483463689408e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CYTL1,Cytokine-like protein 1,37998,0.0145853748979266,0.00219296155395863,0.0102871702521677,0.0188835795436855,3.02289081253521e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SLC16A1,Monocarboxylate transporter 1,39961,0.0379477403336969,0.00571605839457841,0.0267442658803232,0.0491512147870705,3.26756634515916e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,37482,0.0420562382637562,0.00635691658631819,0.0295966817545726,0.0545157947729399,3.83928195811936e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FES,Tyrosine-protein kinase Fes/Fps,39980,0.0298636440213521,0.00452192565460682,0.0210006697383227,0.0387266183043815,4.12684124429516e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NAMPT,Nicotinamide phosphoribosyltransferase,39980,0.032398074216288,0.00490665965666184,0.0227810212892308,0.0420151271433452,4.16337011980232e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DEFA1_DEFA1B,Neutrophil defensin 1,40009,0.0324379276907799,0.0049151457475209,0.022804242025639,0.0420716133559209,4.25634414694568e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,QPCT,Glutaminyl-peptide cyclotransferase,40373,0.0168733559599874,0.00255677441646798,0.0118620781037102,0.0218846338162647,4.25657981460944e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD209,CD209 antigen,40382,-0.0243685671404414,0.00369342190955829,-0.0316076740831757,-0.0171294601977072,4.30373405055016e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CABP2,Calcium-binding protein 2,37572,0.041166974153403,0.00623948111995467,0.0289375911582918,0.0533963571485141,4.33264023860331e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PAEP,Glycodelin,40228,-0.0823842786955712,0.0125103918670156,-0.106904646754922,-0.0578639106362206,4.68412911691449e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AGT,Angiotensinogen,37987,0.0152050318877872,0.00230929059154375,0.0106788223283614,0.0197312414472129,4.73934396078786e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RBFOX3,RNA binding protein fox-1 homolog 3,37959,0.0235094559351686,0.00357436988186271,0.0165036909667177,0.0305152209036195,4.96932367338199e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SBSN,Suprabasin,37977,-0.0210612678857097,0.00320405810368488,-0.0273412217689321,-0.0147813140024873,5.10133598470725e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PGA4,Pepsin A-4,37987,0.042625802173655,0.00648490492224494,0.0299153885260549,0.055336215821255,5.10905475198029e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,40357,0.0239528053472242,0.00364846053850383,0.0168018226917567,0.0311037880026917,5.35783944657995e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VIPR1,Vasoactive intestinal polypeptide receptor 1,37628,-0.0163267816553272,0.00248728255380816,-0.0212018554607912,-0.0114517078498632,5.43069775042344e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NOTCH1,Neurogenic locus notch homolog protein 1,40536,0.00964900142186972,0.00147521611206828,0.00675757784221589,0.0125404250015235,6.30623729989819e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,B4GALT1,"Beta-1,4-galactosyltransferase 1",40422,0.0170101117612902,0.00260476810597074,0.0119047662735875,0.0221154572489928,6.75857317981905e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RABEPK,Rab9 effector protein with kelch motifs,39980,0.0373370626753411,0.00572154402561332,0.026122836385139,0.0485512889655432,6.97821977090959e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PBK,Lymphokine-activated killer T-cell-originated protein kinase,37482,-0.0188251801878206,0.00288470981745684,-0.024479211430036,-0.0131711489456052,7.01196867977562e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GBP4,Guanylate-binding protein 4,39961,0.0305903202471806,0.00469108440886498,0.0213957948058052,0.0397848456885559,7.20241910065422e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GIMAP7,GTPase IMAP family member 7,37671,-0.0201513467871336,0.00309505307936139,-0.0262176508226819,-0.0140850427515853,7.74402283281544e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CTSF,Cathepsin F,40411,0.0247195436093629,0.00380341765092567,0.0172648450135486,0.0321742422051772,8.30877593406194e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NAGA,Alpha-N-acetylgalactosaminidase,37567,0.0368251097141626,0.00567907306692981,0.0256941265029802,0.047956092925345,9.23077452202828e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RCOR1,REST corepressor 1,40042,0.0275363989089741,0.00426128781178783,0.0191842747978699,0.0358885230200782,1.06400632897521e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VCAN,Versican core protein,40471,-0.0184660777974926,0.0028594254930923,-0.0240705517639535,-0.0128616038310317,1.09173612470016e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GAS2,Growth arrest-specific protein 2,37714,0.0329773753835756,0.0051067442758106,0.0229681566029869,0.0429865941641644,1.10075690430992e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLU,Clusterin,38013,0.0203451776043073,0.00315568412186425,0.0141600367254534,0.0265303184831612,1.17830100075316e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NFYA,Nuclear transcription factor Y subunit alpha,37562,0.023660735927621,0.00367060454379192,0.0164663510217888,0.0308551208334532,1.18858210834762e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KITLG,Kit ligand,40359,-0.0222791835105292,0.00345806709687857,-0.0290569950204112,-0.0155013720006472,1.20762222913529e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CHI3L1,Chitinase-3-like protein 1,40054,0.045548152871713,0.00707062561922638,0.0316897266580293,0.0594065790853967,1.21454177791921e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AFAP1,Actin filament-associated protein 1,37671,0.0519741766784221,0.00808074519349309,0.0361359160991756,0.0678124372576685,1.30395834039258e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL1B,Interleukin-1 beta,39946,0.0344788964160785,0.00536211555805347,0.0239691499222937,0.0449886429098633,1.3125988370689e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ITGAM,Integrin alpha-M,40332,-0.0193770346099951,0.00301404191853857,-0.0252845567703307,-0.0134695124496595,1.32180489877484e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDH1,Cadherin-1,39806,0.0244744043807443,0.00381327958602292,0.0170003763921393,0.0319484323693492,1.41935948776675e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ATP6V1G2,V-type proton ATPase subunit G 2,37562,0.0619511581258943,0.00967368252640471,0.042990740374141,0.0809115758776475,1.56428069168696e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BCL2,Apoptosis regulator Bcl-2,37901,0.0330104300945691,0.00515579987954777,0.0229050623306554,0.0431157978584827,1.57846331573064e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FCRLB,Fc receptor-like B,39980,0.0371428757528639,0.00580828849012269,0.0257586303122235,0.0485271211935044,1.65345835803132e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PTPRH,Receptor-type tyrosine-protein phosphatase H,37901,0.0292330824625496,0.00457602977056526,0.0202640641122417,0.0382021008128575,1.73255375994263e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GALNT7,N-acetylgalactosaminyltransferase 7,40305,0.012837228016495,0.00200981915839651,0.00889798246603779,0.0167764735669521,1.73594038938896e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SCGB1A1,Uteroglobin,40384,0.0344052564108651,0.00539292708625219,0.0238351193218108,0.0449753934999194,1.82330048389385e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CTSH,Pro-cathepsin H,40013,0.0438973894255232,0.00688592953454324,0.0304009675378184,0.0573938113132279,1.88190046794658e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NPHS1,Nephrin,37598,0.0210536544105889,0.00331252833897582,0.0145610988661963,0.0275462099549815,2.1423898512756e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CEBPA,CCAAT/enhancer-binding protein alpha,37598,0.023369413428268,0.00368011062071516,0.0161563966116662,0.0305824302448697,2.22120977243886e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SEZ6L2,Seizure 6-like protein 2,40305,-0.0143259446678948,0.00225772722557863,-0.018751090030029,-0.00990079930576073,2.28024666905296e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ATXN10,Ataxin-10,39961,0.0436027313645112,0.00689115633865637,0.0300960649407447,0.0571093977882777,2.56256873393886e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LRP1,Prolow-density lipoprotein receptor-related protein 1,40305,-0.0158781518054661,0.00251073594631669,-0.0207991942602468,-0.0109571093506854,2.6152981951329e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NBL1,Neuroblastoma suppressor of tumorigenicity 1,40411,0.0159214223842192,0.00252061597999961,0.01098101506342,0.0208618297050185,2.74671020884529e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SCN4B,Sodium channel subunit beta-4,37628,0.0252601922364426,0.00399970084819454,0.0174207785739813,0.0330996058989039,2.77903692775564e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,XG,Glycoprotein Xg,40458,0.0179672266832419,0.002846795379488,0.0123875077394454,0.0235469456270384,2.83822616715044e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CENPF,Centromere protein F,37714,0.0328785823105123,0.00521172684369215,0.0226635976968757,0.043093566924149,2.9056007429653e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNC,Tenascin,40403,-0.0283356929110467,0.00449264548244194,-0.0371412780566329,-0.0195301077654605,2.91745148384999e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,REG3G,Regenerating islet-derived protein 3-gamma,37900,0.024284977901734,0.00385064251634818,0.0167377185696915,0.0318322372337764,2.93903212261354e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PON1,Serum paraoxonase/arylesterase 1,37987,-0.0155658968127687,0.00246905389316623,-0.0204052424433745,-0.0107265511821629,2.98298936504889e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,40042,-0.0181826714411497,0.00288568209732414,-0.023838608351905,-0.0125267345303944,3.03678645780235e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LMOD1,Leiomodin-1,37959,-0.021791813778718,0.00345834854898589,-0.0285701769347303,-0.0150134506227056,3.04481151536052e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ALPP,"Alkaline phosphatase, placental type",40305,0.061555757832579,0.0097943821466007,0.0423587688252416,0.0807527468399163,3.36848130630532e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VEGFB,Vascular endothelial growth factor B,37598,0.0170986375453693,0.00272411960275372,0.011759363123972,0.0224379119667666,3.56570363655304e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TSPAN1,Tetraspanin-1,40042,0.018208407520559,0.0029044565307222,0.0125156727203435,0.0239011423207745,3.72631433511469e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LTB,Lymphotoxin-beta,37900,0.0211726728722398,0.00338253124747156,0.0145429116271955,0.027802434117284,3.98156842104134e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DNAJB8,DnaJ homolog subfamily B member 8,40042,0.0349572111746821,0.00558816049478122,0.0240044166049109,0.0459100057444533,4.06361851366904e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ECE1,Endothelin-converting enzyme 1,39961,0.0209805753088089,0.00335518661308264,0.014404409547167,0.0275567410704509,4.12718708983525e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DPP4,Dipeptidyl peptidase 4,40068,0.0177604308153093,0.00284158378222663,0.0121909266021451,0.0233299350284735,4.206023673813e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DGCR6,Protein DGCR6,37541,0.0271043452210033,0.00434095808394245,0.0185960673764761,0.0356126230655305,4.40091533956565e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DPP6,Dipeptidyl aminopeptidase-like protein 6,40305,-0.0194683027848821,0.0031186677249352,-0.0255808915257551,-0.0133557140440091,4.41569943141728e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RNASE1,Ribonuclease pancreatic,37987,0.014380476290641,0.00230350014888681,0.00986561599882282,0.0188953365824591,4.42413020513694e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CPE,Carboxypeptidase E,40360,-0.0226492464799879,0.00363753244772026,-0.0297788100775196,-0.0155196828824561,4.88811665419831e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",37959,0.0431400308140429,0.0069297500345198,0.0295577207463841,0.0567223408817017,4.94741311796331e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,JAM2,Junctional adhesion molecule B,40471,0.0154100639064991,0.00248301817363498,0.0105433482861746,0.0202767795268237,5.56226721916983e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PDIA5,Protein disulfide-isomerase A5,37482,0.0363696467216654,0.0058621630949954,0.0248798070554744,0.0478594863878564,5.66641264331099e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HSBP1,Heat shock factor-binding protein 1,37628,0.0564141379777642,0.00911206529104046,0.0385544900073249,0.0742737859482035,6.15013036758509e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CSF3R,Granulocyte colony-stimulating factor receptor,37598,0.0185433550214975,0.00299725365352317,0.0126687378605921,0.0244179721824029,6.3227117292957e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AZU1,Azurocidin,39809,0.0457463354308116,0.00740236121916046,0.0312377074412571,0.0602549634203661,6.57344854668615e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,APOM,Apolipoprotein M,40372,0.015675541261957,0.00254038795183004,0.0106963808763702,0.0206547016475439,6.97082983761701e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SPARCL1,SPARC-like protein 1,40346,-0.0161804362553797,0.00262343722006607,-0.0213223732067091,-0.0110384993040502,7.09904259732085e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GBA,Lysosomal acid glucosylceramidase,37572,0.0310732615578717,0.00504267355044835,0.021189621398993,0.0409569017167505,7.39059155729376e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KIF1C,Kinesin-like protein KIF1C,37562,0.0220687334653455,0.00359115882859148,0.0150300621613062,0.0291074047693848,8.2127517335369e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,OSM,Oncostatin-M,40268,0.0423235415031837,0.00689305107307334,0.02881316139996,0.0558339216064075,8.4476761540241e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MEPE,Matrix extracellular phosphoglycoprotein,40357,0.0155180974664446,0.00252861467771864,0.0105620126981161,0.0204741822347731,8.60903526931718e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MDM1,Nuclear protein MDM1,37572,0.0182867469103637,0.00298490116972206,0.0124363406177084,0.0241371532030189,9.24516393225139e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AHSP,Alpha-hemoglobin-stabilizing protein,40311,0.050996912085383,0.00834232327380257,0.03464595846873,0.0673478657020361,1.00042769507746e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,40403,-0.0257413507448086,0.00421112791182636,-0.0339951614519882,-0.0174875400376289,1.00240686652912e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RALY,RNA-binding protein Raly,37900,0.0281436067504041,0.00460521347708722,0.0191173883353132,0.0371698251654951,1.01585487971127e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCN3,CCN family member 3,40522,0.0195664786630217,0.00320972227563795,0.0132754230027713,0.0258575343232721,1.11237912044912e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PFDN2,Prefoldin subunit 2,39961,0.0324960085795868,0.00534485066318269,0.0220201012797487,0.0429719158794249,1.2309757606214e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,37990,0.0192775674872821,0.00318464933665746,0.0130356547874334,0.0255194801871307,1.45678703610849e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,USP47,Ubiquitin carboxyl-terminal hydrolase 47,37562,0.0488016635560543,0.00807451628726337,0.0329756116330181,0.0646277154790905,1.54503619266235e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DSG4,Desmoglein-4,40250,0.0290701528925878,0.00483873161377133,0.019586238929596,0.0385540668555796,1.92180322899338e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CSF3,Granulocyte colony-stimulating factor,40044,0.0279039749402461,0.00464780738260827,0.0187942724703339,0.0370136774101583,1.97166663765242e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL5RA,Interleukin-5 receptor subunit alpha,40341,-0.0314726842911607,0.00524250844235305,-0.0417480008381726,-0.0211973677441487,1.97476680393558e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PREB,Prolactin regulatory element-binding protein,40044,0.0168983670544091,0.00282195390159455,0.0113673374072838,0.0224293967015344,2.16862120940612e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD14,Monocyte differentiation antigen CD14,40048,0.0236444375359867,0.00395077143080492,0.0159009255316091,0.0313879495403644,2.21449353915415e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",37628,0.0208628331424257,0.00348786523240757,0.0140266172869068,0.0276990489979445,2.26755037585162e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TSHB,Thyrotropin subunit beta,40359,0.0475454751422679,0.00797067030631206,0.0319229613418963,0.0631679889426395,2.49736962648275e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,S100A14,Protein S100-A14,37959,0.0304973059345794,0.00513215027740145,0.0204382913908726,0.0405563204782863,2.87791063375566e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ANGPTL1,Angiopoietin-related protein 1,40136,0.0166329868576987,0.00281024165578685,0.0111249132123565,0.0221410605030409,3.31254736122378e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD7,T-cell antigen CD7,37567,0.0242114735933844,0.00409895095149358,0.016177529728457,0.0322454174583118,3.57570844332126e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CGA,Glycoprotein hormones alpha chain,40332,0.0503450716847375,0.00852593324632202,0.0336342425219463,0.0670559008475287,3.59985750886707e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MNAT1,CDK-activating kinase assembly factor MAT1,37714,0.0242458974924909,0.00410859306672935,0.0161930550817013,0.0322987399032804,3.69530069531028e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MRC1,Macrophage mannose receptor 1,37987,0.0158892255791921,0.00269530079793776,0.0106064360152341,0.0211720151431501,3.83236758214262e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLEC4M,C-type lectin domain family 4 member M,37969,-0.0272345060840221,0.00462490504310688,-0.0362993199685116,-0.0181696921995326,3.98577790347213e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ANXA1,Annexin A1,37608,0.0232907304164691,0.00395876775581785,0.0155315456150661,0.0310499152178721,4.11874815149361e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,40517,0.0151883504441116,0.00258587574873567,0.0101200339765896,0.0202566669116335,4.34902530333002e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MTPN,Myotrophin,40042,0.0184976221224086,0.00315343784158745,0.0123168839528972,0.02467836029192,4.55860648228013e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDH3,Cadherin-3,40471,0.0197635467875745,0.00337182719009324,0.0131547654949918,0.0263723280801573,4.68064544694382e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SLAMF8,SLAM family member 8,39980,0.0298312735800856,0.0050947055961247,0.0198456506116812,0.03981689654849,4.85622295951695e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,40044,0.0201347960166932,0.00343927485963031,0.0133938172918178,0.0268757747415686,4.88434467761849e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,C8B,Complement component C8 beta chain,38013,0.0170231705152859,0.0029133072957583,0.0113130882155996,0.0227332528149722,5.23686693582637e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CA7,Carbonic anhydrase 7,37714,-0.0195919001013365,0.0033595895086599,-0.0261766955383099,-0.0130071046643631,5.6165550981472e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,40396,0.0489775704496321,0.00843041475490879,0.0324539575300109,0.0655011833692534,6.38054035619661e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GPC1,Glypican-1,40489,0.0161854491369396,0.00279260290318885,0.0107119474466895,0.0216589508271898,6.92607944742386e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DSG3,Desmoglein-3,40419,0.0184295452061002,0.00318458738973401,0.0121877539222215,0.0246713364899788,7.29516974539753e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SIRPB1,Signal-regulatory protein beta-1,40335,0.0246937020052538,0.00427055991816626,0.0163234045656479,0.0330639994448597,7.50657572139787e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FABP1,"Fatty acid-binding protein, liver",40357,0.0509971137331777,0.00883425510995031,0.0336819737176751,0.0683122537486803,7.94859166412555e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,40044,0.0230836880142629,0.00400146916156183,0.0152408084576017,0.0309265675709241,8.13504155403671e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CNTN4,Contactin-4,40332,-0.0133110888301897,0.00231352062003366,-0.0178455892454557,-0.00877658841492374,8.8968591220783e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SERPINA12,Serpin A12,39903,0.0624544758870004,0.0108647291037036,0.0411596068437414,0.0837493449302593,9.18088284302594e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GNLY,Granulysin,40332,0.0277204000957743,0.00483146953409131,0.0182507198089554,0.0371900803825933,9.78539077578359e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CSF1R,Macrophage colony-stimulating factor 1 receptor,37987,0.0215596716062684,0.00375753495225354,0.0141949030998515,0.0289244401126853,9.801612412041e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TEK,Angiopoietin-1 receptor,40411,0.0117162185500386,0.00204693081550052,0.00770423415165762,0.0157282029484197,1.06039796915597e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MAEA,E3 ubiquitin-protein transferase MAEA,39980,0.0220173776675041,0.0038669302879174,0.014438194303186,0.0295965610318222,1.26518778485811e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CA12,Carbonic anhydrase 12,40305,-0.0174228993753805,0.00307121434090224,-0.0234424794835489,-0.0114033192672121,1.42795670134326e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CFHR4,Complement factor H-related protein 4,37973,0.0396971045072408,0.00699998394974151,0.0259771359657474,0.0534170730487341,1.44849335853466e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TMPRSS11D,Transmembrane protease serine 11D,37921,0.0208667132294361,0.00368358496558223,0.0136468866968949,0.0280865397619773,1.50222447794004e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNXB,Tenascin-X,40332,-0.0137146318265453,0.00242489813595192,-0.018467432173011,-0.00896183148007952,1.57834886323479e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FOLR2,Folate receptor beta,40471,-0.0158457671986263,0.00280206603417732,-0.0213378166256138,-0.0103537177716387,1.58478659544898e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,37628,-0.0110265056050531,0.00195594254302756,-0.0148601529893872,-0.0071928582207191,1.76141836380828e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PPM1A,Protein phosphatase 1A,39980,0.0165901981709279,0.00295526876643286,0.0107978713887195,0.0223825249531363,2.01353655329422e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ITGBL1,Integrin beta-like protein 1,37998,0.0185931150248642,0.00333154695054039,0.0120632830018051,0.0251229470479234,2.43833845404528e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BOC,Brother of CDO,40042,-0.0125091371326716,0.00224682766733698,-0.0169129193606521,-0.00810535490469114,2.62735423401854e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BCL2L15,Bcl-2-like protein 15,37598,0.0300268040233912,0.00539502462187741,0.0194525557645115,0.0406010522822709,2.66292378453262e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RPS10,40S ribosomal protein S10,37562,-0.0224819443850805,0.00404345373500503,-0.0304071137056904,-0.0145567750644707,2.74914911627747e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ITGB6,Integrin beta-6,40044,0.0159381179829119,0.00287189194058373,0.0103092097793678,0.021567026186456,2.90835138642645e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TBC1D17,TBC1 domain family member 17,39961,0.0242872385920257,0.0043780558749715,0.0157062490770815,0.0328682281069698,2.94533353923797e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,37901,0.0113302443944221,0.00204948561890515,0.00731325258136805,0.0153472362074762,3.29305374483339e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CST7,Cystatin-F,40376,0.0481207312352259,0.00875126404952799,0.030968253698151,0.0652732087723008,3.88449666324266e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL22RA1,Interleukin-22 receptor subunit alpha-1,40044,0.0228308576648147,0.00415624356745999,0.0146846202725932,0.0309770950570363,4.01014782150282e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SIGLEC10,Sialic acid-binding Ig-like lectin 10,40341,0.0175093739397533,0.00319432128020248,0.0112485042305564,0.0237702436489502,4.28385091963218e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,37901,-0.017212344218333,0.00314088940901832,-0.0233684874600089,-0.0110562009766571,4.32771448159561e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GZMH,Granzyme H,40042,0.0387343506171023,0.00710058367764323,0.0248172066089216,0.0526514946252831,4.96928424347188e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FGFBP2,Fibroblast growth factor-binding protein 2,37998,0.0259110389009177,0.00475105429086329,0.0165989724908257,0.0352231053110098,5.01848367163523e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ICOSLG,ICOS ligand,40305,0.00988777800339471,0.00181794396298141,0.00632460783595116,0.0134509481708383,5.43773120725254e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,OLFM4,Olfactomedin-4,37177,0.0639921494907621,0.0117662651732779,0.0409302697511374,0.0870540292303868,5.46893895660951e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PCSK7,Proprotein convertase subtilisin/kexin type 7,37900,0.023460076163539,0.00432403092366972,0.0149849755531464,0.0319351767739317,5.87894715079461e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LUZP2,Leucine zipper protein 2,37900,0.0231350509717825,0.00426526314987463,0.0147751351980283,0.0314949667455368,5.9267229149667e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RAB37,Ras-related protein Rab-37,40044,0.0430180166963081,0.00793387205753772,0.0274676274635342,0.0585684059290821,5.97890964068363e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LIF,Leukemia inhibitory factor,39961,0.0271585086301566,0.00501196285061967,0.017335061442942,0.0369819558173711,6.09172742979877e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FASLG,Tumor necrosis factor ligand superfamily member 6,40516,0.0187997029957437,0.00347074227590276,0.0119970481349743,0.0256023578565131,6.16087223372912e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL1RAP,Interleukin-1 receptor accessory protein,40332,-0.0222106328444091,0.00410057941608621,-0.0302477684999381,-0.0141734971888802,6.16743205087596e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NCAM1,Neural cell adhesion molecule 1,40403,-0.0142092127035211,0.00262727545756896,-0.0193586726003562,-0.0090597528066859,6.45256676588228e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CILP,Cartilage intermediate layer protein 1,37998,0.0277785275779983,0.00513641667545206,0.0177111508941123,0.0378459042618844,6.47587119539616e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TPSAB1,Tryptase alpha/beta-1,40498,0.02711477106123,0.00501419956633053,0.0172869399112222,0.0369426022112379,6.47897225109366e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CA1,Carbonic anhydrase 1,40003,0.0321295011869825,0.00594858465500185,0.0204702752631789,0.0437887271107862,6.71690452952779e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CRLF1,Cytokine receptor-like factor 1,40422,0.0134914586665991,0.00249957492398125,0.0085922918155959,0.0183906255176024,6.8539729359696e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TPM3,Tropomyosin alpha-3 chain,37562,-0.0219115275449305,0.00405923551597184,-0.0298676291562353,-0.0139554259336257,6.85824211620611e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,OBP2B,Odorant-binding protein 2b,40184,-0.0339892387447466,0.00630337804636647,-0.0463438597156249,-0.0216346177738683,7.05945169593867e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MUC16,Mucin-16,40305,0.0960211924906633,0.0178196017010555,0.0610947731565945,0.130947611824732,7.20568958389919e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SEPTIN8,Septin-8,37921,0.0163773249962774,0.00303915316637245,0.0104205847901874,0.0223340652023674,7.21319556704384e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CASP1,Caspase-1,39961,0.0343844805724885,0.00640206630934424,0.0218364306061738,0.0469325305388032,7.95000346285445e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EPHB6,Ephrin type-B receptor 6,40192,0.0158980278506023,0.00297142518971254,0.0100740344787657,0.0217220212224389,8.90352779103492e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HGFAC,Hepatocyte growth factor activator,37849,0.0147763787751802,0.00276219595969464,0.00936247469417865,0.0201902828561817,8.96460545029889e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CSF2,Granulocyte-macrophage colony-stimulating factor,37562,0.0182384274000823,0.00341072234244956,0.0115534116088811,0.0249234431912834,9.07343591175449e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCL28,C-C motif chemokine 28,40278,0.0302737592093474,0.00567183470002899,0.0191569631972906,0.0413905552214042,9.55044681458618e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IFNG,Interferon gamma,40044,0.0577236391292101,0.0108183545981086,0.0365196641169172,0.078927614141503,9.64997932023093e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRKD2,Serine/threonine-protein kinase D2,37562,0.0241748212594533,0.00453408140594251,0.015288021703806,0.0330616208151006,9.88568731024594e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AKR1C4,Aldo-keto reductase family 1 member C4,40042,0.0281318662131554,0.00527763434474286,0.0177877028974594,0.0384760295288514,9.93649253751309e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,37598,0.0184227534726585,0.00345830638128164,0.0116444729653464,0.0252010339799705,1.0143734236412e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SFTPA1,Pulmonary surfactant-associated protein A1,39980,0.0296188250582701,0.00558685700913621,0.0186685853203631,0.040569064796177,1.16415398826621e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ATXN2,Ataxin-2,37541,0.058360306212056,0.0110076818683432,0.0367852497501033,0.0799353626740086,1.1654352455836e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLPS,Colipase,40311,0.0345404184476172,0.00652665737501414,0.0217481699925895,0.0473326669026449,1.22457688685522e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CREBZF,CREB/ATF bZIP transcription factor,37482,-0.0133356645237537,0.00252385485379974,-0.0182824200372012,-0.00838890901030624,1.2853735128341e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",39961,0.0152325862874604,0.00288454821412429,0.00957887178777677,0.020886300787144,1.30390492489903e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SIGLEC1,Sialoadhesin,40422,0.0216689130351074,0.00411878238345719,0.0135960995635313,0.0297417265066835,1.45124628643955e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GGT5,Glutathione hydrolase 5 proenzyme,40228,0.0113418582920552,0.00215662554176528,0.00711487223019521,0.0155688443539151,1.46671076980659e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PLIN3,Perilipin-3,40359,0.0211803457079524,0.00403376266222552,0.0132741708899904,0.0290865205259144,1.53416791557521e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,40228,0.0127476157026609,0.00242788943530296,0.00798895240946715,0.0175062789958547,1.53660904491577e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CHRM1,Muscarinic acetylcholine receptor M1,37572,-0.0188411953135204,0.00359651527540313,-0.0258903652533105,-0.0117920253737302,1.6418273799675e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EPHA2,Ephrin type-A receptor 2,39759,0.0153443326564348,0.00293251180907933,0.0095966095106393,0.0210920558022303,1.69450438321387e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,37572,0.0518642477962423,0.00991533315649826,0.0324301948095057,0.0712983007829789,1.71457299667504e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PILRA,Paired immunoglobulin-like type 2 receptor alpha,40332,0.0209481175709462,0.00400661063905895,0.0130951607183907,0.0288010744235017,1.731616653843e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PADI4,Protein-arginine deiminase type-4,39934,0.0345704126599144,0.00661224658702152,0.0216104093493522,0.0475304159704766,1.73356657501742e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KIAA1549L,UPF0606 protein KIAA1549L,37714,-0.0145216285303468,0.00277740894104673,-0.0199653500547984,-0.00907790700589524,1.73506232560773e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,40434,0.0167945585545925,0.00321417124625114,0.0104947829119403,0.0230943341972448,1.76191373958008e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MBL2,Mannose-binding protein C,37810,-0.0531397122501305,0.0101722416457902,-0.0730773058758793,-0.0332021186243816,1.77739160384092e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GLYR1,Putative oxidoreductase GLYR1,37900,0.0302142813556737,0.00578700919105879,0.0188717433411985,0.0415568193701489,1.80560100109253e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PODXL,Podocalyxin,40305,0.00753308376824363,0.00144550274004191,0.00469989839776148,0.0103662691387258,1.89777661769806e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PDCD1LG2,Programmed cell death 1 ligand 2,40305,0.0153426426616978,0.00294580616655234,0.00956886257525524,0.0211164227481404,1.92962848524623e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,F3,Tissue factor,40393,-0.0138506828339363,0.00267232613610345,-0.0190884420606991,-0.00861292360717352,2.21003417153377e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LY9,T-lymphocyte surface antigen Ly-9,40182,0.0141655843735111,0.00273337001234614,0.00880817914931267,0.0195229895977096,2.2168511494326e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KLK8,Kallikrein-8,39801,0.0175210990211063,0.00338158238542805,0.0108931975456674,0.0241490004965453,2.2309807311522e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PROCR,Endothelial protein C receptor,37562,-0.0182796026748165,0.00353390409154325,-0.0252060546942413,-0.0113531506553917,2.34216751613905e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD160,CD160 antigen,40516,0.0224473992894483,0.00434532217746626,0.0139305678216144,0.0309642307572822,2.42176471481042e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NCR1,Natural cytotoxicity triggering receptor 1,40306,0.0176931112570087,0.00342667595843924,0.0109768263784678,0.0244093961355496,2.45509227769424e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BRD1,Bromodomain-containing protein 1,37714,-0.0152914008942401,0.00296364962593021,-0.0211001541610633,-0.00948264762741691,2.50980254277884e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FOLR1,Folate receptor alpha,40299,0.0139285995153637,0.00269980942932487,0.00863697303388695,0.0192202259968405,2.51126708414523e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LYAR,Cell growth-regulating nucleolar protein,39980,0.0257822848871464,0.00500542876027333,0.0159716445170107,0.0355929252572822,2.62461146404608e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNFSF13,Tumor necrosis factor ligand superfamily member 13,40422,0.0129105621565085,0.00251162331216847,0.00798778046465834,0.0178333438483587,2.77499064632261e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,40332,0.0129392303490029,0.00251910404540919,0.0080017864200009,0.0178766742780049,2.83302838030454e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ITGB1BP1,Integrin beta-1-binding protein 1,39980,0.0203016678931967,0.00395456140526616,0.012550727538875,0.0280526082475184,2.87479721830301e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GBP2,Guanylate-binding protein 2,40044,0.0289553784877244,0.0056657268251732,0.0178505539103849,0.0400602030650638,3.24898084130564e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VIT,Vitrin,37990,0.0179230911883444,0.00351733585179261,0.0110291129188309,0.0248170694578579,3.52238821723065e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KLK11,Kallikrein-11,40260,0.0144037606346255,0.00282790781491136,0.00886106131739927,0.0199464599518518,3.55682172681621e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PGLYRP1,Peptidoglycan recognition protein 1,40451,0.0207057529121818,0.00406903809347924,0.0127304382489625,0.0286810675754011,3.64780529393506e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FSTL1,Follistatin-related protein 1,37628,-0.010916315610808,0.00214710311353085,-0.0151246377133285,-0.00670799350828755,3.74231155783884e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ECM1,Extracellular matrix protein 1,37655,0.0179219622000305,0.00353368354721719,0.0109959424474848,0.0248479819525762,3.99518270331038e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,37901,-0.0333651252417827,0.00659732231539815,-0.0462958769799631,-0.0204343735036024,4.30666308337069e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PTPRS,Receptor-type tyrosine-protein phosphatase S,40536,-0.0116365298860753,0.0023024613097675,-0.0161493540532196,-0.00712370571893097,4.37507460113634e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL1R1,Interleukin-1 receptor type 1,40303,-0.0107409347359446,0.00212547707178099,-0.0149068697966353,-0.00657499967525385,4.38790800568909e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DUSP3,Dual specificity protein phosphatase 3,39961,0.0407972691445025,0.00807546056196776,0.0249693664430457,0.0566251718459593,4.42163554850322e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TDGF1,Teratocarcinoma-derived growth factor 1,39961,0.06837606263301,0.0135552538831218,0.0418077650220914,0.0949443602439287,4.6045134136966e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,40489,0.0121384530283772,0.00240834950100653,0.00741808800640437,0.01685881805035,4.70221200763958e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRUNE2,Protein prune homolog 2,37714,0.0142074718592294,0.00282413987604761,0.00867215770217612,0.0197427860162827,4.95020374799066e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SERPINI1,Neuroserpin,37642,0.0153043641299119,0.00304613161131907,0.00933394617172655,0.0212747820880973,5.12160940302157e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,40305,0.021462512726311,0.00427742039180353,0.0130787687583761,0.0298462566942459,5.28791006218193e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CR2,Complement receptor type 2,40403,0.0220331907959406,0.00442124161508804,0.013367557230368,0.0306988243615131,6.31034967664304e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",37628,0.0162547405683031,0.00326208975515608,0.00986104464819715,0.022648436488409,6.34257970288689e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CALB1,Calbindin,40305,0.0200457421344026,0.00403358420840087,0.0121399170859369,0.0279515671828683,6.77526224610415e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RETN,Resistin,40283,0.019583828975028,0.00394230412856133,0.0118569128830478,0.0273107450670082,6.84899590868702e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CA9,Carbonic anhydrase 9,40489,-0.0212386342381243,0.00428316496914169,-0.029633637577642,-0.0128436308986066,7.17173110177542e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,APOB,Apolipoprotein B-100,37987,0.0105145686187795,0.00213096301857345,0.00633788110237554,0.0146912561351835,8.14425443870219e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MRPL46,"39S ribosomal protein L46, mitochondrial",39961,0.0129651270488649,0.00262832164047471,0.0078136166335345,0.0181166374641954,8.18762094656878e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD109,CD109 antigen,40332,-0.0156891037111621,0.00318147923758848,-0.0219248030168355,-0.0094534044054887,8.24730534140509e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,40516,0.0163593985657962,0.0033179455728138,0.00985622524308111,0.0228625718885112,8.28039277068272e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,37901,0.0185429130219686,0.00376103767968507,0.0111712791697858,0.0259145468741513,8.30977155773545e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LHB,Lutropin subunit beta,39980,0.0397794341931917,0.00808389525190043,0.0239349994994668,0.0556238688869165,8.70634488490063e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HSD17B3,Testosterone 17-beta-dehydrogenase 3,37562,0.0229191699376848,0.00467128062234494,0.0137634599178887,0.0320748799574809,9.38776330139539e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MILR1,Allergin-1,40044,-0.023294878294842,0.00475454267461136,-0.0326137819370802,-0.0139759746526037,9.70456023364975e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CHRDL1,Chordin-like protein 1,40396,0.0142168057203566,0.00290195374177095,0.00852897638648558,0.0199046350542277,9.72478071073526e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FGF16,Fibroblast growth factor 16,37598,0.0229735746977494,0.00469886057278624,0.0137638079750883,0.0321833414204104,1.02453458307466e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SPINK1,Serine protease inhibitor Kazal-type 1,40332,0.0201491251655771,0.00412645688401329,0.012061269672911,0.0282369806582431,1.05547289993679e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RAB44,Ras-related protein Rab-44,37900,0.0185789226988146,0.0038052271237149,0.0111206775363334,0.0260371678612958,1.05966655105393e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EBI3_IL27,Interleukin-27,40453,-0.0144545282778895,0.00296753463137394,-0.0202708961553824,-0.00863816040039656,1.12160084764014e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MATN3,Matrilin-3,40203,-0.014495766813377,0.00297615652556987,-0.0203290336034939,-0.00866250002326005,1.12321446363332e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CNPY2,Protein canopy homolog 2,40042,0.0282964443039332,0.00581944681282836,0.0168903285507897,0.0397025600570768,1.17104874252121e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TFPI2,Tissue factor pathway inhibitor 2,40357,0.0184112155696313,0.00378855152398992,0.010985654582611,0.0258367765566515,1.1868587006385e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RANBP2,E3 SUMO-protein ligase RanBP2,37541,-0.015412863429161,0.00318103353352573,-0.0216476891548715,-0.00917803770345061,1.27909599405081e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL31RA,Interleukin-31 receptor subunit alpha,37544,0.0186872714240327,0.00386950474528476,0.0111030421232746,0.0262715007247908,1.38515114916211e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLEC6A,C-type lectin domain family 6 member A,39980,0.0215120692761431,0.00445849236899641,0.0127734242329101,0.030250714319376,1.4135803319936e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EIF5,Eukaryotic translation initiation factor 5,37562,0.020951716969401,0.00434478257378905,0.0124359431247744,0.0294674908140275,1.43527810543109e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD48,CD48 antigen,40396,0.0134435735254228,0.00279022168593865,0.00797473902098309,0.0189124080298626,1.46263348898118e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CRISP3,Cysteine-rich secretory protein 3,37875,-0.0124018033480999,0.00257779958622207,-0.0174542905370952,-0.00734931615910469,1.51807027269692e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TRAF3,"TNF receptor-associated factor 3, Isoform 2",37598,0.0161456014337304,0.00336107175260933,0.00955790079861613,0.0227333020688447,1.57474474853736e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DLL4,Delta-like protein 4,37628,0.0385220424379685,0.00805395421344969,0.0227362921796071,0.0543077926963299,1.74570720087494e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLASP1,CLIP-associating protein 1,37482,0.0325711122991737,0.0068270603473207,0.0191900740184251,0.0459521505799223,1.85408511696133e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ITM2A,Integral membrane protein 2A,40341,-0.0268253335428112,0.00562558440448508,-0.037851478975602,-0.0157991881100205,1.87292810133741e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SERPINA3,Alpha-1-antichymotrypsin,37958,0.00669541676002501,0.00140669510847271,0.00393829434741851,0.00945253917263152,1.95911574888973e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,37942,0.0283005590022945,0.00594647529114164,0.0166454674316569,0.0399556505729321,1.96363047330321e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ENO1,Alpha-enolase,40299,0.0358677877424644,0.00754220753575787,0.0210850609723789,0.0506505145125498,1.99590695327219e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,OSCAR,Osteoclast-associated immunoglobulin-like receptor,40379,0.0150883907232832,0.00317714776577451,0.00886118110236515,0.0213156003442012,2.06168335446507e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EGFLAM,Pikachurin,37901,0.0139456165863245,0.00293713405177054,0.00818883384485424,0.0197023993277947,2.0752041893822e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLEC10A,C-type lectin domain family 10 member A,40228,-0.0162136842960659,0.00343356595646581,-0.0229434735707389,-0.00948389502139294,2.35415727676351e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NEDD9,Enhancer of filamentation 1,37598,0.0148990177965593,0.00315908084754372,0.00870721933537356,0.0210908162577449,2.42700263155043e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,37901,0.0229589925333843,0.00486878036870221,0.013416183010728,0.0325018020560406,2.43476074903072e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DCN,Decorin,40042,-0.0102255296832283,0.00217075726378352,-0.014480213920244,-0.00597084544621259,2.49140999819037e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD79B,B-cell antigen receptor complex-associated protein beta chain,40516,0.0197310276573195,0.00419952939389641,0.0114999500452825,0.0279621052693564,2.64392929772911e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EPHX2,Bifunctional epoxide hydrolase 2,40042,0.0280284596063613,0.00596714555938521,0.0163328543099663,0.0397240649027563,2.66092891767808e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GZMB,Granzyme B,40341,0.0280567758895426,0.00598646002636471,0.0163233142378678,0.0397902375412175,2.79941634505427e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,37635,-0.021703566651561,0.00464010351492643,-0.0307981695408168,-0.0126089637623052,2.93437039223993e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ATP6V1D,V-type proton ATPase subunit D,40305,0.0116819434717236,0.00250243705946471,0.0067771668351728,0.0165867201082745,3.0629912803442e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CHAD,Chondroadherin,37671,0.0238412061827314,0.00513482428540736,0.0137769505833329,0.0339054617821298,3.46621115376263e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,UROS,Uroporphyrinogen-III synthase,37572,0.0311106372309486,0.0067036296540153,0.0179715231090786,0.0442497513528186,3.50313778835979e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HYAL1,Hyaluronidase-1,40214,0.0101417043608102,0.00218684248423796,0.00585549309170379,0.0144279156299166,3.55306475631759e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,UXS1,UDP-glucuronic acid decarboxylase 1,39980,0.0237564292398676,0.00512304974198061,0.0137152517455856,0.0337976067341496,3.56098743261023e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GIPC2,PDZ domain-containing protein GIPC2,37942,0.0128939003546777,0.00278196697391688,0.00744124508580065,0.0183465556235548,3.60604985435981e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDH6,Cadherin-6,40359,-0.0166875135427407,0.00360632703594187,-0.0237559145331868,-0.00961911255229466,3.73408832518538e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MYL3,Myosin light chain 3,37628,-0.0301299034691985,0.00652815704283962,-0.0429250912731641,-0.0173347156652328,3.96086628020891e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,39823,-0.0377784184556984,0.00824932193274068,-0.0539470894438702,-0.0216097474675267,4.69570111788886e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CST6,Cystatin-M,39992,0.0208183469192916,0.00455478881373236,0.0118909608443761,0.029745732994207,4.89959016942382e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BAMBI,BMP and activin membrane-bound inhibitor homolog,39980,0.0131422596487719,0.00287712953473366,0.00750308576069396,0.0187814335368499,4.965728266233e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RGMA,Repulsive guidance molecule A,40471,-0.0134385040571809,0.00294451461025287,-0.0192097526932765,-0.00766725542108529,5.05823657753888e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ELAVL4,ELAV-like protein 4,37541,0.0379040497151686,0.00833569635519348,0.0215660848589894,0.0542420145713478,5.4853039800166e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EP300,Histone acetyltransferase p300,37598,0.0129692690614004,0.00285260223290926,0.00737816868489821,0.0185603694379025,5.50403453536094e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SAT2,Thialysine N-epsilon-acetyltransferase,37714,0.0297714176901772,0.00655568151233219,0.0169222819260061,0.0426205534543483,5.63969178315986e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDH15,Cadherin-15,40435,0.0191440079974027,0.00421674749685114,0.0108791829035744,0.0274088330912309,5.66664679309806e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FOSB,Protein fosB,39961,0.0169043691464552,0.00372415708279022,0.00960502126418635,0.024203717028724,5.6916065880905e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,37541,0.0268727360235084,0.00592007205566632,0.0152693947944025,0.0384760772526144,5.69556127914637e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FUCA1,Tissue alpha-L-fucosidase,40437,0.0349157554984539,0.00772253056408674,0.0197795955928439,0.050051915404064,6.19071284888249e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ICAM5,Intercellular adhesion molecule 5,40359,0.0189654188383016,0.00419604728247292,0.0107411661646546,0.0271896715119485,6.23356259037791e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LRRN1,Leucine-rich repeat neuronal protein 1,40044,0.016547430016143,0.00366895949831729,0.00935626939944115,0.0237385906328449,6.52651133970972e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PCDH1,Protocadherin-1,40475,0.00934441138429169,0.00207223959667871,0.00528282177480141,0.013406000993782,6.54941332014001e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ARID4B,AT-rich interactive domain-containing protein 4B,39961,0.0174607828126376,0.00390095145499798,0.00981491796084157,0.0251066476644337,7.65848986818001e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LCN2,Neutrophil gelatinase-associated lipocalin,39865,0.0160825255910387,0.0035951732479256,0.00903598602510457,0.0231290651569729,7.75485426349334e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BLVRB,Flavin reductase,40332,0.0281526006076509,0.00631596970476158,0.0157732999863182,0.0405319012289835,8.35402172636062e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL34,Interleukin-34,39934,0.0151061527839319,0.00341791985974734,0.00840702985882708,0.0218052757090366,9.95136672562494e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL10RA,Interleukin-10 receptor subunit alpha,40044,0.0252058856821338,0.00573677398703074,0.0139618086675535,0.036449962696714,1.1215306737916e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SLAMF7,SLAM family member 7,40341,-0.0241220951670222,0.00549053634292834,-0.0348835463991618,-0.0133606439348827,1.12316546958313e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,THBS4,Thrombospondin-4,40355,0.0188227463371189,0.00428970850623964,0.0104149176648892,0.0272305750093486,1.1519523332715e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SEZ6,Seizure protein 6 homolog,37572,-0.0131108706424578,0.00298835831139056,-0.0189680529327833,-0.00725368835213232,1.15653743126886e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DNPEP,Aspartyl aminopeptidase,37942,0.0248666006582165,0.00567412656927647,0.0137453125824346,0.0359878887339984,1.18236481741491e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SNX18,Sorting nexin-18,37901,0.0188803093754854,0.00434135661749664,0.010371250405192,0.0273893683457788,1.37802499298182e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADGRG1,Adhesion G-protein coupled receptor G1,40305,0.0226090578903792,0.00520226812514016,0.0124126123651045,0.0328055034156539,1.3950554894098e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SLC28A1,Sodium/nucleoside cotransporter 1,37482,0.0246670896672451,0.00568595304423914,0.0135226217005364,0.0358115576339538,1.44702176527566e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GFRAL,GDNF family receptor alpha-like,37477,-0.0255642980286117,0.00592277047033043,-0.0371729281504593,-0.013955667906764,1.59856985832209e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,INHBB,Inhibin beta B chain,37671,0.0212230412550209,0.00492159237731472,0.0115767201954841,0.0308693623145578,1.62787351188652e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FABP9,Fatty acid-binding protein 9,40341,0.0229215015333631,0.00531677810245702,0.0125006164525473,0.0333423866141788,1.63375588661075e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NPR1,Atrial natriuretic peptide receptor 1,37562,-0.0166107884191418,0.00385553015864612,-0.0241676275300882,-0.00905394930819545,1.65711000468161e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AMPD3,AMP deaminase 3,37942,0.0297781989181388,0.006923021822006,0.016209076147007,0.0433473216892705,1.7097064383573e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MYOM2,Myomesin-2,37562,-0.0193261344464338,0.00449410918094935,-0.0281345884410945,-0.010517680451773,1.71780610619135e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RPA2,Replication protein A 32 kDa subunit,37598,0.0134054121794867,0.00312051862130931,0.00728919568172045,0.0195216286772529,1.75242058067771e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TFF3,Trefoil factor 3,40309,0.0217969715868483,0.00508231745252044,0.0118356293799082,0.0317583137937883,1.80715260583938e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SOD3,Extracellular superoxide dismutase,37987,-0.0242057852833833,0.00564465164831739,-0.0352693025140854,-0.0131422680526813,1.81318825540827e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CALCB,Calcitonin gene-related peptide 2,37942,0.0163349212758005,0.00381063081080938,0.00886608488661415,0.0238037576649869,1.82629843022672e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,37628,0.0253140857015726,0.00591742865606334,0.0137159255356885,0.0369122458674568,1.90007481099606e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,40167,0.0131033384422915,0.00307119157385574,0.00708380295753429,0.0191228739270488,1.99696526473122e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SPINK4,Serine protease inhibitor Kazal-type 4,40341,0.0264789777056751,0.00621489007347458,0.014297793161665,0.0386601622496853,2.05079622725532e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CRTAP,Cartilage-associated protein,37572,0.0196996528150664,0.00462824795911959,0.010628286815192,0.0287710188149408,2.09192992114598e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EGFR,Epidermal growth factor receptor,40536,0.00662458326492047,0.00155676561450526,0.00357332266049017,0.00967584386935077,2.0990335109703e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NXPH1,Neurexophilin-1,39961,0.0152269614286802,0.00359099912671659,0.0081886031403157,0.0222653197170447,2.24500888591986e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PTK7,Inactive tyrosine-protein kinase 7,39961,0.0155638019345091,0.00367387786587528,0.0083630013173935,0.0227646025516246,2.28502237706526e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,COL1A1,Collagen alpha-1(I) chain,40536,-0.0104668822566962,0.00247132562209126,-0.0153106804759951,-0.00562308403739733,2.2948402098845e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,38013,-0.00790552798697298,0.00186814072206325,-0.0115670838022169,-0.00424397217172901,2.3339174818646e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NTRK2,BDNF/NT-3 growth factors receptor,40359,0.0103670306277875,0.0024515173989315,0.00556205652588173,0.0151720047296932,2.3623108344679e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SLURP1,Secreted Ly-6/uPAR-related protein 1,37919,0.0153844143134616,0.00364775441517745,0.00823481565971383,0.0225340129672095,2.48637536671579e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PSPN,Persephin,40341,0.0398557498968534,0.00945691394241229,0.0213201985697253,0.0583913012239815,2.51763582128295e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CTRL,Chymotrypsin-like protease CTRL-1,37942,-0.026367095383809,0.00626656270942612,-0.0386495582942842,-0.0140846324733338,2.59783605811835e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GSN,Gelsolin,37928,-0.00762761041886313,0.00181505037964677,-0.0111851091629708,-0.00407011167475546,2.65774100789518e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,40228,0.0415869356268046,0.00994889171272314,0.0220871078698672,0.0610867633837419,2.93007215911331e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRDX1,Peroxiredoxin-1,39953,-0.0354415917294144,0.00849189734823173,-0.0520857105319486,-0.0187974729268802,3.01489353468472e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TGFB2,Transforming growth factor beta-2 proprotein,37900,0.0210976698377579,0.00505848583393,0.0111830376032552,0.0310123020722607,3.05506105565983e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NEFL,Neurofilament light polypeptide,39903,0.0169354929837276,0.00406673263767344,0.00896469701388762,0.0249062889535675,3.13869472927613e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,40228,0.0275264501652503,0.00663327097847555,0.0145252390474383,0.0405276612830624,3.34576641938112e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LRRC38,Leucine-rich repeat-containing protein 38,37572,0.0195667021115621,0.00472675493283144,0.0103022624432125,0.0288311417799117,3.50141978373579e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SCG3,Secretogranin-3,40379,-0.0131112662044537,0.00317409363609653,-0.0193324897312029,-0.00689004267770451,3.63487611497565e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD58,Lymphocyte function-associated antigen 3,40335,-0.00694763893332395,0.00168275685464223,-0.0102458423684227,-0.00364943549822518,3.66645398383691e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ACTN2,Alpha-actinin-2,37562,-0.0215911919423743,0.00522932769291388,-0.0318406742204855,-0.0113417096642631,3.6681494085309e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LSM1,U6 snRNA-associated Sm-like protein LSm1,39980,0.0222833449390531,0.00542387382500509,0.0116525522420431,0.0329141376360631,4.00484483625101e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,37990,0.0103815970641035,0.00252814638252099,0.00542643015436237,0.0153367639738447,4.04222222009885e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SCGB2A2,Mammaglobin-A,37562,-0.0125965099041711,0.00306751449444209,-0.0186088383132776,-0.0065841814950646,4.04272083632955e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PILRB,Paired immunoglobulin-like type 2 receptor beta,40359,0.0224170511031835,0.00546561667558782,0.0117044424190313,0.0331296597873356,4.12579793707121e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VSIG10,V-set and immunoglobulin domain-containing protein 10,37900,0.0138869008074897,0.00340475886031534,0.00721357344127161,0.0205602281737077,4.55543445498371e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HMBS,Porphobilinogen deaminase,40489,0.017613392740177,0.00432645218017604,0.00913354646703196,0.0260932390133221,4.70173500559662e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,40471,0.027922275470235,0.00687231382542583,0.0144525403724004,0.0413920105680696,4.86749690483724e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LXN,Latexin,40183,-0.0255838391212755,0.00631552897004339,-0.0379622759025605,-0.0132054023399904,5.12567371691966e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PCDHB15,Protocadherin beta-15,37900,-0.0155889254005889,0.00385001180031091,-0.0231349485291983,-0.00804290227197955,5.1712201258991e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MEGF10,Multiple epidermal growth factor-like domains protein 10,40357,0.0147163809524612,0.0036353973988523,0.00759100205071068,0.0218417598542117,5.18838494311722e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,COMMD9,COMM domain-containing protein 9,37900,0.0151814344570411,0.00375066910481797,0.00783012301159787,0.0225327459024843,5.20217452657017e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TPPP3,Tubulin polymerization-promoting protein family member 3,39961,0.0152592714796401,0.00377373350769376,0.00786275380456037,0.0226557891547199,5.29029427299924e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GDF15,Growth/differentiation factor 15,40536,0.0165074895017244,0.0040916318768739,0.00848789102305156,0.0245270879803973,5.49829646479293e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLEC7A,C-type lectin domain family 7 member A,40516,0.0224561383365784,0.00557396300460201,0.0115311708475584,0.0333811058255983,5.63307808695448e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ROBO4,Roundabout homolog 4,37628,-0.00685655605049826,0.00170756498921578,-0.0102033834293612,-0.00350972867163532,5.96740545256023e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD99,CD99 antigen,40332,-0.00742433160710614,0.00184940111754814,-0.0110491577975005,-0.00379950541671179,5.98578114680466e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VWF,von Willebrand factor,40536,-0.02726164420733,0.00680154595624963,-0.0405926742815793,-0.0139306141330808,6.14710602821711e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CELA2A,Chymotrypsin-like elastase family member 2A,37998,0.0225085089376887,0.00562529038893996,0.0114829397753664,0.033534078100011,6.33288998526826e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RAB39B,Ras-related protein Rab-39B,37562,0.0340737052963066,0.00852282835056971,0.01736896172919,0.0507784488634233,6.42478777166871e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PMS1,PMS1 protein homolog 1,37572,0.0198285845493024,0.00497027702954813,0.0100868415713881,0.0295703275272167,6.65912852334974e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SAA4,Serum amyloid A-4 protein,38013,0.0124252733388015,0.00311712324523765,0.00631571177813568,0.0185348348994673,6.75101346330123e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD200,OX-2 membrane glycoprotein,40341,-0.00986251059343377,0.00247464204348119,-0.0147128089986569,-0.00501221218821065,6.76590975443152e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ARHGAP5,Rho GTPase-activating protein 5,37482,0.0294616125085945,0.00739628697227869,0.0149648900429283,0.0439583349742608,6.83350658741287e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SEMA7A,Semaphorin-7A,40490,0.0101892663637655,0.00255930141389331,0.00517303559253464,0.0152054971349964,6.88505318491013e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DPEP1,Dipeptidase 1,40192,-0.019253139916492,0.00483911279274768,-0.0287378009902774,-0.00976847884270651,6.96179112476882e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FCAR,Immunoglobulin alpha Fc receptor,40341,0.0178045184956026,0.00447625284533564,0.00903106291874475,0.0265779740724605,6.99376984225985e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,STX5,Syntaxin-5,37598,0.0159100613229199,0.00400637238468938,0.00805757144892871,0.0237625511969111,7.18958206225905e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SDC1,Syndecan-1,40359,0.0150375375208743,0.0038061482516633,0.0075774869476142,0.0224975880941343,7.82088084867505e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,37562,-0.0196753282305966,0.00498433564242874,-0.029444626089757,-0.0099060303714363,7.94062695346148e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RNF43,E3 ubiquitin-protein ligase RNF43,37714,0.0222745561078603,0.00565634240101542,0.0111881250018701,0.0333609872138505,8.25911743250186e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SLC13A1,Solute carrier family 13 member 1,37900,0.0233502204903541,0.00593454609574884,0.0117185101426864,0.0349819308380219,8.3745232769765e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDKL5,Cyclin-dependent kinase-like 5,37541,-0.0204377373805923,0.00519593371993909,-0.030621767471673,-0.0102537072895117,8.41813658265691e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CNTN5,Contactin-5,40367,-0.0138680245455337,0.00352763803508841,-0.0207821950943069,-0.00695385399676038,8.48633453875708e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GLP1R,Glucagon-like peptide 1 receptor,37541,-0.0144502997527905,0.00367634522148206,-0.0216559363868953,-0.00724466311868565,8.51646766006578e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ERC2,ERC protein 2,37572,0.0288779623555735,0.0073537156773378,0.0144646796279914,0.0432912450831556,8.64558835324974e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DDX25,ATP-dependent RNA helicase DDX25,37572,-0.0147149765678183,0.00375009651166001,-0.0220651657306719,-0.00736478740496464,8.75739561647319e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NME1,Nucleoside diphosphate kinase A,37598,-0.00823308574194636,0.0021012408502719,-0.0123515178084793,-0.00411465367541343,8.96636531098669e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PADI2,Protein-arginine deiminase type-2,40044,0.0209176159850674,0.00534335913388664,0.0104446320826496,0.0313905998874852,9.09038980622942e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,37998,-0.0144790673125765,0.00369982666659991,-0.0217307275791123,-0.00722740704604066,9.14336958983678e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AHNAK2,Protein AHNAK2,37628,0.0106922408083216,0.00273417401113885,0.0053332597464894,0.0160512218701537,9.25315872314888e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MAPK13,Mitogen-activated protein kinase 13,37482,0.0154365430161696,0.0039488320825499,0.00769683213437176,0.0231762538979674,9.30937258775388e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",37942,0.0202129838911697,0.00517638585245504,0.0100672676203579,0.0303587001619816,9.47450161042097e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BCL7B,B-cell CLL/lymphoma 7 protein family member B,37900,0.0163855133089009,0.00420823108039052,0.00813738039133546,0.0246336462264663,9.92112449173781e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SNU13,NHP2-like protein 1,37562,0.0231663581758371,0.00596591936314066,0.0114731562240814,0.0348595601275928,0.000103632274103049
NMR metabolomics,X23495.Concentration of Large VLDL Particles,COL9A2,Collagen alpha-2(IX) chain,37714,0.0172212215270087,0.00443559944440509,0.00852744661597474,0.0259149964380427,0.000103888555902894
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,40042,-0.00770932025980847,0.00199000221564422,-0.0116097246024711,-0.0038089159171458,0.000107489710006505
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MYOM1,Myomesin-1,37541,0.0173526531180339,0.00448130430356016,0.00856929668305595,0.0261360095530118,0.000108367335126837
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ACP1,Low molecular weight phosphotyrosine protein phosphatase,37598,0.0161345454235808,0.00418189555243227,0.0079380301408135,0.024331060706348,0.000114775606787412
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD27,CD27 antigen,40411,0.0149152019159951,0.00387187799075728,0.00732632105411087,0.0225040827778794,0.000117524789439863
NMR metabolomics,X23495.Concentration of Large VLDL Particles,C1QL2,Complement C1q-like protein 2,37598,0.0158241141737806,0.00410810915521169,0.00777222022956567,0.0238760081179955,0.000117750831604737
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",37714,0.0264144059702159,0.0068590369205131,0.0129706936060102,0.0398581183344215,0.00011817155625758
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PSMD1,26S proteasome non-ATPase regulatory subunit 1,37959,0.0178538757223033,0.00463765098309844,0.00876407979543036,0.0269436716491762,0.000118775238767909
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL15RA,Interleukin-15 receptor subunit alpha,40044,0.0130322716058978,0.00339349672061726,0.00638101803348793,0.0196835251783076,0.000123336655221887
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL1RL1,Interleukin-1 receptor-like 1,40490,-0.0165038345066144,0.00431154646235855,-0.0249544655728371,-0.00805320344039163,0.000129772997238585
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HAVCR2,Hepatitis A virus cellular receptor 2,40332,0.012532003040405,0.00327717709296594,0.0061087359381917,0.0189552701426182,0.000131793035211668
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SATB1,DNA-binding protein SATB1,37959,0.0110036152979926,0.00287748423369325,0.00536374619995384,0.0166434843960314,0.000131872549122379
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,37714,0.0159804974723217,0.00421124566223337,0.00772645597434425,0.0242345389702991,0.000148467510338197
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SSH3,Protein phosphatase Slingshot homolog 3,37482,0.010581314975577,0.00279262741984993,0.00510776523267113,0.0160548647184829,0.00015192472169447
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PDCD6,Programmed cell death protein 6,40359,-0.0250134504638486,0.00663964512334157,-0.038027154905598,-0.0119997460220991,0.000165626222064479
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MYOC,Myocilin,40332,-0.0164448908570762,0.00436620913505709,-0.0250026607617881,-0.00788712095236435,0.000166216013431788
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EXTL1,Exostosin-like 1,37562,0.0171856137589561,0.00456722238558302,0.00823385788321339,0.0261373696346988,0.000168743436181934
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BMP10,Bone morphogenetic protein 10,37671,-0.0102882220025216,0.00274204715155892,-0.0156626344195771,-0.00491380958546615,0.000176163732556853
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SIL1,Nucleotide exchange factor SIL1,37628,0.0114343989540694,0.00305715673006848,0.0054423717631352,0.0174264261450036,0.000184648043375619
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",40306,-0.0246167789159536,0.0065945137641558,-0.037542025893699,-0.0116915319382083,0.000189935888828072
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PLAUR,Urokinase plasminogen activator surface receptor,40264,0.00947441146899715,0.00254071650653029,0.00449460711619779,0.0144542158217965,0.000192888326344176
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRELP,Prolargin,40357,0.00823059792603425,0.00220770494676168,0.00390349623038135,0.0125576996216871,0.000193579355303923
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LIFR,Leukemia inhibitory factor receptor,40341,-0.00866597409543676,0.00233013054347688,-0.0132330299606515,-0.00409891823022207,0.000200626495591924
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NECTIN1,Nectin-1,37598,0.0113438750287757,0.00305436528044985,0.00535731907909398,0.0173304309784574,0.000204862725309483
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MFAP4,Microfibril-associated glycoprotein 4,37671,-0.0111251332565622,0.0029958072045299,-0.0169969153774408,-0.00525335113568359,0.000205198026040123
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,37714,0.0127650923506337,0.0034409241658943,0.00602088098548087,0.0195093037157865,0.000208281494969575
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,37628,-0.00942814069873093,0.00254826618517416,-0.0144227424216723,-0.00443353897578958,0.000216625381143762
NMR metabolomics,X23495.Concentration of Large VLDL Particles,JUN,Transcription factor AP-1,40044,0.0182558508301475,0.00493945316545826,0.0085745226258493,0.0279371790344457,0.000219837340797399
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,40332,0.0127630181328871,0.00345651491800155,0.00598824889360402,0.0195377873721701,0.000222845576631814
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CST1,Cystatin-SN,36179,0.0367829284988524,0.0099809400091545,0.0172202860809096,0.0563455709167952,0.000229447125326909
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,37562,-0.011212281189255,0.00304502024131669,-0.0171805208622357,-0.00524404151627426,0.000232186183684779
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NUP50,Nuclear pore complex protein Nup50,37562,-0.0124992245529654,0.0034010582123023,-0.0191652986490779,-0.00583315045685285,0.000238705508682952
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KLK4,Kallikrein-4,40489,-0.0212577986252718,0.00579085619118731,-0.0326078767599989,-0.00990772049054468,0.000242458483275288
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NMRK2,Nicotinamide riboside kinase 2,37482,-0.0153044681648285,0.00417377710429342,-0.0234850712892436,-0.00712386504041335,0.000246567359755339
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FAM3D,Protein FAM3D,37901,0.0288029921154895,0.0078560126243736,0.0134052073717172,0.0442007768592617,0.000246972564971541
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DRAXIN,Draxin,40228,0.0151150439675129,0.00412510456293948,0.00702983902415155,0.0232002489108743,0.000248964348433766
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TINAGL1,Tubulointerstitial nephritis antigen-like,40325,0.00777239614215962,0.00212651602097439,0.00360442474104981,0.0119403675432694,0.000258020897004201
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GART,Trifunctional purine biosynthetic protein adenosine-3,37959,0.00937744033372675,0.00256817762279907,0.00434381219304058,0.0144110684744129,0.000261801132004525
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,40286,0.0622297248667291,0.0170969847521818,0.0287196347524528,0.0957398149810055,0.000273710969625157
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PKD1,Polycystin-1,37990,0.00898712038721207,0.00246977128148282,0.00414636867550575,0.0138278720989184,0.00027487996122744
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KRT19,"Keratin, type I cytoskeletal 19",40310,0.0235229520579719,0.0064696620088357,0.010842414520654,0.0362034895952899,0.000277904014633458
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FAM171B,Protein FAM171B,37900,0.00960475914910193,0.00264663899655903,0.00441734671584623,0.0147921715823576,0.0002855316318258
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LAG3,Lymphocyte activation gene 3 protein,40305,-0.0141280548082921,0.00391321851852119,-0.0217979631045936,-0.00645814651199056,0.00030673729376649
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CFD,Complement factor D,38013,0.0065525797196739,0.00181779016001286,0.0029897110060487,0.0101154484332991,0.000313639600352818
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ARTN,Artemin,40044,0.0152754701793862,0.00424345351829443,0.00695830128352911,0.0235926390752433,0.000319482637949824
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EDN1,Endothelin-1,37628,0.0100033884984996,0.00277896524489079,0.00455661661851369,0.0154501603784856,0.000319777155087262
NMR metabolomics,X23495.Concentration of Large VLDL Particles,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",37959,0.0150195039727604,0.00417482385849996,0.00683684921010051,0.0232021587354204,0.000322267684208107
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GFRA2,GDNF family receptor alpha-2,40305,0.00723173450146061,0.0020204326059597,0.00327168659377959,0.0111917824091416,0.000345544394579911
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TYMP,Thymidine phosphorylase,40257,0.022631355805891,0.0063398393440788,0.0102052706914965,0.0350574409202854,0.000358443153590956
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LPA,Apolipoprotein(a),37735,-0.0597302962593523,0.0167686771884699,-0.0925969035487533,-0.0268636889699512,0.000369306079119824
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ODAM,Odontogenic ameloblast-associated protein,39934,0.0181605076708888,0.00510454972180134,0.00815559021615822,0.0281654251256195,0.000375220147981421
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AOC3,Membrane primary amine oxidase,40403,-0.0102651607555331,0.00289231513049777,-0.0159340984113087,-0.00459622309975746,0.000387638564193458
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",39961,0.0166494903450866,0.00471686881925879,0.00740442745933939,0.0258945532308339,0.000417116575977591
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TDO2,"Tryptophan 2,3-dioxygenase",37572,0.0130831372703515,0.00371007458835645,0.00581139107717281,0.0203548834635301,0.000422717910482968
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VSTM1,V-set and transmembrane domain-containing protein 1,39961,0.0163275178083514,0.00463256213860096,0.00724769601669351,0.0254073396000093,0.000425486944351488
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD3D,T-cell surface glycoprotein CD3 delta chain,37541,-0.0115194944964024,0.00327880924337508,-0.0179459606134175,-0.00509302837938719,0.0004440431444542
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,40330,0.0105169103424877,0.00299777435295664,0.00464127261069274,0.0163925480742828,0.000452330369900585
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,40341,0.0501153258601894,0.0143161861369039,0.0220556010318577,0.078175050688521,0.000465474317408024
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDH23,Cadherin-23,37942,-0.00883419425079929,0.00252547727325674,-0.0137841297063825,-0.00388425879521609,0.000470218637127263
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ALDH2,"Aldehyde dehydrogenase, mitochondrial",37900,0.0172705617733253,0.00494255614313484,0.00758315173278097,0.0269579718138696,0.000476912649830484
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CYB5A,Cytochrome b5,37482,0.0245357335387074,0.00702410267771217,0.0107684922903916,0.0383029747870233,0.000479072033621319
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PDRG1,p53 and DNA damage-regulated protein 1,37572,0.0179687893538432,0.00514685548081747,0.00788095261144094,0.0280566260962454,0.000482406268708279
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RCC1,Regulator of chromosome condensation,37900,0.0170266490536771,0.00488275107321997,0.00745645695016601,0.0265968411571883,0.000489845003759189
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PI16,Peptidase inhibitor 16,37987,-0.00818096171258473,0.00235202802924864,-0.0127909366499121,-0.0035709867752574,0.000506268852164669
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ACRV1,Acrosomal protein SP-10,37598,0.0117278373053455,0.00337264640828122,0.00511745034511432,0.0183382242655767,0.000508052769264945
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",39961,0.0182987394306147,0.00526651610927061,0.00797636785644434,0.0286211110047851,0.000513121081732019
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL19,Interleukin-19,39924,0.0224403850265414,0.00646250759951675,0.00977387013148858,0.0351068999215943,0.000517244070175894
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DDR1,Epithelial discoidin domain-containing receptor 1,40471,0.00760817772990595,0.00219282928672919,0.00331023232791675,0.0119061231318952,0.000522660689241477
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDH17,Cadherin-17,40359,-0.0223300025753408,0.00644250458273512,-0.0349573115575016,-0.00970269359317997,0.000529571143775181
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KIAA1549,UPF0606 protein KIAA1549,37714,0.0234105420351066,0.00677957860358553,0.0101225679720789,0.0366985160981342,0.000555919894248311
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CPA4,Carboxypeptidase A4,37410,0.0144733049675449,0.00419987896088183,0.00624154220421653,0.0227050677308733,0.000570492077309563
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IDS,Iduronate 2-sulfatase,40516,0.00283174795133045,0.000822826528714989,0.00121900795504907,0.00444448794761183,0.000579995443837495
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NTF4,Neurotrophin-4,39980,0.0133196612849089,0.00389030665834628,0.00569466023455018,0.0209446623352676,0.000619098114474621
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRKCQ,Protein kinase C theta type,40044,0.014468678335758,0.00422859089880946,0.00618064017409151,0.0227567164974246,0.000624064148196997
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TGFBR3,Transforming growth factor beta receptor type 3,40536,-0.01072083374289,0.00314392269579052,-0.0168829222266395,-0.00455874525914062,0.00065118077869233
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,40228,0.0196706008787728,0.00577715816016806,0.00834737088484344,0.0309938308727022,0.000663549916967656
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AKAP12,A-kinase anchor protein 12,37671,-0.00708328786981614,0.00208374767847121,-0.0111674333196197,-0.00299914242001258,0.000677576219238913
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SDK2,Protein sidekick-2,37671,0.012299449911336,0.00364612356852491,0.00515304771702714,0.0194458521056448,0.000744876041866464
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DDI2,Protein DDI1 homolog 2,37671,0.025189697188445,0.00747093459188426,0.0105466653883519,0.0398327289885382,0.00074921801569808
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EPHB4,Ephrin type-B receptor 4,40536,-0.0078846521951998,0.00234331507309784,-0.0124775497384716,-0.00329175465192803,0.000767941325429092
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RBPMS,RNA-binding protein with multiple splicing,37598,0.0207710803883868,0.00618421657819079,0.00865001589513288,0.0328921448816408,0.00078525506534936
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,37562,-0.0131158665377674,0.00390923781943128,-0.0207779726638527,-0.00545376041168206,0.000795626668733315
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TIMP2,Metalloproteinase inhibitor 2,37990,-0.00799743895620271,0.0023840581081984,-0.0126701928482716,-0.00332468506413384,0.000797128445215978
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NMI,N-myc-interactor,37857,0.0229352257950967,0.00683784725571701,0.00953304517389132,0.036337406416302,0.00079827312254032
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TRIM26,Tripartite motif-containing protein 26,37482,0.0176412925658302,0.00526369409621292,0.00732445213725282,0.0279581329944075,0.000806023677237975
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FMR1,Synaptic functional regulator FMR1,39980,0.0112027511345929,0.00334723762801997,0.00464216538367371,0.017763336885512,0.000819250983834356
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SCN2B,Sodium channel subunit beta-2,37572,-0.00948558865482082,0.00283686871256932,-0.0150458513314567,-0.00392532597818495,0.00082905697685239
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RLN2,Prorelaxin H2,37643,0.0449346937405303,0.013473810244254,0.0185260256617924,0.0713433618192682,0.000855451947748706
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SEMA3G,Semaphorin-3G,37671,0.013770421756126,0.00413101581850775,0.00567363075185084,0.0218672127604012,0.000860201628718577
NMR metabolomics,X23495.Concentration of Large VLDL Particles,WASL,Neural Wiskott-Aldrich syndrome protein,37598,-0.019917173802776,0.0059833702653357,-0.0316445795228339,-0.008189768082718,0.000874748142098223
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLEC14A,C-type lectin domain family 14 member A,40332,-0.00996493470906109,0.0029957525770123,-0.0158366097600052,-0.00409325965811698,0.000881895791699868
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SIRT1,NAD-dependent protein deacetylase sirtuin-1,37598,0.0278360416480434,0.00839832228999699,0.0113753299596493,0.0442967533364375,0.000920632154482955
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FCRL6,Fc receptor-like protein 6,40341,0.0212050904116028,0.00642664595044303,0.00860886434873448,0.0338013164744712,0.000970503087179646
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,40228,-0.00886753414727946,0.00269739382909167,-0.0141544260522991,-0.0035806422422598,0.00101321901068122
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD2,T-cell surface antigen CD2,37562,0.0120134629556778,0.00365603058980278,0.00484764299966432,0.0191792829116912,0.0010191299412849
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL11,Interleukin-11,40044,0.019991292360143,0.00608652968145009,0.00806169418450079,0.0319208905357851,0.00102383606316261
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KIRREL2,Kin of IRRE-like protein 2,39961,0.0125622282878744,0.00382471929286947,0.00506577847385021,0.0200586781018985,0.00102395827998612
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ARG1,Arginase-1,40227,0.016521852751731,0.00503378489241273,0.00665563436260209,0.02638807114086,0.0010322698352993
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FDX2,"Ferredoxin-2, mitochondrial",37562,0.0180207593592015,0.00550893872366244,0.00722323946082312,0.0288182792575799,0.00107374347770519
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SYT1,Synaptotagmin-1,37942,0.0121968660400814,0.00373801547888864,0.00487035570145966,0.0195233763787031,0.0011054272127556
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GABARAP,Gamma-aminobutyric acid receptor-associated protein,37900,0.0156904590764698,0.00481228532071016,0.00625837984787786,0.0251225383050617,0.00111492418040687
NMR metabolomics,X23495.Concentration of Large VLDL Particles,UBE2B,Ubiquitin-conjugating enzyme E2 B,37900,0.00885519908428323,0.00271701425966299,0.00352985113534378,0.0141805470332227,0.00112018033226122
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RBM19,Probable RNA-binding protein 19,37562,-0.0149337096699526,0.00458245988248408,-0.0239153310396214,-0.00595208830028381,0.00112135921537795
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MANSC4,MANSC domain-containing protein 4,37562,0.0204959754653002,0.00629033610512131,0.00816691669926239,0.0328250342313379,0.00112356260837633
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRTG,Protogenin,40489,0.00778798589104441,0.00239647284551317,0.00309089911383859,0.0124850726682502,0.001157363223184
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,37562,0.0173985059093471,0.00536859713768287,0.00687605551948864,0.0279209562992055,0.00119495627408926
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TK1,"Thymidine kinase, cytosolic",37714,0.0138478662674555,0.00427637675205262,0.0054661678334324,0.0222295647014787,0.0012057211718485
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NOTCH2,Neurogenic locus notch homolog protein 2,37998,-0.00652906575535057,0.00202282095392321,-0.0104937948250401,-0.00256433668566108,0.00125085251274852
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ART3,Ecto-ADP-ribosyltransferase 3,40403,-0.0101514849167472,0.00316231937059269,-0.0163496308831089,-0.00395333895038553,0.00132933458716555
NMR metabolomics,X23495.Concentration of Large VLDL Particles,STX3,Syntaxin-3,37942,0.0118676573331876,0.00369695904450907,0.00462161760594984,0.0191136970604254,0.00132993328374715
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TERF1,Telomeric repeat-binding factor 1,37598,-0.00911750107667091,0.00284409899547107,-0.0146919351077942,-0.00354306704554761,0.00135027952030569
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLIC5,Chloride intracellular channel protein 5,37572,-0.00987893958212881,0.00308571764356861,-0.0159269461635233,-0.00383093300073433,0.00137037718792616
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GFAP,Glial fibrillary acidic protein,39959,0.014283054083165,0.00446360940177095,0.00553437965569399,0.0230317285106361,0.00137757304598824
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDK1,Cyclin-dependent kinase 1,37482,0.0111944812439912,0.00350233417014236,0.00432990627051215,0.0180590562174702,0.00139538471702412
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLEC12A,C-type lectin domain family 12 member A,37598,0.00624448241402863,0.00195799419625096,0.00240681378937676,0.0100821510386805,0.00142989805916393
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TSC1,Hamartin,37598,0.023251429709686,0.00729872971962318,0.00894591945922455,0.0375569399601474,0.00144750725043383
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD5L,CD5 antigen-like,37934,0.0141302935324675,0.00445067446452636,0.00540697158199581,0.0228536154829391,0.00150243067597194
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CAPS,Calcyphosin,37942,0.0287769594766159,0.00906680980052608,0.0110060122675847,0.046547906685647,0.00150753997514775
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,37714,0.0201583233058693,0.00636366579476947,0.00768553834812115,0.0326311082636175,0.00153986840563986
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TFF2,Trefoil factor 2,40396,0.017145144597711,0.00542379795713434,0.00651450060172767,0.0277757885936943,0.00157471000010916
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GSAP,Gamma-secretase-activating protein,39980,0.0269159891849325,0.00851811305421076,0.0102204875986794,0.0436114907711856,0.00158151405057565
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNR,Tenascin-R,40228,-0.0127520796456718,0.00404187692404913,-0.0206741584168081,-0.00483000087453554,0.0016080527421721
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,37598,0.00918327425823466,0.00291253802638291,0.00347469972652415,0.0148918487899452,0.0016195726059507
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PSMG4,Proteasome assembly chaperone 4,37598,0.0170085675462635,0.00539622524468619,0.00643196606667851,0.0275851690258484,0.00162554987757681
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ACAN,Aggrecan core protein,40224,0.00850201273062392,0.00269927368427779,0.00321143630943946,0.0137925891518084,0.0016372043541941
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FLT1,Vascular endothelial growth factor receptor 1,40272,0.00693822410019511,0.00220366045123595,0.00261904961577264,0.0112573985846176,0.00164415977618076
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,37959,-0.0113649249045614,0.00361411800531489,-0.0184485961949786,-0.0042812536141442,0.00166679336431177
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,37541,-0.0184285069688243,0.00588209383782237,-0.0299574108909562,-0.00689960304669247,0.00173420554500192
NMR metabolomics,X23495.Concentration of Large VLDL Particles,QSOX1,Sulfhydryl oxidase 1,37761,0.0133006486584138,0.00428596429702788,0.00490015863623912,0.0217011386805884,0.00191774161669323
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DDA1,DET1- and DDB1-associated protein 1,37562,0.0121066474198976,0.00390157549203872,0.00445955945550169,0.0197537353842935,0.00191967242330839
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LEO1,RNA polymerase-associated protein LEO1,37959,0.0091737611526594,0.0029597303024613,0.00337268975983526,0.0149748325454835,0.00194228930318006
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ENG,Endoglin,40536,-0.00502184043299711,0.00162211809596257,-0.00820119190108375,-0.00184248896491046,0.00196584344341778
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ATRAID,All-trans retinoic acid-induced differentiation factor,37901,0.00802999120073779,0.00260702449354278,0.00292022319339394,0.0131397592080816,0.00207323154157906
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FGFR4,Fibroblast growth factor receptor 4,37671,0.015734577912932,0.0051126379486277,0.00571380753362167,0.0257553482922423,0.00209112308205407
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",37942,-0.00764277778451225,0.00249141284325325,-0.0125259469572886,-0.00275960861173588,0.00216178034751019
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PTTG1,Securin,37714,0.0121245593823356,0.00395536161431755,0.00437205061827323,0.019877068146398,0.00217853934567345
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SAT1,Diamine acetyltransferase 1,37562,-0.0153032986075832,0.00500171973596623,-0.025106669290077,-0.00549992792508939,0.00222074866396502
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SAFB2,Scaffold attachment factor B2,37959,0.00808714148882447,0.00264561982714819,0.00290172662761401,0.0132725563500349,0.00224147436869317
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,37598,0.00917417718306303,0.00300427933686165,0.0032857896828142,0.0150625646833119,0.00226487630915883
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD86,T-lymphocyte activation antigen CD86,37901,0.00848125775327386,0.00279179256023206,0.00300934433521902,0.0139531711713287,0.00238669706222668
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CTRC,Chymotrypsin-C,40360,0.0180738050470293,0.00596858148245372,0.00637538534142005,0.0297722247526386,0.00246444012732569
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TCN1,Transcobalamin-1,37766,0.00954047614831845,0.00315785524623786,0.00335107986569224,0.0157298724309447,0.00252262530477534
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,40042,0.010054751282101,0.00333405847203005,0.00351999667692206,0.0165895058872798,0.00256741032735599
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MRPL52,"39S ribosomal protein L52, mitochondrial",37460,0.00728061731418689,0.00241918648768775,0.00253901179831891,0.0120222228300549,0.00262152479534786
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NRXN3,Neurexin-3,37572,0.0100223568878209,0.00333326453856016,0.00348915839224303,0.0165555553833988,0.00264540107463361
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,40357,0.00843080228970761,0.00282059986519993,0.00290242655391575,0.0139591780254995,0.00280310327337176
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNN,Tenascin-N,37998,0.0124978201922423,0.00418138410322751,0.00430230734991639,0.0206933330345682,0.00280468268903302
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VTCN1,V-set domain-containing T-cell activation inhibitor 1,39980,-0.00923549416006024,0.00309166964235019,-0.0152951666590666,-0.00317582166105387,0.00281967721337743
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SAG,S-arrestin,37541,-0.0152661216852348,0.00511396101673667,-0.0252894852780386,-0.00524275809243089,0.00283930371008009
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KRT8,"Keratin, type II cytoskeletal 8",37541,0.0175262418448985,0.00589211011741643,0.00597770601476231,0.0290747776750347,0.00293975812730957
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CUZD1,CUB and zona pellucida-like domain-containing protein 1,37572,0.0102896931496777,0.00349373519768651,0.00344197216221212,0.0171374141371432,0.00323329253896605
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,37714,0.0149146365012399,0.00507589257081224,0.00496588706244787,0.0248633859400319,0.00330556142290255
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SH3GL3,Endophilin-A3,37643,0.0232781352929106,0.00793185346141693,0.00773170250853346,0.0388245680772878,0.00334374507698166
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TMOD4,Tropomodulin-4,37482,-0.0117261013192576,0.00400870531691334,-0.0195831637404078,-0.00386903889810748,0.00344873693805422
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NINJ1,Ninjurin-1,39980,0.0157004094158429,0.00536877336935362,0.00517761361190976,0.026223205219776,0.00345626321573132
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LYPD3,Ly6/PLAUR domain-containing protein 3,40284,0.00969128023483442,0.00331922276726169,0.0031856036110015,0.0161969568586673,0.00350813004261088
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,39757,0.0181181456277984,0.00620788539137881,0.00595069026069592,0.0302856009949009,0.00352153340597936
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NDRG1,Protein NDRG1,39961,0.0190848768154019,0.00655429037531581,0.00623846767978288,0.0319312859510209,0.00359848100166102
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FOLH1,Glutamate carboxypeptidase 2,37598,0.030005656224389,0.0103046289985117,0.00980858338730608,0.050202729061472,0.00359885463623471
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CHRDL2,Chordin-like protein 2,40359,0.0157702949259652,0.00541694165122378,0.00515308928956654,0.0263875005623638,0.00360437979277442
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SLC4A1,Band 3 anion transport protein,37998,-0.0128412877988112,0.00441355626899475,-0.0214918580860409,-0.00419071751158147,0.00362584196927988
NMR metabolomics,X23495.Concentration of Large VLDL Particles,REG1B,Lithostathine-1-beta,40536,0.0154521324633829,0.00531805455506852,0.00502874553544858,0.0258755193913172,0.00367050890910947
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TEF,Thyrotroph embryonic factor,37562,0.01197014358701,0.00412307635613489,0.00388891392898562,0.0200513732450344,0.00369978507416273
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ACE,Angiotensin-converting enzyme,37987,-0.00705774925943546,0.00243954261479291,-0.0118392527844296,-0.00227624573444136,0.00382113791940127
NMR metabolomics,X23495.Concentration of Large VLDL Particles,M6PR,Cation-dependent mannose-6-phosphate receptor,37628,0.011687916165493,0.00404132380979196,0.00376692149830074,0.0196089108326852,0.00383301210626263
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CENPJ,Centromere protein J,37714,0.020252593651436,0.00701364852615183,0.00650584254017837,0.0339993447626935,0.00388823844610788
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,37541,-0.0180305690994334,0.00624587805148774,-0.0302724900803494,-0.00578864811851747,0.00389824597350753
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BRD3,Bromodomain-containing protein 3,37562,0.0133482798832091,0.00463387589049057,0.00426588313784761,0.0224306766285706,0.0039757952832117
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NAAA,N-acylethanolamine-hydrolyzing acid amidase,40159,0.0161976569254464,0.00563792884654381,0.00514731638622053,0.0272479974646723,0.00407164659063994
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SEPTIN7,Septin-7,37714,0.0143355489704275,0.00502289351511007,0.00449067768081175,0.0241804202600432,0.00432337103345334
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MKI67,Proliferation marker protein Ki-67,37598,0.0102809734722825,0.0036127524224216,0.00319997872433616,0.0173619682202288,0.00443761406635409
NMR metabolomics,X23495.Concentration of Large VLDL Particles,APOA4,Apolipoprotein A-IV,38013,0.00999411512159431,0.00351428121202625,0.00310612394602286,0.0168821062971658,0.0044637639227412
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NELL1,Protein kinase C-binding protein NELL1,40411,-0.0114893995700128,0.00404357295060629,-0.0194148025532011,-0.00356399658682448,0.0044973143710122
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PNLIPRP2,Pancreatic lipase-related protein 2,40357,0.0789742827284885,0.027848082090654,0.0243920418308066,0.13355652362617,0.00457549188191321
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRR4,Proline-rich protein 4,37577,-0.0186836176836653,0.0065901973470119,-0.0316004044838087,-0.00576683088352201,0.00458868210591219
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FDX1,"Adrenodoxin, mitochondrial",37562,0.0170582303565152,0.00601764693783297,0.00526364235836256,0.0288528183546678,0.00459387264874688
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNFSF8,Tumor necrosis factor ligand superfamily member 8,37998,0.00967327344502859,0.00341342771356502,0.00298295512644116,0.016363591763616,0.00460533683413427
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MMP8,Neutrophil collagenase,40442,0.0196946198849043,0.0069705427085517,0.00603235617614295,0.0333568835936656,0.00472791041295888
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,37562,-0.0162066879601109,0.00573709883031208,-0.0274514016675226,-0.00496197425269923,0.00473678976023929
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PLA2G1B,Phospholipase A2,40514,-0.011257905279934,0.00398950597438192,-0.0190773369897225,-0.0034384735701454,0.00478017283229083
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MYO6,Unconventional myosin-VI,37959,0.0100189321033175,0.00357968385387396,0.00300275174972457,0.0170351124569105,0.00513605905575555
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,37562,-0.012895252305868,0.00464229959286277,-0.0219941595078791,-0.00379634510385698,0.00548107091569043
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CXCL14,C-X-C motif chemokine 14,40044,0.0162587214668729,0.00585639064429472,0.00478019580405522,0.0277372471296905,0.00550578889336567
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",37598,0.0164170068587117,0.00591715454142544,0.0048193839575178,0.0280146297599055,0.00553686432472644
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SOD2,"Superoxide dismutase [Mn], mitochondrial",40332,0.00978458594668567,0.00353097561474939,0.00286387374177686,0.0167052981515945,0.00559371399511911
NMR metabolomics,X23495.Concentration of Large VLDL Particles,L1CAM,Neural cell adhesion molecule L1,40411,-0.00745499393110959,0.00269422525126952,-0.0127356754235978,-0.00217431243862133,0.00566352034225491
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TYRO3,Tyrosine-protein kinase receptor TYRO3,40359,0.0074223714406982,0.00268678596592095,0.00215627094749313,0.0126884719339033,0.00574182331535045
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL20RA,Interleukin-20 receptor subunit alpha,40044,0.0121776169889435,0.00440882700806677,0.00353631605313265,0.0208189179247544,0.00574982918061248
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TMPRSS5,Transmembrane protease serine 5,40159,-0.00993394896941365,0.00359807575539044,-0.0169861774499789,-0.00288172048884838,0.0057708153639938
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VCPKMT,Protein-lysine methyltransferase METTL21D,37482,0.0234748400474968,0.00851537605396067,0.00678470298173386,0.0401649771132597,0.00584585772888449
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ACSL1,Long-chain-fatty-acid--CoA ligase 1,37562,-0.00999971207892499,0.00365712569733837,-0.0171676784457082,-0.00283174571214178,0.00625952740533017
NMR metabolomics,X23495.Concentration of Large VLDL Particles,APOE,Apolipoprotein E,38013,0.0195653946725541,0.00715699935020799,0.00553767594614639,0.0335931133989617,0.00627001866544678
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SSB,Lupus La protein,39961,0.0157273469368675,0.00575823950396891,0.0044411975090884,0.0270134963646465,0.0063160752630798
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,37900,0.0247557794650679,0.00907085662152587,0.00697690048687723,0.0425346584432587,0.00635792891775943
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MYH7B,Myosin-7B,37482,-0.0119008960207343,0.00437506404996005,-0.020476021558656,-0.0033257704828126,0.00653358826691646
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MMP9,Matrix metalloproteinase-9,40312,0.0158153021983645,0.00582301279618315,0.0044021971178455,0.0272284072788834,0.00661475289565056
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NAPRT,Nicotinate phosphoribosyltransferase,37942,0.00858489761580136,0.00316221931154049,0.00238694776518199,0.0147828474664207,0.0066393521354341
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADGRE5,Adhesion G protein-coupled receptor E5,40451,0.00770467295341415,0.00284045733332369,0.00213737658009973,0.0132719693267286,0.00668539693340957
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CEP290,Centrosomal protein of 290 kDa,37714,0.0137968954223745,0.00510006464724333,0.00380076871377753,0.0237930221309714,0.0068342389441457
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDHR1,Cadherin-related family member 1,39961,0.0112939686337995,0.00418953076965935,0.00308248832526714,0.0195054489423318,0.00703040414958217
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AKR1B10,Aldo-keto reductase family 1 member B10,37572,0.0155283236419352,0.00578146526131318,0.00419665172976134,0.026859995554109,0.00724300362449185
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NRCAM,Neuronal cell adhesion molecule,40359,0.00710437089215012,0.00266200061333439,0.00188684969001471,0.0123218920942855,0.0076197974538589
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLSPN,Claspin,39925,0.00863154887031576,0.00325373295892778,0.00225423227081732,0.0150088654698142,0.00799052892818481
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EFHD1,EF-hand domain-containing protein D1,37959,0.00879174941723879,0.00331609426160096,0.00229220466450091,0.0152912941699767,0.00802912998247447
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SCP2,Non-specific lipid-transfer protein,39980,0.0196827537340925,0.00743674187359924,0.00510673966183801,0.034258767806347,0.00813657188917272
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRSS53,Serine protease 53,37942,0.00927466405242827,0.00350817509124315,0.00239864087359169,0.0161506872312648,0.00820931301916109
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IGSF21,Immunoglobulin superfamily member 21,37628,0.00987316680566991,0.00373614230180498,0.00255032789413215,0.0171960057172077,0.00823670257070546
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BMP4,Bone morphogenetic protein 4,40203,-0.0113966635899377,0.00432577996739362,-0.0198751923260292,-0.00291813485384621,0.00843209872948669
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SUSD5,Sushi domain-containing protein 5,37604,-0.00861974283273632,0.00327238507752935,-0.0150336175846938,-0.00220586808077879,0.00844629719414816
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MELTF,Melanotransferrin,37990,0.00734025958580029,0.00278895941993125,0.00187389912273505,0.0128066200488655,0.00850053982004208
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FBLN2,Fibulin-2,37998,-0.00774439521963885,0.00294668013925139,-0.0135198882925716,-0.00196890214670613,0.00859408031073649
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PDGFRB,Platelet-derived growth factor receptor beta,40536,0.00870463282019633,0.00331380375931048,0.00220957745194779,0.0151996881884449,0.00862788076354302
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BCAN,Brevican core protein,40228,-0.00838655193510846,0.0031928059343931,-0.0146444515665189,-0.00212865230369799,0.0086299950704523
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PLA2G2A,"Phospholipase A2, membrane associated",40293,-0.0144010629118066,0.00550379750571258,-0.0251885060230033,-0.00361361980060997,0.00889028690489063
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AMBN,Ameloblastin,40044,-0.00739458757238263,0.00282951154627215,-0.012940430203076,-0.00184874494168923,0.00897377725676665
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NPTX1,Neuronal pentraxin-1,40332,0.00981639006438884,0.00375779159319453,0.00245111854172756,0.0171816615870501,0.00900261961788163
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RAB6A,Ras-related protein Rab-6A,40341,0.0118714288941708,0.00454450895168858,0.0029641913488612,0.0207786664394804,0.00900310319838209
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IFNGR1,Interferon gamma receptor 1,40422,0.00508832752955852,0.00194930644300277,0.00126768690127308,0.00890896815784396,0.00905401254520944
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADGRE1,Adhesion G protein-coupled receptor E1,37901,0.0137531326377454,0.00527985577000143,0.00340461532854263,0.0241016499469482,0.00920207024545148
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MYH4,Myosin-4,37562,-0.0118465015069106,0.00455650613924136,-0.0207772535398237,-0.00291574947399754,0.00933530317905195
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LEG1,Protein LEG1 homolog,37231,-0.0173143178770737,0.00666167022150268,-0.030371191511219,-0.00425744424292847,0.00935771358044934
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,37900,0.0169781471548857,0.0065381977399864,0.00416327958451239,0.0297930147252591,0.00942093753975224
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TFF1,Trefoil factor 1,40261,0.0192165142602521,0.00740495171378904,0.00470280890122555,0.0337302196192786,0.00946535736866056
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD33,Myeloid cell surface antigen CD33,40411,0.0195840581024745,0.00755675086145273,0.00477282641402714,0.0343952897909219,0.00956184085947416
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GPR101,Probable G-protein coupled receptor 101,37541,-0.01592387995059,0.00618581449076666,-0.0280480763524926,-0.00379968354868732,0.0100564361511158
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NGF,Beta-nerve growth factor,40228,0.00298920981602807,0.00116180138892655,0.000712079093732043,0.0052663405383241,0.0100938119741331
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,39961,0.0121981561021129,0.00474175274058842,0.00290432073055959,0.0214919914736662,0.0101059287433417
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NOP56,Nucleolar protein 56,37562,0.0272302573157563,0.0105950713849252,0.00646391740130295,0.0479965972302097,0.0101782342287295
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",37562,-0.0100896932154315,0.00394161296785911,-0.0178152546324354,-0.00236413179842769,0.0104847184268345
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,37572,-0.00782221700874913,0.00307265304796197,-0.0138446169827546,-0.00179981703474367,0.0109155553922278
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MRPS16,"28S ribosomal protein S16, mitochondrial",37598,0.0070434887871198,0.00277862957200923,0.00159737482598171,0.0124896027482579,0.0112601247631045
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LMNB1,Lamin-B1,37874,0.0137792737782849,0.00544004279672106,0.00311678989671159,0.0244417576598581,0.0113224904255226
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MRPL24,"39S ribosomal protein L24, mitochondrial",37562,0.00964865862002144,0.00383517883267149,0.00213170810798532,0.0171656091320576,0.0118870884131034
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RNF31,E3 ubiquitin-protein ligase RNF31,37598,0.00887116449064606,0.00353475495034352,0.00194304478797276,0.0157992841933194,0.0120953946106369
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SERPINA1,Alpha-1-antitrypsin,37779,-0.0019424195235498,0.000775850625783191,-0.00346308675008486,-0.000421752297014751,0.0123055591473371
NMR metabolomics,X23495.Concentration of Large VLDL Particles,THAP12,52 kDa repressor of the inhibitor of the protein kinase,37457,0.0213266310847939,0.00853266199901162,0.0046026135667311,0.0380506486028567,0.0124522136735022
NMR metabolomics,X23495.Concentration of Large VLDL Particles,OMG,Oligodendrocyte-myelin glycoprotein,40305,-0.0149580004645952,0.00598912418082495,-0.0266966838590121,-0.00321931707017831,0.0125163442128419
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SPON1,Spondin-1,40379,0.007808053864582,0.00313099999811954,0.00167129386826771,0.0139448138608963,0.01264882186319
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ASPN,Asporin,37990,0.00647469368521274,0.0026048592025414,0.00136916964823159,0.0115802177221939,0.01294452259443
NMR metabolomics,X23495.Concentration of Large VLDL Particles,OLR1,Oxidized low-density lipoprotein receptor 1,40225,0.0137615049051162,0.0055514049313571,0.00288075123965626,0.0246422585705761,0.0131883514662869
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KLK1,Kallikrein-1,40209,-0.0300358885582474,0.0121507884393579,-0.053851433899389,-0.00622034321710583,0.0134490976351117
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EPHA4,Ephrin type-A receptor 4,37671,0.00665569502059917,0.002693770446596,0.001375904945271,0.0119354850959273,0.0134946580051844
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TXNL1,Thioredoxin-like protein 1,37525,0.022560634700326,0.00913421048521486,0.00465758214930487,0.0404636872513471,0.013527555464835
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLC,Galectin-10,40333,-0.0154227643114423,0.00625884790943728,-0.0276901062139393,-0.00315542240894518,0.0137442273441983
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LTA4H,Leukotriene A-4 hydrolase,40489,0.0134711005592098,0.00551639221335946,0.00265897182102528,0.0242832292973944,0.0146163537004431
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DTX2,Probable E3 ubiquitin-protein ligase DTX2,37572,-0.0153855328305475,0.00630455777645445,-0.0277424660723982,-0.00302859958869676,0.0146848553876166
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SLC12A2,Solute carrier family 12 member 2,37562,-0.00666972204048898,0.00273803291748432,-0.0120362665587582,-0.00130317752221971,0.0148658033132256
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AIF1L,Allograft inflammatory factor 1-like,37628,0.0134902916546657,0.00554137560837256,0.00262919546225553,0.024351387847076,0.0149269592187823
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLMP,CXADR-like membrane protein,40489,0.00471583994698285,0.00194159709875612,0.000910309633420851,0.00852137026054485,0.0151578876670256
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HBQ1,Hemoglobin subunit theta-1,40489,-0.0136561925646587,0.00562631280030788,-0.0246837656532622,-0.0026286194760553,0.0152267574804721
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FCRL5,Fc receptor-like protein 5,40332,-0.0128243629548809,0.00533127758177697,-0.0232736670151638,-0.00237505889459806,0.0161619226613979
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL6ST,Interleukin-6 receptor subunit beta,40359,0.0039958134121339,0.00166276069795961,0.000736802444133054,0.00725482438013474,0.0162672305641322
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GUCA2A,Guanylin,40276,-0.00762685168125053,0.00318966938970793,-0.0138786036850781,-0.00137509967742299,0.0168091123479308
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",40044,0.0273659270218986,0.0114499268598118,0.00492407037666752,0.0498077836671296,0.0168577619386454
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ATP5PO,"ATP synthase subunit O, mitochondrial",39961,0.00973759984348834,0.00410865626237092,0.00168463356924134,0.0177905661177353,0.0177992588640993
NMR metabolomics,X23495.Concentration of Large VLDL Particles,STX1B,Syntaxin-1B,37572,0.00970009329492899,0.00411006802439002,0.00164435996712455,0.0177558266227334,0.0182855012546495
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TUBB3,Tubulin beta-3 chain,37541,-0.00627867841504385,0.00266368035835796,-0.0114994919174255,-0.00105786491266225,0.0184307402488064
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GPNMB,Transmembrane glycoprotein NMB,39957,0.00631522894938008,0.0026894351517467,0.00104393605195654,0.0115865218468036,0.0188788166307523
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,40042,0.00602396071920848,0.00258161211895247,0.000964000966061636,0.0110839204723553,0.0196392589169733
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,40355,-0.0110364645138254,0.00474562528787914,-0.0203378900780685,-0.00173503894958233,0.0200519794517599
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VIM,Vimentin,40042,0.0262366608752281,0.0112824126264917,0.00412313212730432,0.0483501896231518,0.0200607965064191
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CADPS,Calcium-dependent secretion activator 1,37572,-0.00999946544243169,0.00430957405757611,-0.0184462305952809,-0.00155270028958251,0.020340406194922
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GBP6,Guanylate-binding protein 6,37562,-0.0105434648173037,0.00454630545190159,-0.0194542235030308,-0.00163270613157659,0.0204033825184538
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,40536,0.0154760749913516,0.00667752757642423,0.00238812094156008,0.0285640290411431,0.0204816247585947
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDH22,Cadherin-22,37714,-0.00652992580322244,0.00282180314395067,-0.0120606599653658,-0.000999191641079119,0.0206776145019221
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,40536,0.00645714099680648,0.00279385845049911,0.000981178433828233,0.0119331035597847,0.0208348765874018
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RAD51,DNA repair protein RAD51 homolog 1,37714,0.0119665167475087,0.00519887028429039,0.00177673099029954,0.0221563025047179,0.0213645108519053
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",37541,-0.0121206549654967,0.00527515411703864,-0.0224599570348924,-0.00178135289610092,0.0215952865845034
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL2RG,Cytokine receptor common subunit gamma,37900,0.00847865967367541,0.00369308678401334,0.00124020957700927,0.0157171097703415,0.0217015297690869
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CA11,Carbonic anhydrase-related protein 11,39980,0.00721710081826506,0.00315492516380957,0.0010334474971983,0.0134007541393318,0.0221761669851461
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL33,Interleukin-33,40044,0.00841249978485231,0.00368728038170332,0.00118543023671381,0.0156395693329908,0.0225327823624191
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SPINT1,Kunitz-type protease inhibitor 1,40278,0.00555539784840651,0.00243815617509896,0.000776611745212553,0.0103341839516005,0.0227086276070146
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EPO,Erythropoietin,40341,0.0169486721979533,0.00745106022628664,0.00234459415443152,0.0315527502414751,0.0229392498392567
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CEP164,Centrosomal protein of 164 kDa,40044,0.0138242782260519,0.00609770184920553,0.00187278260160903,0.0257757738504947,0.0233959625763238
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,37562,0.0112586185863008,0.00498430529455352,0.00148938020897593,0.0210278569636257,0.0239113160418931
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CTNNA1,Catenin alpha-1,37541,-0.00783913760790845,0.00347557206224762,-0.0146512588499138,-0.00102701636590312,0.0241186796215426
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GUK1,Guanylate kinase,37562,-0.00867245544120402,0.00384577074608046,-0.0162101661035217,-0.00113474477888631,0.0241457974008692
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NFKB2,Nuclear factor NF-kappa-B p100 subunit,37714,0.012096689293326,0.00537692462481202,0.00155791702869445,0.0226354615579576,0.0244817023201422
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MAMDC2,MAM domain-containing protein 2,37990,-0.00724068931625578,0.0032445808474807,-0.013600067777318,-0.000881310855193601,0.0256560287632841
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RALB,Ras-related protein Ral-B,37598,0.00631242278908827,0.00283470817828811,0.000756394759643579,0.011868450818533,0.0259752843694426
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,37572,-0.0104401248440048,0.00468975520969471,-0.0196320450550064,-0.00124820463300313,0.0260206783949626
NMR metabolomics,X23495.Concentration of Large VLDL Particles,COL5A1,Collagen alpha-1(V) chain,37671,0.00845530707722086,0.00379914833973256,0.00100897633134504,0.0159016378230967,0.0260591544054086
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GLI2,Zinc finger protein GLI2,37598,-0.00713786505142113,0.00322345780034733,-0.0134558423401019,-0.000819887762740369,0.0268217735848142
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HIF1A,Hypoxia-inducible factor 1-alpha,37598,0.0143951347660609,0.00653740791842335,0.00158181524595116,0.0272084542861707,0.0276851773114603
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IFNW1,Interferon omega-1,37562,-0.00772715839906526,0.00352470187563869,-0.0146355740753171,-0.000818742722813428,0.0283763007127231
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,37900,0.0100258983043186,0.004574730518472,0.00105942648811347,0.0189923701205237,0.0284267716358174
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ICAM3,Intercellular adhesion molecule 3,40536,-0.00526391749070957,0.00240220711649782,-0.00997224343904531,-0.00055559154237384,0.0284455549239291
NMR metabolomics,X23495.Concentration of Large VLDL Particles,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",37959,0.0144565470698693,0.0066024878737758,0.0015156708372687,0.0273974233024698,0.0285731692363203
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CA3,Carbonic anhydrase 3,40500,0.0127141894058392,0.00580949799848722,0.00132757332880424,0.0241008054828742,0.028646273474906
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NTF3,Neurotrophin-3,40341,0.00726012880993472,0.00332649744715939,0.000740193813502318,0.0137800638063671,0.0290861758043697
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CSPG5,Chondroitin sulfate proteoglycan 5,37541,-0.0104809394956678,0.0048047355010069,-0.0198982210776413,-0.00106365791369427,0.0291732759431648
NMR metabolomics,X23495.Concentration of Large VLDL Particles,UNG,Uracil-DNA glycosylase,37900,0.0070621048205256,0.00324038433073848,0.000710951532278179,0.013413258108773,0.0293190011149742
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LSM8,U6 snRNA-associated Sm-like protein LSm8,37714,0.0190502879205911,0.00877026061775256,0.00186057710979613,0.0362399987313862,0.0298622966914295
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GAD1,Glutamate decarboxylase 1,37482,-0.00537235844997315,0.00247577537342587,-0.0102248781818879,-0.00051983871805845,0.0300271217913839
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TIE1,Tyrosine-protein kinase receptor Tie-1,40536,0.0085559793265876,0.00395241101615531,0.000809253734923185,0.016302704918252,0.0304215433622582
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EPN1,Epsin-1,37714,0.00915839899833958,0.00423300939733985,0.000861700579553482,0.0174550974171257,0.0305154048582978
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL17RA,Interleukin-17 receptor A,40332,0.00904144210947151,0.00417953262106763,0.000849558172178957,0.0172333260467641,0.0305355724938188
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ID4,DNA-binding protein inhibitor ID-4,37714,-0.00942545604673994,0.00435874330073788,-0.0179685929161862,-0.000882319177293702,0.0306032417232577
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,37990,0.00678063120335143,0.00315166930509139,0.0006033593653723,0.0129579030413306,0.031459027217827
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PEPD,Xaa-Pro dipeptidase,37987,0.00529297469791041,0.00246499579231086,0.000461582944981121,0.0101243664508397,0.0317906883090408
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ATP1B4,Protein ATP1B4,37482,-0.00869368257829716,0.00404899299208716,-0.016629708842788,-0.000757656313806325,0.0318019532968326
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CHGA,Chromogranin-A,37998,-0.0185129678908435,0.00862526966535139,-0.0354184964349323,-0.0016074393467548,0.0318616601769582
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NEO1,Neogenin,37959,0.00436705587970539,0.00203847170411699,0.000371651339636101,0.00836246041977468,0.0321856758083454
NMR metabolomics,X23495.Concentration of Large VLDL Particles,OGN,Mimecan,40332,0.008283272329833,0.00387924654482955,0.000679949101967082,0.0158865955576989,0.0327535128017846
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PCDH12,Protocadherin-12,37959,0.00520706642119285,0.00244741713669359,0.000410128833273404,0.0100040040091123,0.0333902998254397
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CALY,Neuron-specific vesicular protein calcyon,37562,-0.00774806581620776,0.00366431654772299,-0.0149301262497448,-0.000566005382670697,0.0344944712373892
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TMEM25,Transmembrane protein 25,37959,-0.00885122215028987,0.00418768936486824,-0.0170590933054316,-0.000643350995148126,0.0345652413225046
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KLK14,Kallikrein-14,40489,-0.0092438797563809,0.00437533032850122,-0.0178195272002433,-0.000668232312518512,0.0346395280397753
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AIDA,"Axin interactor, dorsalization-associated protein",37572,0.0168839496242,0.00800074715659706,0.00120248519726973,0.0325654140511302,0.034851692729729
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AOC1,Amiloride-sensitive amine oxidase [copper-containing],40044,0.0115331236758004,0.00546698782025684,0.000817827548096952,0.0222484198035038,0.0349092519375316
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADRA2A,Alpha-2A adrenergic receptor,37562,-0.0144845277123043,0.00689070635341974,-0.027990312165007,-0.000978743259601653,0.0355689590993311
NMR metabolomics,X23495.Concentration of Large VLDL Particles,COMP,Cartilage oligomeric matrix protein,40198,0.00676159939792067,0.00322016164398161,0.000450082575716717,0.0130731162201246,0.0357649338219805
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,37572,-0.0104715723683499,0.00499435417073977,-0.0202605065429999,-0.000682638193699984,0.0360408350310221
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LYPD8,Ly6/PLAUR domain-containing protein 8,39980,0.0102695416480073,0.00490276581867518,0.000660120643403888,0.0198789626526106,0.0362189481129931
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DCC,Netrin receptor DCC,37572,0.00467296494365737,0.00223427214377471,0.000293791541858939,0.00905213834545581,0.0365030586163583
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BRME1,Break repair meiotic recombinase recruitment factor 1,37541,-0.00826530184911665,0.0039543376937787,-0.0160158037289229,-0.000514799969310397,0.0366203294558202
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TGOLN2,Trans-Golgi network integral membrane protein 2,37987,0.00510393502896061,0.00244800769792144,0.000305839941034594,0.00990203011688663,0.0370939661253697
NMR metabolomics,X23495.Concentration of Large VLDL Particles,OPTC,Opticin,40305,-0.00888133435550659,0.00428951920687568,-0.0172887920009829,-0.000473876710030251,0.0384242077084347
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCDC28A,Coiled-coil domain-containing protein 28A,37572,0.00583063324922101,0.00282144463856736,0.00030060175762898,0.011360664740813,0.038796926841563
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SUMF1,Formylglycine-generating enzyme,37598,0.0132034950757294,0.00642514821465682,0.000610204575002068,0.0257967855764568,0.0399014950256816
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KIAA2013,Uncharacterized protein KIAA2013,37900,0.0112844665179894,0.00550022068355662,0.000504033978218441,0.0220648990577604,0.040224096112558
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL15,Interleukin-15,40341,0.00638743645252549,0.0031205905266553,0.000271079020281113,0.0125037938847699,0.0406874760674564
NMR metabolomics,X23495.Concentration of Large VLDL Particles,STOML2,"Stomatin-like protein 2, mitochondrial",37482,0.0177406610544727,0.00867642777471736,0.000734862616026642,0.0347464594929187,0.0409048449118338
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TCN2,Transcobalamin-2,40497,0.00578670783965725,0.00284196010868063,0.000216466026643205,0.0113569496526713,0.0417498910484702
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SPINK8,Serine protease inhibitor Kazal-type 8,37562,0.0076091850726106,0.00373981923685684,0.000279139368371202,0.01493923077685,0.0419072105437665
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MSLNL,Mesothelin-like protein,37572,-0.00731255094253847,0.00359779173533184,-0.0143642227437889,-0.000260879141288056,0.0421220586652196
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CEP152,Centrosomal protein of 152 kDa,37482,0.00806068544064324,0.00397695557368403,0.000265852516222549,0.0158555183650639,0.0426982565414138
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CORO6,Coronin-6,37541,-0.00704530680295466,0.00349073320868734,-0.0138871438919818,-0.000203469713927478,0.0435815783325254
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GFRA3,GDNF family receptor alpha-3,40194,-0.0054873950471158,0.00271969048151607,-0.0108179883908873,-0.000156801703344304,0.0436442178183818
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TJP3,Tight junction protein ZO-3,37541,-0.0084753085755385,0.00421041808209647,-0.0167277280164476,-0.000222889134629431,0.0441416385532375
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,37562,-0.00645529441729096,0.0032103659812785,-0.0127476117405968,-0.000162977093985102,0.0443706263007759
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GSTP1,Glutathione S-transferase P,39871,-0.0132971447746501,0.00665556555076826,-0.0263420532541559,-0.000252236295144358,0.04574519388802
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD55,Complement decay-accelerating factor,39802,0.00497654369816886,0.00250190173456744,7.28162984166801e-05,0.00988027109792105,0.0467074032383958
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PSMC3,26S proteasome regulatory subunit 6A,37482,-0.00573454722360085,0.0028909581299833,-0.0114008251583681,-6.82692888335735e-05,0.0473197557031773
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RGS8,Regulator of G-protein signaling 8,40044,0.0125346133696942,0.00633803622221015,0.00011206237416235,0.0249571643652261,0.0479822931652307
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GNPDA1,Glucosamine-6-phosphate isomerase 1,37628,0.00618742449892611,0.0031305708009374,5.15057290888105e-05,0.0123233432687634,0.0481243709457052
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NXPH3,Neurexophilin-3,37598,0.00572039264189266,0.00290011201584796,3.61730908306533e-05,0.0114046121929547,0.0485765593072759
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HTR1B,5-hydroxytryptamine receptor 1B,37541,-0.00798023744379002,0.00407608030118335,-0.0159693548341094,8.87994652933391e-06,0.0502721825650537
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PAPPA,Pappalysin-1,40044,0.00874398880009786,0.00448253800513526,-4.17856899672508e-05,0.017529763290163,0.0511132376956876
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CNTN2,Contactin-2,40489,0.00830230787456245,0.00426981079522381,-6.65212840762295e-05,0.0166711370332011,0.0518622182243851
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,40451,0.00640166239561292,0.00329513698428334,-5.68060935824269e-05,0.0128601308848083,0.0520626075199183
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MN1,Transcriptional activator MN1,37572,-0.0110896159654055,0.0057093913485336,-0.0222800230085314,0.000100791077720359,0.0521165450106185
NMR metabolomics,X23495.Concentration of Large VLDL Particles,REXO2,"Oligoribonuclease, mitochondrial",37562,-0.0091010500794008,0.00469374243289461,-0.0183007852478742,9.86850890726445e-05,0.052525791402219
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NELL2,Protein kinase C-binding protein NELL2,40422,0.00520898986594978,0.00268891897901346,-6.12913329165899e-05,0.0104792710648162,0.0527377840845469
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DEFB116,Beta-defensin 116,37541,-0.0146628558485506,0.00757905394840672,-0.0295178015874278,0.000192089890326526,0.0530541474885439
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DOCK9,Dedicator of cytokinesis protein 9,37541,0.0221166708309973,0.0114468950378977,-0.000319243443282127,0.0445525851052767,0.0533673719556684
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,37541,0.0105898341438824,0.00548157144793372,-0.000154045894067719,0.0213337141818324,0.053393716292305
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MSMB,Beta-microseminoprotein,40236,0.0127278762490977,0.00659157965556749,-0.000191619875814576,0.02564737237401,0.053509646108438
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",37562,0.00915236319297336,0.0047444367734001,-0.000146732882890842,0.0184514592688376,0.0537434033144833
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADAMTSL5,ADAMTS-like protein 5,37990,-0.00713335813889147,0.00370377134533998,-0.0143927499757578,0.000126033697974889,0.0541288452430051
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",37562,-0.00813326813207216,0.004226898353724,-0.0164179889053712,0.000151452641226884,0.054354984613091
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CRTAM,Cytotoxic and regulatory T-cell molecule,40228,0.00923323087916492,0.00480762606707399,-0.000189716212300095,0.0186561779706299,0.0548079224296566
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DKKL1,Dickkopf-like protein 1,40305,-0.0160689866158568,0.00837121968013089,-0.0324765771889133,0.000338603957199753,0.0549325137609577
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,37482,0.00486870083090512,0.00253671681598547,-0.000103264128426393,0.00984066579023663,0.0549691788664407
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,37959,-0.00488788929449092,0.00254762652042889,-0.00988123727453154,0.00010545868554971,0.0550553805109503
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DCLRE1C,Protein artemis,37482,-0.00582365541360986,0.00304122301059627,-0.0117844525143786,0.000137141687158832,0.0555263960744504
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VSIG4,V-set and immunoglobulin domain-containing protein 4,40309,0.00711389622150238,0.00371538830325023,-0.000168264852868066,0.0143960572958728,0.0555472967282927
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRAME,Melanoma antigen preferentially expressed in tumors,37482,-0.00466574191808895,0.00244596043321523,-0.0094598243671908,0.000128340531012899,0.0564740047571887
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LYPLA2,Acyl-protein thioesterase 2,37541,0.0197407867396116,0.0103638072033114,-0.000572275378878735,0.0400538488581019,0.0568303954927379
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SOX9,Transcription factor SOX-9,37572,0.00494297707139783,0.00259670490108995,-0.00014656453473848,0.0100325186775341,0.0569896995105072
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",37562,0.0161198852737187,0.00849361034309092,-0.000527590998739485,0.0327673615461769,0.0577333392994788
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LY6D,Lymphocyte antigen 6D,40268,0.00673393233457147,0.00355857123121973,-0.000240867278619214,0.0137087319477621,0.058467470624649
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ACTA2,"Actin, aortic smooth muscle",40042,-0.00785523310979481,0.00416077157966701,-0.0160103454059422,0.00029987918635253,0.0590543014132573
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PPM1B,Protein phosphatase 1B,37598,0.0114339535500694,0.00607354422498997,-0.000470193130910899,0.0233381002310498,0.0597789123700239
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FLT3,Receptor-type tyrosine-protein kinase FLT3,39980,-0.00554165962485932,0.00294982150100752,-0.0113233097668341,0.00023999051711542,0.0603120615139476
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CREB3,Cyclic AMP-responsive element-binding protein 3,37482,-0.0103061772030635,0.00551185361784893,-0.0211094102940474,0.000497055887920411,0.0615311482026647
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ARHGAP30,Rho GTPase-activating protein 30,37714,0.00671268754164383,0.00360711257537935,-0.000357253106099705,0.0137826281893874,0.0627721213260841
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL17A,Interleukin-17A,40028,0.00756762575767356,0.00406702582505128,-0.000403744859426946,0.0155389963747741,0.0628015339811263
NMR metabolomics,X23495.Concentration of Large VLDL Particles,INSL4,Early placenta insulin-like peptide,37900,-0.00960807214966642,0.00517654812935217,-0.0197541064831967,0.00053796218386383,0.0634644358323989
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ZPR1,Zinc finger protein ZPR1,37541,0.0172686537995327,0.00931325665043715,-0.000985329235324156,0.0355226368343895,0.0637328259164532
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,37959,0.0201746115059977,0.0108869573881336,-0.00116382497474417,0.0415130479867395,0.0638899425078459
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LTO1,Protein LTO1 homolog,40044,0.00726584680594494,0.00392416446863062,-0.000425515552571076,0.014957209164461,0.0641071616721825
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BABAM1,BRISC and BRCA1-A complex member 1,37598,0.0052158733356181,0.00281767847860609,-0.000306776482449837,0.010738523153686,0.0641740747182289
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ERVV_1,,37562,-0.00856984990382339,0.004629949616343,-0.0176445511518557,0.000504851344208882,0.0641978357773354
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TSLP,Thymic stromal lymphopoietin,40042,0.0107327903934658,0.00580665364600318,-0.000648250752700469,0.022113831539632,0.0645691047583971
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SPRING1,SREBP regulating gene protein,37482,0.0101912189847778,0.00551602307391602,-0.00062018624009757,0.0210026242096532,0.0646877429994221
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,37987,0.00835488164672468,0.00452350132981804,-0.000511180959718678,0.017220944253168,0.0647697631455732
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SPP1,Osteopontin,40497,-0.00835131063791666,0.00453263931963574,-0.0172352837044027,0.000532662428569381,0.065422977476115
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TTN,Titin,37562,-0.0115772639843554,0.00628642378293482,-0.0238986545989077,0.000744126630196804,0.0655519265279099
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BSND,Barttin,37482,-0.00601876883168848,0.00328434591717584,-0.0124560868293531,0.000418549165976161,0.0668904815139991
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL2RA,Interleukin-2 receptor subunit alpha,40208,0.00701007761006067,0.00383888015674406,-0.000514127497157686,0.014534282717279,0.0678580953195298
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL25,Interleukin-25,37429,0.0060793185541415,0.00334353430307422,-0.000474008679883964,0.012632645788167,0.0690518391346046
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PFDN4,Prefoldin subunit 4,37482,0.00945014527870909,0.00520506925689392,-0.000751790464802981,0.0196520810222212,0.0694599926640942
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TSPAN8,Tetraspanin-8,37901,0.0179276655960889,0.0099251523511393,-0.00152563301214411,0.0373809642043219,0.0708959933917546
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ZP4,Zona pellucida sperm-binding protein 4,37482,-0.00560146714968966,0.00311657652833474,-0.0117099571452258,0.000507022845846434,0.0723089043922362
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ENDOU,Poly(U)-specific endoribonuclease,36973,0.00864222367344363,0.00480945928454124,-0.000784316524257212,0.0180687638711445,0.0723720785097514
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL13RA2,Interleukin-13 receptor subunit alpha-2,37541,-0.00491083189426818,0.00273316527970779,-0.0102678358424955,0.000446172053959093,0.0723973659343845
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LTBR,Tumor necrosis factor receptor superfamily member 3,40289,0.00469514088606871,0.00261413034393281,-0.000428554588039597,0.00981883636017702,0.0725036666962545
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SOX2,Transcription factor SOX-2,37937,0.00399945706576983,0.00222996971097311,-0.000371283567737471,0.00837019769927713,0.072914951188001
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SULT1A1,Sulfotransferase 1A1,40471,-0.0219184706934837,0.0122448719427845,-0.0459184197013414,0.00208147831437402,0.0734708235257336
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CPTP,Ceramide-1-phosphate transfer protein,37562,-0.00688671470451857,0.00386053146523791,-0.0144533563763849,0.000679926967347735,0.0744667172535908
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ZNF75D,Zinc finger protein 75D,37714,0.0100989209504125,0.00569486925270422,-0.00106302278488772,0.0212608646857128,0.0761958675661645
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ACTN4,Alpha-actinin-4,40044,0.00548899008679328,0.0030973513364652,-0.000581818532678523,0.0115597987062651,0.0763881719126641
NMR metabolomics,X23495.Concentration of Large VLDL Particles,COPE,Coatomer subunit epsilon,39961,0.00814504420529572,0.00460794288315023,-0.000886523845678736,0.0171766122562702,0.0771458473990024
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLNS1A,Methylosome subunit pICln,37572,0.00562081746025297,0.00321512624842513,-0.000680829986660286,0.0119224649071662,0.0804455894713674
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NRTN,Neurturin,40044,0.00824889517493926,0.00471945804251697,-0.001001242588394,0.0174990329382725,0.0805100387529009
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCAR2,Cell cycle and apoptosis regulator protein 2,37942,0.00942912746354274,0.00539618100579106,-0.00114738730780773,0.0200056422348932,0.0805958458260423
NMR metabolomics,X23495.Concentration of Large VLDL Particles,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,37562,-0.00337137719902665,0.00193409194520417,-0.00716219741162681,0.000419443013573524,0.0813340363921663
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NLGN2,Neuroligin-2,37541,-0.00804274095505974,0.00462773746503625,-0.0171131063865308,0.00102762447641131,0.0822444893992287
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,37959,-0.0048744004797377,0.0028150532874746,-0.0103919049231879,0.00064310396371252,0.0833768672015813
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SLK,STE20-like serine/threonine-protein kinase,37714,0.0128330031102642,0.00743814430940602,-0.00174575973617166,0.0274117659567,0.084497378220317
NMR metabolomics,X23495.Concentration of Large VLDL Particles,APOH,Beta-2-glycoprotein 1,40332,0.00582582433187783,0.00337989244835759,-0.000798764866903041,0.0124504135306587,0.0847866244886242
NMR metabolomics,X23495.Concentration of Large VLDL Particles,S100G,Protein S100-G,37959,-0.00727182007624727,0.00425135526265742,-0.0156044763910558,0.00106083623856128,0.0872017672369975
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SLITRK1,SLIT and NTRK-like protein 1,37598,-0.00527240888607009,0.0030840786486112,-0.011317203037348,0.000772385265207868,0.0873713841454353
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GHRHR,Growth hormone-releasing hormone receptor,39961,0.00911610344270296,0.00533331925566068,-0.00133720229839196,0.0195694091837979,0.0874202298243882
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PDCL2,Phosducin-like protein 2,37482,0.00878165457574244,0.00516511475934642,-0.00134197035257655,0.0189052795040614,0.08911985426519
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KIF20B,Kinesin-like protein KIF20B,37541,0.0126923308853794,0.00748535676946886,-0.00197896838277954,0.0273636301535384,0.0899813911132958
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KRT17,"Keratin, type I cytoskeletal 17",37562,0.00620008790003886,0.00367095894606342,-0.000994991634245443,0.0133951674343232,0.0912516549713685
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TLR4,Toll-like receptor 4,37598,0.00458486912110767,0.00272155986257658,-0.000749388209542435,0.00991912645175777,0.0920803311644507
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CRHR1,Corticotropin-releasing factor receptor 1,40042,0.0101730211597193,0.00605367541847523,-0.00169218266049217,0.0220382249799307,0.0928859006271469
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PSAPL1,Proactivator polypeptide-like 1,37901,-0.00811798747244907,0.00483395499149858,-0.0175925392557863,0.00135656431088815,0.0931036485934011
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLSTN1,Calsyntenin-1,39961,0.00840059562855113,0.0050109707109536,-0.00142090696491793,0.0182220982220202,0.0936720422485608
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DNER,Delta and Notch-like epidermal growth factor-related receptor,40319,0.00389903757968796,0.00233639926849995,-0.000680304986571937,0.00847838014594787,0.0951721291693271
NMR metabolomics,X23495.Concentration of Large VLDL Particles,USP28,Ubiquitin carboxyl-terminal hydrolase 28,37942,0.00597525057098008,0.00358624216073717,-0.00105378406406477,0.0130042852060249,0.0957049156517046
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DLL1,Delta-like protein 1,40411,0.00463892715407983,0.00278762916312834,-0.000824826005651719,0.0101026803138114,0.0961096809294562
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BEX3,Protein BEX3,37482,-0.00757131089650473,0.0045747350200318,-0.0165377915357671,0.00139516974275761,0.0979430636246294
NMR metabolomics,X23495.Concentration of Large VLDL Particles,WNT9A,Protein Wnt-9a,40044,0.00450576636622832,0.00273308293025704,-0.000851076177075468,0.00986260890953212,0.0992493169334463
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RSPO1,R-spondin-1,40228,0.00550329022713406,0.00337354336881202,-0.0011088547757375,0.0121154352300056,0.102845185300339
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RYR1,Ryanodine receptor 1,37562,-0.00539824587069441,0.00330976826557137,-0.0118853916712143,0.00108889992982547,0.102913458297994
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,40536,0.00424778487519925,0.00261217261834505,-0.000872073456757052,0.00936764320715555,0.103937310063043
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRDX2,Peroxiredoxin-2,37763,0.00973350002483549,0.00599323869090863,-0.00201324780934542,0.0214802478590164,0.104382380210269
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SCARB1,Scavenger receptor class B member 1,39961,0.00916417054261363,0.00565224292292478,-0.00191422558631895,0.0202425666715462,0.104966472196448
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CHIT1,Chitotriosidase-1,40398,0.0229961232342821,0.0142107543048813,-0.00485695520328523,0.0508492016718495,0.105635026488696
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PGLYRP4,Peptidoglycan recognition protein 4,37562,0.00971319931401763,0.00602805718811788,-0.00210179277469341,0.0215281914027287,0.10713152944702
NMR metabolomics,X23495.Concentration of Large VLDL Particles,POLR2A,DNA-directed RNA polymerase II subunit RPB1,37598,-0.0045130802827743,0.00281568713894159,-0.0100318270750998,0.00100566650955121,0.108995238555759
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,37990,0.0111999101032665,0.0070058155446967,-0.00253148836433898,0.0249313085708721,0.10991972802179
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LAMA1,Laminin subunit alpha-1,37562,-0.0085795111073027,0.00537655174005823,-0.0191175525178168,0.00195853030321143,0.110573764536786
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CTHRC1,Collagen triple helix repeat-containing protein 1,37998,-0.00422632179238505,0.00265346708898431,-0.00942711728679429,0.00097447370202419,0.111238596018721
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,37562,0.00696682300180162,0.00437483219814829,-0.00160784810656903,0.0155414941101723,0.111301503952669
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RELB,Transcription factor RelB,37598,0.007862227279575,0.00493768366388467,-0.00181563270163894,0.0175400872607889,0.111343467261042
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CNGB3,Cyclic nucleotide-gated cation channel beta-3,37541,0.00836766694080567,0.00525532803026082,-0.00193277599850555,0.0186681098801169,0.111358208711053
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FGF5,Fibroblast growth factor 5,40044,-0.00488805621970357,0.00307424624759608,-0.0109135788649919,0.00113746642558474,0.111854735588939
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DDX53,Probable ATP-dependent RNA helicase DDX53,37572,0.00536187338449065,0.00338354305936466,-0.00126987101186408,0.0119936177808454,0.113060447196233
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,37900,0.00681055628091148,0.00432635832016654,-0.00166910602661494,0.0152902185884379,0.115464582127321
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DENND2B,DENN domain-containing protein 2B,37562,-0.00789127766789831,0.00502683470409295,-0.0177438736879205,0.00196131835212388,0.116478718851642
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PLXDC2,Plexin domain-containing protein 2,37942,-0.00399038002835466,0.0025532516681465,-0.0089947532979218,0.00101399324121249,0.118108512477246
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RASA1,Ras GTPase-activating protein 1,39961,0.00484078228473898,0.00310582367723364,-0.00124663212263896,0.0109281966921169,0.119108017743875
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",37677,-0.00980348626494569,0.00630281522472564,-0.0221570041054079,0.00255003157551656,0.119871459795246
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DCTPP1,dCTP pyrophosphatase 1,40359,0.00468100432882932,0.00301845697566576,-0.00123517134347557,0.0105971800011342,0.120971003672097
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,37671,0.00597709808964779,0.00385962624663991,-0.00158776935376643,0.013541965533062,0.12149680412617
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IFNL1,Interferon lambda-1,39961,0.00662429737328313,0.00432084146720025,-0.00184455190242936,0.0150931466489956,0.125270741694248
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ANXA10,Annexin A10,39961,0.0120419398379234,0.00786844495364941,-0.00338021227122946,0.0274640919470762,0.125935890888683
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL24,Interleukin-24,40044,0.00719459900521548,0.00470327546147344,-0.00202382089927245,0.0164130189097034,0.126111367253222
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DEFB118,Beta-defensin 118,37541,0.00850908437691652,0.00558316998823323,-0.0024339288000206,0.0194520975538536,0.127517958083378
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADGRB3,Adhesion G protein-coupled receptor B3,40203,-0.00486791492747622,0.00319951413148666,-0.0111389626251901,0.00140313277023763,0.128165914146845
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,40471,0.00664628673869541,0.00439342775900065,-0.00196483166894586,0.0152574051463367,0.130355446250118
NMR metabolomics,X23495.Concentration of Large VLDL Particles,JCHAIN,Immunoglobulin J chain,40044,-0.00890061269118386,0.00588734472511702,-0.0204398083524132,0.00263858297004551,0.130599615695634
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DIPK2B,Divergent protein kinase domain 2B,37671,0.0038517974892119,0.00255325597894441,-0.00115258422951915,0.00885617920794294,0.131429387722564
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,37714,-0.0106440999992395,0.00706056705362916,-0.0244828114243527,0.00319461142587364,0.1316956561211
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FGF12,Fibroblast growth factor 12,37598,0.00692591073465738,0.0046170547556247,-0.00212351658636703,0.0159753380556818,0.133619982316334
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DUSP29,Dual specificity phosphatase 29,37572,-0.00955093033578919,0.00637849177557653,-0.0220527742159192,0.00295091354434081,0.134322366466734
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,40411,-0.00636029891045686,0.00426892502188487,-0.0147273919533512,0.00200679413243749,0.136268598296279
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SHH,Sonic hedgehog protein,37598,-0.00619957803388116,0.00416168916434868,-0.0143564887960046,0.00195733272824225,0.136332833435111
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GGA1,ADP-ribosylation factor-binding protein GGA1,39961,0.00981479911490714,0.0066070580672655,-0.00313503469693324,0.0227646329267475,0.137431173780521
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HDDC2,5'-deoxynucleotidase HDDC2,37901,0.00617130691808724,0.00415500609557784,-0.00197250502924533,0.0143151188654198,0.137495689010277
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RLN1,Prorelaxin H1,37959,-0.0117172053027233,0.00789004673638741,-0.0271816969060426,0.00374728630059599,0.137550848263241
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,37959,-0.00335401398746866,0.00225917149582223,-0.00778199011928023,0.00107396214434291,0.137667521519368
NMR metabolomics,X23495.Concentration of Large VLDL Particles,METAP1,Methionine aminopeptidase 1,39961,0.00434784460533582,0.00292869448528546,-0.00139239658582368,0.0100880857964953,0.137678757458083
NMR metabolomics,X23495.Concentration of Large VLDL Particles,OSTN,Osteocrin,37572,-0.00610647185318667,0.00411837893955212,-0.0141784945747088,0.00196555086833549,0.138168382170771
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PALM3,Paralemmin-3,37562,0.0102805384661509,0.00694357381423513,-0.00332886620974998,0.0238899431420517,0.13874171614983
NMR metabolomics,X23495.Concentration of Large VLDL Particles,REST,RE1-silencing transcription factor,37482,-0.00508355832242983,0.00343374614983891,-0.0118137007761141,0.00164658413125442,0.138772026729273
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HIP1,Huntingtin-interacting protein 1,37562,0.00479379950511525,0.00326014248984752,-0.0015960797749859,0.0111836787852164,0.141470311141223
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,37541,-0.00808928570837602,0.005519965122269,-0.0189084173480233,0.00272984593127122,0.142819595660569
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TAP1,Antigen peptide transporter 1,37714,-0.00862042378706876,0.00590272116210691,-0.0201897572647983,0.00294890969066077,0.144199682720661
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TMEM132A,Transmembrane protein 132A,37628,0.00874418553308149,0.00600903162387402,-0.00303351644971158,0.0205218875158746,0.145644968420554
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CNTNAP4,Contactin-associated protein-like 4,37572,0.0141212898643695,0.0097161110534546,-0.0049222878004015,0.0331648675291405,0.146139669814084
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CBX2,Chromobox protein homolog 2,37562,-0.00571713855807644,0.00393900005001376,-0.0134375786561034,0.00200330153995053,0.146687217614407
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SIGLEC5,Sialic acid-binding Ig-like lectin 5,40332,0.0164576641703503,0.0113501640691923,-0.00578865740526654,0.0387039857459672,0.147080079947554
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CRNN,Cornulin,39857,0.00915888531875368,0.00632827587957714,-0.00324453540521751,0.0215623060427249,0.147834522317756
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GPA33,Cell surface A33 antigen,40305,-0.0187409561323943,0.0129671236127072,-0.0441565184133004,0.00667460614851185,0.148402663283079
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLEC11A,C-type lectin domain family 11 member A,40296,0.00659621150462379,0.00456785213422368,-0.00235677867845463,0.0155492016877022,0.148744399125569
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SEMA6C,Semaphorin-6C,37598,0.00367868328906212,0.00254867507361575,-0.00131671985522475,0.00867408643334899,0.148939861141311
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GKN1,Gastrokine-1,39602,0.00384578340097774,0.00266499161266289,-0.00137760015984152,0.009069166961797,0.149019953451559
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PHLDB2,Pleckstrin homology-like domain family B member 2,37482,-0.013100513586716,0.00913840652590591,-0.0310117903774916,0.0048107632040596,0.151719999588218
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADA2,Adenosine deaminase 2,40258,0.00570309266132787,0.00398873630428707,-0.00211483049507479,0.0135210158177305,0.152794374577199
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DDX39A,ATP-dependent RNA helicase DDX39A,37598,0.00306248388964097,0.00214243780515038,-0.00113669420845376,0.00726166198773571,0.152901893705859
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FAM171A2,Protein FAM171A2,37959,0.0218643054103114,0.0153782514112528,-0.00827706735574414,0.0520056781763669,0.155116707710449
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RRP15,RRP15-like protein,37541,-0.0124062816658563,0.008734649362033,-0.029526194415441,0.00471363108372835,0.155528882685829
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ATP2B4,Plasma membrane calcium-transporting ATPase 4,37562,-0.00851383503318082,0.00599740973576917,-0.0202687581152884,0.00324108804892674,0.155752207901
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DCUN1D1,DCN1-like protein 1,37541,-0.0101384305365832,0.00716478805402951,-0.024181415122481,0.00390455404931466,0.157081832959053
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MORF4L2,Mortality factor 4-like protein 2,37482,-0.00493295045482039,0.00348705948065987,-0.0117675870369137,0.00190168612727295,0.157196570825289
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SHPK,Sedoheptulokinase,37714,-0.00579441600533624,0.00410297271880432,-0.0138362425341927,0.00224741052352022,0.157900344689801
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",37598,0.00487461106436532,0.00347541224477946,-0.00193719693540241,0.0116864190641331,0.160759951033725
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GPR158,Probable G-protein coupled receptor 158,37959,0.00494518954309574,0.00352649209734258,-0.00196673496769573,0.0118571140538872,0.160849536065438
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,37572,-0.00678625557841884,0.00486778700262496,-0.0163271181035638,0.00275460694672608,0.163306445404641
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CHP1,Calcineurin B homologous protein 1,37541,0.00973398415947949,0.00699502976060912,-0.00397627417131438,0.0234442424902734,0.164080169446467
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,37900,0.00861760623345575,0.00621398343497927,-0.00356180129910362,0.0207970137660151,0.165523092572395
NMR metabolomics,X23495.Concentration of Large VLDL Particles,REN,Renin,40359,-0.0093726505443304,0.00678647459847112,-0.0226741407573338,0.003928839668673,0.167274390118732
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GH2,Growth hormone variant,39980,0.0222211427778275,0.0160947036824104,-0.00932447643969688,0.0537667619953519,0.167406662257078
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BHLHE40,Class E basic helix-loop-helix protein 40,37541,-0.00936439177684423,0.00679933005932926,-0.0226910786931296,0.00396229513944111,0.168457862149028
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL10,Interleukin-10,40044,0.0112771050327497,0.00820026381840463,-0.00479541205132339,0.0273496221168227,0.169085342765382
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ACHE,Acetylcholinesterase,37671,-0.00418733627534408,0.00305298968586004,-0.0101711960596298,0.0017965235089416,0.170226003200353
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MMP13,Collagenase 3,39961,-0.00430800482355745,0.00314258376890497,-0.0104674690106112,0.00185145936349628,0.170442166867754
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ATF2,Cyclic AMP-dependent transcription factor ATF-2,39961,0.00884206967376733,0.00645409937552686,-0.00380796510226532,0.0214921044498,0.170708981419111
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ANGPT2,Angiopoietin-2,40489,-0.00504433360740708,0.00368770893376627,-0.012272243117589,0.00218357590277481,0.171369630032981
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,38013,0.00247469750296293,0.0018151687613579,-0.00108303326929855,0.00603242827522442,0.172797090224152
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TCL1B,T-cell leukemia/lymphoma protein 1B,40042,0.0103657054229119,0.00763666795768013,-0.00460216377414115,0.025333574619965,0.174686591378925
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SPINK5,Serine protease inhibitor Kazal-type 5,40332,-0.00420131204000731,0.0030957771227109,-0.0102690352005207,0.00186641112050605,0.174765349758385
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GJA8,Gap junction alpha-8 protein,37482,0.00809199110145918,0.00596543168086817,-0.00360025499304244,0.0197842371959608,0.174969872193743
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GAMT,Guanidinoacetate N-methyltransferase,37562,-0.0050514476684799,0.00372958600497034,-0.0123614362382218,0.00225854090126196,0.175623899822408
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GID8,Glucose-induced degradation protein 8 homolog,37959,0.00437765673220349,0.00323439641376506,-0.00196176023877603,0.010717073703183,0.175928352683522
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TGFBR1,TGF-beta receptor type-1,37598,0.00278955692138113,0.00206239837565843,-0.00125274389490939,0.00683185773767166,0.176213399603272
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL36A,Interleukin-36 alpha,37598,-0.00763956513749056,0.0056625655758969,-0.0187381936662485,0.00345906339126737,0.177316859566725
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ATP5F1D,"ATP synthase subunit delta, mitochondrial",37562,-0.00679239986462234,0.00505580210355391,-0.016701771987588,0.00311697225834333,0.179137876455843
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",37541,0.00417999960602303,0.00311739702589136,-0.00193009856472405,0.0102900977767701,0.179988489360233
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VWA5A,von Willebrand factor A domain-containing protein 5A,37482,0.0105353690771174,0.00786336338082361,-0.00487682314929693,0.0259475613035316,0.180332300704374
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRRT3,Proline-rich transmembrane protein 3,37628,0.00479937310799868,0.00359401684567946,-0.00224489990953307,0.0118436461255304,0.181775540480911
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BTLA,B- and T-lymphocyte attenuator,37482,0.0113621015278893,0.00850937570319165,-0.00531627485036636,0.0280404779061449,0.181819492427011
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FBN2,Fibrillin-2,37572,0.00776153738994697,0.00583071547837923,-0.00366666494767631,0.0191897397275703,0.183163890906961
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,37628,0.00467988313882216,0.00352436794598883,-0.00222787803531596,0.0115876443129603,0.184245871440372
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MUC2,Mucin-2,37998,0.0114901965836474,0.00866548027683369,-0.00549414475894665,0.0284745379262414,0.184870857243187
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,37184,0.00617066578390855,0.00467196955689255,-0.00298639454760085,0.015327726115418,0.186596910397921
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LPO,Lactoperoxidase,39831,-0.00743083293605575,0.00564352114432734,-0.0184921343789373,0.00363046850682584,0.187958310638104
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,37900,-0.0107336899258295,0.00815314833737496,-0.0267138606670845,0.00524648081542538,0.18802582913427
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TMED10,Transmembrane emp24 domain-containing protein 10,37562,-0.00655418593582998,0.00499990269249319,-0.0163539952131166,0.00324562334145666,0.189927116415282
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,37901,-0.0216988781532743,0.0165755320610747,-0.0541869209929808,0.0107891646864321,0.190525927944923
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TLR2,Toll-like receptor 2,37714,0.00288000556758314,0.00220022905632509,-0.00143244338281405,0.00719245451798032,0.190571544083636
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GSTM4,Glutathione S-transferase Mu 4,37562,-0.0089253355321361,0.00686158354196163,-0.0223740392743809,0.00452336821010869,0.19336038041873
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DNLZ,DNL-type zinc finger protein,37541,-0.0118420738240005,0.00911550553941155,-0.0297084646812471,0.00602431703324617,0.193927957234578
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RTKN2,Rhotekin-2,37562,-0.00654061923530842,0.00504614869869032,-0.0164310706847415,0.00334983221412461,0.194942969712073
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KEL,Kell blood group glycoprotein,39961,0.00436066150921963,0.00339474198019392,-0.00229303277196045,0.0110143557903997,0.198974359592857
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SIGLEC15,Sialic acid-binding Ig-like lectin 15,39961,0.00977926257984751,0.00772653921233721,-0.00536475427633343,0.0249232794360284,0.205649631370635
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HLA_DRA,,40288,-0.00432599195197836,0.00343325850998134,-0.0110551786315418,0.00240319472758507,0.207678869689956
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,37541,-0.00381739643553074,0.00303194097403372,-0.00976000074463684,0.00212520787357535,0.208031015066212
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DCUN1D2,DCN1-like protein 2,37482,0.00971078653990995,0.00774732638431762,-0.00547397317335258,0.0248955462531725,0.210069156197217
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,40471,0.0032611849163592,0.00260319196590528,-0.00184107133681515,0.00836344116953356,0.210309930735297
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KDM3A,Lysine-specific demethylase 3A,37598,-0.0110892021800207,0.00887115518232427,-0.0284766663373763,0.00629826197733483,0.211311167051214
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,37998,-0.0164469272468282,0.0131649406518586,-0.042250210924471,0.00935635643081462,0.211577873907828
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",37572,-0.00503155901874168,0.00404445254641253,-0.0129586860097102,0.00289556797222686,0.213498124880591
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NPTXR,Neuronal pentraxin receptor,40359,0.00400246257033341,0.00323121824695949,-0.0023307251937072,0.010335650334374,0.215480339778866
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DSC2,Desmocollin-2,40177,-0.00394898781878309,0.00321112506742948,-0.0102427929509449,0.00234481731337869,0.218796681259769
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RBP7,Retinoid-binding protein 7,37901,0.00683591373581356,0.00558101002835262,-0.00410286591975757,0.0177746933913847,0.220652275898672
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KLHL41,Kelch-like protein 41,37959,0.00554879630586042,0.00454028395414358,-0.003350160244261,0.0144477528559818,0.221681539016174
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DEFB104A_DEFB104B,Beta-defensin 104,37541,0.00660935318621486,0.00543281356215467,-0.0040389613956083,0.017257667768038,0.223792939226265
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TSPAN15,Tetraspanin-15,37562,-0.00594619848400743,0.00488999508514421,-0.0155305888508901,0.00363819188287522,0.22400958486871
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TRPV3,Transient receptor potential cation channel subfamily V member 3,37562,-0.00593863137553451,0.00488707606586743,-0.0155173004646347,0.00364003771356566,0.224322897594684
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GAL,Galanin peptides,40422,-0.00720925820424428,0.00594271470336314,-0.018856979022836,0.00443846261434748,0.225099819805427
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CSH1,Chorionic somatomammotropin hormone 1,37987,0.00405082466167911,0.00333955732392544,-0.00249470769321476,0.010596357016573,0.225157672459068
NMR metabolomics,X23495.Concentration of Large VLDL Particles,UBQLN3,Ubiquilin-3,37562,-0.00518703481781369,0.0043224351283001,-0.0136590076692819,0.0032849380336545,0.230150902473925
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CEP112,Centrosomal protein of 112 kDa,37562,0.00542199263063756,0.00452061768595698,-0.00343841803383811,0.0142824032951132,0.230397237995037
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ESPL1,Separin,37482,-0.0064905501515572,0.00549035287433061,-0.0172516417852452,0.00427054148213078,0.237158403262626
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TOP1,DNA topoisomerase 1,37901,0.012039496658285,0.0102040280451386,-0.00796039831018664,0.0320393916267566,0.238070060235859
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLEC4C,C-type lectin domain family 4 member C,40341,0.00511173725255926,0.00434605449815057,-0.00340652956381586,0.0136300040689344,0.239541047722952
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TPRKB,EKC/KEOPS complex subunit TPRKB,37482,-0.00719888377026583,0.00614598185985182,-0.0192450082155754,0.00484724067504374,0.241493404837348
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CA8,Carbonic anhydrase-related protein,37598,-0.00311384396270081,0.00266416371622338,-0.00833560484649863,0.00210791692109701,0.242510040921555
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",37482,0.00646435730584221,0.00554768932962564,-0.00440911378022404,0.0173378283919085,0.243945538609555
NMR metabolomics,X23495.Concentration of Large VLDL Particles,YY1,Transcriptional repressor protein YY1,37598,0.00311437226185763,0.00268943164347938,-0.00215691375936195,0.00838565828307722,0.246883493071428
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL36G,Interleukin-36 gamma,37551,0.007581581356048,0.00660503389980644,-0.00536428508757262,0.0205274477996686,0.251051880186906
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCNE1,G1/S-specific cyclin-E1,37598,0.0102483710807337,0.00897093943778083,-0.00733467021731673,0.0278314123787841,0.253309992735426
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IDI2,Isopentenyl-diphosphate delta-isomerase 2,39961,0.00504767066911916,0.00442362465627465,-0.00362263365717915,0.0137179749954175,0.253857916350241
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ISM2,Isthmin-2,37998,-0.00485994450205012,0.00426183934652078,-0.0132131496212309,0.00349326061713062,0.254164975358998
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ALPI,Intestinal-type alkaline phosphatase,37598,0.0132175954332532,0.0116151497389441,-0.00954809805507716,0.0359832889215835,0.25515721817813
NMR metabolomics,X23495.Concentration of Large VLDL Particles,POF1B,Protein POF1B,37598,0.00504024453819562,0.0044413586913874,-0.00366481849692368,0.0137453075733149,0.256461823959046
NMR metabolomics,X23495.Concentration of Large VLDL Particles,OSBPL2,Oxysterol-binding protein-related protein 2,37942,0.00431219600397707,0.00381242077073692,-0.00316014870666729,0.0117845407146214,0.258036769087209
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,37482,-0.00481349673632343,0.0042755458545397,-0.0131935666112212,0.00356657313857438,0.260262283545876
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDAN1,Codanin-1,37942,0.00249664914250958,0.00221963592219542,-0.00185383726499345,0.0068471355500126,0.260693299854553
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,37562,-0.0075132141407079,0.00675988869939698,-0.020762595991526,0.00573616771011018,0.266399165704415
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DNAJA1,DnaJ homolog subfamily A member 1,37482,-0.00496578037999994,0.00449982401587192,-0.0137854354511089,0.00385387469110903,0.269808810332919
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AGBL2,Cytosolic carboxypeptidase 2,37541,0.00961732642659914,0.00872479543320286,-0.00748327262247847,0.0267179254756767,0.270352313029191
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FZD10,Frizzled-10,37572,0.00642521168170559,0.00582960882170654,-0.00500082160883922,0.0178512449722504,0.270408606210542
NMR metabolomics,X23495.Concentration of Large VLDL Particles,C9orf40,Uncharacterized protein C9orf40,37901,0.00867606505232437,0.00787272792814646,-0.00675448168684269,0.0241066117914914,0.27046378416496
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",37482,0.00533074883868294,0.00484495065671766,-0.00416535444848368,0.0148268521258496,0.271235276800024
NMR metabolomics,X23495.Concentration of Large VLDL Particles,THRAP3,Thyroid hormone receptor-associated protein 3,37562,0.0125777067914297,0.0114451637193326,-0.00985481409846229,0.0350102276813216,0.27180837491848
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NME3,Nucleoside diphosphate kinase 3,40379,0.00250612529577875,0.00228053986200456,-0.00196373283375018,0.00697598342530768,0.271820638486101
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NPTN,Neuroplastin,39980,0.00881371102590794,0.00805660667110678,-0.00697723804946135,0.0246046601012772,0.273983743138138
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HDAC8,Histone deacetylase 8,37598,0.00650247258421474,0.00599113305153744,-0.00524014819679864,0.0182450933652281,0.27778684242883
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GAGE2A,G antigen 2A,37482,0.0064481025009623,0.00596525116159906,-0.00524378977577186,0.0181399947776965,0.279742026682272
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HNF1A,Hepatocyte nuclear factor 1-alpha,37572,0.00751248277373755,0.00695945260057734,-0.00612804432339404,0.0211530098708691,0.280400506618894
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,37998,-0.00255614080311782,0.00238747272354726,-0.00723558734127046,0.00212330573503481,0.284347202312182
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ANXA5,Annexin A5,39896,0.00312037361458344,0.00291486383650931,-0.0025927595049748,0.00883350673414169,0.284409205206038
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DNAJA4,DnaJ homolog subfamily A member 4,37942,0.00728256402250474,0.00680913535154168,-0.00606334126651696,0.0206284693115264,0.284850749844638
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MAPT,Microtubule-associated protein tau,39961,0.00540131350439668,0.00506579148892311,-0.00452763781389261,0.015330264822686,0.286334975151588
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NENF,Neudesin,37900,0.0110053438002365,0.0103531482769089,-0.00928682682250496,0.0312975144229779,0.2878033523998
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL3RA,Interleukin-3 receptor subunit alpha,40044,0.00322736068590227,0.0030369130034167,-0.00272498880079446,0.009179710172599,0.287929514908061
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CPVL,Probable serine carboxypeptidase CPVL,40465,0.00407438230360641,0.00386079643352396,-0.00349277870610056,0.0116415433133134,0.291294135949118
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GRIK2,"Glutamate receptor ionotropic, kainate 2",37959,0.00426296084809198,0.00404299844751379,-0.00366131610903505,0.012187237805219,0.291716046907976
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SELENOP,Selenoprotein P,38013,-0.00226262768646131,0.00215837246948907,-0.00649303772665989,0.00196778235373728,0.294517848765231
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",37598,-0.00459969363324964,0.00439501611387431,-0.0132139252164433,0.00401453794994401,0.29531701638734
NMR metabolomics,X23495.Concentration of Large VLDL Particles,OSMR,Oncostatin-M-specific receptor subunit beta,40424,-0.00208897096075908,0.00199883572676287,-0.00600668898521431,0.00182874706369614,0.29599540422786
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CSRP3,Cysteine and glycine-rich protein 3,37562,-0.00964651626863903,0.00925667561523327,-0.0277896004744962,0.00849656793721819,0.297377793904726
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DDX1,ATP-dependent RNA helicase DDX1,37901,0.0051412262674175,0.00494642768283814,-0.00455377199094526,0.0148362245257803,0.29864595050052
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DPEP2,Dipeptidase 2,40305,-0.00283252771898069,0.00273031921121685,-0.00818395337296571,0.00251889793500433,0.299549166404991
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",37541,-0.00456130319273543,0.00439853361581014,-0.0131824290797233,0.00405982269425244,0.29975248896097
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,40341,0.00831556836178594,0.00811127747084086,-0.00758253548106215,0.024213672204634,0.305291024995193
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL1A,Interleukin-1 alpha,40044,0.00526427419712888,0.00513624175629668,-0.00480275964521262,0.0153313080394704,0.305413410830295
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DUOX2,Dual oxidase 2,40042,0.00708361153747473,0.00691167907259748,-0.00646327944481633,0.0206305025197658,0.305437770196762
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TAGLN3,Transgelin-3,37482,-0.00596968142036606,0.00584299673085946,-0.0174219550128506,0.00548259217211848,0.306950657691204
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EDNRB,Endothelin receptor type B,37598,0.00462803523769298,0.00453895119754447,-0.00426830910949418,0.0135243795848801,0.307924362855374
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EVI2B,Protein EVI2B,37482,0.00410107485908021,0.00403595762172423,-0.00380940207949929,0.0120115517976597,0.309584317855817
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TOP1MT,"DNA topoisomerase I, mitochondrial",37482,-0.00481434269026548,0.00474298169682882,-0.01411058681605,0.00448190143551902,0.31010293964313
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ITGB7,Integrin beta-7,40489,0.00438796274524163,0.00433510937121892,-0.00410885162234745,0.0128847771128307,0.311461562200666
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TEX33,Testis-expressed protein 33,37714,-0.00380487980077945,0.00378014522066517,-0.0112139644332832,0.00360420483172428,0.314172663298222
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CRTAC1,Cartilage acidic protein 1,40536,0.00278879726273807,0.00278717340636495,-0.00267406261373723,0.00825165713921337,0.317043689893323
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EVPL,Envoplakin,37714,-0.00330507957852599,0.00330353907508184,-0.00978001616568639,0.00316985700863442,0.317103142907532
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TP53BP1,TP53-binding protein 1,37598,0.0084409535996267,0.00851407704788365,-0.00824663741422526,0.0251285446134787,0.321502951474364
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SLC44A4,Choline transporter-like protein 4,37572,-0.00657829338642975,0.00670555221551037,-0.0197211757288301,0.00656458895597057,0.326600045175211
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PNMA2,Paraneoplastic antigen Ma2,37541,0.00406881349491785,0.00416259627622296,-0.00408987520647915,0.0122275021963149,0.328354527049735
NMR metabolomics,X23495.Concentration of Large VLDL Particles,UHRF2,E3 ubiquitin-protein ligase UHRF2,37562,-0.00337586574056946,0.00346622262591913,-0.010169662087371,0.00341793060623204,0.330108186390206
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NCAN,Neurocan core protein,40471,-0.00345425308335732,0.00354979118767242,-0.0104118438111953,0.00350333764448064,0.330525118083911
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EIF5A,Eukaryotic translation initiation factor 5A-1,40044,0.00270985123704858,0.00278643501456851,-0.0027515613915057,0.00817126386560286,0.330809244888419
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PYDC1,Pyrin domain-containing protein 1,37628,-0.00396959643464679,0.00408217249906803,-0.0119706545328201,0.00403146166352654,0.330858248128693
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SLC51B,Organic solute transporter subunit beta,37562,-0.00740282576622305,0.00762217264612055,-0.0223422841526193,0.00753663262017324,0.331455397320096
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SCIN,Adseverin,37541,0.00683036761824514,0.00703570365654553,-0.00695961154858409,0.0206203467850744,0.331658281901232
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ICAM2,Intercellular adhesion molecule 2,40536,0.00287353692686543,0.00296631427183929,-0.00294043904593958,0.00868751289967045,0.332697968961272
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ITGAX,Integrin alpha-X,37714,0.00508173894556117,0.00528828769025762,-0.00528330492734377,0.0154467828184661,0.336598736938096
NMR metabolomics,X23495.Concentration of Large VLDL Particles,WIF1,Wnt inhibitory factor 1,40489,-0.00313107079382275,0.00325975829585624,-0.00952019705370098,0.00325805546605549,0.33680685461138
NMR metabolomics,X23495.Concentration of Large VLDL Particles,OTOA,Otoancorin,37541,-0.00503845683688253,0.00525144999691998,-0.0153312988308457,0.00525438515708063,0.337354312468556
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRTN3,Myeloblastin,39897,0.00426411047314558,0.0044812137122709,-0.00451906840290538,0.0130472893491965,0.341338830172646
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,37562,-0.00343405532267362,0.00362421844968069,-0.0105375234840478,0.00366941283870054,0.343386295395863
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FHIP2A,FHF complex subunit HOOK interacting protein 2A,37562,0.00430563117207639,0.00454551021273056,-0.00460356884487551,0.0132148311890283,0.343540447500933
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL20,Interleukin-20,40044,0.00458102296810088,0.00486432956849151,-0.00495306298614247,0.0141151089223442,0.346330966199967
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SCN3B,Sodium channel subunit beta-3,37541,0.00414233475845756,0.00439876076340512,-0.00447923633781647,0.0127639058547316,0.346361102736527
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LRP2,Low-density lipoprotein receptor-related protein 2,37572,0.0032433158058499,0.00345035856919956,-0.00351938698978123,0.010006018601481,0.347238025024229
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MYBPC1,"Myosin-binding protein C, slow-type",37990,-0.00564834922999865,0.0060488975348053,-0.017504188398217,0.00620748993821973,0.350433215633267
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADGRE2,Adhesion G protein-coupled receptor E2,40422,0.00246374104178188,0.00264914401212617,-0.00272858122198542,0.00765606330554918,0.352377888838631
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SCN2A,Sodium channel protein type 2 subunit alpha,37541,0.00443908765580267,0.00477383651693942,-0.00491763191739859,0.0137958072290039,0.352451175583719
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FGF9,Fibroblast growth factor 9,37457,0.00361185567938709,0.00388816418917615,-0.00400894613139817,0.0112326574901724,0.352939497102497
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NPHS2,Podocin,37598,-0.00932147745162813,0.0100478299953589,-0.0290152242425316,0.0103722693392754,0.353574789237131
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TG,Thyroglobulin,37900,-0.0104167197608927,0.0112298104422589,-0.0324271482277201,0.0115937087059347,0.353634166728601
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KIAA0319,Dyslexia-associated protein KIAA0319,37942,0.0027307985461591,0.00296458741633669,-0.00307979278986081,0.00854138988217902,0.35699407652682
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,39708,-0.00327871864028838,0.00356002539497277,-0.010256368414435,0.00369893113385825,0.357074485646122
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PPIE,Peptidyl-prolyl cis-trans isomerase E,37714,0.00560257807087869,0.00617308297232968,-0.00649666455488749,0.0177018206966449,0.364115677287698
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL17C,Interleukin-17C,40044,-0.00606086934313826,0.00668931153803848,-0.0191719199576937,0.00705018127141717,0.364921915614949
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MUCL3,Mucin-like protein 3,37482,-0.0039097322452321,0.00431715685249287,-0.0123713596761181,0.00455189518565394,0.365150249833274
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SCGN,Secretagogin,40044,-0.00376775621442318,0.00418280292726486,-0.0119660499518623,0.00443053752301594,0.367722903855558
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SERPINA6,Corticosteroid-binding globulin,38013,0.00151938148529692,0.00170659805426143,-0.00182555070105548,0.00486431367164932,0.373321483975308
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LCN15,Lipocalin-15,37959,-0.0054024927916317,0.00609973447465901,-0.0173579723619634,0.00655298677869996,0.375798689995883
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FRMD7,FERM domain-containing protein 7,37572,0.00281129352394134,0.00318497834573491,-0.00343126403369907,0.00905385108158176,0.377429293253782
NMR metabolomics,X23495.Concentration of Large VLDL Particles,OFD1,Oral-facial-digital syndrome 1 protein,37714,0.00574039711330415,0.00650700083968234,-0.00701332453247323,0.0184941187590815,0.377691217586779
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NRN1,Neuritin,37959,-0.00307647472006057,0.00350246155130733,-0.00994129936062294,0.0037883499205018,0.379755862820964
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PEAR1,Platelet endothelial aggregation receptor 1,40536,0.00188206483689812,0.00214898182195624,-0.0023299395341361,0.00609406920793234,0.3811552500951
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RBP1,Retinol-binding protein 1,37572,0.00572207214044948,0.00659379392341978,-0.00720176394945329,0.0186459082303522,0.385521547572535
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRR5,Proline-rich protein 5,37598,0.00399121380566376,0.00462054798851539,-0.00506506025182641,0.0130474878631539,0.387715376241089
NMR metabolomics,X23495.Concentration of Large VLDL Particles,COL9A1,Collagen alpha-1(IX) chain,40341,0.00386331560344461,0.00448942196650356,-0.00493595145090235,0.0126625826577916,0.389505849055882
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BATF,Basic leucine zipper transcriptional factor ATF-like,37572,0.00713040637086724,0.00829198537142853,-0.00912188495713267,0.0233826976988671,0.389851360870461
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,37714,0.00569683346351657,0.00664894254286403,-0.00733509392049693,0.0187287608475301,0.391569286633702
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RPGR,X-linked retinitis pigmentosa GTPase regulator,37572,0.00351241808722691,0.00410470353015734,-0.00453280083188147,0.0115576370063353,0.392176229493362
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,37541,0.00597334874558495,0.00699758973975177,-0.00774192714432851,0.0196886246354984,0.393325951823899
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ZCCHC8,Zinc finger CCHC domain-containing protein 8,37562,0.00490163010281079,0.00574483462882842,-0.00635824576969291,0.0161615059753145,0.393550750157017
NMR metabolomics,X23495.Concentration of Large VLDL Particles,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,37714,0.00515234902247511,0.00604053788343123,-0.00668710522905011,0.0169918032740003,0.393695804773957
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AMIGO1,Amphoterin-induced protein 1,37572,0.00407477758011716,0.00478029220707047,-0.00529459514574095,0.0134441503059753,0.394001121766235
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",37562,-0.00494800290550574,0.0058238427104394,-0.016362734617967,0.00646672880695549,0.395556710440885
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,39980,0.0101995971605076,0.0120672408098989,-0.0134521948268942,0.0338513891479093,0.397995310087984
NMR metabolomics,X23495.Concentration of Large VLDL Particles,UNC5D,Netrin receptor UNC5D,37598,0.00216013704363889,0.00256025094750992,-0.00285795481348055,0.00717822890075834,0.398840779312265
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VWC2L,von Willebrand factor C domain-containing protein 2-like,37959,0.00380053555140401,0.00451755328060638,-0.00505386887858449,0.0126549399813925,0.400204953219159
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCND2,G1/S-specific cyclin-D2,37714,0.0029454565289333,0.0035118168084053,-0.00393770441554109,0.0098286174734077,0.401637488044953
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,40374,0.00454947837151908,0.00543201721413976,-0.00609727536819486,0.015196232111233,0.402307189645207
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GPHA2,Glycoprotein hormone alpha-2,37901,0.00391186433120844,0.0046826171311879,-0.00526606524591984,0.0130897939083367,0.403506651362489
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ITGAV,Integrin alpha-V,40489,-0.00129715960426752,0.00155892467237584,-0.00435265196212416,0.00175833275358913,0.405372717665387
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD3E,T-cell surface glycoprotein CD3 epsilon chain,37714,0.00287428230489657,0.00345497297489117,-0.00389746472589012,0.00964602933568327,0.405465619453294
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CNTF,Ciliary neurotrophic factor,37541,-0.00269560422587329,0.00324536929526418,-0.00905652804459109,0.0036653195928445,0.406214699452628
NMR metabolomics,X23495.Concentration of Large VLDL Particles,THBS2,Thrombospondin-2,40332,-0.00283228063143869,0.00341068730750905,-0.00951722775415642,0.00385266649127904,0.406317544876446
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CINP,Cyclin-dependent kinase 2-interacting protein,37714,0.00356745297568477,0.00430441724886128,-0.00486920483208334,0.0120041107834529,0.407238820189401
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CHEK2,Serine/threonine-protein kinase Chk2,40042,-0.00265976025118496,0.00321595389428168,-0.00896302988397705,0.00364350938160712,0.408220396623689
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KLK15,Kallikrein-15,37880,0.00404729846356471,0.00489865458031996,-0.00555406451386241,0.0136486614409918,0.408701848479946
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,40276,0.00473235473962993,0.00572841429143774,-0.00649533727158804,0.0159600467508479,0.408748763308686
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BTN1A1,Butyrophilin subfamily 1 member A1,37883,0.00331867745705093,0.00402531102109719,-0.00457093214429957,0.0112082870584014,0.40969717483951
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TBR1,T-box brain protein 1,37572,0.00382774146457898,0.00466890136577993,-0.00532330521234969,0.0129787881415077,0.412323516156002
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,37457,-0.00403352992698663,0.00492127812126354,-0.0136792350446632,0.00561217519068991,0.412453356075177
NMR metabolomics,X23495.Concentration of Large VLDL Particles,S100A16,Protein S100-A16,39934,0.00485586881723074,0.00592654164895379,-0.00676015281471868,0.0164718904491802,0.412603511908943
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NEB,Nebulin,37562,0.00285078564070357,0.00348810809410319,-0.00398590622373869,0.00968747750514582,0.413779246719565
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DLGAP5,Disks large-associated protein 5,37959,-0.00415695074998319,0.00513929011045016,-0.0142299593664655,0.00591605786649912,0.418611655393063
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NECTIN4,Nectin-4,40411,0.0023205172339828,0.00291038775357024,-0.00338384276301487,0.00802487723098046,0.425275699377671
NMR metabolomics,X23495.Concentration of Large VLDL Particles,H2AP,Huntingtin-interacting protein M,37482,-0.0039499254126542,0.00499127423308266,-0.0137328229094962,0.00583297208418782,0.428744768879369
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NXPE4,NXPE family member 4,37562,-0.00273078466021566,0.00348374201760936,-0.00955891901473001,0.00409734969429868,0.433133284106226
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HMMR,Hyaluronan mediated motility receptor,37460,-0.00364482703237079,0.00466589228200057,-0.0127899759050919,0.00550032184035034,0.434720266134775
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MMP15,Matrix metalloproteinase-15,37990,0.00371829259192612,0.00476724822647028,-0.00562551393195563,0.0130620991158079,0.435424392666171
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SMPD3,Sphingomyelin phosphodiesterase 3,37598,0.00434685118773843,0.00560994582792693,-0.00664864263499835,0.0153423450104752,0.438443852139009
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MORF4L1,Mortality factor 4-like protein 1,37714,-0.00302761811003558,0.0039129367733108,-0.0106969741857247,0.00464173796565358,0.439094964677772
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TFRC,Transferrin receptor protein 1,40391,-0.00290999742175928,0.00376401874343609,-0.010287474158894,0.00446747931537545,0.439469236835569
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SPESP1,Sperm equatorial segment protein 1,37990,0.00203602433651515,0.00263673985784265,-0.00313198578485645,0.00720403445788674,0.440024324528243
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDSN,Corneodesmosin,40456,-0.0031722577187469,0.00410949366340302,-0.0112268652990168,0.00488234986152302,0.440164940253715
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,40359,-0.0023140829450032,0.00299979819832847,-0.00819368741372699,0.0035655215237206,0.440473706263425
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MTR,Methionine synthase,37562,0.00483204538668585,0.00626838118714673,-0.00745398174012173,0.0171180725134934,0.440803709843275
NMR metabolomics,X23495.Concentration of Large VLDL Particles,STEAP4,Metalloreductase STEAP4,37541,-0.00553112493651109,0.00721836043263837,-0.0196791113844823,0.00861686151146011,0.443536745071635
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IFNL2,Interferon lambda-2,37541,0.00471941708440697,0.00620500132766875,-0.00744238551782378,0.0168812196866377,0.446920016091229
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TEX101,Testis-expressed protein 101,37572,0.00285189036124993,0.00375952078471182,-0.00451677037678524,0.0102205510992851,0.448118567704827
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SPRR1B,Cornifin-B,37714,0.00614105182063108,0.00815929051711925,-0.00985115759292265,0.0221332612341848,0.451676435267651
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KCNH2,Potassium voltage-gated channel subfamily H member 2,37572,-0.00569312210803455,0.00759349265359946,-0.0205763677090895,0.00919012349302039,0.453426585049792
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD3G,T-cell surface glycoprotein CD3 gamma chain,37598,0.00672103696210167,0.00898328008471664,-0.0108861920039429,0.0243282659281463,0.454369913540196
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ATF4,Cyclic AMP-dependent transcription factor ATF-4,37482,-0.00246264888146431,0.00330674310416524,-0.00894386536562818,0.00401856760269956,0.456445083103204
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HLA_A,,37959,0.0023274302420826,0.00312597579652745,-0.0037994823191112,0.0084543428032764,0.456559666288124
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PCARE,Photoreceptor cilium actin regulator,37541,0.00613276665360123,0.00825452669683854,-0.0100461056722023,0.0223116389794048,0.457520442205925
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HEBP1,Heme-binding protein 1,40042,0.00382733899544657,0.00519418484281709,-0.00635326329647494,0.0140079412873681,0.461224205275648
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KLK12,Kallikrein-12,39980,-0.0100603272046076,0.013653721039884,-0.0368216204427803,0.016700966033565,0.461243286415188
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",37541,0.00407550871330768,0.00554935887186652,-0.00680123467555069,0.0149522521021661,0.46271160376634
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PSCA,Prostate stem cell antigen,37901,0.0182342010328911,0.0248499454726543,-0.0304716920935114,0.0669400941592935,0.463100331445208
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RAC3,Ras-related C3 botulinum toxin substrate 3,37572,-0.00492218011154976,0.00670869278383713,-0.0180712179678705,0.00822685774477102,0.463143598734487
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRG3,Proteoglycan 3,37998,-0.00350049715054883,0.0047871119074969,-0.0128832364892427,0.00588224218814509,0.464649118813568
NMR metabolomics,X23495.Concentration of Large VLDL Particles,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,37482,0.00395159405203438,0.00540728302235983,-0.00664668067179089,0.0145498687758596,0.464919929457735
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNNI3,"Troponin I, cardiac muscle",40042,0.0058719305624363,0.00807255551492904,-0.00995027824682463,0.0216941393716972,0.466995391451002
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TXNDC15,Thioredoxin domain-containing protein 15,40411,0.00184631348435204,0.00258773176758154,-0.00322564078010778,0.00691826774881187,0.47555476635961
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RAP1A,Ras-related protein Rap-1A,37598,0.00470388915131794,0.00667699932856642,-0.00838302953267224,0.0177908078353081,0.481139232669418
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MYBPC2,"Myosin-binding protein C, fast-type",37628,-0.00554067661093559,0.00789699645991854,-0.0210187896723759,0.00993743645050475,0.482929677080793
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PITHD1,PITH domain-containing protein 1,37457,-0.00539289940658687,0.00786256102308392,-0.0208035190118314,0.0100177201986576,0.492790899494196
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ANPEP,Aminopeptidase N,40370,0.00184443032973493,0.00269189297794306,-0.00343167990703347,0.00712054056650333,0.493240531136072
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SLC39A14,Zinc transporter ZIP14,39961,0.00217670703734471,0.00318437777841951,-0.00406467340835754,0.00841808748304695,0.494264499460976
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KCNC4,Potassium voltage-gated channel subfamily C member 4,37541,0.00372237966791109,0.00547567230491798,-0.00700993804972814,0.0144546973855503,0.49664108943197
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DOC2B,Double C2-like domain-containing protein beta,37572,0.00232680489337974,0.00344720278305889,-0.00442971256141569,0.00908332234817517,0.499698162037308
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CGN,Cingulin,37572,0.00270740771636118,0.004017007019686,-0.00516592604222339,0.0105807414749457,0.500331894667092
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HK2,Hexokinase-2,40042,-0.00176613801265689,0.00263745911979964,-0.00693555788746419,0.0034032818621504,0.503099670533904
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LY96,Lymphocyte antigen 96,40228,0.0022104183648473,0.00330612745817261,-0.00426959145317102,0.00869042818286561,0.503771736230526
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,37901,-0.00192279976362984,0.00287905995535374,-0.00756575727612317,0.00372015774886349,0.504236466710979
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SMC3,Structural maintenance of chromosomes protein 3,37482,0.00356322056366639,0.00534620030398356,-0.00691533203214139,0.0140417731594742,0.505105986239796
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SEPTIN3,Neuronal-specific septin-3,37959,-0.00468548389102185,0.00704815999909872,-0.0184998774892553,0.00912890970721165,0.50620183203229
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TMED4,Transmembrane emp24 domain-containing protein 4,37562,-0.00363036467863142,0.00555502508271124,-0.0145182138407455,0.00725748448348261,0.513427377389708
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MYL4,Myosin light chain 4,37628,-0.00328639089214393,0.00502899868005765,-0.0131432283050569,0.00657044652076907,0.513453049288262
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL21R,Interleukin-21 receptor,37598,0.00350268353769807,0.00536475421095961,-0.00701223471578277,0.0140176017911789,0.513827898561801
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DPP10,Inactive dipeptidyl peptidase 10,40341,0.00211622011567389,0.00324141637766634,-0.00423695598455214,0.00846939621589991,0.513850212004273
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SAP18,Histone deacetylase complex subunit SAP18,37714,0.00466191537050648,0.00715071741642526,-0.00935349076568702,0.0186773215067,0.514444261670863
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ENOPH1,Enolase-phosphatase E1,37900,0.00356009631491558,0.00548284612365977,-0.00718628208745757,0.0143064747172887,0.516145635813249
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MFAP3L,Microfibrillar-associated protein 3-like,37572,0.00416563625322205,0.00642653539625266,-0.00843037312343316,0.0167616456298773,0.516871372137674
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLEC2L,C-type lectin domain family 2 member L,37572,0.00307403212698183,0.00474969769437292,-0.00623537535398909,0.0123834396079527,0.517510049784017
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SCN3A,Sodium channel protein type 3 subunit alpha,37572,-0.00238090106800414,0.00371290270819861,-0.00965819037607343,0.00489638824006514,0.52137108412521
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CAPN3,Calpain-3,37900,0.00227666838912093,0.0035510627230251,-0.00468341454800826,0.00923675132625012,0.521453623771934
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RAB6B,Ras-related protein Rab-6B,39961,0.002965438723964,0.00465096988524245,-0.0061504622511112,0.0120813396990392,0.523746262684557
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL13,Interleukin-13,40044,0.00291417722017295,0.00457401500965444,-0.00605089219874975,0.0118792466390957,0.524058773530484
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DHODH,Dihydroorotate dehydrogenase,37562,0.00293910940994126,0.00463055618041857,-0.00613678070367914,0.0120149995235616,0.525621730238315
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ALMS1,Alstrom syndrome protein 1,37714,0.00273543652411683,0.00431455269592018,-0.00572108675988672,0.0111919598081204,0.526090226852991
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ITGB5,Integrin beta-5,40411,-0.00223478854702944,0.0035274426779625,-0.00914857619583594,0.00467899910177706,0.526387831778802
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PLXDC1,Plexin domain-containing protein 1,39980,0.00204570251257084,0.00323639992430167,-0.00429764133906043,0.00838904636420212,0.527336066141475
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PLB1,"Phospholipase B1, membrane-associated",37942,-0.00365817545326295,0.0057984882343333,-0.0150232123925562,0.00770686148603032,0.528126836448669
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ABO,Histo-blood group ABO system transferase,37987,-0.00865932133492881,0.0137811421412902,-0.0356703599318576,0.018351717262,0.529788105744091
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,37628,-0.00244374212852938,0.00388983078166144,-0.0100678104605858,0.00518032620352705,0.529858488475474
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NOS1,"Nitric oxide synthase, brain",39961,0.0029648277015231,0.00475414431305072,-0.00635329515205631,0.0122829505551025,0.53287968102334
NMR metabolomics,X23495.Concentration of Large VLDL Particles,STC2,Stanniocalcin-2,40309,0.00161296121191054,0.00258713498254029,-0.00345782335386843,0.0066837457776895,0.532994793331607
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SELL,L-selectin,38013,0.00137149919489804,0.00221289272736363,-0.00296577055073467,0.00570876894053075,0.535415270556216
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRND,Prion-like protein doppel,37942,-0.00317279809407522,0.00513189020737792,-0.0132313029005359,0.00688570671238551,0.536420097678287
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ANKRA2,Ankyrin repeat family A protein 2,37482,0.00333546761008915,0.00540712315620276,-0.00726249377606825,0.0139334289962466,0.537334236798518
NMR metabolomics,X23495.Concentration of Large VLDL Particles,UGDH,UDP-glucose 6-dehydrogenase,37562,0.0056219902535405,0.00930947149485352,-0.0126245738763724,0.0238685543834534,0.545920548096607
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PXDNL,Peroxidasin-like protein,37900,0.00337142155728919,0.00560357071641989,-0.0076115770468938,0.0143544201614722,0.547413332288053
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CHGB,Secretogranin-1,40406,-0.00227345498298168,0.00384069071424549,-0.00980120878290284,0.00525429881693948,0.553899761619399
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,40400,0.00360233020180664,0.00609112759015285,-0.00833627987489294,0.0155409402785062,0.554256715661123
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ARG2,"Arginase-2, mitochondrial",37900,0.0024894933251076,0.00425197873602122,-0.00584438499749398,0.0108233716477092,0.558227750320015
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADGRV1,Adhesion G-protein coupled receptor V1,37541,-0.003935255363663,0.00680458807435312,-0.0172722479893951,0.00940173726206911,0.563055465825443
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,37564,0.00209754306923975,0.00365594661640209,-0.00506811229890834,0.00926319843738784,0.566157251356985
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PDIA2,Protein disulfide-isomerase A2,37482,-0.00227730410957282,0.00398330791832406,-0.010084587629488,0.00552997941034234,0.567527105836865
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TLR1,Toll-like receptor 1,37598,0.00141617940992784,0.00250651787679237,-0.00349659562858521,0.00632895444844089,0.572084271091894
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,39980,0.00650068512164964,0.0115517476931571,-0.0161407403569382,0.0291421106002375,0.573616846068849
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CRYBB2,Beta-crystallin B2,37942,-0.0036966560155466,0.00657170142470843,-0.0165771908079751,0.00918387877688192,0.57377708465519
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CEP350,Centrosome-associated protein 350,37482,0.00201838082984073,0.00358995536714006,-0.00501793168975378,0.00905469334943524,0.573968953119347
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HDAC9,Histone deacetylase 9,37541,-0.00336924373368063,0.00607693654222621,-0.015280039356444,0.00854155188908275,0.579293193289537
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ERCC1,DNA excision repair protein ERCC-1,37482,0.0017542330695211,0.00321741927187041,-0.00455190870334489,0.0080603748423871,0.585604767290654
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ITGB1,Integrin beta-1,40333,0.00113369310813134,0.00208376667390178,-0.00295048957271614,0.00521787578897883,0.58640814929007
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL17F,Interleukin-17F,40044,0.00411067752593834,0.00758518867222598,-0.0107562922716246,0.0189776473235013,0.587871182892507
NMR metabolomics,X23495.Concentration of Large VLDL Particles,OMP,Olfactory marker protein,37541,0.00263021431535999,0.00485348617788418,-0.00688261859329301,0.012143047224013,0.587880985728117
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PTPRF,Receptor-type tyrosine-protein phosphatase F,40536,0.00148571929469136,0.00275677978509711,-0.00391756908409897,0.00688900767348168,0.589940621445737
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CBLN1,Cerebellin-1,37541,-0.00504744373517228,0.00940486558716032,-0.0234809802860065,0.013386092815662,0.591494821899243
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AREG,Amphiregulin,40305,0.00251998632230571,0.00471225826359883,-0.006716039874348,0.0117560125189594,0.592814653488991
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD82,CD82 antigen,37714,-0.00214195576264322,0.00400906912099738,-0.00999973123979808,0.00571581971451164,0.593158454622884
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,40042,-0.00163042681606987,0.0030564317682592,-0.00762103308185789,0.00436017944971816,0.593735766550528
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL22,Interleukin-22,37900,0.00332149846901963,0.00623815476214946,-0.0089052848647933,0.0155482818028326,0.594423940727159
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TPPP2,Tubulin polymerization-promoting protein family member 2,37714,-0.00419255116559149,0.00789390496333954,-0.019664604893737,0.011279502562554,0.595349755099714
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DBH,Dopamine beta-hydroxylase,37967,-0.00534017702538795,0.0100845306200918,-0.0251058570407679,0.014425502989992,0.596438592351732
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NLGN1,Neuroligin-1,37572,-0.0035144829459575,0.00667087347575099,-0.0165893949584295,0.00956042906651445,0.598313613567956
NMR metabolomics,X23495.Concentration of Large VLDL Particles,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,37959,0.00164849721827229,0.00314017180936672,-0.00450623952808649,0.00780323396463106,0.599612391496075
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ARNT,Aryl hydrocarbon receptor nuclear translocator,40044,0.0018747717455373,0.00357788034062705,-0.00513787372209171,0.00888741721316631,0.600293288046519
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CTLA4,Cytotoxic T-lymphocyte protein 4,37998,-0.0014667868457995,0.00282316758992127,-0.00700019532204518,0.00406662163044618,0.603383244003754
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MAPRE3,Microtubule-associated protein RP/EB family member 3,37482,0.00695466156918843,0.013555454163009,-0.0196140285903092,0.0335233517286861,0.607923195642336
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HMCN2,Hemicentin-2,37648,-0.00278673253310057,0.00546610945756724,-0.0135003070699324,0.00792684200373122,0.610186020655759
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ITGB2,Integrin beta-2,40221,0.0013925290106967,0.00273157431954693,-0.00396135665561528,0.00674641467700868,0.610205793830376
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PGM2,Phosphoglucomutase-2,37572,0.00290269041169319,0.00574112729772644,-0.00834991909185063,0.014155299915237,0.613148855505318
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IGLC2,Immunoglobulin lambda constant 2,37978,0.00116675135496114,0.00232083843039083,-0.00338209196860488,0.00571559467852717,0.615163435409757
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,37482,-0.00413991232562186,0.00824442470656444,-0.0202989847504882,0.0120191600992444,0.615572675383625
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HRAS,GTPase Hras,37697,-0.00470055338072008,0.00942436664556592,-0.0231723120060293,0.0137712052445891,0.61795254592082
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,37562,-0.0023443651116225,0.00471284842702633,-0.0115815480285941,0.00689281780534911,0.618886280558801
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CSF2RB,Cytokine receptor common subunit beta,37598,-0.00210474942780391,0.00424087876515052,-0.0104168718074989,0.00620737295189112,0.619690848480751
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DAND5,DAN domain family member 5,37598,-0.00257514870224231,0.00521501832373759,-0.012796584616768,0.00764628721228338,0.621459386592505
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CXCL12,Stromal cell-derived factor 1,40044,0.00189767798543355,0.00387105609846334,-0.0056895919675546,0.0094849479384217,0.623983507356142
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SLC34A3,Sodium-dependent phosphate transport protein 2C,37482,-0.00236575799012138,0.00482998040612062,-0.0118325195861178,0.00710100360587503,0.624278755617253
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RBM25,RNA-binding protein 25,37482,-0.00217153075060642,0.00443790824434217,-0.0108698309095171,0.00652676940830423,0.62462762908086
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SPINT3,Kunitz-type protease inhibitor 3,37901,0.00598780323311606,0.0123070590043314,-0.0181340324153735,0.0301096388816056,0.626596499354118
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ANK2,Ankyrin-2,37562,0.00345833196605009,0.00711207028314054,-0.0104813257889054,0.0173979897210055,0.6267893018637
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ARMCX2,Armadillo repeat-containing X-linked protein 2,37541,0.00306869913103417,0.00638435484889642,-0.00944463637280282,0.0155820346348712,0.630766740307925
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TCP11,T-complex protein 11 homolog,37714,-0.00271385846327151,0.00581922110170595,-0.0141195318226152,0.00869181489607216,0.640964697314112
NMR metabolomics,X23495.Concentration of Large VLDL Particles,S100A3,Protein S100-A3,37900,0.00204481591642953,0.00439269084687919,-0.00656485814345367,0.0106544899763127,0.641577988007465
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",40434,0.00325849718196008,0.00700392137397388,-0.0104691887110287,0.0169861830749489,0.641766671536957
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IKZF2,Zinc finger protein Helios,39980,0.00415333666984719,0.00893367027526141,-0.0133566570696652,0.0216633304093595,0.642003708754158
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MEGF11,Multiple epidermal growth factor-like domains protein 11,37562,0.00144050276022104,0.00311151275142718,-0.00465806223257623,0.0075390677530183,0.643401456591955
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FGF6,Fibroblast growth factor 6,37598,-0.00188936055504053,0.00412038633795632,-0.00996531777743492,0.00618659666735386,0.646572355355052
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EXOSC10,Exosome component 10,37562,0.00275890047746387,0.00601775032224607,-0.00903589015413844,0.0145536911090662,0.646629275214382
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,37541,0.00215286472698843,0.00473943129430526,-0.00713642060984989,0.0114421500638267,0.649659762658168
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FZD8,Frizzled-8,37541,0.00195112131137976,0.00430172548737393,-0.00648026064387315,0.0103825032666327,0.65014793095814
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ARHGEF5,Rho guanine nucleotide exchange factor 5,37541,0.00319851822364394,0.00707420382528038,-0.0106669212739056,0.0170639577211935,0.651176873527747
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,37541,-0.00145920934380445,0.00324639783363806,-0.00782214909773504,0.00490373041012615,0.653088777302634
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RUVBL1,RuvB-like 1,39980,0.00458896540933338,0.0102447312262755,-0.0154907077941666,0.0246686386128333,0.654206939817761
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PKLR,Pyruvate kinase PKLR,40374,0.00282936354569513,0.00633338188614076,-0.00958406495114076,0.015242792042531,0.655070181986415
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL31,Interleukin-31,37598,-0.00248523795419755,0.00557504241849532,-0.0134123210944484,0.00844184518605328,0.655764088613289
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CPLX2,Complexin-2,37482,-0.00132299659406501,0.00296828151503972,-0.00714082836354286,0.00449483517541283,0.655813210841919
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PCNA,Proliferating cell nuclear antigen,37482,0.0026630650991925,0.0059890566934753,-0.00907548602001909,0.0144016162184041,0.656576347341475
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CRISP2,Cysteine-rich secretory protein 2,40489,-0.00258858436082356,0.00583563620782018,-0.0140264313281511,0.00884926260650398,0.657350659889988
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",37572,0.00325585721324417,0.00750544688151624,-0.0114548186745277,0.017966533101016,0.664441360362074
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD164L2,CD164 sialomucin-like 2 protein,37572,0.00152267053901423,0.00352595433242843,-0.00538819995254549,0.00843354103057395,0.665860179932179
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,37482,-0.00249665487684332,0.00580718577693506,-0.013878738999636,0.0088854292459494,0.667257242106276
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MERTK,Tyrosine-protein kinase Mer,40516,-0.0010679811021674,0.00249020319468749,-0.00594877936375489,0.00381281715942009,0.668021346289143
NMR metabolomics,X23495.Concentration of Large VLDL Particles,COL3A1,Collagen alpha-1(III) chain,37998,-0.000946995958978852,0.0022085650732172,-0.00527578350248457,0.00338179158452687,0.668087705847808
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ENPEP,Glutamyl aminopeptidase,37562,-0.00189594066100785,0.0044425852882442,-0.0106034078259665,0.00681152650395078,0.669557386244332
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TXK,Tyrosine-protein kinase TXK,37714,0.00305485500243762,0.00726467630244811,-0.0111839105503607,0.0172936205552359,0.674121149443466
NMR metabolomics,X23495.Concentration of Large VLDL Particles,COL4A4,Collagen alpha-4(IV) chain,37688,-0.00211056726273427,0.00502506228564988,-0.011959689342608,0.00773855481713949,0.674486295874801
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,37541,0.00242290354593185,0.00578141494177911,-0.00890866973995521,0.0137544768318189,0.675160982732892
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ZNF830,Zinc finger protein 830,37900,-0.0032329766081514,0.00772683855037781,-0.0183775801668919,0.0119116269505891,0.675654995327102
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CASQ2,Calsequestrin-2,37562,-0.0020097455573233,0.00480350721181283,-0.0114246196924764,0.00740512857782984,0.675667910310863
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EDDM3B,Epididymal secretory protein E3-beta,37900,-0.00170189497410772,0.00408287818664804,-0.00970433621993787,0.00630054627172243,0.676804240132997
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDH4,Cadherin-4,37541,0.00197161468943307,0.00474574154236969,-0.00733003873361151,0.0112732681124777,0.677819881194
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,40471,0.00186171280169993,0.0045169857908539,-0.00699157934837371,0.0107150049517736,0.680228976631007
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLEC1A,C-type lectin domain family 1 member A,40042,-0.00128101648619495,0.00314926340836178,-0.00745357276658404,0.00489153979419413,0.684184696752649
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD70,CD70 antigen,40341,-0.00160362988778938,0.00395828429996308,-0.00936186711571701,0.00615460734013826,0.685385521655669
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CYTH3,Cytohesin-3,37482,0.00282735039815842,0.00706616177841685,-0.0110223266875386,0.0166770274838554,0.689070758963018
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDC123,Cell division cycle protein 123 homolog,37482,0.00245408596627512,0.00614063165430486,-0.0095815520761624,0.0144897240087126,0.689422970730988
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AXL,Tyrosine-protein kinase receptor UFO,40403,0.00103954301286315,0.0026189272504116,-0.00409355439794359,0.00617264042366989,0.691420950589478
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,40365,-0.00184328369130922,0.00471101550469862,-0.0110768740805185,0.00739030669790007,0.695602179814059
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LMOD2,Leiomodin-2,37541,0.00243555551690539,0.00622980183352759,-0.00977485607680869,0.0146459671106195,0.695838838439749
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SERPINB5,Serpin B5,40042,-0.00179526377841076,0.00465242432405107,-0.0109140154535509,0.00732348789672935,0.699592992795779
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MED21,Mediator of RNA polymerase II transcription subunit 21,37562,0.00178582576600713,0.00465866206932407,-0.00734515188986804,0.0109168034218823,0.701477998192683
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL9,Interleukin-9,37714,0.00210733393422817,0.00550423763180448,-0.0086809718241086,0.012895639692565,0.701832197218959
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HSP90B1,Endoplasmin,39878,-0.00255293127379742,0.00669284475578609,-0.0156709069951382,0.0105650444475433,0.702880644880725
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MLLT1,Protein ENL,37482,0.00260899765638389,0.00686238169477663,-0.0108412704653783,0.0160592657781461,0.70381179444086
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TPSG1,Tryptase gamma,37598,-0.000975866296892986,0.00261434660318235,-0.0060999856391304,0.00414825304534443,0.708950918936963
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VNN2,Vascular non-inflammatory molecule 2,40305,0.00158636077986592,0.00427462301690115,-0.00679190033326034,0.00996462189299217,0.710559615715985
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ZNF174,Zinc finger protein 174,37598,-0.00137933476074968,0.00371847811279429,-0.00866755186182648,0.00590888234032712,0.710687699937391
NMR metabolomics,X23495.Concentration of Large VLDL Particles,REG1A,Lithostathine-1-alpha,40274,0.0017115550002187,0.00464536187211134,-0.00739335426911952,0.0108164642695569,0.712547237318516
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",37562,0.00236679521010221,0.00643642295129107,-0.0102485937744283,0.0149821841946327,0.71308868487096
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,37900,-0.00269274943111604,0.00744008483595995,-0.0172753157095975,0.0118898168473655,0.717414092646835
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BCL7A,B-cell CLL/lymphoma 7 protein family member A,37482,0.00218743336596638,0.00610051618819142,-0.00976957836288881,0.0141444450948216,0.719926124788971
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IGFBP7,Insulin-like growth factor-binding protein 7,40536,0.000987498311367409,0.00280778141628061,-0.00451575326454259,0.00649074988727741,0.725067443832069
NMR metabolomics,X23495.Concentration of Large VLDL Particles,THY1,Thy-1 membrane glycoprotein,40471,0.000937393102193506,0.00266763635760851,-0.00429117415871917,0.00616596036310618,0.725296928863391
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CEND1,Cell cycle exit and neuronal differentiation protein 1,37541,-0.00194011953568476,0.00553207412433196,-0.0127829848193754,0.00890274574800589,0.725816202267003
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",37598,-0.000940369403735353,0.0026985053462366,-0.0062294398823591,0.00434870107488839,0.727486908721877
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,39980,-0.00252906653581936,0.00731883233149694,-0.0168739779055534,0.0118158448339146,0.729681087575674
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PMCH,Pro-MCH,37562,-0.00279827073077873,0.00813903340706894,-0.0187507762086339,0.0131542347470764,0.730995648906941
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",37598,0.00158813984168262,0.0046482185766424,-0.00752236856853648,0.0106986482519017,0.732607465103892
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SHC1,SHC-transforming protein 1,37482,0.0037991507813079,0.0111868641252132,-0.01812710290411,0.0257254044667258,0.73415707618318
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BTNL10,Butyrophilin-like protein 10,37482,0.00133845941738044,0.00400911220521531,-0.00651940050484157,0.00919631933960245,0.738494865990553
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,37714,-0.00202565864244859,0.00610842313348603,-0.0139981679840812,0.00994685069918403,0.740183512523045
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FGF3,Fibroblast growth factor 3,37598,0.00096181543944813,0.00291867563689667,-0.00475878880886935,0.00668241968776561,0.741754091838632
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CTSV,Cathepsin L2,40444,-0.0013156634229972,0.00404291135757537,-0.00923976968384493,0.00660844283785053,0.744863882671603
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LAYN,Layilin,40192,0.00106517792318488,0.00327394455672129,-0.00535175340798885,0.00748210925435862,0.744920503112282
NMR metabolomics,X23495.Concentration of Large VLDL Particles,UPK3A,Uroplakin-3a,37541,0.00154672398749384,0.00479751998022088,-0.00785641517373909,0.0109498631487268,0.747154273580087
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MRPL28,"39S ribosomal protein L28, mitochondrial",37959,0.0011119364834093,0.00352905809344337,-0.00580501737973971,0.0080288903465583,0.752705595808594
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PSMA1,Proteasome subunit alpha type-1,39980,-0.00138161688364815,0.00443998944746773,-0.0100839962006849,0.0073207624333886,0.755671222204715
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TPT1,Translationally-controlled tumor protein,40044,0.00197043315172348,0.00634203562289378,-0.0104599566691483,0.0144008229725953,0.756037323811654
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNPO1,Transportin-1,37714,-0.00104577249650296,0.00339684341615369,-0.0077035855921642,0.00561204059915828,0.758189154952417
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PPT1,Palmitoyl-protein thioesterase 1,37572,0.0022593204380727,0.00747240922109712,-0.0123866016352777,0.0169052425114231,0.762386232884745
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",37482,-0.00161053953682231,0.00537781659162238,-0.0121510600564022,0.00892998098275756,0.764579879855542
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MORC3,MORC family CW-type zinc finger protein 3,37942,0.000807599894168384,0.00270154887013846,-0.004487435891303,0.00610263567963977,0.764990748820738
NMR metabolomics,X23495.Concentration of Large VLDL Particles,THSD1,Thrombospondin type-1 domain-containing protein 1,37500,0.000987220855228596,0.00330444661578099,-0.00548949451170214,0.00746393622215933,0.765131536752693
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TP53INP1,Tumor protein p53-inducible nuclear protein 1,40042,0.000930820826324209,0.00313696989459838,-0.00521764016708861,0.00707928181973703,0.766679585918061
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TP73,Tumor protein p73,37572,0.000991152755838423,0.00334660237922032,-0.0055681879074334,0.00755049341911024,0.767107334991014
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EFNB2,Ephrin-B2,37572,0.00163314056585757,0.00554181156907682,-0.00922881010953301,0.0124950912412481,0.768232041144633
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PSMD5,26S proteasome non-ATPase regulatory subunit 5,37572,0.00159820636068322,0.00545943813573281,-0.00910229238535308,0.0122987051067195,0.769724060487015
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NGFR,Tumor necrosis factor receptor superfamily member 16,37990,-0.000803193729021488,0.00282056194015924,-0.00633149513173361,0.00472510767369063,0.775829519837272
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FGF7,Fibroblast growth factor 7,37482,0.00219632574794572,0.00776228115390598,-0.01301774531371,0.0174103968096014,0.77722081613224
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TPBGL,Trophoblast glycoprotein-like,37572,0.00113064867543387,0.00399676199574328,-0.00670300483622295,0.00896430218709069,0.777264726798542
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ESR1,Estrogen receptor,37598,0.00154867021727098,0.00557610093690323,-0.00938048761905935,0.0124778280536013,0.781221284242014
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCDC50,Coiled-coil domain-containing protein 50,37959,0.00203149444704831,0.00749917525976521,-0.0126668890620915,0.0167298779561881,0.786475379878691
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RICTOR,Rapamycin-insensitive companion of mTOR,37598,0.00126698286887208,0.00483539150760029,-0.00821038448602448,0.0107443502237686,0.793307962125877
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,37562,0.00163586105718742,0.00631931574268091,-0.0107499977984672,0.014021719912842,0.795742077557805
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FOLR3,Folate receptor gamma,40355,-0.00451378320458513,0.0175515114061933,-0.038914745560724,0.0298871791515537,0.797048185485339
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ARID3A,AT-rich interactive domain-containing protein 3A,37541,-0.000987708239835837,0.00385028214685032,-0.00853426124766246,0.00655884476799078,0.797546580626576
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MB,Myoglobin,40536,0.00119586708408631,0.00467641495445083,-0.00796990622663731,0.0103616403948099,0.798167967440633
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL4,Interleukin-4,40044,0.00217729140871225,0.00856668605090856,-0.0146134132510685,0.018967996068493,0.799376882688415
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MFAP3,Microfibril-associated glycoprotein 3,40042,0.0011964235172057,0.00474683923003228,-0.00810738137365757,0.010500228408069,0.801008557880968
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GIPR,Gastric inhibitory polypeptide receptor,37598,0.00115272978476468,0.00468648327894253,-0.00803277744196267,0.010338237011492,0.805710040263878
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL20RB,Interleukin-20 receptor subunit beta,37598,0.000993399798499084,0.00408737972463326,-0.00701786446178211,0.00900466405878027,0.807977628341378
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SHD,SH2 domain-containing adapter protein D,37531,0.00200079680151924,0.00841049294787747,-0.0144837693763206,0.0184853629793591,0.811967866463364
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PGR,Progesterone receptor,37598,-0.00233333850389998,0.00991816858415115,-0.0217729489288362,0.0171062719210363,0.814011373443875
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GUCY2C,Heat-stable enterotoxin receptor,37714,-0.00190519903380396,0.00812760194716482,-0.017835298850247,0.0140249007826391,0.814669563812876
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BRD2,Bromodomain-containing protein 2,37541,-0.000767413535663218,0.00330995062587579,-0.00725491676237977,0.00572008969105334,0.816657797013966
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ZP3,Zona pellucida sperm-binding protein 3,37628,-0.00581724018963175,0.0251162045399068,-0.055045001087849,0.0434105207085855,0.816842184300429
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL4R,Interleukin-4 receptor subunit alpha,40341,0.000798460519052501,0.00345509558853932,-0.00597352683448457,0.00757044787258958,0.817242804907417
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,37562,-0.00119620006593251,0.00517982940408035,-0.01134866569793,0.00895626556606498,0.817369478720416
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL2RB,Interleukin-2 receptor subunit beta,40044,0.000827829793159803,0.00370219064531381,-0.00642846387165526,0.00808412345797487,0.823067296600974
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TET2,Methylcytosine dioxygenase TET2,37697,0.00214133927426181,0.00964259736674753,-0.0167581515645633,0.021040830113087,0.82426219538331
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KRT14,"Keratin, type I cytoskeletal 14",39530,0.000599279569275679,0.00272477181899962,-0.00474127319596357,0.00593983233451493,0.825922788705919
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,39980,0.000745889523111944,0.00339937002794028,-0.005916875731651,0.00740865477787489,0.826325832836468
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EDA2R,Tumor necrosis factor receptor superfamily member 27,40489,-0.000738785674362474,0.0033778660569872,-0.00735940314605739,0.00588183179733245,0.82687583846498
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NCLN,Nicalin,40044,-0.00110832103889566,0.00509298568141796,-0.0110905729744749,0.00887393089668354,0.827730267034437
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FOS,Proto-oncogene c-Fos,37457,0.000731668840154016,0.0033631525784117,-0.00586011021353291,0.00732344789384094,0.827779683894743
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HCG22,Protein PBMUCL2,37562,-0.00108393877761122,0.00511651829460965,-0.0111123146350461,0.0089444370798237,0.832226685198817
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ART5,Ecto-ADP-ribosyltransferase 5,37541,0.00128225411462711,0.00609949335357377,-0.0106727528583775,0.0132372610876317,0.833496860017228
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MZB1,Marginal zone B- and B1-cell-specific protein,40405,-0.000996069372900376,0.00485555344158089,-0.0105129541183989,0.00852081537259817,0.83746517930636
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDC25A,M-phase inducer phosphatase 1,37482,-0.000798561748991149,0.00392355190874974,-0.00848872349014065,0.00689159999215835,0.838723733234949
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",37959,0.000828443706441097,0.0040752166211689,-0.00715898087104995,0.00881586828393215,0.838912791379301
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HBZ,Hemoglobin subunit zeta,37990,0.00203538004619111,0.0100321551491204,-0.0176276440460848,0.021698404138467,0.839227480839501
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AMY2A,Pancreatic alpha-amylase,39695,0.000898158198572421,0.00449508408191323,-0.0079122066019775,0.00970852299912234,0.841632637500432
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TGM2,Protein-glutamine gamma-glutamyltransferase 2,40333,0.00140884026934055,0.00706823437183497,-0.012444899099456,0.0152625796381371,0.842015009843981
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,37562,-0.000487466179539939,0.00245757034111186,-0.00530430404811918,0.0043293716890393,0.842772048986005
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IMPG1,Interphotoreceptor matrix proteoglycan 1,37541,-0.000567513978437876,0.00287325261847856,-0.00619908911065586,0.00506406115378011,0.843426661650152
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,37572,-0.000778809354237236,0.00395446712796145,-0.00852956492504168,0.00697194621656721,0.843874257128617
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KHDC3L,KH domain-containing protein 3,37482,-0.00124228994534225,0.00653425990493783,-0.0140494393590204,0.0115648594683359,0.849218485245926
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FGF20,Fibroblast growth factor 20,37598,-0.000801633351713794,0.00428232965548498,-0.00919499947646435,0.00759173277303676,0.851510148318041
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PCDH17,Protocadherin-17,40359,0.000615512863782271,0.00331675177166094,-0.00588532060867317,0.00711634633623771,0.852778852920757
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VASN,Vasorin,40116,0.000469504455400088,0.00261372953681951,-0.00465340543676615,0.00559241434756633,0.857445308944745
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LRP2BP,LRP2-binding protein,37572,0.00148381869290457,0.00831423715123194,-0.01481208612351,0.0177797235093192,0.858358827304875
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DDX4,Probable ATP-dependent RNA helicase DDX4,37598,-0.000938650532393507,0.00525956821288171,-0.0112474042296417,0.00937010316485465,0.858360303381355
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RNASE10,Inactive ribonuclease-like protein 10,37628,-0.000827630152688842,0.00467084693627138,-0.00998249014778074,0.00832722984240305,0.859361405641935
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PROK1,Prokineticin-1,40341,0.00115976907336403,0.00655702314161137,-0.0116919962841943,0.0140115344309223,0.859609356971548
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RNF4,E3 ubiquitin-protein ligase RNF4,37714,-0.00113315154620625,0.00643469802245307,-0.0137451596702143,0.0114788565778018,0.860217920217617
NMR metabolomics,X23495.Concentration of Large VLDL Particles,WFDC12,WAP four-disulfide core domain protein 12,40465,0.00106979749415529,0.00608307112235788,-0.0108530219056661,0.0129926168939767,0.860402460097882
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RANGAP1,Ran GTPase-activating protein 1,39980,-0.000835215770582182,0.00474958620940299,-0.010144404741012,0.00847397319984767,0.860413909069542
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RNF168,E3 ubiquitin-protein ligase RNF168,37598,-0.000670774782102721,0.00393033007361814,-0.00837422172639428,0.00703267216218883,0.864488811061536
NMR metabolomics,X23495.Concentration of Large VLDL Particles,INSL3,Insulin-like 3,37942,-0.000957997522044473,0.00570507276427107,-0.0121399401400158,0.0102239450959268,0.866648498126379
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MAGEA3,Melanoma-associated antigen 3,37714,0.00131069034180802,0.00809436645401062,-0.0145542679080528,0.0171756485916688,0.871366404127077
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MAG,Myelin-associated glycoprotein,37572,0.000720193477533773,0.00446122432808651,-0.00802380620551579,0.00946419316058334,0.871754042009945
NMR metabolomics,X23495.Concentration of Large VLDL Particles,UPK3BL1,Uroplakin-3b-like protein 1,37692,0.000851772577232595,0.00533579626259044,-0.00960638809744467,0.0113099332519099,0.873172113304978
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD34,Hematopoietic progenitor cell antigen CD34,40408,0.000362557061139322,0.00231026287528303,-0.00416555817441541,0.00489067229669406,0.875299440464583
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EPHA10,Ephrin type-A receptor 10,39961,0.000976836529752615,0.00623144469754639,-0.0112367950774383,0.0131904681369435,0.875436638514415
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PALLD,Palladin,37598,-0.000620612678644473,0.00397664846280725,-0.00841484366574668,0.00717361830845773,0.875984770007034
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KIRREL1,Kin of IRRE-like protein 1,37541,0.0009082123227918,0.00591571622531042,-0.0106865914788166,0.0125030161244002,0.877986378418372
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IGFL4,Insulin growth factor-like family member 4,37598,-0.00112952134556354,0.00753953663430122,-0.0159070131487939,0.0136479704576669,0.880914373018689
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL18RAP,Interleukin-18 receptor accessory protein,40128,0.00249325922778498,0.0166650682948638,-0.030170274630148,0.035156793085718,0.881074320430323
NMR metabolomics,X23495.Concentration of Large VLDL Particles,C1GALT1C1,C1GALT1-specific chaperone 1,37562,0.000469371425599279,0.00314195042558502,-0.00568885140854737,0.00662759425974592,0.881249342174933
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SERPINA11,Serpin A11,40536,-0.000543408507704406,0.0038234314561411,-0.00803733416174096,0.00695051714633215,0.886982367404556
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLINT1,Clathrin interactor 1,37482,-0.000623430617729819,0.00439911540635859,-0.00924569681419266,0.00799883557873303,0.887305525519741
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",40411,0.000452403276672204,0.00330630946441967,-0.00602796327359035,0.00693276982693476,0.891166668344564
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LELP1,Late cornified envelope-like proline-rich protein 1,37541,0.000936256910877582,0.00724111910716163,-0.0132563365391592,0.0151288503609144,0.897124420552837
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HTR1A,5-hydroxytryptamine receptor 1A,37541,-0.000994130766785333,0.00775291081671196,-0.0161898359675408,0.0142015744339701,0.897971479935356
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AMY2B,Alpha-amylase 2B,39311,-0.000587520950754602,0.00460264127693559,-0.00960869785354835,0.00843365595203915,0.898428755341611
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SMPD1,Sphingomyelin phosphodiesterase,40380,0.00056811856748384,0.00452717059074929,-0.00830513579038478,0.00944137292535246,0.90013653786459
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SKIV2L,Helicase SKI2W,37562,-0.000468759394938369,0.0038876591293224,-0.00808857128841027,0.00715105249853353,0.90402852178314
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TFAP2A,Transcription factor AP-2-alpha,37541,-0.000631092178943987,0.00581169065427227,-0.0120220058613176,0.0107598215034297,0.913529262935758
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NOS2,"Nitric oxide synthase, inducible",37562,0.000396446676243453,0.00376309686689513,-0.00697922318287099,0.0077721165353579,0.916098768902531
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TMED1,Transmembrane emp24 domain-containing protein 1,37714,-0.000514011227812774,0.00520764459223153,-0.0107209946285866,0.00969297217296103,0.921375413364357
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TMPRSS11B,Transmembrane protease serine 11B,37541,-0.000741099931690641,0.00752926865021156,-0.0154984664861053,0.014016266622724,0.921592991811865
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SEMA4C,Semaphorin-4C,40305,-0.000261659304544043,0.00269636035671454,-0.00554652560370454,0.00502320699461645,0.922694531622868
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SUSD4,Sushi domain-containing protein 4,37900,-0.000406616540280735,0.00426581986329619,-0.00876762347234126,0.00795439039177979,0.92406233986399
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SLAMF1,Signaling lymphocytic activation molecule,40044,-0.000522684280331591,0.00567217892691912,-0.0116401549770931,0.0105947864164299,0.926581028580035
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FH,"Fumarate hydratase, mitochondrial",37541,0.000712990988228675,0.0081995856632236,-0.0153581969116896,0.0167841788881469,0.930708997605927
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LYPD1,Ly6/PLAUR domain-containing protein 1,39961,-0.000526791360497733,0.00625537100041908,-0.0127873185213191,0.0117337358003237,0.932887177651176
NMR metabolomics,X23495.Concentration of Large VLDL Particles,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,37671,0.000300951747586658,0.00367343160961465,-0.00689897420725806,0.00750087770243138,0.934706325305539
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IGLON5,IgLON family member 5,37482,-0.000705097510315762,0.00902314105971921,-0.0183904539873654,0.0169802589667339,0.937715308770295
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VSTM2B,V-set and transmembrane domain-containing protein 2B,37714,0.000281781865190387,0.00394304229072723,-0.00744658102463499,0.00801014475501576,0.943030301324935
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SLC1A4,Neutral amino acid transporter A,37572,0.000350542428121191,0.00502785500934893,-0.00950405339020271,0.0102051382464451,0.944417525709345
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ECSCR,Endothelial cell-specific chemotaxis regulator,37541,0.000335888998905324,0.00483848879763705,-0.00914754904446329,0.00981932704227394,0.944656188051157
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL3,Interleukin-3,37482,-0.000380687635591015,0.00576677081662645,-0.0116835584361789,0.0109221831649968,0.947367688433467
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KRT6C,"Keratin, type II cytoskeletal 6C",37562,-0.000259593999136734,0.00394405120030423,-0.00798993435173303,0.00747074635345957,0.947522833270904
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PLAU,Urokinase-type plasminogen activator,40332,0.000179928501739055,0.00279802446372541,-0.00530419944716276,0.00566405645064087,0.948727743842823
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CNTNAP2,Contactin-associated protein-like 2,40341,0.000245434952273649,0.00382174840591861,-0.00724519192332683,0.00773606182787413,0.948795387578037
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PODXL2,Podocalyxin-like protein 2,40411,-0.000161549020239295,0.00259870696502847,-0.00525501467169509,0.00493191663121651,0.950432089890585
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,37714,-0.000288778347163514,0.00484072141850095,-0.00977659232742537,0.00919903563309835,0.952430470595182
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MORN4,MORN repeat-containing protein 4,37482,0.00043972732800321,0.00755713013291573,-0.0143722477325116,0.015251702388518,0.953600505013031
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL5,Interleukin-5,40044,0.000804414025101578,0.0139093211365109,-0.0264578554024598,0.028066683452663,0.953882607473295
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KCNIP4,Kv channel-interacting protein 4,39961,0.00028157004591876,0.00489460691074396,-0.0093118594991394,0.00987499959097692,0.954126466365527
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRC1,Protein regulator of cytokinesis 1,37900,0.000249551573788231,0.00446258117422871,-0.00849710752770005,0.00899621067527651,0.955405648586813
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EPGN,Epigen,37900,-0.000260856890042228,0.00473255772450507,-0.00953667003007217,0.00901495624998772,0.95604396626239
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PFDN6,Prefoldin subunit 6,37572,0.000326382652450926,0.00632944445158595,-0.0120793284726575,0.0127320937775594,0.958875482704322
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CTAG1A_CTAG1B,Cancer/testis antigen 1,37687,-0.000247710607351455,0.0048425861019755,-0.00973917936722344,0.00924375815252053,0.959204737218154
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EPB41L5,Band 4.1-like protein 5,37572,-0.000290514509629691,0.00609591716426978,-0.0122385121515985,0.0116574831323391,0.961990148423931
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL2,Interleukin-2,40044,0.000118350342717836,0.00298738895063319,-0.00573693200052321,0.00597363268595888,0.968399260229048
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD177,CD177 antigen,40316,-0.00046786146934234,0.0121749876364273,-0.0243308372367399,0.0233951142980552,0.969346851836361
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SEZ6L,Seizure 6-like protein,40411,-9.10446523202268e-05,0.00261401493412308,-0.00521451392320146,0.00503242461856101,0.972216188052319
NMR metabolomics,X23495.Concentration of Large VLDL Particles,REG3A,Regenerating islet-derived protein 3-alpha,40536,-0.000189099937435501,0.00580140389750247,-0.0115598515765403,0.0111816517016693,0.973997524826745
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CASP4,Caspase-4,37714,0.000515345208594924,0.0163548164551265,-0.0315400950434529,0.0325707854606428,0.974863050445381
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CRX,Cone-rod homeobox protein,40042,-0.000315580576857729,0.0102452669453188,-0.0203963037896826,0.0197651426359671,0.975427383211826
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KLK3,Prostate-specific antigen,37998,-0.000158503355229732,0.00546804431868997,-0.0108758702198621,0.0105588635094026,0.976875217360762
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TPSD1,Tryptase delta,37959,8.07233960877723e-05,0.00365299641949289,-0.00707914958611828,0.00724059637829383,0.982370221559937
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IZUMO1,Izumo sperm-egg fusion protein 1,37482,-8.06329317084258e-05,0.00472433687279209,-0.00934033320238092,0.00917906733896407,0.986382974985852
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MYL6B,Myosin light chain 6B,37572,0.000149757991533819,0.00885494864643844,-0.0172059413554855,0.0175054573385532,0.986506797392785
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TSPAN7,Tetraspanin-7,37541,0.00014170559687037,0.00877856915524959,-0.0170642899474188,0.0173477011411596,0.987121177029946
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,40422,6.20210004154199e-05,0.00394970665967979,-0.00767940405255697,0.00780344605338781,0.987471780915623
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DCDC2C,Doublecortin domain-containing protein 2C,37482,-5.57861060835857e-05,0.00608192756465753,-0.0119763641328124,0.0118647919206452,0.992681696040062
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL12RB2,Interleukin-12 receptor subunit beta-2,37598,1.68063244767198e-05,0.00402961787365346,-0.00788124470788406,0.0079148573568375,0.996672336346123
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GAD2,Glutamate decarboxylase 2,37598,1.82399560364575e-05,0.00453782151866864,-0.00887589022055408,0.008912370132627,0.996792940555655
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DIPK1C,Divergent protein kinase domain 1C,37572,-1.09830104231795e-05,0.00410780806837373,-0.0080622868244357,0.00804032080358934,0.997866746235232
